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PREFACE
Na vier jaar onderzoek is dit werk het resultaat van wat gelukt en minder goed is gelukt. 
Voor het tot stand komen van dit werk, zijn er een aantal mensen die specifiek moeten 
bedankt worden. Vooreerst wil ik de professoren van de jury bedanken, voor het vele lees- 
en verbeterwerk. De medewerkers van het “Mapil”-project ben ik dankbaar, prof. Binnemans 
en prof. Fransaer, voor het mogelijk maken van de samenwerking en de conferenties en 
natuurlijk de medewerkers die bijgedragen hebben tot dit werk. Hiervoor wil ik zeker de 
Leuvense medewerkers Dr. Neil Brooks, Dr. Stijn Schaltin, Sil Wellens, Evert Vanecht en 
Gana niet vergeten. Daarnaast droegen ook Dr. Ewa Liwarska-Bizukojc (Łódź), prof. Kristof 
Van Hecke e cara Klicia bij tot het welslagen van dit onderzoek. Deze (internationale) 
samenwerking heeft aan dit lab-curiosum zeker een meerwaarde gegeven en draagt er ook 
toe bij dat de vergaarde kennis opgeslagen is in ons collectieve “ROM”-geheugen. 
Naast het welslagen van het project moest natuurlijk nog de synthese op poten gezet 
worden, en hiervoor is zeker het vertrouwen, de hulp en medewerking van prof. Stevens niet 
te onderschatten. De vele ideeën, de bijsturing waar nodig, de hulp bij de officiële zaken en 
zeker de gemoedelijke sfeer zitten verweven in deze thesis en zal ik niet snel vergeten. 
Daarnaast verdient Nils zeker een pluim voor het omgaan met zijn bikkelharde onderwerp 
en dito thesisstudent, en zeker ook voor het ineensteken van het labo op het vierde en de 
samenwerking naar manuscripten en ideeën toe. Naast hem was het aangenaam werken op 
het bureau, en de collega’s (An, Fien, Karel, Thomas, Gert, Tamara, Sara, Frederik, Karen) 
op het zesde hebben daar zeker toe bijgedragen. 
Tijdens het synthese werk was het ook aangenaam vertoeven in het labo, en zeker de tijd 
op het vierde heeft me met plezier in actie doen schieten. Daarna vond ik evenveel plezier 
op het vijfde, zeker omdat ik daar de meest plezante thesistudenten mocht begeleiden. Jan 
en Carla, bedankt voor de wel zeer fijne samenwerking en het eindeloze maar plezante 
discussiëren over de muziek op de radio. Daarnaast ben ik alle studenten en doctorandi as 
well as the people from abroad, in het lab dankbaar. Jullie zijn niet op te noemen maar wel 
allemaal fantastisch op je eigen manier en ik wens je allemaal je mooiste dromen toe. Zeker 
niet te vergeten zijn Pieter, Ans, Els, Andy en Dries. Niettegenstaande jullie arbeid op de 
achtergrond, zijn jullie onmisbaar en fantastisch om mee samen te werken. 
Niet in het minste te bedanken zijn ook de mensen die het mogelijk maakten me te 
ontspannen na het werk, mijn ouders, broer en zus en vrienden. Ook al waren 
wetenschappelijke discussies soms niet aan de orde, toch was het goedkeuren om bezig te 
zijn met wat ik graag deed, genoeg. Bedankt daarvoor alleen al, maar zeker ook om mijn 
zeer uitgebreide studieperiode de meest aangename te maken die een mens zich kan 
inbeelden.
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I) INTRODUCTION AND GOALS 
The research performed in this PhD thesis is conducted within the framework of the MAPIL 
project (acronym for “Materials Processing in Ionic Liquids”). This project is a collaboration of 
different partners from both the industry and the academic world. The industrial partners steer 
the project by bringing in the technical demands. The academic partners apply their divergent 
expertise in the different fields of material chemistry, such as physical chemistry, organic 
synthesis and electrochemistry. 
 
 
 
 
 
 
Figure 1: Visual summary of the different work packages and  
the interaction in the MAPIL project. 
The project is divided in different work packages, of which the research part is represented in 
Figure 1 as a continuous wheel. This represents the interaction of the different disciplines. 
These disciplines are amongst others the organic synthesis of novel ionic liquids and liquid 
metal salts with the investigation of their properties and the electroplating of different metals, 
alloys, catalysts and nanoparticles by electrodeposition in ionic liquids as well as the 
characterisation of the newly constructed materials.  
The partners conducting the organic synthesis investigate routes towards large-scale and 
accessible novel and cheap ionic liquids and deep-eutectic solvents and will evaluate their 
properties as well as their applicability in e.g. electrochemistry, solvation of macromolecules, 
CO2 binding and organic synthesis. The inorganic section includes the synthesis of liquid 
metal salts, electroplating in ionic liquids of different metals (e.g. germanium, aluminium, 
platinum, tungsten, molybdenum) and alloys (e.g. brass, zinc-nickel alloy) and design and 
synthesis of novel catalysts. The interplay between the different research activities and the 
partners of the MAPIL project and the accessibility of the know-how and expertise in divergent 
disciplines will result in the added value of the performed research. This synergistic interaction 
will become apparent throughout the following chapters. 
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Ionic liquids were discovered in 1914 as [EtNH3][NO3], this compound was found to melt at 12 
°C.[1] Nowadays, an increasing amount of compounds are being investigated and reviewed. 
Ionic liquids are in fact molten salts, since they are completely composed of ions. The 
oppositely charged ions are interacting with ionic bonds. These are too strong for the products 
to completely volatise and often lead to a solid salt.  
Nonetheless, slightly coordinating ions can be designed, which inductively or mesomerically 
delocalise the charge over multiple atoms. For cations, often heteroatomic alkylated species 
are applied (e.g. imidazolium, pyridinium, phosphonium or ammonium, ...), while for anions 
different species have emerged in the past (e.g. chloroaluminate, [AlCl4]-) and in recent years 
(e.g. bistriflimide, [NTf2]-). As the low symmetry and the low coordinating properties of these 
ions hinder them to form a crystal easily, the salts obtain a large liquid range. In some papers, 
the arbitrary 100 °C is regarded as the melting point limit under which a compound is called an 
ionic liquid.[2] But as this number is only arbitrary, it is more sensible to declare compounds 
room temperature ionic liquids (RTILs) if they are liquid at ambient temperature. Where 
possible, the viscosity of the obtained liquids should be low, which facilitates their 
manipulation. 
As ionic liquids are completely composed of ions, they are often investigated as electrolytes 
(e.g. in dye sensitised solar cell electrolytes, in lithium-ion batteries and electrolytes for metal 
deposition).[3] Due to their high thermal stability and fluidity, they have also been studied as 
heat transfer fluids (HTF)[4] or as revolutionary solvents for (bio)catalysis[5] and lignocellulosic 
biomass.[6] The possibility for modification also allows their investigation as stationary phases 
in chromatographic analysis.[7]  
The goal of this specific research part is situated in the organic synthesis part of the project, 
more specifically in the design of novel imidazolium ionic liquids with a broad scope of 
applicability. While several influences on the stabilities will be studied, the properties should 
stay within a workable range. The method to achieve the improvement of the properties is to 
make use of accessible imidazolium ionic liquids, which are easily modified during their 
synthesis. Thus, a major goal will be to design fully substituted imidazolium ionic liquids and to 
investigate their stability. Nonetheless, the substances need to maintain their applicability and 
their liquid character. These key properties of the newly designed compounds will also be 
studied.  
The designed solvents should fit within the concept of green chemistry. This implies a 
sustainable synthesis of a sustainable product, with a thorough understanding of the end-of-
life treatment and environmental fate. All of these properties will be addresses as broadly as 
possible in the experimental section. 
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First of all, the focus will be on the improvement of the sustainability of the synthesis 
methodology, i.e. on thorough investigation of the synthetic chemistry (i.e. mechanisms, reagent 
choice) to improve yields and hence the carbon economy. Optimising the synthesis chemistry 
and post-processing does not only decrease the environmental impact but, as the overall 
costs decrease, optimisation is also economical beneficial and will allow efficient scale-up. 
 
Scheme 1: Debus-Radziszewski imidazole synthesis. 
The imidazole scaffolds will be synthesised via the Debus-Radziszewski imidazole synthesis 
reaction. This multicomponent reaction is a condensation reaction between an -dicarbonyl 
compound, an aldehyde, an ammonia source and a primary amine to functionalise one of the 
nitrogens at once (Scheme 1).[8] The mechanism is believed to involve the condensation 
between an amine, ammonium and the dicarbonyl compound. After this, ring closure and 
aromatisation occurs by the aldehyde. Most common side products are the oxazole, formed 
by expulsion of the amine, the 1H-imidazole and when glyoxal is used as dicarbonyl 
compound, also coupled 2,2’-diimidazoles can occur.[8-9] 
To decrease side product formation, the influence of the sequence of product addition, as well 
as the influence of the expelled water will be investigated. The investigation and fine-tuning of 
reaction conditions will be further aided by the application of continuous flow technology 
(Scheme 2), as was already performed in our research group.[10] Different systems available 
at the department of Sustainable Organic Chemistry and Technology (Ghent University) will 
be evaluated for their applicability on the imidazole synthesis. The systems have divergent 
specifications: e.g. channel diameter, reactor length and specific temperature and pressure 
range. These continuous flow syntheses will allow a large-scale synthesis with a minimum of 
side products formed due to the inherent precise monitoring of the reaction conditions. 
Furthermore, post-processing of the reaction mixture will be evaluated on e.g. the recycling of 
solvents and unreacted reagents, type and amount of solvents and reagents used during 
work-up and post reaction purification methods, maintaining a high level of purity of the 
compounds.  
 
Scheme 2: Schematic representation of Debus-Radziszewski reaction in a continuous flow set-up. 
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In the synthesis of ionic liquids, the use of continuous flow processes is in line with the 
search for greener methodology. Due to the microscopic channels, mass and heat transfer 
are improved and if the conversion increases, the need for purification is reduced. The 
continuous flow technology has already been used for the synthesis of ionic liquid 
precursors[11] and the quaternisation thereof[12] (see further section III.1.4).  
Whenever possible, linear synthesis routes will be redesigned into convergent synthesis 
routes. While intensive modification of highly functionalised scaffold molecules is avoided, 
highly modified pieces will be brought together in the final steps. The synthesis routes towards 
ionic liquids are particularly susceptible to this strategy as the last two steps include a 
metathesis step and a quaternisation in which a highly modified alkyl chain R3 and anion [A]- 
can be combined with the imidazole scaffold (Scheme 3). 
 
Scheme 3: General retrosynthetic scheme of the convergent imidazolium ionic liquid synthesis, involving 
metathesis with a specialised anion and quaternisation with possible functionalised compounds. 
Novel methods will be evaluated in the metathesis of the anions, circumventing the generation 
of equimolar amounts of metal salts and in particular the application of toxic silver salts, which 
also induces a quantitative disposal. Apart from synthesis optimisation, the overall efficiency 
of the metathesis procedures will be evaluated, as residual starting material (e.g. neutral 
alkylimidazole, halides, water)[13] can have an important influence on the IL’s properties. 
Since, in general, the purity of the finally synthesised ionic liquids will be mainly dependent on 
this step, close examination of possible contaminants is necessary in this step. The 
application of dimethyl carbonate (DMC) in the quaternisation of imidazoles, as patented by 
BASF in 2001 will here be assessed.[14] In this method, theoretically, a methylated imidazolium 
cation and a methyl carbonate anion are formed. Upon addition of the Brønsted acid of the 
desired anion, the methyl carbonate anion decomposes into volatile CO2 and MeOH which 
can be removed by evaporation (Scheme 4). 
 
Scheme 4: Synthesis of methyl carbonate ionic liquid 11 from the neutral alkylimidazole 5 and DMC and 
subsequent metathesis with formation of volatile MeOH and CO2. 
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Figure 2: First library of dicyanamide and bis(trifluoromethylsulfonyl)imide  
peralkylated imidazolium salts. 
At first, completely substituted (peralkylated) imidazole scaffolds will be prepared by means of 
the optimised Debus-Radziszewski reaction procedure. Upon quaternisation, completely 
substituted imidazolium cations will be obtained (Figure 2). The introduction of alkyl chains will 
substitute the most reactive hydrogen atoms on the aromatic ring and inductively neutralise 
the positive charge of the cation. However, the increased Van der Waals interactions will bring 
about higher melting points. Therefore, also longer N-alkyl chains, known for decreasing the 
melting point of ILs, will be introduced; in the positions C4 and C5 on the ring, initially only 
methyl groups will be evaluated. Formaldehyde based imidazolium salts, bearing a proton as 
R2, will complete the series. The melting points and/or viscosities of series of the obtained 
analogues with different anions (Figure 2) will be analysed by respectively Differential 
Scanning Calorimetry (DSC) and by means of a viscometer equipped with a spindle for small 
samples. These analyses will be performed at the department of Chemistry of KU Leuven. 
 
Figure 3: Introduction of functionalities in the cationic core and subsequent derivatisation. 
Building on the knowledge obtained from the first series of analogues, different functionalities 
such as esters, ethers, alcohols and unsaturated moieties can be introduced, to obtain 
functionalised ionic liquids, again with varying properties (Figure 3). The precursors of these 
ionic liquids, bearing a handle in the molecule, can be further derivatised to combine different 
functionalities. At this point, the introduction of renewable compounds can allow the 
introduction of these functionalities at once. This also allows the exploitation of chiral pool 
molecules, such as amino acids, and hence the introduction of chiral moieties in ionic liquids 
(Scheme 5). 
The designed ionic liquids should have an intrinsic improved sustainability. Although ILs are 
generally called green solvents for having almost no vapour pressure, a high flash point and 
autoignition temperature and being recyclable,[15] the true greenness of the IL lies mainly in its 
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application range, which is defined by the recyclability, the stability and the power to replace 
more polluting or less persistent predecessors, hence being the safer chemical.  
 
Scheme 5: Retrosynthetic scheme of chiral, amino acid derived imidazoles. 
The aim of the synthesis research in the project is application driven, i.e. ionic liquids with 
adequate stability are required. This stability of ionic liquids is defined in several ways. First, 
the thermal stability is the resistance to decomposition at elevated temperatures. Second, the 
application of ionic liquids as electrolytes requires ionic liquids with a high electrochemical 
stability (e.g. the azepanium salts[16]). This is the resistance to receive or donate electrons 
from or to electrodes, and is has been described in the literature.[17] Finally, a high chemical 
stability of the ionic liquids (e.g. by introducing an isopropyl substituent[18]) allows them to be 
used as recyclable solvents in organic synthesis. To achieve information on the stabilities, the 
thermogravimetric analysis (TGA) and electrochemical window (ECW) measurements are 
performed by the collaborators at the department of Metallurgy and Material Engineering 
(MTM) of KU Leuven. The application in organic synthesis will be evaluated at our department 
(Sustainable Organic Chemistry and Technology, Ghent University).  
The influence of ionic liquids properties contributing to (electro)chemical stabilities are 
reviewed by colleague Nils De Vos (paper due to be published in Angewandte Chemie). The 
thermal stability properties will be broadly discussed in the literature overview (see section II). 
Although these papers describe the limitations of the applicability, the structure-stability 
relationships can only be investigated by the design of series of analogues. Aided by the 
design of functionalised ionic liquids, the influence of these specific functionalities may be 
investigated. 
Finally, apart from clean synthesis (efficient synthesis and use of renewable building blocks), 
and inherently increased sustainability (increased lifetime, recyclability and substitution or 
reduction of (hazardous) chemicals), a ‘green chemical’ should be “designed for degradation”. 
Therefore, post-application fate of the ionic liquids will be evaluated by means of 
biodegradability testing of a selected library of imidazolium ionic liquids. 
The thus obtained library of analogues will be interesting for understanding the structural 
influence on the divergent properties discussed above. Moreover, this knowledge will finally 
allow to rationally select the right modifications in order to design solvents with the requested 
properties.[19] 
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II) LITERATURE REVIEW: 
THERMAL STABILITY OF IONIC LIQUIDS 
1. Introduction 
Ionic liquids (ILs) have a very large liquid range (e.g. [C4mim][NTf2]: -89 to 450 °C as 
compared to EtOH: -114 to 78 °C).[20] This range is restricted by their glass forming (Tg) or 
melting temperature (Tm), which are both mostly below ambient temperature, leading to room 
temperature ionic liquids (RTILs), and often even below 0 °C. Because of their non-boiling 
character, the upper temperature limit is given by their thermal degradation point. Although the 
non-volatile and non-flammable character of ILs is outpaced,[15, 21] the very low vapour 
pressure of ILs implies a very low volatility and flammability, which in turn gives them their 
‘green’ character as well as engineering advantages. Due to these properties, together with 
their low corrosivity and high chemical resistance, a myriad of high temperature applications 
for ionic liquids have been proposed already, e.g. solvents for organic reactions at high 
temperature,[22] solvents for cellulose,[6, 13a, 23] thermal energy storage (TES)[24] and heat-
transfer fluids (HTF),[25] high-temperature lubricants,[26] propellants,[27] curing of ionogels[28] 
and in analytical apparatus, such as matrices in matrix-assisted desorption/ionisation time-of-
flight mass spectrometry (MALDI-ToF)[29] or as stationary phase in gas chromatography.[30] In 
order to determine the thermal behaviour and the temperatures which allow for a correct and 
safe application, it is important to study the behaviour of ionic liquids at elevated temperatures 
and to understand the degradation mechanisms. 
These studies can give valuable information on maximum operating temperature, the speed of 
decomposition and the decomposition products.[31] However, there is an important contribution 
of the methodology on the obtained results, e.g. the variation in heating rate already shows 
different thermal decomposition pathways and kinetics.[27a] Therefore, the chosen methods 
should be in line with the engineered heat exposure in the target application, as well as with 
the possible contact with gas-flow or the open atmosphere. For long-term high temperature 
applications, a maximum weight loss at a given minimum temperature can be given, although 
a single parametric temperature value can give valuable comparative information. The 
question that is rising therefore is how thermal stability is defined and how it should be 
evaluated.[32] In this literature review the thermal stabilities, degradation mechanism and 
analysis methodologies known up to date will be presented, hereby focussing on pure 
conventional non-protic ionic liquids, i.e. ion pairs comprised of one cation and one anion, 
neither immobilised or polymerised. 
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2. Measurement of thermal stability 
2.1. Short-term thermal stability 
Ionic liquids are often claimed as thermally stable because of their very high decomposition 
temperature. Many thermal stability measurements are done by thermogravimetric analysis 
(TGA), more specifically ramped temperature analysis (also called step-tangent or dynamic 
analysis) with most common heating rates: 10 °C min-1 and 20 °C min-1.[25a, 33] This type of 
experiment is also referred to as short-term stability.[20] 
Table 1: Short-term thermal stabilities (Tonset, °C) of ammonium and imidazolium based IL with divergent 
substitution patterns.1 
Ammonium ionic liquids [secC4mim][BF4] 362[34] 
[N1,1,18,18][Br] 225[33a] [C5mim][Cl] 262[34] 
[N2222][Cl] 264[35] [C5mim][BF4] 408[34] 
[N2222][BF4] 383[35] [secC5mim][Cl] 273[34] 
[N2222][PF6] 388[35] [secC5mim][BF4] 366[34] 
[N2222][NTf2] 439[35] [eC3mim][Cl][c] 284[34] 
[N2222][Beti][a] 470[35] [eC3mim][BF4][c] 363[34] 
[N2222][Me]b 411[35] [C6mim][Cl] 
128[20], 
253[33b] 
[N4444][NTf2] 403[35] [C6mim][BF4] 348[20] 
[N4444][Beti][a] 423[35] [C6mim][PF6] 
390[33b], 
439[20] 
[N4444][Me][b] 403[35] [C6mim][NTf2] 428[36] 
[N6222][N(CN)2] 230[37] [C8mim][Cl] 243[33b] 
[C2C1pyrrol][N(CN)2] 250[37] [C8mim][PF6] 
376[33b], 
416[20] 
Imidazolium ionic liquids [C8mim][NTf2] 425[36] 
[C2mim][Cl] 285[35] [C12mim][Cl] 239[33a] 
[C2mim][Br] 311[35] [C16mim][Cl] 230[33a] 
[C2mim][I] 303[35] [Amim][Cl][d] 249[23] 
                                                          
1 The nomenclature of ILs is not generalised up to date, although the nomenclature applied here follows 
a general consensus. The ion-pair is given between brackets, [Cat][An]. Hereby, the cations are either 
denoted with a heteroatom symbol followed by digits denoting the alkyl chain length (commas are used 
to avoid ambiguity), or denoted with an abbreviation for the core i.e. imidazolium (im), pyridinium (pyr), 
pyrrolidinium (pyrrol), or piperidinium (pip). The latter are preceded by the substituents, i.e. Cn: alkyl 
chain with length n; or mn: methyl groups with number n, the first one being placed on the N-atom. The 
(in)organic anions are denoted with their chemical formula or with an abbreviation for the more complex 
organic anions, i.e. Me (methide, [C(CN)3]-), Beti (bis(pentafluoroethylsulfonyl)imide), FAP 
(tris(pentafluoroethyl)trifluorophosphate). 
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[C2mim][CF3CO2] 150[38] [Amim][BF4][d] 400[39] 
[C2mim][MeSO4] 390[40] [Bnmim][Cl] 278[34] 
[C2mim][EtSO4] 408[40] [mBnmim][Cl][e] 248[34] 
[C2mim][TfO] 440[38] [Bnmim][BF4] 384[34] 
[C2mim][N(CN)2] 275[41] [mBnmim][BF4][e] 228[34] 
[C2mim][MeSO3] 293[42] C2/4/5 substituted imidazolium salts 
[C2mim][CF3SO3] 348[42] [C2m2im][Br] 322[35] 
[C2mim][BF4] 450[35], 445[25a] [C2m2im][Cl] 287[35] 
[C2mim][PF6] 375[35] [C2m2im][PF6] 500[35] 
[C2mim][AsF6] 416[35] [C2m2im][NTf2] 456[35] 
[C2mim][NTf2] 
419[42], 439[36], 410[33a], 
440[38], 455[35] [C2m2im][Beti]
[a] 420[35] 
[C2mim][C(CN)3] 450[35] [C3m2im][Cl] 260[33a], 286[35] 
[C2mim][Beti][a] 462[35] [C3m2im][BF4] 390[33a] 
[C3mim][Cl] 282[35], 269[34] [C3m2im][PF6] 399[35] 
[C3mim][BF4] 393[34] [C3m2im][NTf2] 457[25a], 462[35], 462[43] 
[C3mim][PF6] 335[35] [C4m2im][Cl] 257[33a] 
[C3mim][NTf2] 452[35] [C4m2im][BF4] 380[43], 405[33a] 
[isoC3mim][Cl] 277[34] [C4m2im][PF6] 373[43], 425[33a] 
[isoC3mim][I] 296[35] [isoC4m2im][BF4] 350[33a] 
[isoC3mim][BF4] 370[34] [isoC4m2im][PF6] 382[33a] 
[isoC3mim][PF6] 332[35] [C10m2im][BF4] 400[33a] 
[isoC3mim][NTf2] 432[35] [C10m2im][PF6] 420[33a] 
[C4mim][Cl] 
125[20], 264[43], 234[33a], 
254[33b], 268[34] [C16m2im][Cl] 239
[33a] 
[C4mim][Br] 273[43] [C16m2im][BF4] 400[33a] 
[C4mim][I] 265[33b] [C16m2im][PF6] 400[33a] 
[C4mim][MeSO4] 395[40] [C16m2im][Br] 253[33a] 
[C4mim][EtSO4] 387[40] [C20m2im][Br] 259[33a] 
[C4mim][N(CN)2] 300[43] [C20m2im][BF4] 390[33a] 
[C4mim][TfO] 392[43] [m5im][I] 303[35] 
[C4mim][BF4] 
360[44], 361[43], 403[33b], 
424[25a], 380[34] [m5im][PF6] 401
[35] 
[C4mim][PF6] 349[33b] [m5im][NTf2] 470[35] 
[C4mim][NTf2]  
409[42], 427[36], 439[33b], 
450[20] [Am2im][BF4]
[d] 332[33a] 
[C4mim][Me][b] 413[43] [2-phenylethyl-m2im][PF6] 386[33a] 
[secC4mim][Cl] 278[34] [2-phenylethyl-m2im][Br] 275[33a] 
All TGA experiments were performed under N2 atmosphere and at a heating rate of 10 °C min-1, unless indicated. 
In references ([20, 39]) an argon atmosphere was used, in references ([34-35]) the heating rate was 20 °C min-1. The 
pan material was platinum for references ([20, 33b]), aluminium for references ([25a, 35-36, 43]), the others were 
unspecified. [a] [Beti]: bis(pentafluoroethylsulfonyl)imide; [b] [Me]: tris(trifluoromethylsulfonyl)methide; [c] 
[eC3mim]: N-(1-ethylpropyl)-N’-methylimidazolium; 
[d] [Amim] = N-allyl-3(N’)-methylimidazolium; [e] [mBnmim]: N-
(1-methylbenzyl)-N’-methylimidazolium. 
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The short-term stability experiments (Figure 4) give rise to a point of thermal degradation, 
which is at times termed Tdecomp, but in order to avoid ambiguity, we will further use Tonset to 
depict the short-term stability. Tonset is in fact a value calculated by the thermal analysis 
software, which is the translation of the intercept of two linear functions: the baseline of zero 
weight loss and the tangent of weight vs. temperature upon decomposition.[20, 43]  
The actual degradation already starts at a lower temperature (Tstart) than the Tonset.[45] Recent 
work of Del Sesto et al. proves that conventional ionic liquids such as [C4mim][NTf2] and 
[C4mpyrrol][NTf2] already start degrading at temperatures of about 150 °C.[46] Hence, the 
maximum operating temperature is considerably lower (e.g. [C2mim][BF4] has a Tonset of 455 
°C but decomposes at 1.37 wt.% h-1 at 200 °C).[25a] It should be stressed that Tonset gives an 
overestimation of the thermal stability (sometimes Tonset > 400 °C), since the actual critical 
temperature is passed through quickly.[32b] Typically, the ramped temperature method is also 
characterised by a temperature of maximum degradation (Tpeak) in between 10 to 100 °C 
higher than Tonset.[33a] Also reported is Tdec or T10%, which reflects the temperature at which a 
weight loss of 10% is observed, and other research groups have also applied this 
technique.[47] Although this is a true physical property compared to the calculated Tonset, the 
experiments are still performed at a heating rate of 10 °C min-1 and hence give an 
overestimation of the true thermal stability. 
 
Figure 4: Ramped temperature TGA (20 °C min-1, Pt pans) of imidazolium salts with different anions (DBS: 
paradodecylbenzenesulfonate).[25d] 
While the ramped temperature TGA method offers a fairly good reproducibility if well-
defined,[48] and although Tonset correlates well with e.g. the flash point[15a, 21b] and the activation 
energy of thermal decomposition,[13a] this parameter is not very significant due to lack of 
parameter knowledge.[49] Because of the high heating rate, decomposition and evaporation do 
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not reach equilibrium and the temperature profile in the sample is hard to be figured out. The 
temperature profile is dependent on several factors, such as the viscosity and heat transfer, 
heating rate, exo- and endothermic decomposition reactions, instrumentation and sample 
geometry and mass. Increasing the mass of the sample from 13 to 30 mg was shown to give 
an overestimation of the Tonset of 50 °C at a heating rate of 10 °C min-1. Hence, it is advisable 
to always report the sample mass and to compare results of samples with similar mass when 
analysing a series of ionic liquids.[49]  
2.2. Contribution of evaporation 
Partial evaporation of ionic liquids can also contribute to mass loss, although volatilisation of 
ILs is not related to their decomposition.[32b, 50] Hereby, imidazolium ionic liquids with [NTf2]- 
counter ions are considered relatively volatile as compared to their [MeSO3]- and [CF3SO3]- 
analogues, although having vapour pressures substantially lower than hexadecane and 
anthracene (e.g. Pvap,500K for [C2mim][NTf2]: 0.10 Pa, [C2mim][MeSO3]: 0.014 Pa, 
[C2mim][CF3SO3]: 0.013 Pa).[42, 51] In particular for the ‘volatile’ ILs, evaporation has to be 
taken into account when the IL is in permanent contact with an inert gas which flows over or 
through the sample. Whether there is any contribution of evaporation is analysed by 
performing isothermal TGA experiments with different inert gasses (H2 and N2), the observed 
mass loss should be different for the different inert gasses.[42] Therefore, the flow rate and 
type of the purge gas is to be reported. The higher the heating rate, the bigger part of the 
ramped temperature experiment in which the evaporation dominates over decomposition and 
the lower the temperature in isothermal experiments, the higher the contribution of 
evaporation.[32b, 52] For a correct and complete thermal mass loss calculation, Hvap and Pvap 
should be taken into account.[32b, 52] Although there is a lot of research being performed on the 
thermodynamic properties of ionic liquids,[53] this is beyond the scope of this section. 
2.3. Short-term stability derived parameters 
Next to the discussed weight change curves (m vs. t), other ramped temperature 
measurements can give additional information on the thermal behaviour. Thus, the derivative 
function (dm/dt vs. t) shows the behaviour at a given temperature,[54] and is used as control 
mechanism in High Resolution Modulated Thermogravimetric Analysis (HRMTGA).[32a] In this 
technique, the heating rate is variable beneath a nominal value (e.g. 2 °C min-1) as a function 
of the mass loss rate. This way, Tonset is reduced and closer to the actual start of the 
degradation, hence closer to long-term stability parametric temperatures. Calorimetric 
information (exothermic vs. endothermic decomposition) can be accessed by monitoring the 
difference of jacket and sample temperature (T vs. t)[13a] or by synchronous scanning 
differential thermal analysis (SDTA, see par. 2.3, p11).[35] Apart from temperature, pressure 
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and colour change can be quantitatively measured as well.[13a] Given the dependence of the 
thermal degradation on the heating rate, rapid heating (> 5 °C s-1) implies different 
degradation mechanisms. Superfast heating of ionic liquids has already been applied by laser 
ablation or confined rapid heating, providing information on degradation patters upon e.g. 
combustion or application in mass spectrometry.[27a, 50a] [55] 
2.4. Long-term thermal stability 
To overcome the limitations posed by the ramped temperature TGA method and to obtain 
more profound information of the stability at higher temperatures, it is necessary to perform 
‘long-term’ isothermal (static) TGA measurements for prolonged times (e.g. 2, 15 or 20 h).[20, 
25c, 49, 56] These thermal analyses will give rise to rates of decomposition at a given 
temperature instead of critical or onset temperatures. Isothermal analyses show that in 10 
hours over 10 weight% can be lost at temperatures lower than Tonset (Figure 5). The 
information obtained in these experiments is further elaborated in section 6. 
 
Figure 5: Isothermal gravimetrical analyses of [C4mim][Br] at temperatures of Tonset ± 20 °C, N2-atmosphere.[48b] 
For uniform reporting and interpretation of long-term thermal stability, the right criterion is to 
be applied, and different ways have been proposed. First, the weight loss for a given time and 
temperature (depending on the application) can be given, (e.g. dm([Amim][Cl], 100 °C, 15 
days) = 1.9%).[23] Second, a maximum weight loss can be suggested a priori, leading on the 
one hand (e.g. 1%) to the maximum time (life-time) the IL can be held at a given temperature 
(e.g. t1%(200 °C, [C4mim][PF6]) = 2.0 days),[25d] or on the other hand (e.g. 10%), to the 
maximum temperature at which no more than this weight loss occurs for a given time (e.g. 
T10%,10h([C4mim][N(CN)2]) = 110 °C).[57] 
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3. Influence of salt structure on thermal stability 
3.1. Type of cationic core 
Thermal stability is often claimed as merely dependent on the anion of the ionic liquid, but this 
is only the case when arrays of analogous cations are studied. Although analogues with 
different anions do have very divergent properties, it is clear that there is a great difference in 
reactivity between cation types. Thus, it is shown that pyrrolidinium ionic liquids are more 
temperature resistant than their imidazolium, pyridinium and non-cyclic tetraalkylammonium 
counterparts, in that order.[35, 41, 45, 58] In the series of saturated cyclic ammonium salts, the 
stability was found to decrease in the order pyrrolidinium > piperidinium ≈ morpholinium.[47d, 59] 
In the following paragraphs nitrogen containing ionic liquids will be elaborated first, after which 
also ILs with phosphorous and sulphur containing cations will be discussed. 
3.2. Nitrogen-based ionic liquids 
3.2.1) Influence of N-substituents 
In general, the alkyl chain length of the cation has a significant influence on the thermal 
stability of ionic liquids. Increasing the alkyl chain length decreases the thermal stability, this is 
observed for imidazolium ionic liquids with basic [Cl]-,[33b] and weakly coordinating [BF4]-, [PF6]-
,[49, 60] or [NTf2]- anions.[33b, 36] This same decrease of stability was observed in a series of 
diaryl dialkylammonium chlorides. The stability decreased by variaying the aromatic moiety. 
Furthermore, it was clear that the diaryl diethylammonium chloride derivatives started 
degrading at substantially lower temperatures that their diaryl dimethylammonium analogues. 
Upon increment of the number of carbon atoms between the central nitrogen and the aryl 
substituent, a decrease in thermal stability was also apparent.[61] The same trend is 
observable in N-alkyl-N-methylpiperidinium bis(trifluoromethylsulfonyl)imide salts 
([Cnmpip][NTf2]) in both short and long-term experiments. The reduction of thermal stability 
upon increased alkyl chain length, is believed to be due to the increased stability of both 
carbenium ion and carbon radicals when the alkyl chain length increases.[62]  
In an isothermal experiment without inert atmosphere, Kosmulski et al. also observed a 
decreased thermal stability for imidazolium [PF6]- and [TfO]- salts with increasing the alkyl 
chain length.[49] An opposite trend was found by Zhang et al. in an isothermal experiment at 
285 °C under argon atmosphere. At 285 °C, [C6mim][PF6] is not stable, although [C8mim][PF6] 
shows no decomposition. Conversely, at 333 °C, the weight loss rate is again much higher for 
the salt bearing the longest alkyl chains.[20]  
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Branching of the alkyl substituents on imidazolium salts also influences thermal stability, 
although dependent on the anion. Thus, Erdmenger et al. found that the branched 
imidazolium [Cl]- salts are more stable, while the branched imidazolium [BF4]- salts are less 
stable than their linear counterparts (Table 1). This observation is explained by the differences 
in degradation mechanisms (vide infra).[34] The same decrease in stability is found for 
isopropyl substituted imidazolium salts ([isoC3mim][PF6] and [isoC3mim][NTf2]) and also for 
isobutyl substituted imidazolium salts ([isoC4mim][BF4] and [isoC4mim][PF6]).[33a, 35] When the 
nitrogen is substituted with benzyl, an increase in thermal stability of the [Cl]- salt was found, 
while on the other hand, the benzylated [BF4]- salt was not as stable as the linear analogues, 
suggesting the predominance of an SN1 degradation mechanism in ionic liquids with non-
coordinating anions. The N-(1-methylbenzyl)-N’-methylimidazolium cation however, showed 
lower stabilities than the linear analogues when combined with either [Cl]- or [BF4]-. This 
indicates that here, the enhanced stabilisation of the benzylic cation by the methyl group 
provokes an SN1 mechanism in the case of the [Cl]- salt too.[34] Because of the promising 
stabilities of N-benzyl substituted imidazolium ionic liquids combined with more basic anions, 
1-benzyl-3-methylimidazolium triflate [Bzmim][TfO] (21) and 1-(4-methoxyphenyl)-3-
methylimidazolium triflate [MPmim][TfO] (22) (Figure 6) were used as a liquid phase stable up 
to 260 °C in GLC (gas-liquid chromatography) by Anderson and co-workers.[30a]  
Imidazolium ionic liquids containing unsaturated side chains possess generally lower thermal 
stability than their fully saturated analogues. Increasing distance between alkene and nitrogen 
in imidazolium ionic liquids leads to increased thermal stability, while alkyne functionalities 
imply decreased stability (propargyl vs. allyl), attributed to the rigidity of the group.[32a] 
 
Figure 6: Examples of imidazolium cations with improved thermal stabilities: [Bzmim][TfO] and 
[MPmim][TfO].[30a] 
The thermal stabilities of ether containing ammonium [NTf2] salts, i.e. the diethyl-bis-(2-
methoxyethyl)ammonium [N22(1O2)(1O2)]+, ethyl-tris-(2-methoxyethyl)ammonium [N2(1O2)(1O2)(1O2)], 
methyl-tris-(2-methoxyethyl)ammonium [N1(1O2)(1O2)(1O2)]+ and tetrakis-(2-
methoxyethyl)ammonium [N(1O2)(1O2)(1O2)(1O2)]+ salts, were characterised by Tonset values in the 
range 280-370 °C, indicating that these polyalkoxyalkylammonium salts are less stable than 
their hydrocarbon analogues.[63] Reduction of thermal stability is also observed upon 
introduction of alkoxylated side chains in pyrrolidinium, piperidinium and imidazolium 
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cations.[64] In general, a small decreasing effect is found for an increasing number of alkoxy 
groups on the thermal stability.[65] Not only alkoxylated side chains have an adverse effect on 
the thermal stability, also cyclic ammonium ionic liquids with ether functionalities incorporated 
in the N-heterocyclic core have decreased Tonset values compared to their cyclic alkyl 
analogues, i.e. morpholinium and, more significantly, oxazolidinium salts are less temperature 
resistant than their respective analogous piperidinium and pyrrolidinium salts.[63b, 66] The 
influence of the distance between the ether functionality and the nitrogen atom is apparent. 
Thus, methoxymethyl groups are much more susceptible to thermal degradation (up to 100 °C 
decrease) than analogues containing methoxyethyl side chains. Also, much lower resistant to 
thermal degradation than their hydrocarbon analogues are the symmetrical methoxyalkyl 
substituted imidazolium salts (alkyl: C3 to C12), with a decreased stability for the shorter 
alkylchains.[67] The thermal instability of alkoxymethyl substituents is attributed to the 
increased acidity of the protons on the OCH2N carbon. Although the instability could clearly be 
attributed to these alkoxy substituents for the [BF4]- and [NTf2]- salts, while this was not 
observed for the (perfluoroalkyl)trifluoroborate ([RFBF3]-) anion. This observation 
demonstrates the virtual independency of thermal stability on the cation structure when 
combined with low-stability anions, as is demonstrated in Figure 7.[63b] 
 
Figure 7: Tonset of different cyclic quaternary ammonium cations combined with (in)organic fluorinated anions. 
Cations: pyrrolidinium (PY), piperidinium (PI ), morpholinium (MO), oxazolinium (OX); alkyl groups: 1: methyl, 4: 
butyl, 1O2: methoxyethyl, 1O1: methoxymethyl.[63b] 
3.2.2) Influence of C-substituents 
Generally, substitution of imidazolium ring protons by methyl groups leads to only a small 
increase in thermal stability.[25c, 25d, 35] Although methyl substitution at the imidazolium C2 
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clearly renders more stable ionic liquids, increased alkylation of this position does not lead to 
an increased thermal stability.[33a, 35, 43, 45, 68] This might be explained by the acidity of the C2 
proton (pKa: ±25),[69] which can be deprotonated by sufficiently basic anions.[35] However, 
methyl substitution in the 2-position was found to raise the thermal stability of ionic liquids 
containing not only halide, but also perfluorinated inorganic and perfluorinated organic anions. 
Only for the [Beti]- anion, which has the highest Tonset in the latter experiments, an anomaly is 
observed (see Table 1).[33a, 35] The difference in Tonset between [C4mim][Cl] and [C4m2im][Cl] is 
as large as 23 °C.[33a] The influence of the substitution pattern of pyridinium [Br]- and [NTf2]- 
salts was investigated by Crosthwaite et al. The thermal degradation behaviour of a series N-
hexylpyridinium [C6pyr], N-hexyl-3-methylpyridinium [C6mpyr]+ and 3,5-dimethyl-N-
hexylpyridinium [C6m2pyr]+ was compared. In the case of the [Br]- salt, no obvious difference 
is seen, but for the [NTf2]- salts, an increase of degree of substitution clearly leads to an 
increase of the thermal degradation resistance. Upon ethyl substitution in the 2-position, the 
adverse effect is observed. Moreover, it was found that the introduction of a substituted amino 
group (dimethylamino and piperidino group) in the 4-position leads to the stabilisation of the 
positive charge and hence to an increased thermal stability.[45] 
3.3. Dicationic ionic liquids 
This novel class of ionic liquids has found application in various field such as stationary 
phases in GC and GLC chromatography,[30a-c] high temperature lubricants,[26] and as 
solvents.[22c] For example, a Claisen rearrangement at 250 °C was successfully performed in 
the dicationic 1,9-bis-(3-methyl-1-imidazolyl)nonane ionic liquid ([C9(mim)2][NTf2]).[22a] The 
thermal stabilities of dicationic ionic liquids are higher than those of their monocationic building 
blocks.[47b, 70] The germinal dicationic (with two identical cations) imidazolium and pyridinium 
ionic liquids [C9(mim)2][NTf2] and [C9(mpyr)2][NTf2] have an increased thermal stability, with a 
Tonset of about 150 °C above the decomposition temperature of [C4mim][NTf2].[70] The same 
increase in stability is found for unsymmetrical dicationic ionic liquids, which comprise two 
different cations.[71] The observed higher thermal stability of dicationic ionic liquids is attributed 
to the greater charge and intermolecular interactions, their higher molecular weight, higher 
density, smaller free volume and higher shear viscosity.[30c] The reversibility of the degradation 
reactions allows the recombination of the fragments which do not move away due to this ‘cage 
effect’.[47b]  
The type of linker between the two cations also has an important influence on the thermal 
stability, changing the linker from 1,4-dimethylene-2,3,5,6-tetrafluorobenzene to 1,4-
dimethylenebenzene and further to a polyether chain in imidazolium dicationic ionic liquids 
increases the thermal stability.[26a] Imidazolium based dicationic ionic liquids connected with 
PEG-linkers have also been synthesised, they show similar thermal resistance as do 
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dicationic ionic liquids with hydrocarbon linkers.[30c] Apart from nitrogen-based dicationic, also 
phosphonium dicationic ionic liquids show improved thermal performance over their 
monocationic analogues.[30b] 
3.4. Phosphonium ionic liquids 
Tetraalkyl phosphonium dicyanamide salts are thermally more stable than their corresponding 
tetraalkylammonium salts. In a series of phosphonium dicyanamide salts, the decomposition 
temperature at which 10% weight loss occurs (T10%, Table 2) is about 100 °C higher than for 
the analogous ammonium salts.[47a] However, the long-chain phosphonium chloride salts 
[P888n][Cl] (n = 2-14) have a Tonset from 295 to 330 °C, which is relatively low compared to 
pyridinium or imidazolium based salts.[72] This was confirmed by the decrease of Tonset with 
about 54 °C for [P66614][NTf2], as compared to [C2mim][NTf2].[32a]  
Table 2: Temperatures of 10% weight loss (T10%, 10 °C min-1) of polyalkoxy phosphonium 
and their analogous ammonium ionic liquids.[47a] 
IL[a] T10% ( °C) 
[P2225][N(CN)2] 393 
[P2228][N(CN)2] 394 
[P222(101)][N(CN)2] 278 
[P222(201)][N(CN)2] 244 
[P4441][N(CN)2] 387 
[P4448][N(CN)2] 389 
[N2225][N(CN)2] 270 
[N2228][N(CN)2] 271 
[N222(101)][N(CN)2] 154 
[N4441][N(CN)2] 260 
[a] (1O1): methoxymethyl, (2O1): methoxyethyl. 
The unsaturated allyltributylphosphonium salt [P444(Al)][NTf2] was found to have a higher 
temperature stability than its corresponding saturated analogue [P4443][NTf2].[73] The same 
increase in thermal stability upon introduction of unsaturated moieties was found for the 
analogous (4-pentenyl)triethylphosphonium ([P222(Pe)][NTf2]) and benzyltriethylphosphonium 
([P222(Bz)][NTf2]) salts.[73-74] It is presumed that the interaction of the empty d-orbitals of the 
phosphonium cation with the counter anion is assisted by the -electron systems provided by 
the unsaturated carbons, resulting in an additional increase of the bond strength.[73] 
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3.5. Sulfonium ionic liquids 
Both cyclic and linear tertiary sulfonium ionic liquids are found to be less thermally stable than 
imidazolium and quaternary ammonium salts.[75] In ramped temperature experiments, a very 
narrow temperature range in which decomposition takes place was found for different 
trialkylsulfonium dicyanamide salts; all ionic liquids start degrading between 176 and 183 °C, 
indicating a very small contribution of the cation structure. In a long-term thermal stability test, 
trimethylsulfonium dicyanamide lost about 5% of its weight after 12 h at 100 °C. The weight 
loss is attributed to the thermolytic formation of volatile dimethylsulfide and non-volatile methyl 
dicyanamide.[76] Thermal degradation of alkyldimethylsulfonium [PF6]- and [NTf2]- salts was 
investigated by Yang et al., while Fang and co-workers also investigated alkyldiethylsulfonium 
and alkylethylmethylsulfonium [NTf2]- salts. All these ILs start decomposing at temperatures of 
about 270-315 °C, although the hexyldimethylsulfonium salt, [S116][PF6], is stable up to 390 
°C.[77] For trialkylsulfonium [NTf2]- salts, a reduction in thermal stability is observed when 
functional groups (cyano, ether and ester groups) are introduced.[65a] 
3.6. Type of anion 
The thermal stability of analogous salts with different anions correlates well with the anion 
hydrophobicity, since this is a measure for the hydrogen bonding capacity and hence often the 
nucleophilicity.[33b] In general, the thermal stability of common anions can be condensed to the 
following relative order: [PF6]- > [Beti]- > [NTf2]- > [BF4]- > [Me]- ~ [AsF6]- > [I]-, [Br]-, [Cl]-.[33, 35, 
78] In [P66614]+ salts, the thermal stability decreases consistently in the order [NTf2]- > [FAP]-, 
[N(CN)2]- > [Cl]- > [MeSO4]-.[32a] It is clear that halides significantly reduce thermal stability 
since they possess both a relative big nucleophilic and basic character. The observed results 
are in line with the corresponding nucleophilicity order in ionic liquids. Lancaster et al. found 
that I- is more nucleophilic than Cl-, which is a little more nucleophilic than Br- (I- >>Cl- > Br- >F-
). This might indicate an SN2 character of the thermal degradation of halide salts.[79] Basicity of 
anions should also be considered, in order not to exclude the possibilities of elimination. As 
basicity decreases in the order F- > Cl- > Br- > I-, the chloride salts will show greater 
vulnerability to elimination as well. In general [Br]- salts are about 10 to 30 °C more stable than 
their [Cl]- counterparts, however [I]- salts have about the same stability as the [Br]- salts.[33a, 35] 
The non-coordinative anions exert a higher thermal stability, the (perfluoroalkylsulfonyl)imides 
and [PF6]- showing the best stabilities. 
The cyclic ammonium analogues combined with the [RFBF3]- anion (RF = C4F9, C3F7, C2F5) 
were all found to have thermal decomposition temperatures (Tonset) of about 280 to 330 °C, 
independent on the cation (Figure 7). The [CF3BF3]- salt was found to decrease Tonset with an 
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additional 50 °C, due to a decomposition reaction in which a difluorocarbene is formed 
([CF3BF3]-→ [BF4]- + CF2).[80] 
The influence of alkylsulfate anions in piperidinium, pyrrolidinium and morpholinium salts on 
thermal stabilities were investigated by Wu et al.[47d] The thermal decomposition pattern of 
these salts reveals that the first stage thermal decomposition (fast decomposition from 100 to 
ca. 20 wt.%) of these ILs, represented by Tonset, is related to the structure of the anions; the 
thermal stability of anions at Tonset being methylsulfate > ethylsulfate. The second stage 
thermal decomposition at higher temperatures (370 - 700 °C) of these ILs is more related to 
the structure of the cations. The imidazolium salts with different alkylsulfates investigated by 
Holbrey et al. showed no distinct differences in Tonset, although the weight loss percentage 
observed in the range 50-400 °C was substantially bigger for the ethylsulfate derivatives than 
for the methylsulfates.[40] 
The decrease in nucleophilicity by fluorinating the anion is directly translated into thermal 
stability, thus, upon fluorination of the [OMs]- anion, more stable [TfO]- imidazolium salts are 
obtained.[25d] Replacing the [NMs2]- anion by the fluorinated [NTf2]- anion in ammonium, 
imidazolium and phosphonium salts, also increased the Tonset with over 100 °C.[81] Between 
different fluorinated anions, thermal stability decreases also with increasing nucleophilicity, 
thus Bonhôte et al. noticed the superior stabilities of [TfO]- and [NTf2]- salts over to the 
[CF3COO]- anion (see Table 1).[38] 
Han et al. noticed a decrease of the thermal stability, independent on the cation species, when 
passing from [NTf2]- to the [N(SO2F)2]- (bis(fluorosulfonyl)imide) anion.[65a] Sulfonium IL 
comprising the latter anion were still found more thermally stable than their [N(CN)2]- 
analogues.[65a] Since salts with the asymmetric [(FSO2)N(SO2C2F5)]- anion also show reduced 
thermal stability with respect to [NTf2]- salts, the reduced thermal stability is explained by the 
greater lability of FSO2-functions towards pyrolysis.[82] 
4. Influence of environment and impurities  
Although (fast) ramped temperature analyses do not always show clear differences between 
oxygen and nitrogen purged experiments and the low solubility of O2 in ILs is proposed to lead 
to only little influence of the applied atmosphere,[23, 35] a dependence of the atmosphere on the 
decomposition behaviour can be demonstrated.[33a, 62] For both the tetraalkylammonium halide 
salt [N1,1,18,18][Br][33a] and the cyclic ammonium salts [Cnmpip][NTf2] (n = 3-8),[62] a lower Tonset 
was observed in the presence of air. In the latter case, both ramped temperature and 
isothermal experiments showed degradation temperatures of about 50 °C lower in the 
presence of air compared to those in an inert atmosphere.[83] The presence of air seems to 
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decrease the Tonset significantly for imidazolium [PF6]- and [BF4]- salts, however, this decrease 
was not found for the same cation type with halide anions. This suggests a lower activation 
energy for the non-oxidative decomposition than for the oxidative degradation of halide 
containing imidazolium ionic liquids, and a fairly higher activation barrier for non-oxidative 
decomposition in the ILs with inorganic perfluorinated anion types. In the same way, thermal 
decomposition temperatures of imidazolium salts comprising the organic perfluorinated anion 
[NTf2]- are also influenced by the atmosphere, albeit to a lesser extent.[33a]  
In general, the presence of water alters ionic liquid properties significantly, and drying of the 
ionic liquids will improve the thermal stability. In contrast to [C4mim][NTf2], which is less stable 
in the presence of water, a higher thermal stability of [C4mim][PF6] and [C4mim][Cl] is found in 
the presence of water.[13a, 33b] Although no volatile compounds are formed by reaction of ILs 
with water,[21b] water in particular can alter heat transfer properties and consequently influence 
ramped temperature TGA measurements. Hence, the presence of water can explain for the 
anomalies found in some publications[49] and in particular hygroscopic IL such as nitrates 
should be thoroughly dried before investigation,[27a, 84] although water-equilibrated IL can be 
analysed, dependent on the application conditions.[48b] Investigation of water equilibrated ionic 
liquids (up to 31 wt.% H2O in [C2mim][BF4]) shows that water does not affect the 
decomposition on isothermal gravimetric analysis, although it was presumed that water in 
combination with the anion would lead to the formation of HF. A clear weight loss is observed 
at about 100 °C, which is attributed to the evaporation of the present water. The resulting salt 
acts as if it is in its pure form. 
Analogously to the presence of water, the addition of 10 mol% Cl does not affect the 
isothermal gravimetric behaviour.[25a] The independency of the isothermal decomposition rate 
on addition of chloride is in line with the observation where at first a fast weight decrease is 
observed, attributed to and seen as a measure of impurities, followed by a constant weight 
decrease, specific for the ionic liquids.[49] In a ramped temperature experiment, the addition of 
small amounts of [C4C1mim][Cl] to [C4C1mim][BF4] leads to an equimolar loss of 
[C4C1mim].[56a] Other residual starting material might also decrease thermal stability, e.g. basic 
imidazole can subtract C2 protons in imidazolium IL, leading to carbenes which can undergo 
further degradation reactions. Apart from ionic liquid synthesis, also recycling of IL contributes 
to contamination, thus, recycled [C2mim][Ac], used for spinning of cellulose, shows a 
significant lower thermal stability.[13a] 
The influence of inorganic impurities on the thermal stability was investigated by Kosmulski et 
al. A significant raise in isothermal weight loss is observed upon addition of amorphous silica, 
and also upon addition of TiO2 and Al2O3, albeit to a lesser extent, indicating the possible 
catalytic activity of oxides.[49] Therefore, careful selection and reporting of pan material 
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(crucible in which the sample is placed during a TGA experiment) is paramount (most 
commonly used are aluminium, alumina and platinum). Thermal decomposition is generally 
lower on aluminium than on alumina pans, but this is nonetheless dependent on the salt 
structure. Thus, in contrast to the imidazolium salts with organic (perfluorinated) anions, which 
are not or only little more stable on aluminium pans, a faster decomposition of the [Br]- salts is 
observed in aluminium pans.[31] The Tonset values of imidazolium [PF6]- salts are in between 51 
and 106 °C higher on alumina pans. Moreover, for these [PF6]- salts, an exothermic 
decomposition occurs on aluminium pans, while this is an endothermic reaction on the 
alumina pans.[35] This difference is less pronounced for imidazolium [TfO]- salts, which give 
only slightly lower degradation temperatures on aluminium. For these salts, no significant 
difference was found between alumina pans and homemade silver pans.[49] 
Bridges et al. have constructed [C4C1mim][NTf2] based Nanoparticle-Enhanced Ionic Liquids 
(NEILs) as heat-transfer fluids by deliberate addition of Al2O3 and carbon black to the IL and 
studied their thermal stability by long-term isothermal heating. The obtained data suggests 
that no significant weight-loss occurs below 300 °C and that the impurities in the ionic liquid 
cause only a small increase in the isothermal decomposition rates.[25c] 
5. Mechanisms of decomposition 
The exact mechanism of thermal ionic liquid degradation is not straightforward since multiple 
parameters must be taken into account. Thus, the decomposition mechanisms are subject to 
multiple simultaneous initiation reactions (i.e. homolytic cleavage and proton transfer), 
autocatalytic effects and finally, competing reaction pathways with different reaction rates 
dependent on temperature and heating rate.[27a] 
5.1. Analytical and computational methods  
Apart from short and long-term (calorimetric) TGA and superfast heating experiments (vide 
supra), other techniques have been applied in the publications cited. These specialised 
techniques can contribute to the exact unravelling of the thermal degradation pathways, 
mainly by identification of the degradation products. Thus, investigation of thermal stabilities 
has already been performed by coating the ionic liquid in fused silica capillaries which are 
heated and monitored by FID or mass spectrometry (MS),[30c, 30d, 70] as well as by pyrolysis-
GC,[60, 85] headspace GC/MS,[13a] pyrolysis-MS,[31] TGA-MS,[4, 23, 52, 55] and thermal desorption 
mass spectroscopy (TDMS).[33a] Although TGA-MS is a very powerful method, it should be 
noted that the absence of molecular ions does not necessarily exclude vaporisation, since the 
transfer of TGA to MS and pressure differences herein involved hinder the detection.[52] 
Recently, also a highly sensitive potentiometric titration method has been applied to 
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investigate long-term thermal stability behaviour of ionic liquids at elevated temperatures.[86] 
Chowdhury et al. have applied a ‘confined rapid thermolysis’, i.e. an analysis of degradation 
products formed by heating the sample to above 400 °C within 5s. The (very small) sample is 
hereby confined between two heaters which allow a very high heating rate. In combination 
with FTIR and ToF-MS, the formed degradation products can be monitored on-the-fly.[27a] All 
these methods are preferentially aided by mathematical (in silico) predictions and modelling, 
which in turn can be verified by the experimental results.[23, 32b, 55, 87] 
5.2. Anion degradation 
Ngo et al. observed the heat transfer for a series of ionic liquids in a SDTA experiment. Herein 
it is clear that in general, ionic liquids have an endothermic degradation mechanism, probably 
by loss of an alkyl chain. In contrast to imidazolium ionic liquids containing inorganic anions 
(e.g. [PF6]),[60] thermal degradation of those with perfluorinated organic anions such as [NTf2]- 
and [Beti]- generally occurs exothermic.[35] The observed exothermic behaviour is due to the 
presence of sulfonyl groups, as evolution of SO2 is predicted by DFT calculations (Scheme 
6).[87] An exception however, is the N-isopropyl substituted imidazolium salt [isoC3mim][NTf2], 
which has an endothermic degradation since the alkyl chain is cleaved off first. Also for 
tetraalkylammonium salts comprising these fluorinated organic anions a lower degradation 
temperature and an endothermic reaction is observed, indicating a similar mechanism, in 
which the decomposition of the cation is more readily established. Furthermore, the 
endothermic degrading salts change thermodynamic behaviour (i.e. from endothermic to 
exothermic degradation) halfway the weight loss process in the presence of oxygen.[35] For 
dicyanamide salts, Kroon et al. predicted by means of DFT calculations that the 
decomposition reaction differs from the expected formation of N,N,N-dicyanomethylamine 
(Scheme 7) and is therefore referred to as a reverse Menshutkin-like decomposition 
reaction.[87] 
As in imidazolium type ionic liquids increased thermal stability is observed for increasing ring 
substitution (from [C4mim]+ over [C4m2im]+ to [m5im]+ salts),[35] it is suggested that the removal 
of (acidic) protons decreases the thermal degradation. A proposed decomposition mechanism 
therefore involves proton abstraction to produce both volatile anion-derived acids and 
imidazolium-derived carbenes.[33b] Thus, during thermal decomposition of [C2mim][Ac], acetic 
acid was observed by headspace GS/MS analysis.[13a] However, the inverse relation between 
substitution and stability was found in DFT-calculations by Kroon et al., who attributed the 
lower thermal stability of 2H-imidazolium ionic liquids to the acidity in the presence of traces of 
water.[87]  
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Scheme 6: Exothermic thermal decomposition of the bis(trifluoromethylsulfonyl)imide anion.[87] 
 
Scheme 7: Thermal decomposition of [C4mim][N(CN)2] via a reverse Menshutkin-like reaction.[87] 
The thermal degradation of imidazolium [BF4]- salts was predicted by ab initio calculations to 
form alkylimidazoles, alkylfluorides and BF3 and in the presence of water, an alcohol and HF 
might be formed.[87] Since the formation of HF upon pyrolysis of both [BF4]- and [PF6]- salts is 
experimentally confirmed, an alkaline trap should be used when performing thermolytic 
analysis on these types of ionic liquids.[85] 
Baranyai et al. did some interesting work on the speciation of degradation products of 
imidazolium IL by pyrolysis mass spectrometry.[31] Three ILs were examined: [C2mim][NTf2], 
[C2mim][NMs2] and [C2mim][Br]. Upon pyrolysis of [C2mim][NMs2] and [C2mim][Br], the neutral 
1-alkylimidazoles were almost exclusively detected as cation degradation products, 
predominantly 1-ethylimidazole but also 1-methylimidazole, indicating the higher vulnerability 
of the methyl substituent. The anions were found to be alkylated for the [NMs2]- and [Br]- salt, 
although alkylated [NTf2]- species were not detected, neither were any of their corresponding 
(super)acids. In addition to these decomposition species, also dimethylsulfone was detected 
upon pyrolysis of [C2mim][NMs2], originating from the methylated anion. 
Upon thermal degradation of the commercial ILs [P66614][CH3(CH2)8CO2] and [P66614][NTf2] in 
ambient atmosphere, mainly organophosphorous compounds with different number 
(dependent on the oxidation state) and length of hydrocarbon substituents are found, next to 
H3PO4, presumably originating from the reaction of P2O5 and water. Among the degradation 
products of the phosphonium bis(trifluoromethylsulfonyl)imide salt, also SO2, SO2CF3, CF2CF2 
and HF were found.[4] Investigation of [C2mim][NTf2] degradation shows that CF3, F and NH2 
as anion fragments are responsible for the subsequent cation decomposition.[52] 
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5.3. Reverse Menshutkin reaction  
In imidazolium salts, a major thermal degradation component is the neutral 1-
alkylimidazole.[88],[23, 27a, 31] The reverse Menshutkin reaction, which is the dealkylation process 
furnishing neutral species, is possible at temperatures as low as 100 °C, which is below 
commonly applied temperatures in TGA experiments.[89] On the other hand, no imidazole ring 
degradation occurs up to 600 °C (no formation of HCN).[27a, 85, 90] Hence, the main degradation 
mechanisms in the temperature range of thermogravimetrical experiments will include loss of 
an alkyl chain. Thus, the formation of alkylhalides has already been demonstrated in 
ammonium[60] and imidazolium halide salts.[85] The stability of ILs in general might therefore be 
described by the kinetics of both reverse Menshutkin and Menshutkin reactions, the 
nucleophilicity of both anion and neutral 1-alkylimidazole or other corresponding building 
block, the kinetics of evaporation and the boiling points of the degradation products (Scheme 
8). Hence, a lower thermal stability can be expected for ionic liquids derived from smaller 
neutral building blocks (such as alkylamines). 
 
Scheme 8: Reverse Menshutkin reaction for [N2222][Cl]. 
The degradation of [Amim][Cl] and [C4mim][Cl] proceeds via two channels: reverse 
Menshutkin reaction on both the N-substituents. Given the higher thermodynamic stability of 
allylchloride and BuCl vs. MeCl, the decomposition pathway at lower temperatures is 
proposed to be the formation of methylimidazole and AllylCl or BuCl, respectively. Increasing 
temperature should lead to the cleavage of the methyl group. The formed AllylIm, BuIm and 
BuCl are susceptive to further decomposition, the latter two are even never directly detected 
by MS.[23] 
In the rapid thermolysis experiment of [C2mim][Cl] by Chowdhury et al., also the formation of 
both (MeCl + EtIm) and (EtCl + MeIm) was observed, although it was clear that the pathway 
involving substitution of the methyl group was dominant. More important, the FTIR spectra 
never indicated the formation of HCl (a strong IR absorber), which means no direct proton 
transfer occurs to the anion,[27a] although the reaction of alkylchlorides with water can induce 
HCl formation.[13a] No difference is found in degradation pattern between [Cl]- and [Br]- 
imidazolium salts.[85] Since MeCl is stable against degradation in these MS-experiments, CH3+ 
peaks are observed in the MS-spectra. The IL [C2mim][NO3] pyrolyses to form MeONO2 or 
EtONO2, however, while also more EtIm than MeIm mass peaks are observed, here the 
amount of CH3+ peaks is relatively small, indicating the involvement of the nitrate counter ion 
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in both dealkylation and secondary reactions. Nitric acid (HNO3), formed by abstraction of ring 
protons by the anion was not found, although MeOH was found as a degradation product, 
indicating that a methoxide is formed as a secondary degradation product of MeONO2, which 
in turn deprotonates the imidazolium C2, C4 and C5 positions and can couple to form the 
detected methoxyethylimidazole.[27a] 
In contrast to the higher thermodynamic stability of degradation products formed by loss of the 
longest alkyl chain, nucleophilic attack will preferentially occur on the methyl substituent, this 
is a result of the higher steric hindrance of the longer alkyl chain. Moreover, by increasing the 
alkyl chain length, this preference will increase.[27a, 31, 85] Hence, thermal degradation is 
kinetically driven. The calculated charge pattern of imidazolium salts by Natural Atomic Orbital 
(NAO) analysis shows partial positive charges on the carbons adjacent to the nitrogen, which 
confirms the proposed thermal degradation mechanism via nucleophilic attack. Moreover, the 
higher partial positive charge on the methyl group gives an additional explanation to the higher 
vulnerability of the N-methyl substituent.[91] This vulnerability is also reflected by the lower 
thermal stability of different dimethylimidazolium salts as compared to [C2mim]+ salts.[25d] 
5.4. SN1 vs. SN2 
To distinguish between the SN1 and SN2 mechanisms in the reverse Menshutkin reaction, 
some key research was done by Chan et al. They investigated the rate at which different 
substituents are cleaved off in dialkylimidazolium halide salts and found the relative rates to 
decrease in the order: allyl (2.8) > methyl (1.0) > benzyl (0.56) > ethyl (0.14) > propyl (0.095) > 
butyl (0.04). Furthermore, an even lower rate of cleavage for the isopropyl group and no 
cleavage at all for the conjugated vinyl and phenyl groups was found. However, due to the low 
volatility and high reactivity of benzyl halides, the actual rate was considered higher than 
suggested by the data. Given the higher rates of cleavage of the allyl and benzyl groups, an 
SN1 mechanism could here be proposed, although this would implicate the isopropyl to cleave 
readily as well, which is not the case. Neither was a rearrangement from propyl derivatives 
into the more stable isopropyl derivatives evident in any case. This would certainly be the 
case if the propyl group was to be cleaved via an SN1 process. As a conclusion, SN1 
mechanism might be possible for the allyl and benzyl substituted salts, in the other cases 
steric factors are more important and SN2 kinetics are dominant.[88] 
The degradation of halide imidazolium ionic liquids in particular is proposed to proceed via an 
SN2 mechanism, since the observed degradation rate follows the nucleophilicity order of the 
halides.[33a] To distinguish between SN1 and SN2 as the underlying mechanisms, the effect of 
changing the anion was investigated, since pyrolysis via an SN2 mechanism should depend on 
the nucleophilicity and size of the anion. In the case of [C2mim]+ salts, the ratio of 1-
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methylimidazole to 1-ethylimidazole formed increases, as expected, with decreasing anion 
size (from I- over Br- to Cl-). Smaller anions show a lower preference for Me to Et. 1-Allyl-3-
methylimidazole [Amim]+ salts were investigated since here no alkene elimination is possible 
and due to the high volatility of allylhalides, requaternisation can be excluded. Mainly 1-
methylimidazole is found, with an increasing amount of 1-allylimidazole when decreasing the 
size of the halide anion. This controversial result is explained by the possibility for both SN1 
and SN2’ at the least hindered side of the allyl group. However, a pure SN1 mechanism would 
only allow 1-methylimidazole to be formed. The same is valid for 1-benzyl-3-
methylimidazolium [Bnmim]+ salts, but here also 1-benzylimidazole is formed. A bigger 
proportion benzylimidazole should be formed with decreasing anion size, which is verified in 
the experiments. Since the benzylhalides exert a low volatility and high reactivity, the amount 
of 1-methylimidazole was lower than expected. As a conclusion, substituents forming stable 
carbenium ions do not exclusively cleave via SN1 mechanism and in general, the anion plays 
an important role in degradation mechanisms.[88] 
While the chloride anion of imidazolium chloride ionic liquids can contribute to an SN2 reverse 
Menshutkin reaction, this mechanism is hindered by branching of the alkyl chains. Therefore, 
halide salts with branched substituents are more thermally stable. The degradation of salts 
with the non-nucleophilic [BF4]- anion on the other hand, is proposed to proceed via an SN1 
mechanism to give the neutral 1-alkylimidazole and a substituted alkyl carbenium ion. 
Therefore, the branched imidazolium tetrafluoroborate salts are less stable than their linear 
analogues.[34] The same trend was found for isopropyl substituted imidazolium [PF6]- and 
[NTf2]- salts and also for isobutyl substituted imidazolium [BF4]- and [PF6]- salts (see Table 
1).[33a, 35] 
In [C4C1pyrrol][BF4], an SN2 mechanism is calculated to be dominant,[87] while in imidazolium 
ionic liquids comprising non-coordinative anions, the possibility of both SN1 and SN2 
mechanisms is experimentally confirmed. Thus in the thermal decomposition of [C2mim][NTf2], 
the ratio of SN2 vs. SN1 was estimated to be 93 to 7%, but more important, the ratio of 
elimination vs. substitution was estimated to be 77% vs. 23%, revealing the importance of 
elimination for ILs comprising non-coordinative anions.[52] 
5.5. Thermal rearrangement reactions and alkene formation 
Upon pyrolysis of [C4mim][Br], 1-butene is found, while in [C4mim][BF4] also ethylene, 
propylene, (E)-2-butene and (Z)-2-butene are found.[85] Thermolysis of ionic liquids containing 
less coordinating anions hence occurs rather at the longer alkyl chain side, in contrast with the 
halide anions which preferentially react at the methyl side. The increase in alkene formation 
by thermal cleavage is a result of the low nucleophilic character of the anion. In addition to 
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butenes, the thermal rearrangement reactions of [C4mim][BF4] also lead secondarily to ethane 
and propylene as well as 2-fluoropropane and 1-fluorobutane. The formation of shorter 
alkenes indicates the possibility of cleavage of the C-C bond in addition to the C-N bond. The 
decomposition of [PF6]- salts shows a similar pattern as for the [BF4]- salts. However, pyrolysis 
of the latter does not lead to organic compounds containing boron, while thermal 
decomposition of [PF6]- salts lead to the formation of PF3 and phosphorous containing organic 
compounds, although the substances could not be identified. Another key difference is the 
formation of neutral 1-alkylimidazoles with cleaved C-C bonds, e.g. ethylimidazole in the case 
of [C4mim][PF6], apart from alkenes. Pyrolysis of [C4mim][TfO] does not lead to any C-C bond 
fragmentation or halide addition products, this can be attributed to the strong C-F bond. Here, 
fragmentation of the anion into SO2 and CF3H is observed as well as butenes.[85]  
When [C2mim][NTf2] is subjected to thermal analysis, next to neutral 1-alkylimidazoles, 1H-2-
ethylimidazole and 1H-2-methylimidazole are detected (Scheme 9).[31] The formation of the 
latter compounds is presumed to originate from thermal rearrangement reactions. These 
rearrangement reactions could be of the sigmatropic type, since free-radical pathways are 
experimentally excluded.[90] A similar rearrangement was also detected upon laser ablation of 
[Cnmim][Cl] (n=4,6).[50a] 
 
Scheme 9: Formation of neutral 1-alkylimidazoles in ionic liquids containing coordinating anions (up), and 
formation of neutral 1-alkylimidazoles and rearrangement products (below).[31] 
When increasing the length of the alkyl chain R in a series of [NR4][BF4] salts, a decrease of 
thermal stability was observed in the order Bu ≈ Me > Et > Pr. This is in accordance with the 
calculated activation energies for the dealkylation reaction (Scheme 10), which decreases 
upon elongation of the alkyl chain. However, an anomaly was found for the 
tetrabutylammonium tetrafluoroborate [N4444][BF4], which has an activation energy as large as 
for the methyl derivative. This increased activation energy was attributed to the formation of 
an aziridine ring by intramolecular rearrangement during the first-stage decomposition and 
loss of hexane, preceded by the elimination of one alkyl chain (Scheme 11). This cyclisation of 
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the triethylamine was proposed to occur via the quaternairy ammonium product but was not 
mechanistically explicated further.[60, 92] 
 
Scheme 10: Reverse Menshutkin-like reaction as depicted for tetraalkylammonium haloborates.[60] 
 
Scheme 11: Second stage intramolecular formation of aziridines in [N4444]+ salts.[60] 
6. Kinetics of thermal degradation 
The thermal decomposition is a process under kinetic control and the understanding of this 
process allows for time-saving modelling and prediction of the thermogravimetric properties. 
To investigate thermal degradation kinetics, generally, isothermal TGA measurements are 
applied. At a given temperature, the weight loss is linear and the rate increases as the 
temperature increases (see the mass vs. t plot in Figure 5), this suggests complete removal of 
volatile products and no alteration in reaction pattern over time (dm/dt = C). The overall mass 
loss is the sum of evaporation and degradation and, for a constant temperature, both terms 
are constant (dmvap/dt = C’; dmdeg/dt = C”).[52] However, at higher temperatures the linear 
regime is abandoned after a certain amount of time.[23, 56b] The rate is regarded as of pseudo-
zeroth order (first order-derived with constant reagent concentration), since the volatile 
degradation products are removed from the sample. The zero-order rate constant k is the 
slope in the mass vs. t plot. Equation 1 shows the relation between k and conversion , which 
is in turn derived from the initial weight (Wi) and weight at time t (Wt).[31, 48b, 49, 56b] The 
degradation rate (not evaporation) corresponds to the Arrhenius law (equation 3), and is 
pressure independent.[42] 
Wooster et al. propose to calculate t0.99 (time at which 1% mass loss occurs) from Equation 1 
after obtaining k for different temperatures. These t0.99,T can be plotted against the 
temperature T and the resulting curve can be fitted by an exponential equation from which t0.99 
for every temperature can be derived.[48c]  
 ݀ߙ
݀ݐ ൌ ݇ ⇔ ߙ ൌ ݇ݐ ൅ ܥ (Equation 1)
 ߙ ൌ ሺ ௜ܹ െ ௧ܹሻ
௜ܹ
(Equation 2)
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Figure 8: Mass loss after 10 h vs. temperature in isothermal experiments (top) and Arrhenius plot (bottom) for 
[C4mim][Br] (♦) and [C8mim][Br] (○).[48b] 
The activation energy Ea and the pre-exponential parameter A can be derived from the 
Arrhenius plot (natural log of the rate k vs. 1/T, Figure 8). Since (i) the mass loss rate for a 
given temperature does not change over time and (ii) the contribution of evaporation is 
assumed to be small, an overall Ea and A can be determined comprising both evaporation and 
degradation. The knowledge of these parameters allows the prediction of the ‘life-time’ (time in 
function of weight loss) of ILs at different temperatures, within the boundaries of validity of the 
TGA-experiment.[23, 25d] However, as can be seen in Table 3, inter-experimental variability 
leads to diverse parameters. 
These parameters can also be derived from non-isothermal (ramped temperature) TGA 
measurements by pre-defined methods, which can be found in the specialised literature.[25d, 57, 
93] One way is to derive them from the plot where, for a given conversion in the experiment, 
the inverse of the temperature at which this conversion is reached, is plotted in function of the 
log of the heating rate of the experiment (Figure 9). The kinetic parameters are then derived 
via algorithms provided by the ASTM.[94] 
Table 3: Kinetic parameters derived from isothermal TGA experiments (valid from 150-200 °C).  
IL Ea (kJ mol-1) A (min-1) 
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[C4mim][Cl][56b] 121 3.81010 
[C6mim][Cl][56b] 117 1.01010 
[C4mim][Br][48b] 212.50 2.431018 
[C8mim][Br][48b] 219.69 8.461020 
[Amim][Cl][23] 125 3.01013 
[C4mim][Cl][23] 129 2.81013 
On the other hand, given only evaporation occurs at lower temperatures, thermodynamic 
vaporisation parameters can a priori be derived from the low temperature isothermal 
experiments (for [C2mim][NTf2]: T < 350 °C)[52] followed by numerical solving of the derivative 
equation proposed by Seeberger et al. with the non-isothermal TGA data (mass vs. time for 
an array of different heating rates) giving Ea and A. The former mathematical model shows to 
be consistent with experimental values for both isothermal and ramped temperature 
thermogravimetrical analyses.[32b]  
 
Figure 9: Families of mass conversion plotted in function of the heating rate for [C4mim][PF6].[25d] 
Hao et al. have modelled the degradation patterns of [C4mim][Cl] and [Amim][Cl] via DFT 
calculations, hereby calculating the energies of the transition states of the reverse Menshutkin 
reaction, which correspond well to the experimental values (from 120 to 134 kJ mol-1). 
However, the latter should be regarded to as relative values, since during calculations, the ILs 
are simplified to single molecules in an ideal gas model at zero degrees.[23] 
7. Conclusions 
The properties of different ionic liquid families were elaborated, giving overall orders of 
thermal stability. Hereby, attention should be paid to the ‘masking’ effect that less stable 
counter-ions can have on the ion under investigation.  
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Different tools for analysis and prediction of the thermal stability are discussed. Although Tonset 
gives an overestimation of the actual degradation temperature, ramped temperature analysis 
is valuable if interpreted as such and given with detailed information on apparatus and 
conditions (heating rate, sample weight, apparatus and pan type and gas flow rate). Hereby, 
the effect of the presence of oxygen is inferior to the effect of the flow rate of inert gas 
(accounting for evaporation) and the heating rate. Mathematical models (based on ramped 
temperature TGA measurements) allow for a rapid complete identification of thermal stability 
properties where otherwise time consuming isothermal TGA analyses are necessary. 
However, attention should be given to the validity-boundaries of these tools in order not to 
extrapolate data. 
For investigation of the degradation mechanisms, several powerful analysis methods are 
known up to date. These unambiguously reveal the cleavage of the N-C bond as main 
degradation process. Ionic liquids with basic anions will predominantly decompose via a SN2 
pathway. The ILs comprising non-coordinative anions also show elimination and sometimes 
rearrangements. The possible formation of inorganic acids should be considered when water 
is present. The latter analysis methods allow for verification of molecular modelling. Combined 
these methods allow synthetic chemists to design solvents which meet the stability 
requirements. 
The high dependency of the results on the experimental factors is detrimental for comparison 
of data from different sources. Therefore, an overview of these factors and an extensive 
rationale for predicting the relative stability is given in this section. The future research 
towards thermal stability of ionic liquids for engineering applications should analyse the IL with 
thought for evaporation or at given temperatures for which evaporation kinetics are known. 
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III) RESULTS AND DISCUSSION 
1. Peralkylated imidazolium ionic liquids 
1.1. Synthesis of imidazoles 
Peralkylated imidazoles were synthesised via a modified Debus-Radziszewski2 reaction.[8, 95] 
This condensation reaction of a 1,2-diketo compound, ammonia, an amine and an aldehyde 
forms tetrasubstituted imidazoles and water. Earlier research showed that the imidazole 
synthesis is very effective at 120 °C, and that application of an excess of amine (1) does not 
lead to higher yields.[10] Since the starting materials are volatile, pressure vials were used in 
order to keep these volatile components in the reaction mixture. This also allows for the use of 
methanol as a solvent. Methanol can easily be removed via rotary evaporation and also takes 
up some of the reaction water, hence it is the most appropriate solvent. The substituents on 
the C2 and N1 positions are built in directly via the corresponding aldehydes and amines, 
eliminating the need for bases and haloalkanes for the N-alkylation or for the nucleophilic 
substitution at the C2 positions, which normally suffers from a low yield.[96] 
 
Compound R1 R2 Yield (%) 
41a Et H 42 
41b Et Me 38 
41c Et Et 36 
41d Et iPr 41 
41e Hex H 40 
41f Hex Me 38 
41g Hex Et 32 
41h Hex iPr 38 
Scheme 12: One-pot modified Debus-Radziszewski reaction procedure with intermediate imine formation. 
Previous research at both our research group and beyond, showed that the addition of acetic 
acid increases the selectivity towards the N-alkylated imidazole, although then N-alkyl 
                                                          
2 In 1858, Heinrich Debus reported on the condensation of glyoxal with ammonia and formaldehyde to 
form imidazoles. Bronisław Leonard Radziszewski modified this reaction in 1882 to a four component 
reaction in which N-alkylated imidazoles were formed. 
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acetamides were formed.[10, 97] Therefore, a new set-up circumventing the use of AcOH was 
elaborated. The condensation was performed as a two-step multicomponent reaction, which 
allows the selective synthesis of N-alkylated imidazoles. In a first step, the intermediate imine 
was generated, which was then reacted with the ammonia source and the 1,2-diketone in a 
second step (Scheme 12). After reaction, the conversion of starting material was in between 
32 and 42% and the product was extracted from the reaction mixture with a 0.5 M HCl solution. 
The aqueous phase was made alkaline and extracted. After removal of the solvent by rotary 
evaporation, the resulting oil was purified by distillation under reduced pressure. 
 
Scheme 13: [1,3]-prototropic shift of ethylpropylideneamine (39c) and subsequent formation of 1-ethyl-2,4,5-
trimethylimidazole (41b) in alkaline media. 
This reaction sequence yielded pure N-alkylated imidazoles as expected, although in the 
synthesis of hexyl derivatives, a small amount (up to 12 mol% of the extracted mixture) of 1H-
imidazoles was obtained. In order to remove the 1H-imidazoles from the reaction mixture, it 
was sufficient to extract the alkaline aqueous phase with hexanes, since the 1H-imidazoles 
are not soluble in this solvent. There is, however, an exception to the selectivity: after reaction 
with propionaldehyde to form 1,2-diethyl-4,5-dimethylimidazole (41c), 38 mol% of 1-ethyl-
2,4,5-trimethylimidazole (41b) was found in the extracted mixture. This is assumed to be 
caused by a [1,3]-prototropic shift during the imine formation, as depicted in Scheme 13. 
During the synthesis of the N-hexyl derivative 2-ethyl-1-hexyl-4,5-dimethylimidazole (41g), the 
same formation of the 2-methyl analogue (41f) was observed, but this formation of a side 
product was never observed with other aldehydes. To circumvent this problem, an alternative 
approach was followed, in which the 1,2-diketone (40) and the amine (1) were mixed in the 
first step. In this way, no 1-alkyl-2,4,5-trimethylimidazole (41b or 41f) was formed.  
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1.2. Continuous flow synthesis of the N-hexyl imidazoles 
Batch experiments led to the selective synthesis of N-alkylated imidazoles via a priori imine 
formation. Synthesis of these imidazoles in continuous flow (of which the upscaling is reffered 
to as numbering-up) allows for production at an industrial rate. Earlier research at the 
department of Sustainable Organic Chemistry and Technology, using a Cytos CPC college 
system showed that imidazoles were synthesised optimally at 120 °C in a continuous flow 
reactor with a residence time of 118 min and using solutions of the starting materials at a 0.5 
M concentration.[10] Although in this former set-up, the amine and the aldehyde were not mixed 
before being pumped into the reactor, here the goal was to synthesise the imine in batch, and 
subsequently react it with NH4OAc and the 1,2-diketone in the continuous flow reactor (Figure 
10). The reactor had an internal volume of 48 mL and was equipped with two pumps (with 
pumping speeds v1 and v2) for both the influent solutions. 
 
Figure 10: Scheme of the microreactor setup mixing unit and residence time unit within the dashed square. 
Continuous flow synthesis of N-hexylimidazoles was performed in n-pentanol, allowing the 
reaction to be carried out at a temperature of 120 °C, which exchludes the need to pressurise 
the system. In a first attempt, the solubility limit of starting materials was examined and 1.0 M 
was found to be the maximum concentration for dissolution of NH4OAc in n-pentanol. 
However, at this concentration, a substantial amount of 1H-imidazole was formed. Therefore, 
a lower concentration was applied. At a concentration of 0.5 M of NH4OAc, no 1H-imidazole 
was found, and this concentration was used during further experiments. In a second step, the 
flow rate and hence residence time were optimised.  
The yield and throughput of 1-hexyl-4,5-dimethylimidazole (41e) and 1-hexyl-2,4,5-
trimethylimidazole (41f) for pump speeds from 0.5 to 2.0 mL min-1 (= v1 = v2), in intervals of 
0.25 mL min-1, were determined by GC-FID analysis. The response factor used was 
calculated from the total obtained yield after distillation, i.e. in Figure 11, the maximum 
obtainable yield and throughput after purification are given as a function of the residence time 
(tres). The best yields of extracted product (36 %) were those obtained with a flow rate of 2  
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0.5 mL min-1, i.e. a tres of 48 min. Additional prolongation of the residence time would not 
increase the yield significantly (Figure 11). To obtain a sufficient throughput combined with an 
acceptable yield, a tres of 20 min was chosen. For the analogous 2-ethyl-1-hexyl-4,5-
dimethylimidazole (41g) and 1-hexyl-2-isopropyl-4,5-dimethylimidazole (41h), the same 
conditions were applied and no analytic experiments in function of tres were performed. 
Although, to avoid the earlier observed prototropic shift during continuous synthesis of 2-ethyl-
1-hexyl-4,5-dimethylimidazole, n-pentanol solutions of preformed 3-ethylimino-butan-2-one 
and NH4OAc with propionaldehyde were used. 
After collection of the reaction mixture at a rate of ca. 4 grams per hour, the water formed in 
the reaction and the solvent were distilled off, yielding a dark liquid which could be extracted 
and distilled in the same way as in the batch procedure. The distilled solvent was successfully 
recycled and used for subsequent microreactor experiments. The n-pentanol was hereby not 
dried, demonstrating the negligible influence of water in the modified Debus-Radziszewski 
reaction procedure. During final distillation of 1-hexyl-2-isopropyl-4,5-dimethylimidazole (41h) 
a small fraction of another compound was obtained, but this compound could not be identified.  
 
Figure 11: Yield after purification (%) (●) and throughput (g h-1) (▲) of 1-hexyl-4,5-dimethylimidazole (41e) (solid) 
and 1-hexyl-2,4,5-trimethylimidazole (41f) (dashed) in the CPC College system microreactor. 
The synthesis of the N-ethylimidazole derivatives was not feasible however, the gaseous 
EtNH2 would volatilise and form gas bubbles in the microreactor channels. This expansion 
reduces the residence time of the liquid phase and also severely disturbs the heat and mass 
transfer. The application of aqueous EtNH2 could have been applied, however, the batch 
reactions performed with EtNH2 (aq.) suffered from lower yields, due to an increased side 
product formation. 
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The plot (●) in Figure 11 is the inverse of the yield (and throughput) vs. the applied pump 
speed (= v1 + v2), but gives a more comprehensible overview. Moreover, this plot translates 
the conversion of the reaction over time. Hence, apart from a controllable system, in which 
temperature, reaction time and concentration can be precisely adjusted to exclude the 1H-
formation, the microreactor allows for a superficial study of the reaction kinetics, by plotting 
the effluent composition vs. the residence time. 
1.3. Thorough purification of imidazoles 
Certain imidazoles gave clear liquids after distillation (e.g. 1-ethyl-4,5-dimethylimidazole and 
1-hexyl-4,5-dimethylimidazole), while other give intensive yellow liquids, which darkened even 
upon storage at -18 °C in the absence of air and light, although being pure by NMR analysis. 
The colouration was intensive upon quaternisation, and this could eventually lead to black 
salts. The colouration was also found in commercially available ionic liquids and was 
attributed to very low-level (parts per billion) compounds with very high extinction 
coefficients.[98] Therefore, different post-quaternisation decolouration methods were already 
reported in literature. Thus, good decolouration was achieved by means of activated 
charcoal[99] combined with silica gel[98] or alumina,[100] while reversed phase packing was used 
for ionic liquids with hydrogen bonding anions.[101] Unfortunately, none of these post-
quaternisation purification methods were found effective for the compounds synthesised in 
this research. 
Synthesis of the 1H-2-isopropyl-4,5-dimethylimidazole (vide infra) gave a clear precipitate in a 
coloured reaction mixture. This indicates that side reactions of the amines and carbonyl 
compounds induce the colouration of the imidazoles. Upon quaternisation, it is likely that 
temporary local higher temperatures induce the colouration.[99] Although some of the here 
synthesised peralkylated ionic liquids (e.g. the iodide salts, vide infra) could be recrystallised, 
the room temperature ionic liquids could not be purified in this way. Moreover, the acetone 
applied as recrystallisation solvent was earlier reported to also lead to colourisation.[100] 
Therefore, it was chosen to apply an intensive purification on the imidazoles. 
1.3.1) Reduction and distillation 
During reduction of the amino acid derived compound 88b (Scheme 30, p67), it was found 
that the black colour disappeared, hence, ionic liquids giving colouration problems were 
treated with 20 weight% NaBH4 in methanol and again distilled after reaction. This yields 
transparent liquids (yield 80%). The treatment of the black oil, obtained after extraction of the 
imidazoles from the reaction mixture, with NaBH4 or LiAlH4, did not lead to a reduced 
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coloration of the distilled imidazoles. Hence, this laborious and resource demanding method 
was only applied when necessary. 
1.3.2) Transformation into the imidazolium hydrochloride salt 
Some of the imidazoles could be transformed into their hydrochloride salts by bubbling an 
excess of freshly prepared dry HCl gas through an imidazole solution in CH2Cl2. Initially, it was 
proposed that this could not be applied to all imidazoles, e.g. 1-allyl-2-isopropyl-4,5-
dimethylimidazole (59a, Scheme 20) turned black very fast upon addition of hydrochloride, 
probably due to reaction of HCl with the double bound, although 1-allyl-2H-4,5-
dimethylimidazole (41i), also comprising a double bond, could be obtained as its 
hydrochloride salt. 
After complete neutralisation of the free imidazole base, the salt solution could be evaporated 
and recrystallised in acetone. This furnished very pure crystals, harvested after long storage 
at -18 °C. Alternatively, an excess of Et2O could be poured into the solution, after which the 
salts precipitated as a powder. Not only was the later method the fastest, it also gave higher 
yields, e.g. 1-ethyl-2,4,5-trimethylimidazole hydrochloride salt (43b): 93%. Direct precipitation 
by bubbling HCl gas through an ethereal solution was not successful. Attempts to obtain a 
solid fraction by acidifying the black liquor obtained after extraction of the crude imidazole 
mixture were also unfruitful, hence, distillation prior to precipitation is necessary. The purified 
imidazole was finally obtained by extraction from an alkaline aqueous solution with EtOAc. An 
aliquot of ice water was added to compensate for the heat generated during the neutralisation 
of the hydrochloride salt. 
 
Scheme 14: Formation of imidazolium hydrochloride salts by bubbling dry HCl through a dichloromethane 
solution of the imidazoles. Identification of the compounds is given in Table 4. 
These salts were found by coincidence after extraction of one specific batch of the 
hydrophobic 1-hexyl-2-isopropyl-4,5-dimethylimidazolium hydrochloride salt (43f), which 
unexpectedly led to the formation of a solid. After several unsuccessful quaternisation 
attempts, intensive NMR study of the unreactive compound led to the observation of small 
downfield shifts. This indicated that the 1-hexyl-2-isopropyl-4,5-dimethylimidazolium 
hydrochloride salt (43f) is quite hydrophobic and migrates from the acidic aqueous phase to 
the CH2Cl2 phase. This particular problem was circumvented by substituting the extraction 
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solvent by the less polar EtOAc. Because these compounds are not considered as ionic 
liquids but rather as salts, their melting points are given in this section. As apparent from 
Table 4, the melting points of the HCl salts are higher than the analogous N-methyl iodide 
salts (vide infra). Nonetheless, the same trend is found in melting points upon alternating the 
C2 substituent. 
Table 4: Melting points (Tm) in °C of the imidazolium HCl salts and N-methylimidazolium iodide salts. 
HCl salt Imidazole R1 R2 Tm HCl salt ( °C) Tm iodide salt ( °C) 
43a 41a Et H 210 136 
43b 41b Et Me 172 134 
43c 41c Et Et 123 n/a[a] 
43d 41d Et iPr 131 121 
43e 41e Hex H 130 52 
43f 41h Hex iPr 120 35 
43g 41i Allyl H 137 n/a[b] 
[a] No solidification observed; [b] Compound is not synthesised. 
1.4. Synthesis of ionic liquids 
Continuous flow processes find many applications in ionic liquid synthesis (quaternisation), as 
this allows reduction of solvent[102] and quaternisation agent usage, improved parameter 
control, as well as a safer process for scaling up. Thus, the solvent-free syntheses of 1-ethyl-
3-methylimidazolium ethylsulfate ([C2mim][EtSO4]),[103] 1-ethyl-3-methylimidazolium 
trifluoromethylsulfonate ([C2mim][TfO])[104] and 1-butyl-3-methylimidazolium bromide 
([C4mim][Br])[102] have already been successfully established in a continuous flow process. 
The precise heat and mass transfer control and consequent elimination of thermal runaway 
can also reduce the colouration associated with the temporary local high temperatures 
discussed in the previous section. 
The quaternisation of peralkylated imidazoles in continuous flow was not investigated due to 
the small scale synthesis, the toxicity of the reagents and the absence of an innovation. The 
batch-wise synthesis is elaborated in the next section, while alternative ways to form ionic 
liquids, circumventing halide salt formation and the thus implied metathesis methods are 
described in section III.4. 
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1.4.1) Quaternisation of imidazoles 
To avoid the presence of starting materials in the end product, iodomethane (MeI) was used 
for quaternisation of the imidazoles. The use of the reactive MeI allows for a quantitative 
alkylation reaction and a complete removal of the alkylating reagent, due to the low boiling 
point in comparison with other alkylating agents, e.g. dimethylsulfate and bromoalkanes. The 
corresponding ionic liquids were thus obtained by adding MeI dropwise to a solution of the 
desired imidazole in dry acetonitrile. 
 
Scheme 15: Methylation of the imidazole core (41a-h) with methyl iodide  
to form the iodide ionic liquids (44-51a). Identification of the compounds is given in Table 5. 
This exothermic reaction was conducted at 0 °C, to avoid evaporation of MeI. The reaction 
was monitored by 1H NMR and after completion (overnight), the solvent and excess MeI were 
removed in vacuo. N-ethyl substituted imidazolium iodide salts were slightly coloured solids. 
These solids could be recrystallised in dry acetone which allowed to obtain transparent 
crystals. N-hexyl substituted imidazolium iodide salts were obtained as transparent yellow oils. 
These oils were dissolved in CH3CN and washed with hexanes to completely remove any 
traces of the imidazole precursor. The latter ionic liquids were never thoroughly dried to avoid 
thermally induced degradation reactions caused by the nucleophilic iodide anion. Melting 
points of the solid iodide salts are reported in Table 5. 
The colouration upon methylation was most pronounced in the case of the 2-ethyl derivatives, 
which turned black after a few hours. The liquid iodide salts were also susceptible to 
colouration upon storage at ambient temperature, even when shielded from light. Therefore, 
storage at -18 °C under a nitrogen atmosphere is advised, but immediate use in the 
metathesis reaction is preferred. After metathesis, colouration does no longer occur, hence 
the colouration is induced by the oxidative properties of iodide. The solid salts could be 
recrystallised and stored under ambient conditions. 
1.4.2) Metathesis of imidazolium iodide ionic liquids 
The silver dicyanamide, used during metathesis, was synthesised by dissolving NaN(CN)2 in 
demineralised water to which a small excess of AgNO3 was added (Scheme 16). Immediately 
after addition of the AgNO3, a white solid precipitated. The mixture was stirred vigorously for 
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multiple hours at 50 °C to ensure complete cation exchange. The precipitate was filtered off, 
rinsed with demineralised water and dried under reduced pressure. 
The iodide ionic liquids were transformed into the corresponding dicyanamide and 
bis(trifluoromethylsulfonyl)imide salts according to metathesis reactions described in literature 
(Scheme 17).[41, 105] Efficient mixing was ensured by mild heating. Upon metathesis with 
AgN(CN)2 of the N-hexyl derivatives in demineralised water, precipitation of yellow AgI in an 
oily matrix was observed, therefore, a 2:1 mixture of demineralised water and CH3CN was 
used to ensure efficient mixing. Excess AgN(CN)2 and AgI were filtered off and the solvent 
was removed in vacuo, after which the remainder of contaminants was precipitated in CH2Cl2 
at -18 °C. The metathesis reaction with LiNTf2 was performed with only a 3 wt.% excess, 
hereby avoiding the presence of residual LiNTf2, which influences the electrochemistry of the 
ionic liquids.[100] Excess LiNTf2 and LiI were washed out with demineralised water. Upon 
residual halide control by addition of AgNO3 to an aqueous solution of the [N(CN)2]- salts and 
to the washing water of the [NTf2]- salts, no precipitation was visible.[19] 
 
Scheme 16: Metathesis of sodium dicyanamide with silver nitrate to form silver dicyanamide. 
After metathesis, the ionic liquids were thoroughly dried before further experiments were 
conducted. Drying proceeded for 4 to 8 hours at a pressure of 0.5 mbar and at temperatures 
of 80 and 120 °C for the [N(CN)2]- and [NTf2]- salts, respectively. The water content of the 
samples was analysed by a coulometric Karl Fischer titration, the [N(CN)2]- salts all contained 
less than 500 ppm of H2O, while [NTf2]- salts all had water contents lower than 200 ppm 
(Table 6). 
 
Scheme 17. Aqueous metathesis of iodide salts (44-51a) into the corresponding 
bis(trifluoromethylsulfonyl)imide (44-51b) and dicyanamide ionic liquids (44-51c). Identification of the 
compounds is given in Table 5. 
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1.5. Melting point and viscosity of the ionic liquids 
Alkylation on C2 prevents the formation of a hydrogen bond. Normally, this hydrogen bond 
reduces both melting point and viscosity in three ways: (i) the charge transfer established by 
this bond decreases the Coulomb forces,[106] (ii) the hydrogen bond can hinder a good 
stacking of the molecules by distortion of the crystal lattice[47c] and (iii) the C2 proton is an 
interaction site which allows the free movement of the anion through the plane of symmetry of 
the cation, resulting in an increased entropy.[91] Therefore, alkylation at the C2 position is 
expected to increase the melting points, as was shown earlier by several research groups.[38, 
91] For the same reasons, the substitution of the C4 and C5 protons, which can form weak 
hydrogen bonds,41 by methyl groups, might be expected to further increase the melting points.  
Most of the N-ethylimidazolium salts were solid at room temperature, however, all the N-
hexylimidazolium salts remained liquid at room temperature (Table 5). In general, the 
observed melting points are higher than the reported values for the corresponding non-
peralkylated salts ([C2mim][NTf2] -3 °C, [C2mim][N(CN)2]: 21 °C).[38, 41] It is suggested that 
increased Van der Waals attraction forces and the suppression of hydrogen bonding are the 
main causes for this increase in melting points.  
However, as represented in Table 5, melting points do not increase upon methylation at the 
C2 position as expected. Contrarily, Tm seems to be inversely related to the degree of 
substitution at C2. Only for [C2Ci3m3im][NTf2] (47b), a higher melting point is observed than for 
[C2C2m3im][NTf2] (46b). Therefore, the possibility of entropy reduction by hindered isopropyl 
rotation in the [C2Ci3m3im]+ cation was investigated. From NMR spectral data and semi-
empirical calculations (RM1 model, Hyperchem 8.0), which attributes a rotational energy 
barrier of 80 kJ mol-1, it is assumed that there is free rotation. As a conclusion, the increased 
melting point of [C2Ci3m3im][NTf2] compared to [C2C2m3im][NTf2] cannot be attributed to a 
decrease in entropy when going from ethyl to isopropyl C2 substitution.  
All N-ethyl derivatives solidify very rapidly upon cooling but do not crystallise, except for the 
iodide salts. This behaviour was already previously reported for the [C2C1mim][NTf2] ionic 
liquid.[38] On the other hand, the N-hexyl derivatives do not show any phase transition after 
keeping the samples at -60 °C for several hours. Since the N-hexyl salts are expected to have 
melting points of about 60-70 °C lower than their iodide precursors (as is the case for the N-
ethyl derivatives), this observation suggests that these ionic liquids undercool very well. 
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Table 5: Melting points (Tm) of the synthesised peralkylated ionic liquids. 
 IL[a] R1 R2 A- Tm ( °C) 
44a [C2m3im][I] Et H I- 136 
45a [C2C1m3im][I] Et Me I- 134 
46a [C2C2m3im][I] Et Et I- n.s.[b] 
47a [C2Ci3m3im][I] Et iPr I- 121 
44b [C2m3im][NTf2] Et H NTf2- 58 
45b [C2C1m3im][NTf2] Et Me NTf2- 59 
46b [C2C2m3im][NTf2] Et Et NTf2- 32 
47b [C2Ci3m3im][NTf2] Et iPr NTf2- 42 
44c [C2m3im][N(CN)2] Et H N(CN)2- 87 
45c [C2C1m3im][N(CN)2] Et Me N(CN)2- 42 
46c [C2C2m3im][N(CN)2] Et Et N(CN)2- n.s.[b] 
47c [C2Ci3m3im][N(CN)2] Et iPr N(CN)2- 25 
48a [C6m3im][I] Hex H I- 52 
49a [C6C1m3im]I] Hex Me I- n.s.[b] 
50a [C6C2m3im][I] Hex Et I- 40 
51a [C6Ci3m3im][I] Hex iPr I- 35 
48b [C6m3im][NTf2] Hex H NTf2- n.s.[c] 
49b [C6C1m3im][NTf2] Hex Me NTf2- n.s.[c] 
50b [C6C2m3im][NTf2] Hex Et NTf2- n.s.[c] 
51b [C6Ci3m3im][NTf2] Hex iPr NTf2- n.s.[c] 
48c [C6m3im][N(CN)2] Hex H N(CN)2- n.s.[c] 
49c [C6C1m3im][N(CN)2] Hex Me N(CN)2- n.s.[c] 
50c [C6C2m3im][N(CN)2] Hex Et N(CN)2- n.s.[c] 
51c [C6Ci3m3im][N(CN)2] Hex iPr N(CN)2- n.s.[c] 
[a] The 1N-alkyl substituents are identified by ‘C2’ or ‘C6’ (referring to the number of carbon atoms in the alkyl 
chain); The C2 alkyl substituents – if present – methyl, ethyl and isopropyl are identified with ‘C1’, ‘C2’, or ‘Ci3’ 
respectively. The 3N-, 4- and 5-methyl substituents are combined to ‘m3’, while imidazolium is referred to with 
‘im’; numbering of the R-groups is depicted in Scheme 15; [b] No solidification at room temperature; [c] No 
solidification at -60 °C. 
As can be seen in Table 6, the viscosity of [C6m3im][NTf2] (48b) ionic liquid is about the same 
as that of the regular [C6mim][NTf2] (71 mPa·s, 25 °C).[107] Furthermore, methyl substitution at 
the 2-position increases the viscosity by 51 mPa·s, which is within the same range as the 
viscosity increase of [C2C1mim][NTf2] measured by Noack et al.[47c] This increase was already 
reported by Hunt et al. to be more pronounced for the larger and more diffuse anions.[91] On the 
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other hand, the viscosities of the dicyanamide salts are substantially larger than those of the non-
4,5-alkylated imidazolium ionic liquids (e.g.: [C2mim][N(CN)2]: 21 mPa·s (20 °C),[41] 
[C6mim][N(CN)2]: 47 mPa·s (25 °C)[108]). Only small variations in viscosities of the dicyanamide salts 
are observed. In general, an increment of the viscosities can be measured when the degree of 
substitution increases. 
Table 6: Viscosities of [C6R2m3im][NTf2] and [N(CN)2]- salts (in mPa·s at 25 °C), Karl Fisher water content (in ppm) 
between brackets. 
Compound Cation [NTf2] (b) [N(CN)2] (c) 
48 [C6m3im] 84 (87) 242 (305) 
49 [C6C1m3im] 135 (83) 250 (325) 
50 [C6C2m3im] 113 (79) 305 (/) 
51 [C6Ci3m3im] 382 (97) 265 (420) 
 
In previous research, [N(CN)2]- salts were found to have lower viscosities than their [NTf2]- 
analogues,[37] however, in this research, this was found to be true only for the 2-
isopropylimidazolium salts ([C6Ci3m3im]+). Since molar densities of [N(CN)2]- are higher than 
those of [NTf2]- salts,[109] the cations in the [N(CN)2]- salts are presumed to be more densely 
packed and thus the Van der Waals contribution to the melting points and viscosities might be 
larger. 
1.6. Chemical stability 
Begtrup reported earlier on the methylation of the C2 position with MeI after deprotonation of 
imidazolium salts with NaH. Upon addition of multiple equivalents NaH, the introduced methyl 
group could be deprotonated and alkylated until the 2-isopropylimidazolium was formed. The 
latter compound showed no tendency to further alkylation.[110] The base stability of the thus 
obtained 2-isopropyl substituted imidazolium ionic liquid [C4Ci3mim][NTf2] was investigated 
and the compound was suggested to withstand Grignard reagents. Experiments with an 
organolithium compound gave only a very modest yield of addition product, therefore it was 
proposed that the ionic liquid imidazolium ring was lithiated. Handy suggested the stability 
against Grignard reagents to be due to preferable perpendicular position of the isopropyl 
proton to the ring -orbitals, which does not allow a stabilisation of the lone electron pair. 
However, we have found the isopropyl group to be able to rotate and moreover, upon 
deprotonating, the isopropyl secondary carbon atom changes hybridisation state. Therefore, 
we attribute the base stability to the increase of pKa.[111] 
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The base stability of the ionic liquids was first investigated by means of deuterium exchange in 
neutral and alkaline media, as demonstrated in Table 7. All IL were soluble in the 7:3 
CD3OD/D2O mixture. After one week, still no deuterium exchange was observable for the 
[C6m3im][NTf2] (48b) ionic liquid (entry 1). After a very fast complete deuterium exchange in 
0.1 M KOH on C2 (entry 2), which was also reported earlier,[96] no further reaction took place in 
the timespan of one week. In a 0.1 M KOH solution, no deuteration of any of the 
[C6Ci3m3im][NTf2] (51b) protons was observed (entry 3).  
Table 7: Conditions and results of base stability experiments. 
Entry IL Reaction conditions Results 
1 48b 7:3 CD3OD/D2O[a] 1h, 1d, 7d: 0 atom% D[b] 
2 48b 7:3 CD3OD/D2O 0.1 M KOH[a] 1h: 97 atom% D[b] 
1d: 98 atom% D[b] 
7d: 99 atom% D[b] 
3 51b 7:3 CD3OD/D2O 0.1 M KOH[a] 12h: 0 atom% D[c] 
4 51c 1 M NaOH in H2O, 24h,  53 % IL[d] 
5 51b 1 M NaOH in H2O, 24h,  97 % IL[d] 
6 51b 2 M BuLi Formation of 55[e] 
7 51b 2 M BuLi, -10 °C, D2O[f] 30 min, 1h: 0 atom% D[c] 
[a] 0.1 M of ionic liquid concentration, experiments conducted at r.t.; [b] H/D exchange on C2 monitored by 1H 
NMR; [c] No deuterium exchange observable by NMR; [d] Percentage of IL recuperated; [e] See Scheme 18. [f] D2O 
was added after the indicated amount of time. 
The stability against Hofmann elimination of both hydrophilic [C6Ci3m3im][N(CN)2] (51c) and 
hydrophobic [C6Ci3m3im][NTf2] (51b) was tested by refluxing the ionic liquids in a strong basic 
aqueous solutions (entries 4 and 5). After 24h, the reaction mixtures were extracted multiple 
times with CH2Cl2. In both cases, the extracted fraction was pure IL, however in the former 
case, only 53 % was recuperated. Additional extraction of the organic phase could attribute 
this loss to solvation of the hydrophilic IL in the aqueous phase, furthermore, no other 
products than IL were found in the aqueous phase by HPLC-MS. 
In a last instance, the stability of the IL (51b) in the presence of organolithium reagents was 
investigated in a model lithiation reaction as depicted in Scheme 18 (entry 6). After one hour, 
the reaction was quenched with H2O and the presence of the product diphenylmethanol (55) 
was demonstrated by GC-FID. The reaction mixture was slightly coloured after reaction. Since 
it was not excluded that the base was scavenged by the bromobenzene prior to attack on the 
ionic liquid in the reaction mixture, the result of addition of 2 M BuLi (in hexanes) to IL was 
evaluated by quenching this mixture with D2O (entry 7). Although the mixture turned 
completely black, no deuteration of the ionic liquid was observed. 
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Scheme 18: Model lithiation reaction in ionic liquid 51b. 
1.7. Thermogravimetrical analysis 
Although dynamic thermogravimetrical analysis does not give a clear view on the long-term 
stability of ionic liquids at elevated temperatures, it does provide valuable information on the 
influence of variation of the salt composition on the thermal stability. The onset temperature 
for thermal decomposition Tonset, i.e. the calculated intercept of the line where no weight loss 
occurs and the tangent upon weight loss, is given in Figure 12 and Table 8. For most of the 
salts, a lower thermal stability for the N-hexyl substituted analogues is observed, although 
literature states that the alkyl chain length should not affect the thermal degradation 
temperature.[33b] A significant reduction of Tonset for the 2H-imidazolium salts (44c, 48c, Table 
8) is apparent, this is in agreement with different experimental results.[15a, 33a, 41, 43, 58b] 
 
Scheme 19: Carbene formation via an E1 mechanism (a) and reverse Menshutkin-like reaction for the 
imidazolium dicyanamide salts as proposed by Kroon et al. (b).[87] 
Two decomposition mechanisms are proposed: on the one hand an E1-type elimination 
(Scheme 19, a), forming a volatile carbene and an isopropyl cation at high temperatures,[33b] 
and on the other hand the reverse Menshutkin-like reaction (Scheme 19, b).[87] Although the 
reported ionic liquids have only weakly coordinating anions, Hofmann elimination cannot be 
excluded. 
The decomposition of the bis(trifluoromethylsulfonyl)imide salts is assumed to proceed via the 
exothermal decomposition of the anion, releasing SO2.[87] At a heating rate of 10 °C min-1, all 
the [NTf2]- salts were found to be stable up to 400 °C, which was set as the upper limit of 
measurement. 
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Figure 12: Thermogravimetrical analysis of 1-ethyl-3,4,5-trimethylimidazolium dicyanamide (44-47c) (solid) and 
1-hexyl-3,4,5-trimethylimidazolium dicyanamide (48-51c) (dashed) salts with different substitution on C2: H (◊), 
Me (▲), Et (□) and iPr (●). 
Table 8: Onset temperature (Tonset) for thermal decomposition for dicyanamide ionic liquids (10 °C min-1, Ar). 
 IL Tonset ( °C) 
44c [C2m3im][N(CN)2] 312 
45c [C2C1m3im][N(CN)2] 329 
46c [C2C2m3im][N(CN)2] 322 
47c [C2Ci3m3im][N(CN)2] 324 
48c [C6m3im][N(CN)2] 273 
49c [C6C1m3im][N(CN)2] 310 
50c [C6C2m3im][N(CN)2] 322 
51c [C6Ci3m3im][N(CN)2] 309 
1.8. Electrochemical analysis 
Cyclic voltammograms (CVs) of a series of completely substituted imidazolium salts were 
recorded at 90 °C to investigate the influence of the substituents on the electrochemical 
stability. The tested salts were the 2-alkyl-1-hexyl-3,4,5-trimethylimidazolium 
bis(trifluoromethylsulfonyl)imide derivatives, since the bis(trifluoromethylsulfonyl)imide salts 
have the lowest viscosity and the hexyl-substituted imidazolium salts have a higher cathodic 
stability. The increased stability is due to the inductive donating character, which lowers the 
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electron affinity (EA) of the cation,[112] but also to the steric hindrance of the hexyl chain, 
hindering the positive charge to approach the vicinity of the cathode (Figure 13).[62, 113] 
Table 9: Cathodic limit (Vcat), anodic limit (Van) potential and electrochemical windows V   
(in V vs. Fc+/Fc). Cut-off current density j = 0.3 A dm-2, at 90 °C with CV, Pt working electrode. 
R2 H (48b) Me (49b) Et (50b) iPr (51b) 
Vcat -2.20 -2.47 -2.50 -2.70 
Van 1.53 1.53 1.58 1.48 
V = Vcath - Van 3.73 4.00 4.08 4.18 
 
 
Figure 13. Cyclic voltammograms of [C6R2m3im][NTf2], (R2: H, Me, Et, iPr); Pt working electrode at 90 °C. 
Cathodic and anodic decomposition potentials as well as the electrochemical window are 
given in Table 9. These are the potentials with an observed current density of 3 mA cm-2, the 
current density at which all baseline noise could be neglected. Although [NTf2]- anions can 
influence the cathodic decomposition behaviour,[114] and imidazolium cations can be oxidised 
at positive potentials,[115] a clear qualitative effect on the electrochemical window by the 
substituents was observed. The stability against cathodic reduction of the cation increases by 
changing the alkyl substituent in the order (H < Me < Et < iPr), and at positive potentials no 
significant influence was apparent. Thus, as for the N-hexyl substitution, the increased 
substitution on the C2 position is also believed to increase the cathodic stability by increment 
of both steric bulk and electron density in the aromatic system. 
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1.9. Conclusions 
Tetrasubstituted imidazoles are readily synthesised via a one-pot reaction. Formation of 1H-
imidazole is thereby avoided. It is also possible to synthesise the N-hexylimidazoles using 
continuous flow technology, which can provide the imidazoles on an industrial scale. The 
imidazole core is easily methylated with methyl iodide to obtain imidazolium iodides, and 
subsequent metathesis reactions give dicyanamide and bis(trifluoromethylsulfonyl)imide ionic 
liquids in almost quantitative yields. 
The N-ethyl substituted imidazolium iodide salts are solid, which allows for an easy 
purification, while the N-hexylimidazolium iodide analogues are liquid at room temperature. 
Although these imidazolium ionic liquids are fully substituted, the dicyanamide and 
bis(trifluoromethylsulfonyl)imide salts all remain liquid below 100 °C and several are liquid at 
room temperature. The N-hexyl substituted derivatives undercool easily, and thus possess a 
wide liquid range. Unlike literature values, melting points are found to decrease upon 
methylation at the C2 position. However, viscosities increase upon increasing the alkyl 
groups, which is in agreement with previous research.  
Thermal stability is clearly increased upon alkylation of the C2 position, however a distinct 
effect was not observed when changing the alkyl substituent from methyl to isopropyl. On the 
other hand, the best electrochemical performance was observed for the isopropyl substituted 
derivative. This stabilising effect was attributed to both steric hindrance and inductive 
neutralisation of the positive charge. Compared to conventional imidazolium ionic liquids, 
these fully substituted ionic liquids are resistant against strong alkaline conditions. 
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2. Peralkylated alkoxy- and alkenylimidazolium ionic liquids 
In the previous chapter, it was demonstrated that completely substituted imidazolium salts (in 
particular 2-isopropylimidazolium salts) possess improved thermal and (electro)chemical 
stability, while the melting points do not increase dramatically.[68, 111] Due to the increased 
substitution of these peralkylated imidazolium ionic liquids, melting points (Tm) of N-ethyl 
substituted analogues are above room temperature, while longer N-alkyl chains (C6) decrease 
Tm, however increase viscosity.[68] In order to decrease melting points and viscosities of short 
chained, completely substituted imidazolium salts, the incorporation of different functional 
groups is evaluated. 
2.1. Synthesis of imidazoles 
The previously optimised (i.e. sequential) Debus-Radziszewski reaction procedure (Scheme 
20) allowed the synthesis of 1N-allyl-2-isopropyl-4,5-dimethylimidazole (59a), 1N-(2-
hydroxyethyl)-2-isopropyl-4,5-dimethylimidazole (59b) and 2-isopropyl-1N-(2-methoxyethyl)-
4,5-dimethylimidazole (59c). The yield of the imidazole synthesis reaction was always in the 
same order of magnitude. However, the selectivity of the substituted imidazole over 1H-2-
isopropyl-4,5-dimethylimidazole (60) differs. 
The selectivity was related to the properties of the amine used (Table 10). Upon addition of 
NH4OAc, a competing transamination on the intermediate imine (39) can occur. Imines with 
more electron donating substitution led to a higher selectivity. This is likely due to (i) higher 
stability of the intermediate imine towards transamination and (ii) faster reaction to form the 
imidazole. Hence, the addition in portions of NH4OAc and diketone decreases the formation of 
the side product. Although a steric factor will contribute, which is apparent from the two first 
entries in Table 10, it is the electron withdrawing nature of the hydroxyl group which reduces 
selectivity. 
 
Scheme 20: The previously optimised Debus-Radziszewski reaction procedure, with formation of products 59a-c 
and the side product 1H-imidazole 60. Identification of the compounds is given in Table 10. 
Peralkylated alkoxy- and alkenylimidazolium ionic liquids 
 50  
Table 10: Yield of 1N-alkyl-2-isopropyl-4,5-dimethylimidazole after distillation and selectivity in the modified 
Debus-Radziszewski reaction procedure with different amines. 
Imidazole Amine Yield (%) (4) Selectivity (%) (4/4+5)[c] 
41d Ethylamine 42 100 
41h Hexylamine 40 88 
59a Allylamine 63 88 
59b Hydroxyethylamine / 75 
59b Hydroxyethylamine[a] 38[b] 95 
59c Methoxyethylamine 53 86 
[a] Addition in portions; [b] crude yield; [c] measured by 1H NMR. 
If present in large quantities, the formed 1H-analogue could be precipitated from the crude 
mixture in acetonitrile, yielding the pure side product. During vacuum distillation, the 
remainder of the side product crystallises in the still, since it is not distillable in the workable 
range due to its hydrogen-bonding properties. Analogously, the hydroxyethyl derivative (59b) 
could not be distilled, and was therefore applied as such in the further functionalisation with 
both dimethylsulfate and iodomethane as methylating agents and allyl bromide (Scheme 21). 
While the methylating agents gave rise to formation of N-alkylated products, the allyl bromide 
was found to be very selective towards O-alkylation. This selectivity occurs most probably 
since the oxygen anion is a hard nucleophile compared to the nitrogen atom. The allyloxyethyl 
derivative was successfully distilled to obtain a clear yellow oil. The distilled imidazoles were 
obtained as clear liquids or as slightly yellowish liquids in which the colour sometimes 
spontaneously intensifies over a few days, only 59c was a solid. 
 
Scheme 21: Alkylation of the crude 2-imidazolylethanol (59b) with allyl bromide, dimethylsulfate and methyl 
iodide. Conversions are determined in the reaction mixture by 1H NMR and in reference to the amount of 59b 
present in the crude starting material. 
2.2. Synthesis of ionic liquids 
The least symmetric ionic liquids, containing an N-methyl substituent (61-63), were 
synthesised by methylating the tetraalkylimidazole (59a,c,d) with methyl iodide (MeI) or 
methyl methanesulfonate (MeOMs) (Scheme 22). The methylation with MeI proceeded 
smoothly at 0 °C overnight, while reaction with MeOMs needed to be refluxed for over 24 
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hours. The latter reaction could be accelerated by microwave heating for 30 min at 80 °C. The 
low volatility of MeOMs allowed the use of a smaller excess of methylating reagent. An 
overview of the applied nomenclature and alkylation agents used are given in Table 11. 
 
Scheme 22: Methylation of the tetraalkylimidazoles. Identification of the compounds is given in Table 11. 
Quaternisation with allyl bromide or allyl methanesulfonate always required high temperatures 
and/or long reaction times. Reactions in conventional flask proceeded very slowly. After 32 h 
at 50 °C only 16% of 41d was converted with allyl methanesulfonate, after 16 h at 60 °C only 
46%, while at 80 °C after 24 and 38 hours, still only 77 and 95% were converted. Fortunately, 
here too, microwave irradiation could be applied to very efficiently accelerate the synthesis 
(Scheme 23). In all allylation reactions, formation of a side product was observed: small 
quadruplets of the (NCH2) were visible in the 1H NMR spectrum (in CDCl3) upfield (4.2 ppm) of 
the (NCH2) of the desired end product (4.3 ppm), accounting for 11-28 mol%. Prolonged 
heating of the mixture at high vacuum and washing an aqueous solution with Et2O or EtOAc 
removed the starting materials, however, the side product was then still present and is 
therefore most likely a salt. 
 
Scheme 23: Synthesis of allyl functionalised imidazolium salts by quaternisation and metathesis.  
X = OMs (64a-66a), X = Br (64b-66b). Identification of the compounds is given in Table 11. 
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The formation of HOMs or HBr by the action of water was proposed, leading to inert 
protonated imidazoles (67, Scheme 23), although the presence of AllOH could not be proven 
by LC-MS or GC. The use of intensively dried CH3CN (percolated over alumina and stored 
over 3Å Molecular Sieves) did not decrease the formation of side products, while the use of 
dichloromethane led to formation of multiple side products. Hence, the reaction mixture was 
neutralised with a stoichiometric amount of NaOH in demineralised water and the formed free 
imidazole base was extracted with EtOAc from the aqueous mixture. When the water was 
removed by rotary evaporation or lyophilisation, crystals of NaOMs or NaBr were formed in 
the ionic liquid. Dissolution of the mixture in hot acetone gave a fine suspension, which could 
be filtered after cooling (pathway A, Scheme 23); complete removal of NaOMs was confirmed 
by 1H NMR, although residual traces of NaOH could not be excluded. A fine suspension of 
NaBr was removed by precipitation from an aliquot of CH2Cl2 and subsequent filtration. Direct 
metathesis into the hydrophobic [NTf2]- salt allowed the use of a small excess of NaOH 
solution (pathway B). In this case, residual sodium salts were discarded with the aqueous 
phase and the residual neutral imidazole was removed by distillation. The 
pentaalkylimidazolium derivatives were obtained quantitatively after metathesis. To obtain the 
[NTf2]- and [N(CN)2]- salts of both N-methylated and N-allyl analogues, standard metathesis 
reactions could successfully be applied on the extracted mesylate or bromide salt (pathway C, 
Scheme 23). The metathesis involved the use of a small excess of LiNTf2 or AgN(CN)2. In the 
synthesis of compounds 64c, 65c and 66c, pathway B was applied. Given the precipitation of 
NaOMs in the ionic liquids and acetone and the ability to monitor residual NaOMs or HOMs 
species via 1H NMR, all [NTf2]- and [N(CN)2]- salts could be obtained via halide and silver-free 
ionic liquid synthesis by adding LiNTf2 or NaN(CN)2, respectively, to an aqueous solution of 
the methanesulfonate salts (Scheme 24). The [NTf2]- salt was obtained by decanting and 
washing the organic layer, while the [N(CN)2]- salt was obtained by evaporation of the 
aqueous solution and precipitation of the sodium salts in an acetone or CH2Cl2 solution. 
Nonetheless, in the synthesis of the [NTf2]- salts, the commercially available allyl bromide was 
used. To obtain the N-allylimidazolium [N(CN)2]- salts (61d-63d), the methanesulfonate 
pathway was chosen, as NaOMs was more easily removed than NaBr, which led to a finer 
suspension. 
  
Scheme 24: Metathesis of methanesulfonate [OMs]- salts into [NTf2]- and [N(CN)2]- ionic liquids.  
Identification of the compounds is given in Table 11.
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Table 11: Overview of synthesised ionic liquids, quaternisation agent (RX) and physical state at room 
temperature. 
 Ionic Liquid[a] R1[b] R2[b] RX Physical state 
61a [CAC1Ci3m2im][OMs] allyl methyl MeOMs liquid 
61b [CAC1Ci3m2im][I] allyl methyl MeI liquid 
61c [CAC1Ci3m2im][NTf2] allyl methyl MeI liquid 
61d [CAC1Ci3m2im][N(CN)2] allyl methyl MeOMs liquid 
62a [C2O1C1Ci3m2im][OMs] methoxyethyl methyl MeOMs cryst. 
62b [C2O1C1Ci3m2im][I] methoxyethyl methyl MeI cryst. 
62c [C2O1C1Ci3m2im][NTf2] methoxyethyl methyl MeI cryst. 
62d [C2O1C1Ci3m2im][N(CN)2] methoxyethyl methyl MeOMs cryst. 
63a [C2OAC1Ci3m2im][OMs] allyloxyethyl methyl MeOMs liquid 
63b [C2OAC1Ci3m2im][I] allyloxyethyl methyl MeI liquid 
63c [C2OAC1Ci3m2im][NTf2] allyloxyethyl methyl MeI liquid 
63d [C2OAC1Ci3m2im][N(CN)2] allyloxyethyl methyl MeOMs liquid 
64a [CAC2Ci3m2im][OMs] allyl ethyl AllOMs liquid[c] 
64b [CAC2Ci3m2im][Br] allyl ethyl AllBr solid 
64c [CAC2Ci3m2im][NTf2] allyl ethyl AllBr cryst. 
64d [CAC2Ci3m2im][N(CN)2] allyl ethyl AllBr solid 
65a [CACACi3m2im][OMs] allyl allyl AllOMs liquid[c] 
65b [CACACi3m2im][Br] allyl allyl AllBr liquid[c] 
65c [CACACi3m2im][NTf2] allyl allyl AllBr cryst. 
65d [CACACi3m2im][N(CN)2] allyl allyl AllBr cryst. 
66a [C2O1CACi3m2im][OMs] allyl methoxyethyl AllOMs glass 
66b [C2O1CACi3m2im][Br] allyl methoxyethyl AllBr liquid 
66c [C2O1CACi3m2im][N(CN)2] allyl methoxyethyl AllBr liquid 
66d [C2O1CACi3m2im][NTf2] allyl methoxyethyl AllBr liquid 
[a] Ci3: 2-isopropyl; for convenience, the N-methyl group is referred to as C1; [b] R1 and R2 are the substituents as 
depicted in Scheme 24; [c] very viscous liquid: very slow crystallisation: not completely crystallised after several 
weeks.  
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Figure 14: Ether containing imidazolium ionic liquids.  
Anions (A-): a: [OMs]-; 62b,63b: [I]-; 66b: [Br]-; c: [N(CN)2]-; d: [NTf2]-. 
2.3. Melting points and viscosities 
By several research groups, alkene functionalities were shown to reduce viscosity, this was 
proposed to be due to an increased planarity which allows a molecular ‘flow’ with little 
resistance.[39] Schneider et al. found 1-allyl-3-methylimidazolium bromide ([CAC1im][Br]) to be 
crystalline, although readily undercooled.[116] The symmetrically allyl functionalised 1,3-
diallylimidazolium bromide and bis(trifluoromethylsulfonyl)imide ([CACAim][Br] and 
[CACAim][NTf2]) are not solid, therefore the allyl group seems to increase the undercooling 
properties, presumably by increasing the possible hydrogen bond donor sites.[117] 
The substitution of alkyl groups by iso-electronic alkyl ether chains (Figure 14) induces 
repulsion between neighbouring oxygen atoms, leading to significant ion pairing and to 
intermolecular hydrogen bonding interactions between imidazolium hydrogens and alkoxy 
oxygen lone pairs. This combined effect leads in general to higher melting points (Tm) and 
glass transition temperatures (Tg) than the alkyl analogues.[38, 118] However, the oxygen lone 
pairs are believed to reduce the electrostatic interaction between anion and cation. Thus, 
reduction of Tm and viscosity reduction is nonetheless observed upon substitution of alkyl 
chains by alkyl ether chains in imidazolium,[64] ammonium[65a] as well as in phosphonium ionic 
liquids.[47a] Moreover, as sometimes no difference is observed at all,[119] this trend is not 
unambiguously applicable to all ionic liquid analogues and should be investigated for every 
analogue separately. 
As can be seen in Table 11, the more symmetric compounds with non-coordinating anions 
(64, 65) are (crystalline) solids. When combined with more basic anions ([Br]-, [OMs]-), very 
viscous liquids were obtained. Although some of them formed crystals at room temperature, 
isolation from the mother liquor could not be achieved. Their readily crystallisable [NTf2]- and 
[N(CN)2]- salts indicate that (i) the high symmetry induces rapid crystallisation (ii) the hydrogen 
bonding capacities of [Br]- and [OMs]- hinder crystallisation. This suggests an extra possible 
hydrogen bonding site provided by the allyl group (apart from isopropyl and NCH3 protons). 
This extra hydrogen bonding site increases entropy,[91, 120] and the interaction with the 
coordinating anions is also visible by the chemical shift in the 1H NMR spectra (in CDCl3). In 
our studies, we did never observe solidification of the [CAC1Ci3im]+ analogues. The 
incorporation of methoxyethyl side chains (C2O1) in the cation leads to more readily 
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crystallising salts, although room temperature ionic liquids (RTILs) were obtained when 
combined with [NTf2]- or [N(CN)2]-  (see Table 12). When combined with an allyl substitution, 
again solidification is hindered. Only the [C2O1CACi3m2im][OMs] salt was found to solidify (as a 
glass). Hence, the main factor in the solidification of the salts is the methoxy group. 
Solidification could be forced for 64b and 65d by rapidly undercooling the samples with liquid 
nitrogen and recrystallising the thus formed white flakes in acetone. In a single case (65a), the 
salt could be precipitated by adding ether dropwise to an acetone solution of the crude 
mixture. For other derivatives rapid cooling did not lead to crystallised products. Holding the 
samples for prolonged times at different elevated temperatures to reduce viscosities and 
hence promote crystal formation did not produce crystals in any case. 
Table 12: Melting points (in °C) of alkoxy and alkenyl derivatised imidazolium ILs, [R1R2Ci3m2im][A]. 
 R1 R2 [OMs] (a) [I]/[Br][a] (b) [NTf2] (c) [N(CN)2] (d) 
62 C2O1 C1 132 123 22 20 
64 CA C2 [c] 109 58 28 
65 CA CA 41 [c] 63 60 
66 C2O1 CA 70[b] [c] [c] [c] 
 [a] For compound 62, the halide salt is the [I]- salt, otherwise the [Br]- salt; 
[b] Glass transition temperature; [c] Compound is liquid. 
Table 13: Viscosities of [R1R2Ci3m2im][A] (in mPa s at 23 °C), water content (in ppm) between brackets. 
 R1 R2 [NTf2] (c) [N(CN)2] (d)
61 CA C1 721 (320) 2520 (4860) 
62 C2O1 C1 131 (250) 380 (330) 
63 C2OA C1 286 (140) 306 (310) 
64 CA C2 [a] 2350 (1370) 
66 C2O1 Ca 860 (290) 1075 (560) 
[a] Compound 64c is solid. 
Viscosities of the liquid salts are given in Table 13. Halide and methanesulfonate salts are 
omitted because of their very high viscosities. The salts of analogues 62 and 64 (except 64c) 
were found to be liquid at the analysis temperature and therefore also analysed. Derivatives 
containing an alkoxy side chain have a reduced viscosity compared to the ones containing 
alkenyl side chains, which were very viscous. Of the derivatives combining both functionalities 
(63, 66), the salts with the [C20AC1C1im]+ cation (63), bearing both functionalities in one 
substituent and substituted with N-methyl, have the lowest viscosity. 
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2.4. Crystallographic analysis 
The high melting points induced by the alkylation pattern of some of the ionic liquids described 
here mean that it is possible to study them in the solid state. One of the most powerful 
techniques is single crystal X-ray diffraction, which gives absolute atomic positions and 
arrangements of molecules as well as accurate intermolecular distances. This analysis was 
performed at the department of Chemistry at KU Leuven. From a comparison of the 
intermolecular distances in the different compounds, the relation between intermolecular 
interactions and melting points can be probed. Single crystals could be grown and analysed 
with X-ray diffraction in the case of the following six compounds: 62a, 62b, 62c, 64c, 65c and 
65d. Within this set, three have the same cation (62a, 62b and 62c), three have the same 
anion (62c, 64c and 65c) and a further set of two (65c and 65d) also have the same cation. 
The last compound 65d, containing a [N(CN)2]- anion is valuable as crystallographic 
information on dicyanamide ionic liquids is scarce. 
In all bis(trifluoromethylsulfonyl)imide containing salts, the anions are distorted at 100 K, 
consistent to earlier observations,[119b, 121] and in trans-conformation, indicating the low 
hydrogen-bonding ability between cation and the [NTf2]- anion.[122] 
 
Figure 15: Formation of bilayers with intercalated anions in [C2O1Ci3m3im][I] (62b) (left) and alternated ion pairing 
in [CACACi3m2im][NTf2] (65c) (right). 
In the non-peralkylated [C2O1C1im][Br], increased ion paring in the solid state was observed by 
repulsion of neighbouring oxygens. In this salt, cations form layers governed by - stacking, 
and different conformations of the pendant alkoxy chains with respect to the imidazolium ring 
within the different moieties in the unit cell were found.[118] Controversially, in 
[C2O1C1Ci3m2im][I] (62b) no such multiple conformers exist, presumably by steric hindrance of 
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the alkyl chains or by elimination of hydrogen-bonding acceptor sites for intermolecular 
hydrogen-bonding. Cationic bilayers are formed with the alkoxy groups pointed inwards, and 
the anions intercalated between the bilayers (Figure 15, left). Hereby, the interaction of the 
oxygen lone pairs with the anions negative charge is minimised while compromising the inter-
oxygen distance. The cations are not perfectly stacked on top of each other, therefore the 
layers are slightly tilted. 
In [C2O1C1Ci3m3im][OMs] (62a) no cationic bilayer is found, i.e. anion and cation are 
alternated. Since a decrease in repulsion between the [OMs]- anion and methoxyl group 
compared to the iodide salt is unlikely to be significant, the driving force for forming the 
alternating layers is believed to be the anion size and increased hydrogen-bonding. The 
cationic bilayer is also absent in the [NTf2]- salts of other cations, e.g. in 65c (Figure 15, right) 
and the destruction of the cationic bilayer when anion size is increased, is earlier observed in 
[C2O1mim][PF6] as well.[119b]  
 
Figure 16: Presentation of the crystal structure of [C2O1C1Ci3m2im][OMs] (62a) (left) with intra- and intermolecular 
C–H···O bonds and [C2O1C1Ci3m2im][NTf2] (62c) (right) with intermolecular C–H···O bonds. 
The structures of 62a, 62b and 62c all contain a [C201C1Ci3m2im]+ cation and in each structure 
the C2O1 group lies perpendicularly to the imidazolium ring as was also earlier observed in 
[C201C1C1im][Br], [C201C1C1im][PF6][119b] and [C201C1im][I].[118] Moreover, this was found by 
DFT calculations to be the most stable conformation of the C2O1 group with respect to the 
imidazolium ring by Fei et al.[118] There is an intramolecular C–H···O hydrogen bond formed 
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between the methoxy group and one of the hydrogen atoms of the methyl on the isopropyl 
group of 62a (Figure 16, left) and 62b, but not in 62c (Figure 16, right). 
A strong difference in interaction can be found upon anion variation between the different 
compounds 62a, 62b and 62c. In 62a, eight interactions via C–H···O from the cation to the 
anion can be found, while in 62b, six C–H···I interactions are found, and finally, 62c contains 
only 0.5 C–H···O cation-anion interactions, i.e. with only one of the two crystallographically 
distinct anions (Figure 16, right). A clear relationship can be found between the number of 
intra- and intermolecular interactions and the melting point, i.e. 62a (nine interactions) has a 
melting point of 132 °C, 62b (seven interactions) has a melting point of 123 °C and 7c (0.5 
interactions) and has a melting point of 22 °C. 
In the series of [NTf2]- containing ionic liquids 62c, 64c and 65c, all containing low melting 
points, a low number of intermolecular interactions was found in all of the crystal structures. In 
compound 62c, the melting point is near room temperature (22 °C), compound 65c has the 
highest number of interactions (i.e. 1 and 3 interactions with the two crystallographically 
distinct anions) and the highest melting point (63 °C), while 64c has as much intermolecular 
interactions as 62c but only a slightly lower melting point (58 °C) than 65c. 
 
Figure 17: ORTEP diagram of [CACACi3m2im][N(CN)2] showing the two allyl groups on the same side of the 
imidazolium plane and the [N(CN)2] anion. Displacement ellipsoids are drawn at the 50% probability level. 
The ionic liquids [CACACi3m2im][NTf2] (65c) and [CACACi3m2im][N(CN)2] (65d) contain the 
same cation but the cation has a different conformation in the two structures. In 65c, the two 
allyl groups are located on opposing sides of the imidazolium ring (Figure 15, right), whereas 
in 65d, they are on the same side of the ring (Figure 17). The structure of 65d contains three 
intermolecular C–H···N interactions between the cation and the [N(CN)2]- anion, so 
comparable to those in 65c, but 65d has the lower melting point (47 °C compared to 63 °C). 
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2.5. Electrochemical analysis 
In previous research in our group,[68] it was shown that completely substituted imidazoles 
possess wider electrochemical windows (ECWs) than their non-substituted analogues. Hence, 
the effect of the functionalities on the electrochemical window can be investigated without 
interference of the imidazolium ring hydrogen atoms, which are all substituted. Moreover, the 
influence of the functionalities, altering the rheologic or complexing behaviour of the 
substances, on the electrochemical performance can be investigated. On the one hand, 
alkenes induce generally a minute stability increase at the cathode, while substantially at the 
anode.[39, 123] On the other hand the effect of alkoxyl groups on the electrochemical windows 
was earlier found to be very small or absent.[119a, 124] The anodic (Van) and cathodic limit 
potentials (Vcat) and electrochemical windows (V) of compounds 61-66c are given in Table 
14, with a cut-off current density value of 0.25 A dm-2, which is the value at which all baseline 
noise can be ignored. 
Table 14: Cathodic limit (Vcat), anodic limit (Van) potential and electrochemical windows V  
(in V vs. Fc+/Fc). Cut-off current density j = 0.25 A dm-2, at 90 °C with CV, Pt working electrode. 
Ionic Liquid Vcat Van V
61c [CAC1Ci3m2im][NTf2] -2.58 1.61 4.19 
62c [C2O1C1Ci3m2im][NTf2] -2.24 1.47 3.71 
63c [C2OAC1Ci3m2im][NTf2] -2.26 1.21 3.47 
64c [CAC2Ci3m2im][NTf2] -2.44 1.68 4.12 
65c [CACACi3m2im][NTf2] -2.3 1.82 4.12 
66c [C2O1CACi3m2im][NTf2] -2.33 1.49 3.82 
In the compounds analysed, the introduction of the ether function decreases both the anodic 
and cathodic stability, while the decrease of the latter is more pronounced (Figure 18). This 
reduction of the cathodic stability seen for ether functionalised cations was earlier attributed to 
a certain complexation of the oxygen electron lone pairs to the positive charge, distributing the 
charge and hence rendering the parent cation more stable but the ether function less stable 
towards reduction, reducing the overall cathodic stability.[80] 
On the anodic side, it appears that allyl groups can increase the oxidative stability (Van(61c) < 
Van(65c) and Van(62c) < Van(66c); Table 14). Hence, there is a clear influence of the 
unsaturated side chains on the oxidative stability. Given the high vulnerability of unsaturated 
bonds towards oxidation compared to saturated side chains, this observation was attributed 
by Min et al. to the formation of a passivation layer on the electrode formed by oxidation of the 
unsaturated bonds.[39] However, introduction of allyl groups shifts the overall electrochemical 
window to the anodic side, which can be attributed to electron withdrawal from the ring. 
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Figure 18: ECWs of alkenyl (left) and alkoxy (right) functionalised peralkylated ionic liquids, X-axis: potential E 
vs. Fc+/Fc, Y-axis: current density j, at 90 °C with LSV, Pt working electrode. 
2.6. Application in synthetic reactions 
Apart from the rheological implications, the oxygen with its lone-pair electrons is not seldom 
introduced in ionic liquids to enhance metal complexation and transport properties, e.g. for 
Li[125] and Mg.[124, 126] The latter was introduced by means of commercial MeMgBr in THF 
solutions in e.g. 1-allyl-3-(2-methoxyethyl)-2-methylimidazolium bis(trifluoromethylsulfonyl)-
imide ([C2O1CAC1im][NTf2]) by Kakibe et al.[124] This particular ionic liquid possesses improved 
conductivity and is sufficiently stable to withstand the Grignard reagents.  
Given the omnipotence of organometallic compounds with regard to C-C bond formation, the 
application of Grignard reactions in ionic liquids has already attracted specific attention. Thus, 
phosphonium salts are up to date very successful, the hydrophobic tetraoctylphosphonium 
bis(trifluoromethylsulfonyl)imide allows addition reactions with commercial THF solutions of 
PhMgBr. The stability is attributed to the shielding of the most acidic protons by the long alkyl 
chains. Unfortunately, the lipophilic character of the cation hampers the extraction of the 
products.[127] In analogous salts substituted with an alkyl ether moiety an accelerating effect of 
the addition reaction is observed. Although reaction with pure PhMgBr (i.e. after evaporation 
of the THF) was successful, generation of the Grignard reagent in this ether containing ionic 
liquid could not be achieved.[128] Commercial solutions of Grignard reagents have also been 
applied in 2-alkylimidazolinium and imidazolium salts.[18, 111] The synthesis of the Grignard 
reagent was obtained by Chan et al. in N-butylpyridinium tetrafluoroborate [C4py][BF4].[129]  
 
Scheme 25: Application of ionic liquids 62c and 63c in the Grignard addition reaction of 
ethylmagnesiumbromide and acetophenone. 
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Grignard addition reactions in ionic liquids are in general performed using the hydrophobic 
[BF4]-, [PF6]- or [NTf2]- salts, which allows an aqueous reaction work-up.[18, 126-127] On the other 
hand, the organomagnesium compounds were found to be stabilised by the anion of the 
tetraalkyl phosphonium decanoate salt.[130] Therefore, next to the alkoxy derivatised [NTf2]- 
salts [C201C1Ci3m2im][NTf2] (62c) and [C20AC1Ci3m2im][NTf2] (63c), also their [OMs]- analogues 
(62a and 63a) were proposed for evaluation.  
First, the synthesis of EtMgBr via the Grignard reaction of EtBr with magnesium was 
evaluated. Neither in 62c nor in 63c the reaction succeeded even after prolonged heating at 
120 °C. Therefore, small amounts of dry THF were added step by step. The reaction 
proceeded smoothly when a 1:1 mixture of IL to THF was reached (Scheme 25). When the 
reaction was complete, the solvent was removed in vacuo and acetophenone was added 
dropwise to the mixture at 0 °C. After completion of the addition reaction, the ionic liquid was 
washed with water and the products were extracted with Et2O. The addition products were 
analysed by GC-FID and acetophenone was found to be converted in 72 to 83% yield. The 
remainder of the organomagnesium compound might have reacted with residual water in the 
ionic liquids. Since 62a and 63a are insoluble in THF, these ionic liquids were not further 
evaluated. 
2.7. Conclusions 
The previous reported modified Radziszewski reaction can successfully be applied in the 
synthesis of alkenyl and alkoxy substituted imidazoles, although side product formation is 
found to be dependent on the nature of the amine. The imidazoles can be transformed in their 
corresponding ionic liquids via the earlier described method or aided by microwave irradiation. 
In quaternisation reactions with allyl bromide and allyl methanesulfonate, a side product needs 
to be extracted from the resulting ionic liquids. The obtained (after metathesis) salts show high 
crystallinity when incorporating an alkoxy moiety due to the constraint conformation, but show 
improved undercooling properties when an allyl substituent is introduced, unless the salt 
possesses high symmetry. Compared to alkyl functionalised IL, the electrochemical window of 
the alkenyl substituted imidazolium salts shifts towards more positive potentials, while 
derivatives with alkoxy substitution have a decreased electrochemical window. In general a 
high chemical stability could be observed for these ionic liquids. 
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3. Chiral peralkylated imidazolium ionic liquids 
3.1. Introduction 
In the previous chapter it was shown that 1-methoxyethyl-2-isopropyl-3,4,5-
trimethylimidazolium ionic liquids have moderate viscosities, while their melting points are 
around room temperature. Alkenyl substitution decreased the melting points, at the expense 
of the viscosity. Increased (asymmetric) branching of the N-alkoxyl chains might decrease the 
symmetry and hinder the packing efficiency of the ion pairs. In this way, the crystal forming 
properties of alkoxy functionalities might also be suppressed. Next to the rheological 
implications, the introduction of short chained chiral moieties also allows the exploitation of 
chiral pool molecules, i.e. naturally occurring, enantiopure building blocks, which are 
preferentially cheap and can be obtained via fermentation or enzymatic synthesis, i.e. via 
renewable synthesis. 
The stability of the previously described ionic liquids (e.g. 62c and 63c) towards Grignard 
reagents invites for the design of an enantiopure recyclable ionic liquid which is stable enough 
to withstand bases with no degradation nor racemisation. This type of chiral imidazolium ionic 
liquids could find its application as recyclable (co)-solvents in asymmetric addition reactions. 
An ionic liquid able to perform this task, should have a low viscosity and a high chemical 
stability. 
The field of chiral ionic liquids is wide and still growing. Some of these compounds have found 
application e.g. in chiral C-C bond formation via Michael addition,[131] or as chiral shift reagents 
(CSRs) for the determination of enantiomeric purity by NMR.[132] A very brief outline of the 
currently known imidazolium ionic liquids based on the chiral pool is given in the next 
paragraphs, although for a complete overview of this very extensive field, review literature on 
the topic should be consulted.[133] 
Next to the introduction of chiral aminoalcohols in the imidazole synthesis reaction,[134] the 
introduction of amino acids in ionic liquids has already been extensively studied. They have 
been applied in their native forms as both the cationic and anionic part of ionic liquids. Also 
single transformations as well as dual transformations have been applied to achieve ionic 
liquids. The divergent synthesis routes towards amino acid based ionic liquids was extensively 
reviewed by Plaquevent et al.[133b] 
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Scheme 26: Synthesis of amino acid containing ionic liquids by neutralisation of [C2mim][OH], leading to an 
extended library of ionic liquids.[135] 
The application of amino acids in their zwitterionic form was studied by the group of Ohno.[135] 
They have synthesised a library of 20 ionic liquids with different amino acids as anion, 
combined with the [C2mim]+ cation, since this cation proved to always form room temperature 
ionic liquids (Scheme 26). The improved solubility of the amino acids in molecular solvents by 
their transformation into ionic liquids opens up possibilities for many new applications.  
Amongst the many other derivatised amino acid based imidazolium ionic liquids, the group of 
Luis has reported several ionic liquids based on amino acid derived imidazoles, i.e. amino 
acid based imidazolylesters, -amides and -alcohols.[132b, 136] Alternatively, amino acids have 
been applied in the synthesis of imidazolinium ionic liquids.[132d, 137] 
Lactate derived quaternisation agents were already applied by Jodry and Mikami to obtain a 
chiral ester containing ionic liquid (73, Figure 19). However, the ester function is not 
chemically stable, as it has an acidic proton in the -position.[132e] The compound 73 was 
synthesised by substitution of the lactate derived trifluoromethanesulfonate ester, however, a 
complete racemisation was observed when the synthesis was performed at 0 °C. Bao et al. 
reported on the transformation of ethyl L-lactate into a quaternisation agent by benzylation of 
the secondary alcohol, subsequent reduction of the ester and tosylation of the primary alcohol, 
resulting in the ionic liquid 74 .[131c] Analogously, chiral dicationic imidazolium salts were 
prepared with a tartrate-derived quaternisation agent,[131c] while imidazolium ionic liquids 
comprising the lactate or tartrate anion have also been reported.[138] 
 
Figure 19: L-lactate derived imidazolium salts applied as chiral shift reagent (left)[132e] and in asymmetric Baylis-
Hillman reactions (right).[131c] 
Another important group of chiral pool molecules are the terpenes, e.g. camphor, borneol, 
menthol and pinene. These compounds are predominantly obtained via extraction or semi-
synthetic production. Their sulfate and sulfonate acids were already reported as chiral ionic 
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liquid anions.[132c, 139] Nevertheless, they have also been modified in order to obtain terpene-
derived cations. To that end, chloromethyl mentylethers have shown to be directly applicable 
as quaternisation agents, leading to menthoxymethyl derived imidazoles (75, Figure 20), while 
several terpenols can also be coupled to the imidazolium core by means of chloroacetyl 
chloride, with formation of ester functionalised chiral imidazolium cations (76) Note that the 
chemical stability of these two compounds is doubtable.  
 
Figure 20: Menthoxymethyl substituted (left)[140] and borneol derived (right)[141] chiral imidazolium ionic liquids. 
Alternatively, the use of an -pinene derived oxazolinium ionic liquid (Figure 21) has been 
evaluated in the 1,4-addition of diethylzinc to cyclohexenone.[131a] The addition of 35 mol% of 
this particulate IL to the neat reaction mixture could induce an e.e. of 76%. Here, the effect of 
the IL was attributed to a complexation with the copper catalyst.  
 
Figure 21: An -pinene derived oxazolinium ionic liquid applied in Michael addition reactions.[131a] 
Based on the knowledge from the previous chapters, the goal in this part of the research was 
to design enantiopure ionic liquids with high stability. If the asymmetric centre is situated in the 
cation, both hydrophobic and hydrophilic ionic liquids can be obtained. To assure high 
stability, low viscosity and metal transport properties, the amino acid carboxylates were 
transformed into the alkoxy-substituted derivatives. The introduction of chiral pool based 
moieties in the cation of imidazolium ionic liquids by either a priori synthesis of a chiral 
imidazole or application of a chiral quarterisation agent was studied. The routes towards 
different chiral imidazolium ionic liquids were evaluated on their synthesis, i.e. reproducibility 
(robustness), yields and enantioselectivity.  
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3.2. Synthesis of amino acid derived ionic liquids 
The use of amino acids in ionic liquids has several advantages. (i) The presence of the amino 
group can be exploited in the previously optimised Debus-Radziszewski reaction procedure, 
via the intermediate imine, which is then converted into the imidazole by addition of 
ammonium acetate and diacetyl. Moreover, the optimisation of the continuous flow process 
might allow large scale production of amino acid based imidazoles. 
(ii) The thus obtained imidazole derivatives possess a carboxylate function, which is an easily 
modifiable handle to introduce a myriad of functionalities. However, the focus here will be on 
the conversion to the ether derivatives via the ester (Scheme 27). This implies that also the 
commercially available amino acid esters can be used. 
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Scheme 27: Transformation of the amino acid derived imidazoles into the ester and the ether derivatives and 
subsequent conversion of the alkoxy-substituted imidazoles in chiral ionic liquids. 
(iii) The building blocks are naturally occurring compounds, making their use environmentally 
safe and they are most often industrially prepared via enantioselective renewable 
processes.[142] 
The amino acids of interest here, besides glycine (Gly), are alanine (Ala), serine (Ser) and 
threonine (Thr) (Figure 22). The simplest of chiral amino acids, alanine, introduces a methyl 
group on the position adjacent to the imidazole. Serine provides a second alcohol function to 
be converted into an ether function, in order to create an increased concentration of ether 
functions in the liquid, although a prochiral imidazole is created when R1 and R2 are the same. 
The optical rotation will then be dependent on R1 and R2. This can be circumvented by the 
introduction of threonine, introducing two chiral centres. 
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Figure 22: Different envisioned amino acid based 1-alkoxy-2-isopropyl-4,5-dimethylimidazoles, derived from 
(fltr.) Gly, Ala, Ser and Thr. 
3.2.1) Via amino acid zwitterions 
Bao et al. reported on the synthesis of amino acid based imidazoles via slow addition of the 
ammonia source and diketone to a hot methanol solution of the amino acid and aldehyde.[136a] 
This strategy was evaluated with D/L-alanine (rac)-83 and after reaction, a solid was obtained 
upon evaporation of the volatiles. The intermediate sodium salt (rac)-84 could not be purified 
by aqueous extraction (amino acid cannot be separated), or by distillation as it is non-volatile. 
Therefore, a second step was needed in which the sodium salt (rac)-84 is converted into its 
ester.  
 
Scheme 28: Modified Debus-Radziszewski reaction with zwitterionic amino acid and ammonium hydroxide, and 
subsequent esterification using SOCl2, HCl or H2SO4. 
Addition of H2SO4 or dry HCl to an ethanolic mixture did not lead to the formation of the ethyl 
derivative. The presence of the imidazole zwitterion and neutralisation of the inorganic acids 
might have hindered the esterification here although HCl was added sufficiently long in order 
to neutralise the complete solution. Nonetheless, application of SOCl2 in ethanol was also 
unsuccessful (Scheme 28). In one case, upon H2SO4 catalysed esterification, only 1% of the 
ethyl ester could be purified via column chromatography. The 1H NMR spectrum of the 
obtained (S)-O-ethyl-2-(2-isopropyl-4,5-dimethylimidazolyl)propionate ((rac)-85) showed the 
presence of two diasterotopic hydrogens on the OCH2 group (10.7 Hz difference between the 
two OCH2 quadruplet signals, while a 2J-coupling is not observed). 
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3.2.2) Via amino acid esters 
The direct application of glycine and alanine methyl ester HCl salts (86a and 86b, 
respectively) in the previously optimised (i.e. sequential) Debus-Radziszewski reaction 
procedure gave very poor yields. The end product could not be purified from the extract. It 
was anticipated to be due to the presence of the HCl, making the amino group less 
nucleophilic. Therefore, an alternative setup was used in which the imine was synthesised in 
CH2Cl2, in the presence of Et3N (Scheme 29). Subsequently, the imine was applied in the 
second step of the modified Debus-Radziszewski reaction. In both cases, the presence of the 
resulting product 88 could be demonstrated by GC-FID, but no product could be isolated. 
 
Scheme 29: Synthesis of amino acid derived imidazolyl esters via intermediate imine formation in CH2Cl2. 
Since the yield and selectivity via the modified Debus-Radziszewski reaction were not 
satisfying, the synthesis in strong alkaline medium was evaluated. Addition of one equivalent 
of NaOH to deprotonate the hydrochloride salt in the first step and addition in several portions 
in the second step, led to the best results obtained (Scheme 30). 
 
Scheme 30: Modified Debus-Radziszewski reaction procedure, using one equivalent of NaOH to deprotonate the 
hydrochloride salt. In the second step, the diketone and NH4OAc were added in 4 portions over time. 
The imidazolyl ester 88b was present and could be purified via acid-base extraction. NMR 
analysis of the evaporated extract, showed the presence of the ester 88b (in 26% yield), while 
also a substantial amount of the 1H-2-isopropyl-4,5-dimethylimidazole (60) was formed (16%). 
Hence, the selectivity towards the N-substituted imidazole was 61%, which is lower than with 
any other amine noted in Table 10. The combination of a sterically hindered centre and the 
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electron-withdrawing effect on the amino function are detrimental to the selectivity and hence 
also to the yield. Crystallisation of 60 in acetone or preferably CH3CN was successful, but the 
last crop could not easily be removed. Distillation could be applied to finally purify the ester, 
however leading to a substantial mass loss. This demonstrated the low thermal stability of 
imidazoles with an ester group.  
The remainder of the side products was removed by filtration over a column packed with 
neutral alumina. The very low yields of compounds 88b and 88c (Table 10) were attributed to 
the steric hindrance and therefore, serine and threonine based imidazole synthesis was not 
further examined. Preliminary experiments to obtain an amino alcohol from the commercially 
available amino acid esters (reducing the electron withdrawal effect) failed due to the high 
aqueous solubility of the different compounds. 
Table 15: Yield of 1N-alkyl-2-isopropyl-4,5-dimethylimidazole obtained after distillation and selectivity in the 
modified Debus-Radziszewski reaction with different amines. 
Imidazole Amine Yield (%) (4) Selectivity (%) (4/4+5)[b] 
41d Ethylamine 42 100 
41h Hexylamine 40 88 
59a Allylamine 63 88 
59b Hydroxyethylamine / 75 
59c Methoxyethylamine 53 86 
88b O-Me-Alanine·HCl[a] 26[b] 61 
88c O-Me-Serine·HCl[a] 18[b] 64 
[a] Amino acid methyl ester hydrochloride salt, synthesis as in Scheme 30; [b] measured by 1H NMR. 
Since the imidazolyl ester 88b degraded during distillation, and the majority of the 1H-
imidazole 60 could be removed via crystallisation, the crude mixture of 88b was used in 
subsequent reduction step (Scheme 31). The reduction with sodium borohydride proceeded 
smoothly and allowed the isolation of the imidazolyl alcohol (89) in moderate to good yields. 
Subsequently, methylation of the alcohol to the ether functionalised imidazoles (59c, 90) was 
achieved by slow addition of Me2SO4 to the sodium alkoxide.  
The product was obtained by alkaline aqueous washing to remove the N-alkylated side 
product and unreacted alcohol. Only a small increase of the maximum yield at 0 °C (52%) was 
found by reducing the temperature to -78 °C (58%) . Application of potassium hydride in 
combination with 18-6 crown-ether at -78 °C to obtain a more reactive alkoxide did not 
improve the yield. Since (i) the intermediate alcohol 89 is not distillable and (ii) the majority of 
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88 was found to be destructed upon distillation, the reaction was carried out with the crude 
imidazolyl alcohol and the alkoxyimidazole (59c, 90) was distilled. 
 
Scheme 31: Optimised conditions for the transformation of imidazolyl ester 88 into the ethers 59c and 90. 
The reduction of the black imidazolyl ester led to a colourless product. Therefore, the strong 
colouration of imidazoles and their liquid salts might result from oxidised species which can be 
removed by reduction. This was further used for the purification of other imidazoles, see 
section III.1.3.1. The use of degassed solvents to avoid oxidation was not feasible, as the 
reaction vessels were opened multiple times during reaction for the addition of reagents. Here 
too, the small fraction of coloured species, distilled with the product, induces colouration upon 
methylation with MeI. 
The 13C and 1H NMR spectra (in CDCl3) of the imidazoles 88b and 90 showed the presence of 
two different diasterotopic methyl groups on the isopropyl substituent. The two resulting 
doublet signals in 1H NMR were separated by 3.3 Hz and 11.6 Hz in 88b and 90, respectively. 
NMR analysis at higher temperature, and comparison with 1,2-diisopropyl-4,5-
dimethylimidazole, showed that the shifts were not resulting from a hindered rotation.  
 
Scheme 32: Formation of the stabilised -imino-ester 91 under alkaline conditions, leading to racemisation. The 
optical rotations of the ester 88b and ether 90 show the complete racemisation. 
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The enantiomeric purity of imidazoles 88b and 90 was assessed by optical rotation and NMR 
spectroscopy with the chiral shift reagent (R)-1-anthracen-9-yl-2,2,2-trifluoroethanol, also 
known as Pirkle’s alcohol (102, Figure 24, p75). The two isopropyl doublets were found to be 
split by an equimolar amount of Pirkle’s alcohol by ca. 12 Hz and 35 Hz in 88b and 90, 
respectively. As depicted in Scheme 32, racemisation occurs already in the first step of the 
modified Debus-Radziszewski reaction. 
The racemic mixture of 2-isopropyl-3-methoxyprop-2-yl-4,5-dimethylimidazole was used in the 
ionic liquid synthesis as shown in Scheme 33. The ionic liquids were obtained quantitatively 
as pale yellow oils.  
 
Scheme 33: Synthesis of the racemic 2-isopropyl-3-methoxyprop-2-yl-4,5-dimethylimidazolium iodide and 
bis(trifluoromethylsulfonyl)imide ionic liquids via the standard procedures. 
3.3. Synthesis of ionic liquids using a chiral quaternisation agent 
In order to overcome the low yield and post processing of the chiral imidazoles, a chiral moiety 
was introduced in the quaternisation step. The thus resulting convergent synthesis would 
allow for an increase of the overall yields and also for the fast synthesis of a divergent library 
of analogues. The lactate derived chiral moiety was provided with an ether functionality and a 
leaving group by subsequent methylation, reduction and mesylation (Scheme 34).  
3.3.1) Synthesis of the quaternisation agent 
The methylation step of ethyl lactate was successfully performed with MeI and NaH,[143] this 
method allowed to perform the reaction at low temperatures. The pure NaH was added to a 
mixture of ethyl L-lactate and methyl iodide. Hereby, all base (NaH and formed alkoxide) was 
immediately reacted, preventing racemisation or self-condensation of the alkoxide. The one-
pot reaction of methylation and reduction was found to be impossible as violent gas formation 
occurred upon addition of the reducing agent (both LiAlH4 as NaBH4) in the presence of iodide 
salts. Therefore, the work-up included partial evaporation of THF and aqueous extraction of 
the salts from an Et2O solution.  
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The majority of the Et2O was evaporated at low temperatures, in order to dissolve the (S)-
ethyl-2-methoxy-propionate ((S)-94) in dry THF for reduction of the ester (Scheme 34). The 
moderate yields of (S)-95 were initially attributed to the high volatility during the intensive 
evaporation of THF. However, the persistent efforts to evaporate at very low temperatures and 
to get reproducible yields, suggest degradation (e.g. by alkene formation) or a high water 
solubility of the product. Evaluation of the reagent amounts might improve the yields further. 
 
Scheme 34: Synthesis of (S)-2-methoxypropyl methanesulfonate. 
The methylated ester was reduced to the alcohol by very slow addition of LiAlH4 at low 
temperatures to prevent thermal runaway. After addition of a minimal amount of water, 
filtration and evaporation, the alcohol (S)-95 was obtained. As the reduction of the ester 
proceeded so efficiently, also the less reactive NaBH4 was evaluated, however the obtained 
yields (23-30%) were even lower due to the acidic aqueous work-up. The obtained alcohol 
(S)-95 could be transformed into (S)-96 via a standard procedure using methanesulfonyl 
chloride. The end product (S)-2-methoxypropyl methanesulfonate ((S)-96) was obtained as a 
clear liquid after short-path vacuum distillation.  
In both the first and the last step (Scheme 34), the base was added dropwise to a mixture of 
the reagents in order to avoid a too high alkalinity which could, especially in a mixture of ethyl 
L-lactate ((S)-93) and ethyl 2-methoxypropionate ((S)-94) lead to partial racemisation. 
 
Scheme 35: Evaluation of dimethyl sulfate (DMS) in the methylation of ethyl L-lactate. 
Alternatively, dimethyl sulfate (DMS) in combination with potassium carbonate was evaluated 
as methylating agent (Scheme 35). Although racemisation might occur due to the high amount 
of base needed, the conditions were evaluated as they allow easy work-up, i.e. filtration of the 
side products (KMeSO4, KHCO3 and K2CO3) vs. evaporation, extraction, drying and 
evaporation when using MeI. Moreover, if this method was to be found to racemise the 
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products, the procedure would still be useful in the racemic synthesis (see Scheme 39). 
Maximum one equivalent of DMS was used since an excess present in the second step would 
consume the reducing agent and removal of the toxic compound would require evaporation at 
high temperature after reaction (Tb(DMS): 188 °C). Unfortunately, the methylation reaction did 
not proceed smoothly, and after twenty four hours a complex mixture was obtained. 
3.3.2) Application in quaternisation reaction 
As previously observed for other methanesulfonate esters, high temperatures were required to 
obtain the quaternised product 98a (Scheme 36). The reaction was only completed after 90 
min (45 min for 97a) under microwave irradiation at 100 °C and the product needed to be 
evaporated at high temperatures for prolonged times to remove the excess of the starting 
materials. In the case of 97a, a pale yellow oil was obtained. The 2H-imidazoles and their 
imidazolium salts were always only slightly coloured, indicating the absence of contaminants 
with high extinction coefficients in these compounds. 
 
Scheme 36: Quaternisation with the (S)-2-methoxypropyl methanesulfonate and subsequent metathesis. 
After quaternisation by microwave irradiation, here too a side product (20 mol% in 98a) was 
observed in the 1H NMR spectra. Analogously to the MsOH formation during alkenyl 
substituted imidazolium salt synthesis (section III.2.2), the product signals were found slightly 
upfield, indicating a protonated imidazolium salt. Since elimination of the (S)-2-methoxypropyl 
methanesulfonate was not expected to readily occur, it was clear that here too, water was 
involved in a concurrent nucleophilic attack. 
 
Scheme 37: Failed microwave mediated quaternisation of 1-ethyl-2-isopropyl-4,5-dimethylimidazole with the (S)-
2-methoxypropyl methanesulfonate. 
The isopropyl derivative did not lead to any reaction under stringent conditions (Scheme 37). 
The maximum conversion obtained was 12% after one hour of microwave irradiation at 100 
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°C, although most often just starting materials were found. Irradiation during 2h at this 
temperature or at 100 °C did not improve the conversion. Therefore, another method was 
applied, in which the 1H-2-isopropyl-4,5-dimethylimidazole was reacted with the (S)-2-
methoxypropyl methanesulfonate (Scheme 38). 
The synthesis of 1H-2-isopropyl-4,5-dimethylimidazole (60), was achieved by performing the 
Debus-Radziszewski reaction in one step and adding two equivalents of NH4OAc. Very 
rapidly, the product was formed as a fine suspension in the reaction solvent. After acid-base 
extraction, 89% of the 1H-imidazole could be isolated. Deprotonation of this imidazole and 
application in the reaction with (S)-2-methoxypropyl methanesulfonate, yielded the (S)-2-
isopropyl-1-(2-methoxypropyl)-4,5-dimethylimidazole ((S)-100) in 61%. The main side product 
formed was the double alkylated imidazolium cation. The pure compound (S)-100 could be 
obtained as a colourless liquid via short-path vacuum distillation. 
 
Scheme 38: Synthesis of (S)-2-isopropyl-1-(2-methoxypropyl)-4,5-dimethylimidazole ((S)-100) and subsequent 
application of this imidazole in the standard ionic liquid synthesis and metathesis. 
The obtained chiral imidazole could be successfully applied in the ionic liquid synthesis with 
methyl iodide and subsequent metathesis with lithium bis(trifluoromethylsulfonyl)imide to 
obtain quantitatively the chiral imidazolium ionic liquids (S)-99b and (S)-99c respectively. 
3.3.3) Enantiomeric purity assessment 
During the synthesis of the intermediates and the ionic liquids, several times bases and high 
temperatures were applied, which might have led to product racemisation. Analysis of the 
enantiomeric purity of the ionic liquids thus formed, was in first instance performed via optical 
rotation. The obtained optical rotations (ሾߙሿ஽ଶହ, Table 16) indicate that no complete racemisation 
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occurs during the synthesis, under the applied alkaline conditions and high temperatures. This 
is a good indicator that these type of compounds have potency to withstand demanding 
reaction conditions, i.e. high temperatures and alkalinity. 
From the obtained values, it is clear that changing the anion from [I]- or [OMs]- to [NTf2]- 
decreases the specific optical rotation ሾߙሿ஽ଶହ. This is at least partially the result of the decreased 
concentration of chiral centres present, as the molecular weight increases upon metathesis 
with the [NTf2]- anion (see Table 16). 
Table 16: Summary of the specific optical rotations (°) of the (S)-2-methoxypropyl substituted imidazole and 
imidazolium ionic liquids, combined with the concentration in CHCl3 at which this value was measured and the 
molecular weight. 
Compound ሾߙሿ஽ଶହ C (× 10-2 g mL-1) MW (g mol-1)
97a 20.3 ± 0.5 0.4 324.2 
97b 14.9 ± 0.7 0.4 477.44 
98a 16.1 ± 0.5 0.4 338.23 
98b 12.3 ± 0.2 0.4 491.47 
100 40.3 ± 0.5 0.3 210.32 
99b 18.8 ± 0.3 0.4 352.25 
99c 16.0 ± 0.5 0.4 505.50 
The achiral ethyl 2-hydroxy-propionate was obtained via hydrogenation of ethyl pyruvate over 
a Raney Nickel catalyst in continuous flow (see section V.1). The hexane solution containing 
87% alcohol was partially evaporated before methylation with MeI via the optimised 
procedure. After methylation, the crude mixture was used in the consecutive reduction and 
mesylation steps, after which the pure racemic methane sulfonate (rac)-96 was obtained by 
distillation (Scheme 39). 
 
Scheme 39: Synthesis of racemic 2-methoxypropyl methanesulfonate. 
The racemic 2-isopropylimidazole and 2H- and 2-methylimidazolium salts (Figure 23) were 
obtained via the corresponding procedures and were all found to be synthesised in good yield 
and purity, as confirmed by mass-spectrometry and NMR spectroscopy. The different 
imidazolium salts and chiral imidazole derived from the achiral compound were analysed by 
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optical rotation. The obtained results and the comparison with the chiral derivatives showed 
that racemic mixtures of compounds (rac)-97a, (rac)-98a and (rac)-100 were obtained by 
functionalisation with the racemic pyruvate derived methanesulfonate ester (rac)-96. 
  
Figure 23: Different racemic 2-methoxypropyl substituted compounds used for enantiomeric purity assessments.  
To determine the enantiomeric purity and detect the presence of the (R)-enantiomer in the 
different compounds, NMR spectroscopy was applied.[144] Therefore, chiral shift reagents 
(CSRs, Figure 24) were added to both the (S)-2-methoxypropyl substituted compounds and 
the obtained racemic mixtures. The most common non-derivatising CSR, Pirkle’s alcohol (1-
anthracen-9-yl-2,2,2-trifluoroethanol, 102), possesses an acidic proton and was therefore 
expected to interact with the neutral imidazoles. However, in contrast to the amino acid 
derived imidazoles, no signal shifts were observed upon addition the of Pirkle’s alcohol to the 
basic imidazole ((S)-100), and no splitting of signals in the racemic mixture ((rac)-100).  
 
Figure 24: Non-derivatising chiral shift reagents Prikle's alcohol (left) and the -Trisphat anion (right). 
A second CSR which was evaluated, is the tetrabutylammonium salt of the -Trisphat anion 
(Tris(tetrachlorobenzenediolato)phosphate, 103).[145] In this anion, no hydrogens are present, 
although the butyl chains of the cation gave a small overlap with the product signals. 
Unfortunately, when combined in equimolar amount with the salt (rac)-98a, also no signal 
splitting was observed  
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A final method which was evaluated to determine the enantiomeric purity was chiral HPLC. In 
this method the product is passed over a column with chiral packing with an isocratic eluent 
mixture. This method is, in contrast to the standard HPLC method a normal phase method, 
using apolar solvent mixtures, preferably hexanes. Unfortunately, none of the ionic liquids 
dissolve in hexanes and therefore EtOH was added. None of the obtained chromatograms of 
the chiral imidazole, the three chiral imidazolium salts and all of their racemic mixtures (the 
methanesulfonate ester cannot be monitored by UV-detection and was hence not 
investigated) were valuable in order to calculate the enantiomeric purity, i.e. no chiral 
resolution was observed. This might be attributed to the presence of too large amounts of 
EtOH in the injection sample. Analysis of the enantiomeric purity could nevertheless 
demonstrate if racemisation occurs during synthesis, storage or application. 
3.4. Conclusions 
The amino acid based pathway has the lowest carbon economy in the first step, i.e. the 
imidazole synthesis. Unfortunately, the first step was also found to completely racemise the 
product. The lactate based pathway has only modest losses in the final steps, but requires a 
low yielding synthesis of the quaternisation agent. The introduction of the chiral centre via the 
quaternisation agent allows to apply this convergent synthesis to a library of organic bases. 
Due to the non-reactivity of the lactate derived quaternisation agent towards the 2-isopropyl 
substituted imidazole, this convergent synthesis was abandoned. Nonetheless, the chiral 
imidazole (S)-100 could be synthesised and applied in ionic liquid synthesis via standard 
synthesis procedures. This indicates that the chiral imidazole can be quaternised via divergent 
methods, e.g. using allyl bromide, methyl iodide or dimethyl carbonate. This allows for the 
introduction of a myriad of anions. The 2-methoxypropyl substituted imidazolium salts were 
found to be non-racemic, it is to say that at least scalemic mixtures were obtained. 
Unfortunately the enantiomeric purity could not be proven via standard methods such as NMR 
or HPLC. None of the ionic liquids synthesised showed any solidification. 
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4. Alternative ionic liquid preparation 
The general synthesis of ionic liquids consists of a quaternisation followed by metathesis. As 
quaternisation proceeds most efficiently with alkyl halides, methods were initially introduced to 
substitute the insufficiently stable and strongly coordinating halide anions for less basic and 
more stable anions, leading to ionic liquids with improved stability and rheology.[13b] 
There is a great interest in novel and greener preparation methods leading to more pure ionic 
liquids, since the previously mentioned general methodology poses different concerns. First of 
all, the exchange of anions via transition metal salts[37] or via an anion exchange resin[146] 
generates equimolar amounts of (polluting) metal halides or hydrogen halide acid respectively. 
Second, quaternisation with alkyl halides induces halide contamination of the ionic liquid end 
product. It is known that minute amounts of halides can poison expensive catalysts and alter 
the physical properties.[13b, 147] 
Finally, the use of silver salts, of interest in the preparation of water soluble ionic liquids and 
most commonly applied in the synthesis of dicyanamide ionic liquids,[37, 148] is expensive and 
leads to silver contamination of waste streams. The step preceding the actual metathesis, 
involves AgNO3 precipitation with NaN(CN)2 in water (vide supra, Scheme 16) and involves 
formation of substantial amounts of contaminated aqueous and solid waste. Moreover, silver 
halides only precipitate slowly from aqueous solutions, the metathesis is therefore sometimes 
carried out in organic solvents.[149] Nonetheless, silver halides are slightly soluble in these 
solvents and in ionic liquids as well, leading to silver contamination of the end product in this 
case too.[150]  
MacFarlane et al. have analysed the iodide contamination in ionic liquids prepared with 
AgN(CN)2 by means of mass spectrometry and found a concentration < 0.5 wt.% [I]- (being 
the detection limit).[37] As this does not exclude the presence of residual silver metals, an 
alternative method was recently reported.[151] This method comprises the melting of 
[C2mim][Cl] with the sodium or lithium salts of the desired anion (i.e. LiNTf2, NaBF4, NaN(CN)2, 
NaSCN), dissolution of the resulting melt in CH2Cl2 or THF and filtration led to the pure ionic 
liquids, as no residual chlorine was observed by high resolution mass spectroscopy. The use 
of the ‘phenolate platform’ to synthesise hydrophilic ionic liquids was recently described by 
Lethesh et al.[152] Hereby, the tert-butylphenolate salt of the cation of choice is mixed with the 
Brønsted acid of choice in an aqeuous medium, after which the tert-butylphenol migrates to 
the hydrophopic layer. 
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To overcome the problem of halide contamination, the direct synthesis using methylating 
agents which provide the desired anion immediately as ‘by-product’ has been applied by 
several research groups. Although this method is free from waste-generation, it is not feasible 
for the weakly coordinating [NTf2]- and [N(CN)2]- anions, as their methylated derivatives do not 
exist. The strongly methylating (carcinogenic) character of e.g. 
methyltrifluoromethanesulfonate (MeOTf) limits the industrial use, although microreactor 
technology can here introduce a safe process alternative (vide supra).[104] Nonetheless, 
amongst others, imidazolium trifluoroacetates, trifluoromethanesulfonates, methyl- and 
ethylsulfates and alkylnitrates have already been successfully synthesised via this direct 
alkylation.[38, 40, 153] Recently, an anion exchange method was reported in which bromide 
anions are exchanged with methylsulfate by addition of dimethylsulfate and evaporation of the 
volatile methyl bromide.[154] 
 
Scheme 40: Halide free ionic liquid synthesis procedure patented by Earle and Seddon.[155]  
Seddon et al. filed a patent in which, after quaternisation of N-alkylimidazoles with ethyl 
trifluoroacetate or butyl methanesulfonate, the anions were exchanged by evaporation of their 
corresponding acids upon addition of HPF6 or HBF4.[156] An alternative method applying 
Brønsted acids, was filed in another patent by the same group. Here, the imidazolylidene 
carbene was prepared and isolated under reduced pressure in a Kugelrohr apparatus, which 
was then reacted with the acid to afford the 2H-imidazolium salt (Scheme 40).[155] Brønsted 
acids have also been applied to exchange anions in carbonate ionic liquids (vide infra). 
In the following sections alternative metathesis procedures will be proposed and evaluated in 
order to tackle the before mentioned problems of ionic liquid purity, waste generation and 
toxicity. The focus will be on the reduction of the amount and the toxicity of reagents and by-
products, the reduction of energy demands but also of solvents, especially water, which are 
contaminated after use. Finally, these novel methods should allow the synthesis of very pure 
ionic liquids.  
One of the most promising quaternisation agents is dimethyl carbonate (DMC),[157] which is a 
greener alternative to both quaternisation and metathesis. However, not many groups have 
applied this technique, probably due to the absence of an autoclave or high pressure reaction 
vessels in the laboratory environment. In the next section first the synthesis and 
quaternisation of methanesulfonate ionic liquids will be elaborated. 
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4.1. Synthesis and metathesis of methanesulfonate salts 
Although the use of methyl methanesulfonate (MeOMs) will not be accepted in large-scale 
industrial processes since it is a carcinogenic and toxic compound, several researchers have 
reported methane sulfonate ([OMs]-) based ionic liquids.[158] In this research, the rheology of 
methanesulfonate ionic liquids as well as their applicability as a handle for anion metathesis 
are evaluated. The interest in this method is a priori based on the observation of the NaOMs 
precipitation (see section III.2.2) and practically, for circumventing silver dicyanamide based 
synthesis, which did not always straightforwardly lead to compounds of high purity. The latter 
silver salt mediated metathesis is based on the fact that silver halides are less soluble than 
AgN(CN)2, which is synthesised from NaN(CN)2 (Scheme 16). Hence, the direct application of 
NaN(CN)2 reduces the ionic liquid synthesis with one step. 
The synthesis of the methanesulfonate salts does not proceed smoothly in the normal 
synthesis setup, i.e. acetonitrile at 0 °C. Applying higher temperatures, in solvents such as 
acetonitrile or toluene, did not ameliorate the conversion (see section III.2.2). The more 
stringent conditions achieved in the microwave reactor did allow efficient conversion, although 
no (very) high temperatures were required. The results verify the efficient heating in a 
pressurised vial with accurate temperature control, since there is no special effect originating 
from microwave irradiation.[159] 
Table 17: Applied reaction conditions during methanesulfonate ionic liquid synthesis with imidazoles 41a-d. 
IL R eq. MeOMs T ( °C) t (min) 
44d H 1.1 100 30 
45d Me 1.0 80 40 
46d Et 1.1 80 30 
47d iPr 1.1 80 60 
 
 
 
Scheme 41: Neutralisation of the recrystallised imidazolium hydrogen chloride and subsequent quaternisation 
with methyl methanesulfonate to obtain methanesulfonate salts of high purity (R = H, Me, Et, iPr). 
Table 17 shows the applied conditions for the methylation of 2-alkyl-1N-ethyl-4,5-
dimethylimidazoles (41a-d) with methyl methanesulfonate. The methylation reaction of 
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compounds 41a-c was studied on a 1 gram scale, which was added to 4 mL of dry CH3CN in 
a small microwave vial (6 mL). The heating (reaction temperature and time) was minimised in 
order to decrease the colouration of the ionic liquids as much as possible. It was found that 80 
°C was sufficient to reach complete conversion, although then 40 minutes were required. After 
30 minutes, small amounts of starting imidazole were still present, although these could 
efficiently be removed, together with the excess of MeOMs, by washing an aqueous solution 
multiple times with ethyl acetate (EtOAc). More lipophilic cations (N-hexyl or N-allyloxyethyl 
substituted imidazoles) can induce losses in this step, although this did not pose a problem for 
any of the N-ethylimidazolium salts. The 1-ethyl-2H-3,4,5-trimethylimidazolium 
methanesulfonate ionic liquid (44d) was the only solid compound. The other analogues could 
not be crystallised from acetone or an acetone-Et2O mixture, addition of a too high amount of 
Et2O always led to the separation of a liquid layer. 
The large scale synthesis was evaluated by methylating 7 grams of the 2-isopropyl substituted 
imidazole (41d) with 1.1 eq. MeOMs. Hereto was added only 10 mL of CH3CN as then the 
volume upper limit of the large microwave vial was reached. To ensure complete reaction, the 
mixture was heated and stirred for 1 hour in the microwave reactor. During large scale 
production of 1-ethyl-2H-3,4,5-trimethylimidazolium methanesulfonate (44d), the exothermic 
reaction initiates immediately upon addition of the methyl methanesulfonate, producing a 
substantial amount of heat, causing the solvent to boil. This leads to mass loss, but more 
important to the exposure to toxic MeOMs. Hence, the vial must be sufficiently cooled and 
manipulated carefully. As this rapid heating was not found for the other imidazole derivatives, 
this indicates the faster reaction of the less sterically hindered 1-ethyl-2H-4,5-
dimethylimidazole. Overall, the optimised conditions for the quaternisation of imidazoles with 
methanesulfonate are as given in Scheme 41 (for the 1 gram synthesis, 40 minutes is 
sufficient), followed by washing an aqueous solution with ethyl acetate. 
Table 18: Conditions used during metathesis of methanesulfonate ionic liquids with NaN(CN)2  
of the samples provided for sodium analysis (vide infra). 
IL R eq. NaN(CN)2 t (h) Solvent 
44d H 1.2 4 CH2Cl2 
45d Me 1.2 20 CHCl3 
46d Et 1.5 20 CHCl3 
47d iPr 1.2 40 CHCl3 
In Table 18, the different conditions applied in the metathesis of the methanesulfonate ionic 
liquids into the dicyanamide ionic liquids are given. The methanesulfonate salts were 
dissolved in demineralised water and 1.05 to 1.5 equivalents of Na(CN)2 were added. The 
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mixtures were heated to 50 °C and stirred overnight to ensure complete exchange of the ions 
(Scheme 42). After reaction, the water was removed by rotary evaporation, and acetone was 
added. The dissolution of the wet ionic liquid in acetone allows precipitation of the main part of 
NaOMs and excess NaN(CN)2. After filtration, the solvent and residual water were removed by 
rotary evaporation and the ionic liquid was dissolved in dichloromethane or chloroform and 
stored at -18 °C for at least 4 hours. This allowed the precipitation of the remainder of the 
sodium salts. This last step was repeated until no further precipitation was observed. 
Subsequently, the resulting ionic liquid was obtained after evaporation of the solvents and the 
contamination could be evaluated. 
 
Scheme 42: Metathesis of imidazolium methanesulfonate ionic liquids into the dicyanamide ionic liquid with the 
by-products formed. 
Thus, remaining NaOMs or imidazolium [OMs]- salt could be monitored by 1H and 13C NMR. 
Here it was found that addition of 1.05 eq. NaN(CN)2 did not lead to complete conversion, 
while no residual methanesulfonate anion was observed when applying a larger excess (1.2 
eq.) NaN(CN)2. The residual NaN(CN)2 cannot be monitored by NMR and therefore ICP-MS 
sodium analyses were applied on the ionic liquid samples.  
Approximately two grams of the freshly prepared imidazolium dicyanamide ionic liquids 44-
47c were provided to Desmet Ballestra (Zaventem) for sodium analysis. The different samples 
were prepared via the optimised quaternisation procedure, but with different conditions for the 
metathesis reaction with NaN(CN)2 as given in Table 18. In Table 19 the expected and 
experimental sodium content is given. The complete mineral composition analysis table is 
given in experimental section (Table 31). The large excess of NaN(CN)2 used during the 
synthesis of 46c was expected to pollute the end product, moreover the chloroform solutions 
were turbid although no precipitate could be filtered off. The analyses show that a hundred-
fold higher sodium content is present in 46c than in the compounds 45c and 47c where the 
sodium content is negligible. Since no sodium methanesulfonate was observed in 46c by 
NMR, the sodium content is attributed to a high amount of residual sodium dicyanamide 
present (3 mol%). During metathesis of the solid methanesulfonate salt 44d, the mixture was 
heated for only 4 hours and dichloromethane was used instead of chloroform during the final 
precipitation steps. Since the resulting dicyanamide is also a solid, the visual evaluation of the 
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metathesis reaction is hindered, and prediction on the sodium content was not made (Table 
19). The experimental sodium content here show a result intermediate to those of 46c and 
45c, hence not negligible. Therefore, it is proposed to increase metathesis times to 20 hours 
and to use chloroform to precipitate the residual NaN(CN)2. An excess of chloroform should 
be used to hinder precipitation of the solid imidazolium salt in the case of 44d. 
Table 19: Expected sodium contamination and analytical ICP-MS results (in ppm and mol% vs. the IL) of the 
synthesised dicyanamide salts. 
IL R Physical state Expected content sample mass (g)
mass Na 
(ppm) 
mol% Na 
(%) 
44c H Solid / 1.0027 160 0.27 
45c Me Liquid Low 0.449 18 0.03 
46c Et Liquid High 0.5188 1803 3.25 
47c iPr Liquid Low 0.9992 8.7 0.02 
4.2. Quaternisation and metathesis using dimethyl carbonate 
The interest in the synthesis of ionic liquids by the quaternisation of organic bases with 
dimethyl carbonate (DMC) initiated some 20 years ago by the work of Albert and Mori.[160]  
 
Scheme 43: Synthesis of intermediate imidazolium methyl carbonate salt and metathesis towards a library of 
imidazolium ionic liquids by means of Brønsted acids. 
First, this methylating agent is environmently friendly because of both its synthesis and its 
biodegradability.[157]  That is to say, since the 1980s, DMC is synthesised from CO and MeOH 
over a Cu(I) catalyst, a method developped by Enichem, Italy.[161] Second, quaternisation of 
neutral building blocks with DMC leads to methyl carbonate ionic liquids (carbonate ionic 
liquids, CILs).  
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These carbonate ionic liquids can easily be methatisised with the Brønsted acid of the anion 
of choice, hereby, the methyl carbonate anion decomposes into MeOH and CO2. Alternatively, 
the carbonates can be precipitated by addition of calcium salts. In this way, a library of 
analogues can be synthesised very efficiently starting from different Brønsted acids (Scheme 
43). The hydrogen carbonate ionic liquids are currently commercialy available as a novel tool 
called CBILS© (Carbonate Based Ionic Liquid Synthesis) from Proionic GmbH (Austria).  
In the reaction of a nucleophile with dimethyl carbonate (DMC), both alkylation (SN,Al) and 
acylation (SN,Ac) can occur, depending on the temperature (Scheme 44). At reflux (Tb of DMC: 
90 °C), only the reversible SN,Ac occurs, while alkylation requires temperatures higher than 120 
°C, preferably above 160 °C. Therefore, the alkylation reaction is mostly performed in an 
autoclave or a sealed vial, where the autogenous pressure keeps the DMC in the liquid 
phase.[157]   
 
Scheme 44: Predicted temperature dependent outcome of the reaction of imidazoles with DMC.[157]  
An alternative to the sealed reactor is application of the microwave reactor, which is resistant 
to high pressures and allows precise temperature control. The application of microwave 
irradiation in the methylation reaction of different organic bases (e.g. acyclic and cyclic 
amines, imidazoles) with DMC was intensively studied by Holbrey et al.[162] They found an 
important increase of the reaction rate by increasing the base to DMC ratio from 1:1 to 1:2 and 
increasing the temperature from 130 to 140 °C, while further increment of both parameters 
only led to small increases of the reaction rate.  
In the first sections, the influence of different conditions on the conversion of different 
imidazoles with dimethyl carbonate will be discussed. The optimisation of temperature, 
reagent stoichiometry and reaction times will be elaborated. In a subsequent section, the 
analysis of the reaction mixtures by NMR will be discussed as well as the observations of 
some remarkable side reactions. Finally, the application of the carbonate ionic liquids (CILs) in 
metathesis reactions will be discussed. 
Alternative ionic liquid preparation 
 84  
4.2.1) Reaction optimisation 
a) Quaternisation of 2-isopropylimidazoles 
Reacting 1-ethyl-2-isopropyl-4,5-dimethylimidazole (41d) with DMC at 140 °C under 
microwave irradiation for 12h led to a conversion of 60% (entry 1, Table 20). Application of 
microwave irradiation at 170 °C always led to evaporation of the volatiles, not allowing any 
reaction. Therefore, in the further experiments given in Table 20 and 21, thick wall pressure 
vials were used, which were submerged in an oil bath at 170 °C. However, the temperature 
resistance of the screw caps is limited to 180 °C and exceding this temperature leads to 
rupture and explosion of the pressure vials. 
Table 20: Conditions of quaternisation of 1-ethyl-2-isopropyl-4,5-dimethylimidazole (41d) with DMC and 
conversion as determined by 1H NMR (entries 10-13 are discussed in section III.4.2.4). 
Entry Catalyst Solvent Conversion (%) DMC (eq.) T ( °C) t (h) 
1  neat 60 2 140 (MW) 12h 
2  neat crude 2 170 24h 
3 0.20 eq. BF3·OEt2 neat 76 2 170 5h 
4  1 eq. MeOH 81 3 170 27h 
5  1 eq. MeOH 100 6 170 24h 
6 0.20 eq. BF3·OEt2 0.5 eq. MeOH 100 3 170 24h 
7 0.04 eq. BF3·OEt2 0.5 eq. MeOH 100 3 170 24h 
8 0.20 eq. BF3·OEt2 1.5 eq MeOH 100 3 170 8h 
9 50 w% K10 1.5 eq MeOH 100 3 170 24h 
10 50 w% K10 1.5 eq MeOH 65 3 170 3h 
11 50 w% K10 1.5 eq MeOH 75 3 170 6h 
12 50 w% K10 1.5 eq MeOH 15 3 150 3h 
13 50 w% K10 1.5 eq MeOH 22 3 150 6h 
Performing the quaternisation reaction of 1-ethyl-2-isopropyl-4,5-dimethylimidazole (41d) in a 
sealed pressure vial at 170 °C (entry 2), led to the complete conversion of the starting 
material, although a very complex mixture was obtained. To increase the contact of DMC and 
the imidazole in the liquid phase, the addition of solvents was evaluated. The addition of 
CH3CN and MeOH increased the conversion, however multiple products were still formed. 
Drying of the solvent over 3Å molecular sieves did not have a significant effect on the 
outcome of the reaction. Addition of 1 eq. MeOH and 3 eq. DMC led to 81% conversion after 
24h (entry 4), although a pure product could be obtained after washing an acetonitrile solution 
of the reaction mixture with Et2O.  
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To reduce the formation of side products, increase the conversion and speed up the reaction 
(in order to reduce temperature and colouration), the effect of a catalytic amount of Lewis acid 
was evaluated by addition of 4 to 20 mol% of BF3·OEt2 to a neat solution of imidazole and two 
eq. DMC. After 16h of reaction with 10 mol% BF3·OEt2 and after 5h with 20 mol% (entry 3), 
76% conversion was obtained. Combination of a small amount of solvent (0.5 weight eq. 
MeOH), an increased amount of DMC and only 4 mol% of catalyst, led to complete conversion 
after 24h, without the formation of side products (entry 7). Application of 20 mol% BF3·OEt2 
and 1.5 weight eq. of MeOH allowed complete conversion after 8h (entry 8). 
The halogenated character of BF3·OEt2 does not fit in the Green Chemistry concept. 
Moreover, the catalyst formed side products, which could not be completely removed from the 
resulting reaction mixture as shown by 19F NMR. Therefore, alternative catalysts were 
required. Clay minerals are known to have Lewis acidic activity,[163] and they are solid. This 
means that they allow removal by filtration and recycling in contrast to BF3·OEt2. Thus, K10 
(an iron (Fe) doped Montmorillonite clay mineral) was introduced in the reaction mixture by 10, 
20, 50 weight equivalents. Without activation (drying) of the catalyst, the reaction was 
completed after 24 hours and showed reduced side product formation (entry 9). Hence, 
compared to BF3·OEt2, the demanded reaction times were longer and the catalyst loading was 
higher. The K10-clay could be successfully recovered by filtration, after which it was dried and 
recycled, and proved equally reactive as in the first runs. 
b) Quaternisation of 2-methylimidazoles 
The methylation reaction with dimethyl carbonate of 1-ethyl-2,4,5-trimethylimidazole (41b) 
proceeded as slow as with the 2-isopropyl derivatives. Here too, 24 hours of reaction were 
required for complete conversion under the conditions as optimised for the 2-isopropyl 
derivatives. Remarkably, signals of the 2-Me group are often not visible or reduced in 1H NMR 
and diffuse in 13C NMR spectra (in CDCl3). Clearly, this is a result of deuterium exchange with 
the protonated imidazole (see section III.4.2.2).  
c) Quaternisation of 2H-imidazoles 
2H-Imidazole 41a was found to be completely converted to different products (111, 114, 
Figure 27, p88) without any catalysis upon heating in a thick wall pressure vial. Entries 1-3 in 
Table 21 show the influence of temperature and reaction time. First, 140 °C is the lower 
temperature limit of the reaction, and 170 °C is needed to react DMC with imidazoles 
sufficiently fast (imidazoles are the least reactive amongst the neutral organic bases).[162] 
Second, upon comparison with 2-alkylimidazoles, the necessary reaction times are quite 
short, i.e. one to four hours were sufficient (entries 4-7). As also observed during 
quaternisation of 2-alkylated imidazoles with DMC, addition of K10 catalyst supressed the 
formation of side products here, product 114. Since compound 114 was later found not to be 
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an unwanted side product, the addition of solvent and K10 catalyst are not beneficial for the 
outcome during the methylation of 1-ethyl-4,5-dimethylimidazole (entries 8-12, Table 21). 
Table 21: Conditions of quaternisation of 1-ethyl-2H-4,5-dimethylimidazole (41a) with DMC and amounts of 
starting imidazole and products 111 and 114, analysed by 1H NMR. 
Entry K10 (w%) MeOH (eq.) DMC (eq.) T ( °C) t (h) 41a 111 114 
1 0.1 0 6 140 2 100 0 0 
2 0 0.5 3 145 4 60 32 7.6 
3 0 0.5 3 175 2.3 0 87 13 
4 0 0.5 3 170 1 64 36 0 
5 0.5 0.5 3 170 5 8 84 8 
6 0.5 0.5 3 170 6 0 88 12 
7 0 0.5 3 175 4 0 92 8 
8 0.5 0 6 175 2.75 0 85 15 
9 0.2 0 6 175 4 0 88 12 
10 0.1 0 6 175 1 0 82 18 
11 0 0 6 175 2 0 70 30 
12 0 0 6 170 2 0 50 50 
4.2.2) Structure of the CILs 
a) Structure of the 2-alkylimidazolium carbonate ionic liquids. 
Quaternisation of 1-ethyl-2-isopropyl-4,5-dimethylimidazole (41d) performed without a catalyst 
and with the addition of 1 eq. MeOH and 6 eq. DMC showed complete conversion (entry 5,  
Table 20). After evaporation at 100 °C at 0.5 mbar, clean NMR spectra were obtained, 
although neither 13C nor 1H NMR revealed the methyl carbonate (47e) or methoxide (47g) 
anion (Figure 25). Therefore reaction mixtures were not as thoroughly evaporated in further 
experiments. In this way, clean spectra of the imidazolium cation were obtained with additional 
peaks at 3.49 (MeOH) and 3.47 ppm ([CH3CO3]-) in 1H NMR (the cumulative integrations not 
accounting for 3 protons). In the 13C NMR spectrum of the freshly filtrated and evaporated 
reaction mixture, MeOH, [CH3O]- and [CH3CO3]- were observed. The signals found near 59, 
52 and 157 ppm (Figure 26, spectrum A) are respectively attributed to the [MeO]- and the 
[CH3COO]- anion. 
Upon addition of water and subsequent evaporation, the [MeO]- and [CH3CO3]- signals at 59, 
52 and 157 ppm disappeared (Figure 26, spectrum B), due to the shifting of the equilibrium to 
the hydrogen carbonate IL (47f) or the hydroxide IL (47h), since MeOH has the lower boiling 
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point. This indicates that interconversion of hydrogen carbonate to methyl carbonate anions 
and vice versa is possible by reaction of the anion with the solvent. In spectrum B, only a 
signal at 160 ppm is observed apart from the imidazolium signals, attributed to hydrogen 
carbonate anion (47f). By means of this spectrum the presence of compound 47h cannot be 
excluded. 
The [MeCO3]- salts (47e) were not found to be stable without the presence of methanol for all 
cations investigated, and upon evaporation, mixtures of methyl carbonate (47e) and hydrogen 
carbonate (47f) were formed, to be eventually completely transformed to the hydrogen 
carbonate salt over time. The transformation of the anions is elaborated in the next section. 
The 1H NMR analysis of the 2-alkylimidazolium [HCO3]- salts in CDCl3 or CD3CN did never 
reveal the [HCO3]- proton, nor was the 2-methylgroup visible. This was due to H/D exchange 
with the solvent (see next section). 
 
Figure 25: Proposed analogues of ionic liquids with different anions formed  
during methylation reaction with DMC (R= Me (45), iPr (47)). 
 
Figure 26: 13C NMR spectra (CDCl3) of 1-ethyl-2-isopropyl-3,4,5-trimethylimidazolium salt, as the reaction mixture, 
containing different anions (47e, 47g) and MeOH (A), and the [HCO3]- salt, 47f (B). 
b) Structure of the 2H-imidazolium carbonate ionic liquids 
Upon quaternisation of imidazoles containing hydrogen on the C2 position, the acidity of this 
C2 proton increases. Given the formation of salts with alkaline carbonate anions and the 
release of substantial amounts of CO2, the combination with these 2H-imidazoles was 
expected to involve carbene formation and other characteristic behaviour. The group of 
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Holbrey and Rogers was the first to completely describe the formation of the zwitterionic 
carboxylate 110b during reaction of 1-methylimidazole with DMC in high yields.[164] The 
formation is attributed to an SN,Al mechanism and deprotonation by the [MeCO3]- anion 
(Scheme 45). Later, they reported on the conversion of these carboxylates into hydrogen 
carbonates as ionic liquid precursors (CBILS©).[165] Alternatively, hydrogen carbonate salts can 
be prepared by oxidation of formate salts over a Pd catalyst, as patented in 2006 by BASF.[166] 
 
Scheme 45: Formation of the zwitterionic carboxylate 110b by reaction of 1-methylimidazole with dimethyl 
carbonate. The formed product precipitates from the acetonitrile reaction solution and is obtained in high 
yields.[164] 
In the 1H NMR spectra (in CDCl3) of the reaction mixtures of 1-ethyl-2H-4,5-dimethylimidazole 
(41a) with DMC, multiple quadruplets, triplets and singlets (accounting for NCH2, CH3 and 
NCH3 respectively) were observed in a small ppm range. This suggests that a series of 
analogues is formed via both SN,Ac and SN,Al mechanisms. The proposed possible analogues 
are illustrated in Figure 27. Amongst them (the starting material is not observed) are two 
analogues forming the major fraction (later assigned to 111 and 114, see Table 21), and two 
other compounds accounting for a smaller quantity (0.1-0.2 eq.). In the 1H NMR spectra, the 
major products 111 and 114 are identified by a singlet (NCH3) at 3.90 and 3.96 ppm, resp. and 
a quadruplet (NCH2) for 111 at 4.1 ppm and for compound 114 more downfield at 4.2 ppm. 
The deshielding observed for analogue 114 indicated an extra electron withdrawal by a 
carbonyl group (e.g. compounds 112, 113 and 114 in Figure 27). A complex mixture of singlet 
signals between 3.4 and 3.7 ppm hinders the assignment of methyl signals (corresponding 
with the [OMe]- or [MeCO3]- anions, cations 111-113, or the zwitterion 114.  
113 114111 112
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Figure 27: Proposed analogues of imidazolium cations formed during quaternisation of 1-ethyl-2H-4,5-
dimethylimidazole (41a) with DMC. 
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Aromatic 1H NMR signals (indicating a C2 proton) were only found for the entries containing 
starting imidazole (at 7.30 ppm) (entries 1 and 2, Table 21) and for the anion exchanged salts 
(after addition of a Brønsted acid). These singlets were not found in the mixtures containing 
no starting materials (entries 2, 3 and 5), although all tetraalkyl-2H-imidazolium ionic liquids, 
methylated via standard procedures (e.g. with alkyl halogenides or methanesulfonate esters), 
have specific aromatic singlets with accurate integration. Since spectra of freshly prepared or 
concentrated CDCl3 solutions of CILs did contain an aromatic signal (integrating for less than 
one proton), the absence of the aromatic singlets is attributed to H/D exchange of the C2 
proton with the deuterated solvent, promoted by the basicity of the anions (Scheme 46).  
Hence, in the presence of carbonates, the CDCl3 (pKa: ±15)[167] can be deprotonated and 
immediately receives a deuterium/proton back (pKa1(H2CO3): ±6, pKa2(H2CO3): ±10).[165c] The 
loss of the aromatic singlet in the 1H NMR spectra by hydrogen-deuterium (H/D) exchange is 
very fast and does not need any heating. Hence, the exchange is promoted by the carbonate 
anions and the excess of deuterated solvent. Upon abstraction of the deuterium by the 
carbonate, the latter can donate this deuterium atom (for MeCO3D) or either a proton or 
deuterium (for HCO3D) to any basic site (originating from the solvent or the cation) in the 
mixture. The analogous reaction happens at the exchangeable proton sites at the imidazolium 
cation (Scheme 46). This means that after a short time, all [HCO3]- anions are deuterated, and 
are hence not visible in the 1H NMR spectrum (Scheme 46). The loss of this singlet is 
experimentally confirmed in CDCl3 (pKa: ±15)[167], but also in CD3CN (pKa: ±31),[69] although 
they have been reported in literature at 9.6 ppm in DMSO-d6 (pKa: ±35).[69, 165c] 
 
Scheme 46: Equilibrium of the carbonate ionic liquid with the carbene and fast H/D-exchange in CDCl3. Note that 
deuteration of the carbonate molecule occurs via the anion. 
In several trials, a solid fraction of the residue obtained after solvent evaporation was found to 
be insoluble in acetone, hexanes, diethylether, but proved to be soluble in chlorinated solvents 
and protic solvents, as well as in hot acetonitrile. Therefore, this solid fraction was 
recrystallised in an acetonitrile:acetone (3:1) mixture, or washed with an acetonitrile:acetone 
(1:1) mixture. The resulting crystals were obtained in 7 to 21% yield in the first crop. After 
solvent evaporation of the mother liquor, subsequent and important crops of crystals form over 
time, yielding successive crops (up to 4 times, total yield 40-50%). 
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1H NMR analysis of the crystals allowed the elucidation of the reaction mixture spectra and the 
assignment of the signals. In CDCl3, two compounds were present, i.e. the hydrogen 
carbonate salt 44h (with cation 111) and the carboxylate 114. The ratio of the compounds was 
always ca. 3:1, respectively. No change is noticeable over time (72h), but upon mild heating of 
the CDCl3 solution (60 °C, 2h), the amount of 114 decreases, to eventually disappear (vide 
infra). In 13C NMR, the major compound 44h has peaks in the range of other 2H-imidazolium 
salts (Spectrum B, Figure 29), but distinctive here are an intense signal at 160 ppm 
(accounting for [HCO3]-) and the broad peak for C2 at 136 ppm, which correlates with a proton 
singlet at 9.64 ppm. The smaller signals in Spectrum B belonging to the carboxylate 114 are 
the peak of C2 at 141 ppm and a relatively large carboxylate peak at 156 ppm. The 
composition of the solid is verified by the complete transformation in the pure ionic liquid upon 
addition of a Brønsted acid, regenerating the imidazolium 2H signal.  
The group of Rogers have earlier observed the presence of two components (the carboxylate 
and methyl carbonate salt) in DMSO-d6 NMR spectra of [C4mim][MeCO3], and attributed this 
to the presence of these two compounds in the reaction mixture.[162] Therefore, the here 
obtained solid fraction was first believed to be either the 3:1 mixture of the hydrogen 
carbonate salt (44h) and carboxylate (114) or alternatively, the pure hydrated carboxylate 
([C2m3im-COO].H2O), which decomposes into the hydrogen carbonate salt (44h) upon 
dissolution in CDCl3. Nonetheless, single crystal X-ray diffraction data (analyses performed at 
the department of Inorganic and Physical Chemistry, University of Ghent) showed that the 
obtained crystals were the pure 1-ethyl-3,4,5-trimethylimidazolium hydrogen carbonate salt 
([C2m3im][HCO3], 44h), in which the anion pairs are stabilised by H-bonding towards each 
other and the cations by -stacking (Figure 28). The crystals do not contain the crystal water 
reported by the group of Rogers.[165c, 168]  
 
Figure 28: Single crystal X-ray diffraction image of the [C2m3im][HCO3] salt 44h. 
Given the formation of the pure 44h ([C2m3im][HCO3]) salt as a crystalline solid, the 
carboxylate zwitterion 114 observed in the 1H NMR spectra of these crystals in CDCl3 is 
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formed in situ by thermodynamic stabilisation and water expulsion (Scheme 47). Since no 
carboxylate is formed in D2O and only a very small amount in CD3OD, the carbonate salts 44e 
([C2m3im][CH3CO3]) and 44h are better stabilised in these solvents. Moreover, the amount of 
expelled water upon dissolution of the 44h in CDCl3 could hinder the complete carboxylate 
formation via a dynamic equilibrium (Scheme 47). The recurring 3:1 ratio of hydrogen 
carbonate 44h vs. carboxylate 114 observed in CDCl3 might be an indication of the 
stabilisation of the expelled water by three hydrogen carbonate molecules. 
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Scheme 47: Acid-base equilibrium between hydrogen carbonate imidazolium salt (44h) and the unstable carbene 
(115a) which is trapped as the corresponding carboxylate (114). 
An equilibrated formation of the carboxylate (114) from the dissolved methyl carbonate salt 
(44e) formed during the reaction, and the subsequent transformation into the hydrogen 
carbonate crystals (44h), explain the successive low yielding crops of crystalline 
[C2m3im][HCO3]. The solid product 44h is removed from the equilibrium and its formation is 
dependent on the reaction with air moisture or water present in the reaction or recrystallisation 
solvents (Scheme 48). 
 
Scheme 48: Equilibrium of the imidazolylidene carboxylate (114) with the methyl carbonate salt (44e) and the 
hydrogen carbonate salt (44h). 
This proposed conversion was experimentally confirmed. Upon dissolution of the powder or 
crystals in MeOH and subsequent evaporation, a liquid is obtained, in which only the methyl 
carbonate salt 44e was observed by 13C NMR (Spectrum A, Figure 29). Upon consecutive 
dissolution of the mixture in water and evaporation, the hydrogen carbonate was once again 
obtained, shifting the carbonate C=O 13C-signal again back from 159 ppm ([MeCO3]-) to 160 
ppm ([HCO3]-). This proves the possibility of the interconversion as shown in Scheme 48.[165c] 
The reactivity of the carboxylate with regard to protic, nucleophilic solvents, demonstrates the 
influence of solvent choice and presence of water on the product outcome.  
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Figure 29: 13C NMR spectra (CDCl3) of the formation of the methyl carbonate (44e) in the presence of MeOH 
(Spectrum A) and 1-ethyl-2H-3,4,5-trimethylimidazolium hydrogen carbonate (44h) in equilibrium with the 
carboxylate (114) (Spectrum B). 
The efficient interconversion also shows that, upon mild evaporation, the carbonate anions do 
not decompose and an equimolar amount of CO2 remains present independent of the 
carboxylate formation. Although this conversion reaction of the anions can be accelerated via 
the carboxylate 114, as shown in Scheme 48, the carboxylate is not necessary as 
interconversion of anions was observed in the [C2Ci3m3im]+ salts too (from 47e to 47f). 
c) Carboxylate formation and synthesis  
Since almost no CO2 is lost upon dissolution of the crystalline [C2m3im][HCO3] and most of the 
carbonate anions can be regenerated from the carboxylate, it seems that the imidazolylidene 
carbene immediately forms a carboxylate. As the chances of dissolved CO2 and a free 
carbene colliding are very slim, the decomposition of H2CO3 might be promoted by the 
nucleophilic carbene,[169] to form the carboxylate at once (i.e. negligible lifetime of the 
intermediate 115a in Scheme 47). This can be supported by the calculated energies of 
formation for carboxylates from carbenes and CO2, which show no activation energy barrier at 
all.[170]  
As seen in Scheme 48, the carboxylate 114 is rapidly transformed into the hydrogen 
carbonate salt 44h by addition of protic solvents and the reverse reaction is only likely upon 
evaporation. The lower ratios of 44h to 114 sometimes obtained in the reaction mixtures 
(Table 21) are attributed to the high reaction temperature which favours the anion 
decomposition (S > 0), leading to formation of CO2 and an increase of the solution alkalinity. 
Note that this is a reversible anion decomposition, as the CO2 cannot be lost in the 
pressurised vials and is stored as the carboxylate. Furthermore, increased temperatures (175 
vs. 170 °C) led to higher ratios of 44h to 114. 
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Although the carboxylate is thermodynamically favoured over the hydrogen carbonate[165c] and 
even more stable when the N-substituents are not bulky and allow for a planar p-orbital 
overlap,[170] it was not possible to isolate the carboxylate. This was attributed to the formation 
of the solid hydrogen carbonate salt 44h. 
Except for very bulky imidazolylidene derived carboxylates, only the N,N’-dimethylimidazolium 
carbonate is solid and sufficiently stable to precipitate from solution (Scheme 45). In general, 
imidazolylidene carbenes have a very high affinity for CO2 and therefore, 2H-imidazolium ionic 
liquids combined with basic anions (e.g. [C4mim][OAc]) are excellent for the chemisorption of 
carbon dioxide.[171] The zwitterionic carboxylates themselves are also of particular interest, as 
they have already been applied in the synthesis of hydrogen carbonate ILs (which are 
commercially available as CBILS©),[165c] or directly in IL syntheses,[168] as easy to handle pre-
catalysts[172] and as CO2 transfer reagents in carboxylation reactions.[173] 
4.2.3) Basicity of the CILs and [Cl]- formation 
As mentioned in the previous section, upon mild heating and/or extensive evaporation of the 
CDCl3 solution the intensity of the carboxylate (156 ppm) and the [HCO3]- signals (160 ppm) 
are reduced in the 13C NMR spectrum. In both cases the carboxylate and carbonate signals 
eventually disappear completely, indicating the loss of CO2. After evaporation of the CDCl3 
mixture, a solid is obtained. This solid could be recrystallised, although the molecular structure 
was not clear. It is to say that the formation of [OMe]- or [OH]- salts, due to loss of CO2 
(Scheme 49), is unlikely. First, the 2H-imidazolium hydroxides are unstable (non-existing)[174] 
and second, alkoxide anions are unlikely to be formed in the presence of the imidazolylidene 
carbene.[170] Moreover, the [OH]- and [OMe]- anions are not experimentally observed in 
combination with the 2H-imidazolium cation, although [C4mim][OMe] was reported by Seddon 
and Earle, with the 13C NMR signal (of a neat sample) for the anion at 42.3 ppm (in CDCl3).[155] 
 
Scheme 49: Decomposition of the hydrogen carbonate salt upon heating to form the hydroxide salt and the 
imidazolylidene carbene. 
The solids obtained are analysed by single crystal X-ray diffraction and are found to be the 
[C2m3im][Cl] salt (Figure 30). This remarkable result is explained by the alkaline action of the 
salts on chloroform residues originating from NMR sampling or recrystallisation (Scheme 50). 
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Upon abstraction of the proton of CHCl3,3 one chloride is expelled to form dichlorocarbene 
(reaction 1), which forms consecutively the unstable dichloromethanol and formylchloride 
(reactions 2 and 3). The latter decomposes rapidly into carbon monoxide (CO) and a chloride 
anion. Overall, 3 [OH]- anions are converted to 3 [Cl]- anions, with formation of water and CO 
(reaction 5). 
In contrast to the H/D exchange, the formation of the [Cl]- salt is not readily established, i.e. 
13C NMR spectra of carbonate salts can be recorded in CDCl3. On the contrary, it requires 
evaporation and heating. The proton transfer required during carboxylate formation and H/D 
exchange in CDCl3 prove that both the imidazolium cation and CDCl3 can be deprotonated. It 
is believed that upon heating and evaporation of the solution, decomposition of the dihydrogen 
carbonate (H2CO3) leads to the increase of the concentrations of CCl3- (pKa: ±15)[167] and/or 
the more basic imidazolylidene carbene (pKa: ±25 (DMSO); pKa: ±36 (CH3CN))[69, 175]. The 
loss of the dihydrogen carbonate as a proton source, allows the chloroform to decompose to 
the dichlorocarbene. On the contrary, in the presence of neutral carbonates, the CCl3- anion is 
immediately protonated (pKa1(H2CO3): ±6, pKa2(H2CO3): ±10)[165c], hindering the complete 
decomposition. Scheme 50 shows that exact one molecule of H2O is needed to establish the 
decomposition of one CDCl3 molecule (and transformation of three anions), therefore, after 
evaporation and decomposition of the carbonate anion, contact with air might provide 
sufficient water to establish the complete anion transformation. 
 
Figure 30: Single crystal X-ray diffraction image of the [C2m3im][Cl] (44k) salt. 
                                                          
3 Note that the proton abstracted from chloroform mentioned throughout this section can also be a 
deuterium ion. Analogously, chloroform mentioned can be deuterochloroform, and the single crystal X-
ray diffraction analyses do not distinguish between deuterium or hydrogen. 
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Scheme 50: Degradation reactions of chloroform in alkaline medium.[176] 
The 2-isopropylimidazolium and 2-methylimidazolium chloride salts cannot be retrieved in the 
same way. To control whether the carbonate anions can possibly deprotonate chloroform to 
create chloride anions and carbon monoxide (see Scheme 50), the 2-alkylimidazolium 
derivatives were boiled in CHCl3. However, no formation of the chloride salt occurrs, i.e. the 
carbonate peak does not disappear. Although for the [C2C1m3im]+ salt, some decomposition of 
the cation is observed, the [HCO3]- signal remains visible on 13C NMR. It seems that the 
imidazolylidene carbene is necessary to accomplish degradation of chloroform. Hence, during 
the heating process, the carbonate decomposition is aided by the carboxylate formation, 
eventually leading to the basic carbene, prior to chloroform decomposition. Alternatively, after 
evaporation of the volatiles, the basic carbene is left, deprotonates freshly added chloroform 
and stabilises the newly formed chloride anion. 
The chloride and carbonate salts can be clearly distinguished by their large difference in 
melting points and by infrared absorption spectra. The chloride salt [C2m3im][Cl] (Tm: 250 °C) 
has characteristic absorption peaks at 2953 and 1937 cm-1, while the hydrogen carbonate salt 
[C2m3im][HCO3] (Tm: 149 °C) has a broad absorption peak at 1617 cm-1. Furthermore, once 
the [Cl]- salt (44k) is formed, the aromatic singlet can be emerged in the 1H NMR spectrum 
after shaking the CDCl3 solution with a drop of water (Scheme 46), this is not the case for the 
[HCO3]- salt. 
4.2.4) N-Protonated imidazoles 
In entries 10 to 13 (Table 20, p84), in which the reaction was preliminary stopped after three 
or six hours, 15% to 75% of the end product was found, while no starting material was 
observed in the 1H NMR spectrum (in CDCl3). In the spectrum, peaks analogous to the free 
imidazole were shifted slightly upfield, although here an N-methyl peak was missing. This 
spectrum is typical for protonated imidazoles (117), which are proposed to be formed by 
neutralisation of MeCO3H, originating from DMC and water (Scheme 51). The amount of 
protonated imidazole found, indicates the amount of MeCO3H present in the reaction mixture. 
This in turn indicates the minimum amount of water, present in the solvent or 
dimethylcarbonate, needed to react with DMC (up to 0.85 eq. H2O vs. 1-ethyl-2-isopropyl-4,5-
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dimethylimidazole (41d) in entry 12 in Table 21). Formation of MeCO3H during work-up could 
be excluded since the protonated imidazoles were not always found in experiments where 
unreacted imidazole was still present (e.g. entries 1, 2 and 4). This indicates that (i), elevated 
temperatures are needed for the substitution reaction of DMC by water, (ii) a significant 
amount of DMC is consumed by water present in the mixture and (iii) protonated imidazoles 
can react further by the presence of the basic anions in the reaction mixture.[177] 
 
Scheme 51: Formation of hydrogen methyl carbonate (118) by reaction of water with DMC. The methyl carbonate 
anion deprotonates the hydrogen imidazolium cation (117) and liberates CO2 and a free imidazole, which can be 
methylated to form the N-methylimidazolium methyl carbonate salt (47e). 
The proposed hypothesis was verified by reacting 1-ethyl-2,4,5-trimethylimidazolium 
hydrochloride salt (43b) with dimethyl carbonate (Scheme 52). Protonated imidazolium salts 
cannot be quaternised with MeI, although by using DMC as methylating agent, the salts can 
be successfully quaternised. Here, this is probably due to catalytic amounts of water present, 
forming monomethyl carbonate. This means that monomethyl carbonate is sufficiently weak 
as a base to liberate the imidazole, allowing the latter to react with freshly formed MeCl or 
dimethyl carbonate. The monomethyl carbonate is formed by an anion exchange between 43b 
and 45e, therefire, only a trace of water is needed. The reaction to form 45i proceeded very 
clean, quantitatively and was completed in three hours, giving a white powder. This illustrated 
that any 1H-imidazolium salt, containing the desired anion in stoichiometric amounts, can be 
methylated by reaction with DMC to form the N-methylimidazolium salt with the desired anion. 
 
Scheme 52: Quaternisation and in situ metathesis of 43b via neutralisation by the methyl carbonate anion. The 
latter needs only to be present in catalytic amounts, as it is regenerated from compound 45e. 
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As mentioned in the imidazole purification section, the hydrochloride salts of peralkylated 
imidazoles are often solid and can be recrystallised, making this method very interesting 
towards the synthesis of the chloride salts, which was also experimentally confirmed for the 
chloride salt 44k (using equal amounts of solvent, catalyst, dimethyl carbonate and the same 
temperature as for the methylation reaction of 1-alkylimidazoles). 
4.2.5) Carbon dioxide formation 
Upon opening of the sealed pressure vial, in every experiment for every imidazole analogue, a 
substantial amount of CO2 evolved. The sealed vials were always pressurised and had to be 
opened carefully. Only at -78 °C, the evolution of gas from the liquid phase can be supressed. 
Given the multiple side products obtained upon quaternisation of the 2H-imidazole derivatives 
with DMC (vide supra) and the large amount of CO2 formed, methylation was initially assumed 
to proceed at least partially with the involvement of compound 120 (Scheme 53). However, 
trials at lower temperatures (140 °C) to selectively promote SN,Ac, did not allow to observe any 
reaction with the compounds 41b,d at all.  
 
Scheme 53: Proposed CO2 formation via SN,Al and SN,Ac of imidazoles with DMC (R = Me, iPr). 
In preliminar work on dimethyl carbonate alkylation, Tundo stated that the alkylation reaction 
(SN,Al) is irreverisble as the formed methyl carbonate anion decomposes to CO2 and [MeO]-
.[178] Later, Holbrey et al. proposed that the anion only decomposes upon protonation.[164] This 
can be confirmed by the present work, i.e. carbonate anions do not degrade during the 
reaction or over time. Since during the described experiments, water is found to play an 
important role, the most plausible explanation for the CO2 formation, is the reaction of water 
with DMC, to form H2CO3, which decomposes to water and CO2. 
4.2.6) Metathesis of the CILs 
After crystallisation and filtration of the 1-ethyl-2H-3,4,5-trimethylimidazolium hydrogen 
carbonate ([C2m3im][HCO3]) salt, it could be applied successfully in metathesis reactions with 
Brønsted acids, such as acetic acid, lactic acid or aqueous HNTf2 (80%). Hereby, CO2 gas 
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evolved and the temperature of the mixtures slightly increased. To assure complete reaction, 
the products were stirred in distilled water and heated to 50 °C overnight.  
Dicyanamide salts could not be obtained via the corresponding Brønsted acid, nonetheless, 
the ammonium salt (52b) could be applied in the metathesis reaction. Ammonium 
dicyanamide can be synthesised by percolating a NaN(CN)2 solution through an acidic ion 
exchange resin (high sodium affinity), which is neutralised with an ammonium solution prior to 
the exchange reaction (Scheme 54).[179] After evaporation of the collected aqueous solution, 
NH4N(CN)2 is obtained as a white powder in good purity (as analysed by elemental analysis). 
This process is possible on a large scale, although stoichiometric amounts of ion exchange 
resin are needed and the recyclability of the resin was not investigated. 
 
Scheme 54: Metathesis with ammonia to form ammonium dicyanamide (NH4N(CN)2) via an ion exchange resin. 
The most straightforward metathesis reaction is with aqueous HNTf2. The use of HNTf2, which 
is cheaper with regard to its lithium salt, is more environmentally benign since no carcinogenic 
quaternisation agents are used and no stoichiometric amounts of lithium salts are formed as a 
by-product. Here, a small excess of the bis(trifluorosulfonylmethyl)imide acid leads to rapid 
and complete conversion, while the remainder of the acid can be evaporated.  
Upon application of the more hygroscopic acetic or lactic acid, problems regarding the 
stoichiometry of the metathesis reaction arise. Namely, even after extensive evaporation, the 
anion signals in 1H NMR integrations are too large (accounting for ca. 1.2 eq.), probably due 
to strong intermolecular (H-bonding) interactions. The excess of acid originated by faulty mass 
calculation of the Brønsted acid and/or the carbonate salts, comprising a mixture of anions, 
which are not always visible by NMR. Although the removal of the carbonate anion can be 
monitored by 13C NMR, detection of minute excesses of acid cannot be achieved by standard 
spectrometric and spectroscopic methods such as NMR, IR, LC, GC or MS. Only Elemental 
Analysis (EA) can prove that the compound is pure, on condition that the compound is solid, 
which was not the case for the acetate or lactate salts. 
Alternatively, the stoichiometry can be improved by addition of solid ammonium or calcium 
salts, or by the direct quaternisation of recrystallised protonated imidazolium salts, such as 
imidazolium hydrochloride salts (vide supra). The latter method uses protonated imidazolium 
salts which exist of equimolar amounts of imidazole and the desired Brønsted acid, given 
these compounds are solid and can be recrystallised. 
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4.3. Conclusions 
Completely substituted imidazoles can successfully be methylated using dimethyl carbonate. 
Although K10 Montmorillonite is found to be an excellent catalyst, which allows complete 
conversion without formation of side products, the high temperatures applied still lead to very 
intense colouration. In the case of the 2H-imidazolium salts, the product is solid and can be 
recrystallised to obtain a colourless compound. In the case of the liquid 2-alkylimidazolium 
salts, the product can be washed with Et2O in CH3CN or with EtOAc in demineralised water. 
The carbonate anions are stable and do not decompose under ambient conditions, unless a 
carboxylate can be formed. This carboxylate is formed from a carbene, which reacts 
immediately with the mutually formed H2CO3. The carbene derived from [C2m3im][HCO3] has 
a very high affinity for CO2 and the resulting carboxylate is thermodynamically favoured, 
although unstable in contact with air or nucleophilic and protic solvents. The presence of this 
compound in the reaction mixture was confirmed by 1H NMR analysis in CD3OD, while the 
amount is strongly dependent on the solvent. The formation of the carboxylate is more 
pronounced in chloroform and might be the crucial step in chloroform decomposition to form 
the chloride anion. 
The carbonate salts are reactive species, which will transform when dissolved in different 
solvents or left open at ambient air. Thus, [imidazolium][MeCO3] forms the (sometimes 
crystalline) [imidazolium][HCO3] when in contact with air moisture. The conversion of the 
[MeCO3]- to the [HCO3]- anion is observed in water, while in the presence of methanol, the 
methyl carbonate anion is stable. 
The methanesulfonate ionic liquids were found to be easily prepared via microwave 
irradiation. Except for the 2H-imidazolium salt, the methanesulfonate ionic liquids were all 
room temperature ionic liquids. After metathesis with sodium dicyanamide, the by-product 
sodium methanesulfonate and the excess sodium dicyanamide could be precipitated and 
removed via filtration. The ICP-MS analysis of the obtained ionic liquids showed that this 
procedure allowed a complete removal of sodium salts from the ionic liquids. 
To conclude, a comparison between the silver, the methanesulfonate and dimethyl carbonate 
mediated ionic liquid synthesis methods is given in Table 22. Here, it is shown that both 
toxicity and resource usage are considerably reduced by applying imidazolium 
methanesulfonate salts in ionic liquids. One drawback is that chloroform is used to completely 
precipitate NaOMs, although in the silver mediated metathesis of iodide ionic liquids, also 
dichloromethane is applied to precipitate remainders of AgI. ICP-MS analyses of synthesis 
experiments where other solvents are used to precipitate NaOMs, might allow to circumvent 
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this problem, although a hydrophobic solvent allowing ionic liquid dissolution is the solvent of 
choice.  
In the dimethyl carbonate based metathesis, no halogenated solvents are required, although 
here the main drawbacks are the high temperature, long reaction times and colouration of 
liquid samples (solids can be recrystallised). Dimethyl carbonate, which is the methylating 
agent, is also used as a solvent and is not disposed in the atmosphere due to its relatively 
high boiling point (Tb DMC: 90 °C). For the preparation of dicyanamide ionic liquids, a two-step 
metathesis is needed, since ammonium dicyanamide (NH4N(CN)2) is prepared prior to the 
ionic liquid metathesis (just as AgN(CN)2 is prepared from NaN(CN)2 prior to metathesis). 
Table 22: Comparative study between the silver based, methanesulfonate and dimethyl carbonate based 
quaternisation and metathesis methods of a 10 gram sample. 
 Method 
[Cation][I] + 
AgN(CN)2 
[Cation][OMs] + 
NaN(CN)2 
[Cation][CH3CO3] + 
NH4N(CN)2 
Quaternisation 
Solvent 100 mL CH3CN 10 mL CH3CN 2 mL MeOH[a] 
Conditions 0 °C, 12h 80 °C (9W), 1h 170 °C, 24h 
Methylating agent 
2.6 eq.  
MeI 
1.1 eq.  
MeOMs 
3 eq.  
DMC 
Removal of excess 
methylating agent 
evaporation extractionl evaporation 
Metathesis 
Reaction steps 2 reaction steps 1 reaction step 2 reaction steps 
By-product AgI (insoluble) NaOMs (hydrophilic) MeOH, CO2 
[a] Large scale experiments were not conducted, therefore the solvent volume given is calculated. 
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5. Biodegradability of ionic liquids 
5.1. Introduction 
Apart from clean synthesis and an inherently green application, a greener chemical should be 
designed for degradation.[180] This implies (i) rational design of products to enhance the 
environmental decomposition and (ii) complete understanding of the end-of-life fate of ionic 
liquids as part of their properties before the introduction in new technologies. The study on the 
biodegradability of ionic liquids is increasing and was initiated by the group of Gathergood and 
Scammells.[181] It is known that biodegradability of ionic liquids is in general very low, although 
ester functionalities can increase the biodegradability (Figure 31). The amount of 
(eco)toxicological reports on ILs increased by e.g. the research of Stolte[182] and here it 
appears that the toxicity exceeds that of conventional molecular solvents (IC50 ten-folds lower 
than for dichloromethane), aggravating with increasing N-alkyl chain length. The influence of 
the N-alkyl chain length is apparent on both toxicity and biodegradability and they both 
increase spectacularly for n=4, to increase gradually on going to n=8.[183] 
 
Figure 31: N-propyloxycarbonylmethyl-substituted imidazolium octylsulfonate (121) 
as the first readily biodegradable ionic liquid.[184] 
Aquatic toxicity of chemical compounds is related to the biodegradability, not only for its 
environmental fate, but also for potential removal in wastewater treatment plants (WWTP). 
Thus, a decreased growth of microorganisms upon addition of ionic liquids to activated sludge 
systems is already observed, indicating a cytotoxic effect of the compounds.[183a, 185] 
Unfortunately, the (aquatic) toxicity of the peralkylated ILs was not assessed. 
The newly synthesised completely substituted imidazolium ionic liquids are evaluated on their 
environmental impact, in collaboration with Dr. Ewa Liwarska-Bizukojc. Dr. Liwarska-Bizukojc, 
collaborator at the Institute of Fermentation Technology and Microbiology at the Łódź 
University of Technology, has gained expertise on the biodegradability of imidazolium ionic 
liquids and the study of their influence on activated sludge systems.[186]  
The behaviour of the peralkylated ionic liquids in activated sludge systems is evaluated in two 
ways. First, the ready and inherent biodegradability of the ionic liquids is evaluated based on 
standard methods of the Organisation for Economic Cooperation and Development (OECD), 
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the Closed Bottle Test (OECD 301D)[187] and the Zahn-Wellens/EMPA test (OECD 302B), 
respectively.[188] Second, the oxygen uptake rate (OUR) is evaluated. 
In the Closed Bottle Test, 5 mg L-1 of the ionic liquid is added as the only carbon source to a 
mineral nutrient solution containing a small inoculum of a mixed culture. In this test, the 
inoculum is the final clean water effluent of a municipal wastewater treatment plant in Zgierz, 
Poland. The biodegradation is then monitored every 7 days by the dissolved oxygen 
concentration (DO) via a modified Winkler titration. This allows the calculation of the ratio of 
oxygen consumption (corrected with a blank for the pure inoculum) to the total calculated 
chemical oxygen demand (COD). The biodegradability of organic chemicals is described as 
readily biodegradable if the oxygen consumption exceeds 60% of the COD in 28 days and 
within a time-span of 10 days after the lag-phase. Due to high dilution in this test, exceeding 
toxicity threshold limits of the compounds on the microorganisms is prevented. A drawback of 
this test is the possible perturbation of the oxygen consumption by nitrification. 
Compounds that are not readily biodegradable are evaluated on the inherent biodegradability, 
which implies a decrease of at least 20% of dissolved organic carbon (DOC) after 28 days and 
a gradual decrease in time. The tetra- and penta-alkylimidazolium salts are evaluated using 
the Zahn-Wellens/EMPA test. Here, the chemical compound is brought in an aerated and 
agitated solution at 50 mg L-1 containing a relatively large amount of carefully prepared 
activated sludge (ca. 490 mg VSS L-1)4, collected from the aeration chamber of the Zgierz 
wastewater treatment plant. The biodegradation is monitored by the DOC level, which is 
analysed with an IL550 TOC-TN analyser (Hach Lange). In this test too, a negative result 
does not exclude the biodegradation of the compound in a diluted solution containing other 
carbon sources. Both tests are run in parallel with a reference compound, sodium 
dodecylsulfate (SDS), in order to monitor the activated sludge activity and to calculate the net 
oxygen consumption realised by the tested compound. 
The oxygen uptake rate and Monod kinetics of the biodegradation of the peralkylated ionic 
liquids is studied in a batch bioreactor. The tests are performed by introducing a synthetic 
waste water containing 300 mg of peptone, 100 mg of sodium acetate, 50 mg of potassium 
monophosphate, 50 mg of sodium bicarbonate, 50 mg of ammonium dihydrogen phosphate, 5 
mg of magnesium sulphate and 5 mg of sodium chloride per litre in the bioreactor. To this 
synthetic waste water is added biomass, taken from the laboratory activated sludge system, 
which is adapted to this synthetic wastewater, to a concentration of 2.2 mg of DOC mg VSS-1 
                                                          
4 VSS: Volatile Suspended Solids: the volatile amount by incineration of Total Suspended Solids (TSS, 
dry mass of non-dissolved solids in the activated sludge). 
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as well as allylthioureum to inhibit nitrification.[189] Typical IL runs are performed by addition of 
50 mg L-1 of ionic liquid to the synthetic waste water. Apart from these tests, two types of 
control tests are made, a type I control is the same as the typical IL tests but without the 
addition of ionic liquid, while type II of the control runs are performed with the ionic liquid as 
the sole carbon source, removing peptone and sodium acetate from the composition of the 
synthetic wastewater. During the experiments, DO and OUR are monitored online via an 
optical dissolved oxygen probe (ProODO™, YSI Environmental) combined with analytical 
software. The measured DO and OUR allow the calculation of Monod kinetics, i.e. the 
maximum specific growth rate µmax and the saturation constant KS.[190]  
5.2. Experimental results 
In a first assessment, four different tetra and penta-alkylated imidazolium iodide salts are 
tested on their biodegradability. The structures, given in Figure 32, demonstrate that the 
analogues have different C2 substitution or an increased N-alkyl chain when combined with a 
C2 proton. 
 
Figure 32: List of N-alkylimidazolium ionic liquid analogues used in the biodegradation tests. 
In the Closed Bottle Test, the ready biodegradability is evaluated on small concentrations with 
minimal inoculum. The measurements of the DO with a 7-day interval, allow to calculate the 
degree of biodegradation. As demonstrated in Table 23, no ionic liquid biodegradation is 
observed in the first 14 days, while the reference compound sodium dodecyl sulfate is 
biodegraded for about 80%. After four weeks, the degree of biodegradation is the highest 
(9.1%) for the analogue bearing the N-hexyl chain (48a) and the lowest (2.1%) for the 2-
methyl compound 45a. Therefore, none of the compounds can be classified as readily 
biodegradable. 
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Table 23: Mean degree of biodegradation with standard deviation (%)  
during the Closed Bottle Test at 7-day intervals. 
t (d) 44a 45a 47a 48a SDS 
7 0 0 0 0 75.4±3.58 
14 0 0 0 0 79.5±2.14 
21 1.70±0.51 0 1.42±0.46 1.13±0.22 81.0±1.75 
28 6.23±2.4 2.11±1.4 6.64±1.34 9.07±0.95 86.8±2.47 
In the agitated and aerated Zahn-Weller/EMPA test, the decrease in DOC is only 1.8 to 2.7% 
for the ionic liquids while the reference compound SDS shows a DOC decrease of 99.9% after 
28 days. Here too, the highest loss is found for the N-hexyl substituted compound 48a. 
Isocratic UPLC analyses show no decrease in IL concentration for the compounds 44a, 45a 
and 47a, while the concentration of compound 48a decreases by 33%. This test also allows 
the evaluation of adsorption by analyses of a sample after three hours of aeration. A fast 
decrease (not gradually in time) in concentration indicates adsorption processes taking place. 
Only N-hexyl analogue 48a (3.5%) and the reference compound SDS (35.1%) show 
adsorption. 
During the oxygen uptake rate (OUR) tests, the oxygen concentration and uptake rate is 
monitored for activated sludge systems containing one of the four ionic liquids. The control 
tests of type I and sample runs containing compounds 44a, 45a and 47a show µmax and KS 
levels in the same range of municipal waste water, while for compound 48a, the µmax slightly 
exceeds this range and the KS value is about the threefold of the values obtained in the other 
runs (including the blank run), although still within the range of normal municipal waste water. 
This indicates that first, the presence of ionic liquids do not hinder the growth of the activated 
sludge system and second, a low biodegradation of compound 48a is obtained, increasing the 
available carbon substrate and hence also the growth rate. In the type II OUR tests, the 
oxygen uptake rate never exceeds 1 mg O2 l-1 h-1, which indicates that the ILs are not 
accessible as the sole carbon source. This was observed earlier in the non-peralkylated IL 
[C4mim][Br] as well.[184] 
Table 24: Mean values of maximum specific growth rate (µmax) and saturation constant (KS)  
with standard deviation in the type I OUR test. 
 44a 45a 47a 48a SDS 
µmax (h-1) 0.115±0.030 0.157±0.083 0.114±0.021 0.553±0.143 0.105±0.017 
Ks (mg O2 l-1) 10.09±1.43 9.93±0.71 12.08±1.26 30.23±8.83 10.77±1.28 
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In conclusion, an increased biodegradability is obtained for the 2H-imidazolium salts (44a and 
48a) and N-hexyl substituted imidazolium salts (48a). Among the lower biodegrading 
compounds 45a and 47a, the 2-isopropyl substituted compound (47a) shows the highest 
degradation in the Closed Bottle Test. Two phenomena are therefore proposed: (i) substitution 
with longer alkyl chains on the nitrogen and on the cation core in general, increase the 
lipohilicity and hence increase adsorption and biodegradation, (ii) the presence of a C2 proton 
increases the biological affinity for the compounds. 
The overall results clearly indicate that ionic liquids are very poorly biodegradable and 
environmentally persistent, although not toxic to the activated sludge system. Ionic liquid 
contamination of water streams should be avoided and post-processing of contaminated 
aqueous waste streams is necessary in order to avoid the compounds to break through the 
WWTP system. 
5.3. Future analysis 
The cooperation between the departments of Sustainable Organic Chemistry and Technology 
of Ghent University and the Institute of Fermentation Technology and Microbiology of Łódź 
University of Technology, is launched in 2012 and will encompass future work on selected 
analogues to investigate the role of structure and properties on the environmental fate of ionic 
liquids. A list of ten new compounds is therefore already mutually composed. 
 
Figure 33: List of N-ethyl and N-hexyl substituted imidazolium ionic liquid analogues to be tested on 
biodegradability. 
Figure 33 shows the iodide and bis(trifluoromethylsulfonyl)imide salts of N-ethyl and N-hexyl 
peralkylated imidazolium cations which will be studied to compare N-ethyl with N-hexyl salts. 
Most probably, the increasing biodegradability by increased hydrophobicity (observed 
between compounds 44a and 48a, Figure 32) will be confirmed in this way. More interesting, 
this allows the investigation of the contribution of the C2- and N-substituents by a comparison 
of the pairs (44a, 48a), (45a, 49a) and (47a, 51a). If for every pair an equivalent 
biodegradability increase is observed when substituting the N-ethyl analogue for the N-hexyl 
analogue, then the increased biodegradability might be attributed mainly to the N-substituent 
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alone. However, when the increase is more pronounced for the 2H-imidazolium pair (44a, 
48a), then the overall hydrophobicity is the major factor, as the change in overall 
hydrophobicity is the largest for the pair (44a, 48a). Finally, it is not excluded that actually the 
biggest difference in biodegradability is found in the 2-alkylimidazolium pairs, which would 
indicate a dominating effect of the C2 proton, allowing biological adsorption. 
Second, in this future part also the bis(trifluoromethylsulfonyl)imide analogues (45b, 49b and 
51b) will be investigated. Here, the influence of the potential toxic anion and the low water 
solubility will be assessed. Nonetheless, the influence of the anion on the aquatic toxicity has 
been found to be absent,[183a, 185] except for octylsulfate anions, which increases 
biodegradability for both imidazolium ([C4mim]) and ester-functionalised imidazolium salts 
(121, Figure 31), in the Closed Bottle Test to 25 and 49%, respectively.[183b] Therefore, 
possible ion exchange should be taken into consideration, i.e. biological adsorption of the 
imidazolium cation and dissolution of the bis(trifluoromethylsulfonyl)imide anion. An additional 
quantification of the dissolved [NTf2]- anion might be of added value here. 
Finally, the contribution of N-alkoxy substituents to the environmental fate of the ILs will be 
evaluated (Figure 34). The ether functionalities introduce an extra interaction and reaction 
site, and might induce biodegradation via the alcohol and oxidation of the latter. Furthermore, 
the alkoxy side chain and an alkyl chain are isoelectronic, however, ether functionalities 
decrease the KOW of imidazolium ILs (decrease of hydrophobicity).[191] By incorporation of an 
allyl functionality on the oxygen, both reactivity and lipophilicity are increased remarkably, 
therefore compounds 63b and 63c are expected to have an increased biodegradability. 
 
Figure 34: List of N-alkoxy substituted imidazolium ionic liquid analogues to be tested on biodegradability. 
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6. Imidazolium liquid metal salts 
At the department of Chemistry of KU Leuven, research is on-going on the synthesis of Ionic 
Liquid Metal salts. This type of compounds is developed from metal ions ligated with neutral 
bases. The increment of cation size with these neutral ligands decreases the Coulombic 
forces. Aided by weakly coordinating anions, metal salts with melting points in the workable 
range are obtained. Thus, liquid metal salts are developed which possess the qualities of ionic 
liquids (low volatility, high conductivity) and have a very high metal concentration. These 
compounds possess very high current densities and hence are extremely useful in 
electrochemical metal deposition. 
In this way, already liquid copper salts are obtained. These salts are ligated by acetonitrile and 
have a chemical formula which is [Cu(CH3CN)4][NTf2].[192] Also silver liquid metal salts have 
been synthesised and investigated, here the metal cation is combined with neutral, 
monodentate bulky amines such as tert-butylamine and piperidine or the bidentate 
ethylenediamine.[193] 
The achieved procedures for the incorporation of different functionalities allows the evaluation 
of these moieties in the liquid metal salt synthesis. An array of earlier synthesised imidazoles 
is completed by 1-allyl-2H-4,5-dimethylimidazole (41i) and 2H-1-(2-methoxethyl)-4,5-
dimethylimidazole (41j) (Figure 35). Thus, a series of 3 imidazoles bearing different 
substituents on the C2 position and a series of 4 imidazoles with varying N-substituents can 
be used for comparative investigation. 
 
Figure 35: Imidazole analogues probed for liquid metal salt synthesis. 
The newly designed 2H-1-methoxyethyl-4,5-dimethylimidazole (41j) is achieved in moderate 
yields (42%), analogous to the earlier obtained imidazoles. After work-up of the 1-allyl-2H-
imidazole synthesis, a second compound is observed. The desired N-allylimidazole could not 
be isolated by fractional distillation. 1H NMR spectra showed that this second compound also 
includes an allyl group (accounting for 17% in 1H NMR) and was therefore proposed to be the 
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product of a rearrangement (Scheme 55), induced by the high temperatures and alkaline 
conditions. Analogous thermal rearrangement reactions in N-allylimidazoles were observed by 
Begg et al. (Scheme 56).[90] In this case, the concerted mechanism via a [3,3] sigmatropic 
rearrangement and a subsequent [1,5]-H sigmatropic shift was experimentally confirmed. An 
exact mechanism (free radical, sigmatropic) could not be designated by the authors. In this 
case, the alkaline conditions might have led to the formation of 123. This anion might be 
involved in a [2,3] sigmatropic rearrangement. Although the upfield shifts in both 1H and 13C 
NMR (in CDCl3) and the absence of a corresponding aromatic proton signal strongly suggest 
the formation of the isomer 125, the LC-MS spectrum of the mixture did not confirm the 
presence of this compound. 
 
Scheme 55: Proposed side product formation via base induced rearrangement mechanism. 
 
Scheme 56: Formation of 4-allylimidazole (127) by consecutive thermal [3,3] and [1,5]-H sigmatropic 
rearrangement reactions and 2-allylimidazole (128).[90] 
Fortunately, the desired N-allyl compound 41i could be isolated via recrystallisation of the 
imidazolium hydrochloride salt in 29% yield. However, the side product could not be isolated 
from the mother liquor, and is therefore believed to be degraded due to the acidic conditions. 
Synthesis of the 1N-(2-allyloxyethyl)-2H-4,5-dimethylimidazole (41l), in a similar way as for the 
1N-(2-allyloxyethyl)-2-isopropyl-4,5-dimethylimidazole (59d), was unsuccessful (Scheme 57). 
Since the alcohol (41k) could not be isolated in a pure form, the crude mixture was further 
used. The combination of impure alcohol and reaction of the base with the C2 proton is 
believed to lead to side products formation and yield decrease. 
 
Scheme 57: Transformation of the imidazolyl-ethanol (41k) into the (2-allyloxyethyl)-4,5-dimethylimidazole (41l). 
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Table 25:Composition and melting points of liquid metal salts. 
Liquid metal salt Imidazole R1 R2 Tm ( °C) 
[Ag(C2m3im)2][NTf2] C2m3im (41a) Ethyl H 81 
[Ag(C2C1m3im)2][NTf2] C2C1m3im (41b) Ethyl Me 94 
[Ag(C2Ci3m3im)2][NTf2] C2Ci3m3im (41d) Ethyl iPr 76 
[Ag(C6m3im)2][NTf2] C6m3im (41e) Hexyl H [a] 
[Ag(CAm3im)2][NTf2] CAm3im (41i) Allyl H [a] 
[Ag(C2O1m3im)2][NTf2] C2O1m3im (41j) Methoxyethyl H 51 
[a] Compounds are liquid at room temperature. 
The synthesised silver liquid metal salts are composed of a monovalent silver ion and the 
provided imidazoles and they have the general formula [Ag(imidazole)2][NTf2]. Four of the 
designed metal salts are solid at room temperature (Table 25), and the trend in their melting 
points is completely analogous to the trends observed in the melting points of the ionic liquids 
based on the respective imidazoles (see Table 5 and Table 12). The melting point of the 
N-methoxyethyl substituted derivative, being relatively low, confirms that the introduction of 
the methoxyethyl moiety induces crystallinity without increasing the melting point 
exceptionally. 
Holding the liquid samples at -60 °C for a prolonged period did not lead to any crystal 
formation. This demonstrates the increased undercooling properties of hexyl and allyl 
substituted imidazolium salts. The formation of salts with melting points above room 
temperature allowed crystallisation and single crystal X-ray diffraction analysis. Although the 
asymmetric unit only consist of half of the anion and cation, a complete picture is given in 
Figure 36. 
Figure 36: Single crystal X-ray diffraction image of [Ag(C2C1m3im)2][NTf2].
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IV) PERSPECTIVES 
The application of the microwave reactor in the quaternisation reaction of peralkylated 
imidazoles with methyl methanesulfonate was successful due to the pressurisation and 
precisely controlled temperature. This suggests to investigate this reaction in continuous flow. 
In this way, temperature and pressure can also be precisely regulated. The application of 
continuous flow would further allow to synthesise these ionic liquids on an industrial scale. 
The investigation of continuous flow hydrogenation with the X-Cube™ reactor (section V.1) 
has just initiated. Extensive research on novel system set-up, e.g. combination of diverse 
immobilized (bio)catalysts, will definitely lead to very efficient synthesis methods. Moreover, 
installation of on-line monitoring probes, e.g. based on IR or UV, can give an enormous amount 
of data. An automation of the data collection and preferably also of the experimental parameter 
variation allows for the collection of large data sets of reaction properties. 
Some of the alkyl-, alkenyl- and alkoxyimidazolium ionic liquids showed excellent stabilities. 
This property can be exploited, especially in the case of the chiral alkoxyl substituted 
analogues. Here, the influence on the reaction outcome can be investigated, e.g. the 2-
isopropyl derivatives can be evaluated in addition reactions with organozinc or 
organomagnesium compounds (Scheme 58).  
 
Scheme 58: Evaluation of asymmetric induction during organomagnesium addition by the chiral ionic liquid. 
Because of the weakly acidic C2 proton, complexation with transition metals can be achieved 
with the 2H-imidazolium derivatives (Figure 37). Thus, chiral imidazolylidene ligands can be 
applied in coordination chemistry. Alternatively, liquid metal salts with different substitution 
patterns can be designed, leading to different properties. The application of these compounds 
in electrodeposition can then be investigated. 
 
Figure 37: Chiral coordination complexes based on a C-linked imidazolylidene carbene and an N-linked imidazole. 
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V) APPENDIX 
1. Continuous flow analysis of catalysts 
In the framework of the MAPIL project, the collaborators at the department of Surface 
Chemistry and Catalysis and the department of Metallurgy and Materials Engineering (KU 
Leuven) developed a strategy for the electrochemical synthesis of a copper gauze supported 
Raney Nickel catalyst. The thus designed catalyst was mounted on the continuous flow 
system (ThalesNano X-Cube™) present at the department of Sustainable Organic Chemistry 
and Technology (UGent) to analyse catalyst activity over time. Furthermore, the use of the 
Raney Nickel catalyst in various types of hydrogenation reactions (e.g. hydrogenation, 
debenzylation, …) was evaluated. 
Hydrogenation in continuous flow systems has recently gained interest, thus, (multistep) 
syntheses involving hydrogenations with H2 on heterogeneous catalysts have been described 
by the group of Kappe and others.[194] In the references cited, the ThalesNaNo H-Cube™ 
system is applied, very similar to the further discussed ThalesNano X-Cube™ system. The 
general success of continuous flow lies in the use of high temperatures and gas pressures, 
which are only applied on small volumes in small channels, allowing for fast heat and mass 
transfer. Second, reactive or hazardous intermediates formed in situ are reacted immediately, 
hence the need for purification or safety measurements are reduced. Finally, continuous flow 
processes allow an easy introduction of immobilised catalysts and a straightforward expansion 
to production scale.[195] 
1.1. The X-Cube™ flow reactor 
The X-Cube™ flow reactor is demonstrated in Figure 38 andFigure 39. The reagent solutions 
are pumped in the stainless steel tubing (which represents the system) by means of two high 
pressure (HPLC) pumps (1, 2). The system pressure (psys) can be set per 5 bar, up to a 
maximum of 150 bar. The tubing of the two pumps is connected to a mixer, after which the 
inlet pressure (pin) is monitored via the inlet pressure sensor (3). The tubing is subsequently 
connected to the top compartment via the gas mixer (5), which is also connected to the gas 
check valve (4). The gas/liquid mixture is then pumped through the bubble detector (6), 
CatCart® (Catalyst Cartridge) holder 1 (7) and cartridge holder 2 (8). The cartridges can be 
mounted and dismounted easily, changed for inert cartridges and can be heated from 20 to 
200 °C in 5 °C intervals, separately. For all experiments with a commercial CatCart, the 
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bubble detector was connected directly to cartridge 2. Finally, the mixture is pumped to the 
system pressure sensor (9) and the system valve (10), to which the outlet is connected. 
 
Figure 38: Photograph of the X-Cube™ system. Top: user interface, centre: cartridges with insulation caps, gas 
valve and bubble detector, bottom: HPLC pumps. 
 
Figure 39: Schematic representation of the X-Cube™ system. 
The parameters are set via the user interface, adjustable are: pump (A,B) speeds v1 and v2 
(min. 5 mL min-1 total), system pressure (psys) and the temperature of the cartridge holders 
(C1, C2). C1 can be used to preheat the reactant mixture in between 10-15 °C above TC2 (see 
Table 26), the catalyst cartridge is loaded in C2 and the connecting tubing is insulated.  
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The pressure relation is given by: 
 ݌୧୬ ൌ ݌ୱ୷ୱ ൅ ݀݌ୱ୷ୱ (Equation 4)
 ݌gas ൌ ݌୧୬ ൅ ݀݌୥ୟୱ (Equation 5)
 
݌୥ୟୱ ൌ ݌ୱ୷ୱ ൅ ݀݌ୱ୷ୱ ൅ ݀݌୥ୟୱ
⇒݌ୱ୷ୱ ൑ ݌୥ୟୱ െ ݀݌ୱ୷ୱ െ ݀݌୥ୟୱ
 (Equation 6)
The inlet pressure (pin) provided by the pumps is dictated by the set system pressure 
parameter (psys) and the pressure drop over the system (dpsys), which is dependent on the 
solvent, catalyst, system set-up and the pump speed. On the one hand, the minimum gas 
pressure (pgas) to open the check valve, until the bubble detector (B) detects 1-10% bubbles, 
needs to be higher (with dpgas: 6-10 bar) than the pressure applied by the pumps (pin). On the 
other hand, the gas pressure (pgas) is limited by the relief valve of the cylinder (pgas ≤ 50 bar), 
hence dictating the maximum system pressure (psys) (equation 6). Gas evolution is manually 
measured by recording the time to fill a 8 or 100 mL recipient, i.e. 1.9 mL min-1 for psys = 15 
bar and 3.7 to 4.4 mL min-1 for psys = 30 bar, accounting for respectively 17 and 33 to 40 eq. 
H2 vs. a 10 mM or 1.4 to 3.3 eq. H2 vs. a 120 mM concentration of acetophenone. 
1.2. Hydrogenation with supported RaNi  
During the MAPIL project, a revolutionary method was developed to produce a Raney Nickel 
(RaNi) catalysts tethered to a copper gauze support.[196] The development of a Raney Nickel 
catalyst on an inert solid support has several advantages over the conventional catalyst 
powder. (i) The fine powder is not easily separated from the reaction mixture, decreasing the 
recyclability and (ii) resulting in an unwanted contamination of the end-product with catalyst 
metal powder (e.g. in pharmaceutical formulations). (iii) In industrial applications, the leaching 
of the catalyst powder from a fixed bed reactor results in an activity decrease and (iv) in the 
clogging of reactor tubing and connections, leading to a backpressure build-up.  
  
Figure 40: X-Ray image of CatCart filled with Cu gauze supported RaNi (CSRN). 
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The Copper gauze Supported RaNi (CSRN) catalyst is brought into an empty CatCart (Figure 
40) with glass wool as packing material, to mount the catalyst in the continuous flow system. 
Subsequently, the hydrogenation of a model compound is monitored during long term 
experiments of at least 300 minutes. In this way, the activity can be studied in function of time 
which allows to decide whether leeching or activity decrease is apparent. 
During the experiments, a 10 mM acetophenone solution (Cin) in ethanol is hydrogenated with 
the parameters given in Table 26. The gas/liquid mixture is preheated by the inert C1 
cartridge, to obtain a homogenous temperature in cartridge C2 and to compensate the 
temperature loss during the C1 to C2 transfer. Effluent samples are collected at time intervals, 
which are carefully noted for all experiments. The undiluted effluent samples are analysed by 
the HPLC system, performing three LC-UV measurements of every sample (measurements at 
214 nm and 256 nm). After calibration to the concentration of the effluent products 
(acetophenone (AF) and 1-phenylethanol (PEA)) (see Figure 51), the average values of these 
three measurements are plotted (Figure 42, Figure 43) with error bars indicating the minimum 
and maximum of the recorded values. These error bars give an image of the analysis error of 
the LC-UV system (no standard deviation was calculated for only three measurements). 
Absorbance results at both 214 and 256 nm obtained from experiment 1-3, show that the 
trends are proportional. As the signal/noise ratio is greater for the former, the absorbance at 
214 nm is preferably monitored. 
Table 26: Conditions of continuous flow experiments with the CSRN cartridge. 
Exp. v (ml/s) Cin (mM) 
vin 
(µmol/min) 
TC1 / TC2 
( °C)[b] 
psys 
(bar) 
pgas 
(bar)[c] 
length 
(min) 
1-1 0.5 10 5 95/80 15 32-35 300 
1-2 0.5 10 5 95/80 15 32-36 300 
1-3 0.3[a] 10 3 135/125 15 32-37 400 
1-4 0.5 10 5 95/80 30 43-48 130 
1-5 0.5 10 5 110/100 30 43-49 600 
1-6 0.5 10 5 110/100 30 43-50 320 
1-7 0.5 10 5 110/100 30 43-51 470 
1-8 0.5 10 5 variable 30 43-51  
[a]Where v1 < 0.5 mL min-1: v2 + v1 = 0.5 mL min-1; [b]C2 is the catalyst cartridge,  
C1 is an inert preheating cartridge; [c]dpsys = 5-10 bar. 
The time to reach steady state conversion (tSS) is calculated by multiplying the residence time 
(tres) (dead volume/pump speed) with 1.6. Given an estimated dead volume of 8 mL, tSS is 
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25,6 min for all the experiments given in Table 26. Although tSS is intrinsic to the experiment 
and should be monitored for every set-up separately, all long-term experiments are found to 
be stabilised after 30 minutes (see plots of experiments 1-1, 1-2, 1-3 and 1-7 in the 
experimental section, Figure 54 andFigure 55).  
1.2.1) Catalyst activity 
Steady conversion is observed in exp. 1-1, 1-2, 1-6 and 1-7 with no trend in time. The 
variation in concentration, over the course of the experiment, is translated by the standard 
deviation (, see Table 27). 
Table 27: Resulting mean () and standard deviation () of AF and PEA effluent concentrations during 
experiments 1-1 to 1-7. 
 µ(CAF) (mM) (CAF) (mM) µ(CPEA) (mM) (CPEA) (mM) (CPEA Ctot
-1) 
(%) 
Exp1-1 7.27 0.38 2.91 0.26 29 
Exp1-2 7.97 0.70 3.23 0.40 29 
Exp1-3 1.69 0.64 8.65 0.53 84 
Exp1-4 6.90 1.06 3.50 0.82 34 
Exp1-5a ≤ 300 min 4.83 0.82 5.82 0.63 55 
Exp1-5b > 300 min 8.69 0.53 1.90 0.49 18 
Exp1-6 8.64 0.68 2.03 0.42 19 
Exp1-7 8.40 0.68 1.86 0.33 18 
The catalyst activity does not decrease within the time-frame of the experiments, i.e. 300-500 
min. Table 27 shows the effluent concentrations of the different experiments. While 
interexperimental variations in influent concentration Cin cannot be excluded, no significant 
changes in effluent concentrations (translated by the standard deviation  in Table 27) can be 
demonstrated. The influence of the gas pressure is only small, as the conversions during 
experiments 1-1, 1-2 and 1-4 (with different pgas, see Table 26) are about the same. However, 
the high temperature experiments 1-5b to 1-7 have lower conversion than the experiments 1-1 
and 1-2 (see Table 27). As conversion increases with increasing temperature (vide infra, 
Figure 43), the lower conversion observed here indicates a more important contribution of the 
equilibrium constants at high temperatures. During experiment 1-3, a small amount of a new 
compound is formed, demonstrated to be ethylbenzene by GC-MS. The formation of the latter 
compound will be elaborated in the next section. 
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To illustrate the changes of equilibria in the cartridge, an overview of the mean concentrations 
in the void volume (̅ܥ௑), absorbed numbers on the catalyst (ߠ௑∗ ), equilibrium constants (ܭ௑ ) 
and rate constants (ݎ௑ ) is given in Figure 41. Note that the concentrations in the cartridge 
follow a plug-flow regime, while for simplification, the concentrations in Figure 41 are the 
overall mean for the void volume. 
 
Figure 41: Schematic presentation of the plug flow reactor with mean concentrations (࡯ഥࢄ), equilibrium constants 
(ࡷࢄ) and rates (࢘ࢄ), amount of total adsorption sites (ࡺࡿ) and fraction of sites occupied by compound x (ࣂࢄ∗ ). 
For experiments 1-5b, 1-6 and 1-7, a constant desorption rate of PEA (r-3) is proposed. At 
steady state, the absorbed amount PEA on the catalyst (ߠ௉ா஺∗ ௌܰ, in moles PEA on the catalyst 
surface) is constant (= generation + adsorption – desorption): 
 ݀ߠ௉ா஺∗ ௌܰ
݀ݐ ൌ 0 ⇒ ݎ௥ ൅	ݎଷ െ ିݎ ଷ ൌ 0 (Equation 7)
If the contribution of adsorption of PEA is considered negligible vs. the desorption (r3 << r-3) at 
100 °C, then the desorption is equal to the generation: 
 r3 << r-3 ⇒ r-3 = rr (Equation 8)
If the difference in the PEA concentration in the liquid phase between the influent and effluent 
is expressed as ∆ܥ௉ா஺, the mean desorption rate r-3 and reaction rate rr in the cartridge are 
given as: 
 ݎ௥ ൌ ିݎ ଷ ൌ ∆ܥ௉ா஺ݐ௥௘௦ ൌ ∆ܥ௉ா஺
ݒ௧௢௧
௩ܸ௢௜ௗ
 (Equation 9)
Since Vvoid and tres are unknown, the mean reaction rate cannot be determined. Hence, for 
experiments 1-5b, 1-6 and 1-7, where Cin = 10 mM, ∆ܥ௉ா஺ ൌ෥ 1.90	mM (Table 27) and the 
production and specific activity are given in equations 10 and 11. The catalyst activity found 
here (for 110 °C) is comparable to that of the batch experiments performed at 80 °C by the 
collaborators of the department of Surface Chemistry and Catalysis (0.08 to 0.33 h-1). 
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 ݌ݎ݋݀ݑܿݐ݅݋݊ ൌ ∆ܥ௉ா஺ ሺݒ௧௢௧ሻ ൌ෥ 0.95 μmol.݉݅݊ିଵ (Equation 10)
 ܽܿݐ݅ݒ݅ݐݕ ൌ
݌ݎ݋݀ݑܿݐ݅݋݊
ܿܽݐ݈ܽݕݏݐ ݉ܽݏݏ ൌ 20 ߤ݉݋݈ ݉݅݊
ିଵ ݃ ܴܽܰ݅ିଵ 
ൌ 0.14 ݄ିଵ 
(Equation 11)
An anomaly is found during experiment 1-5 (Figure 42). A sudden increase of the 
acetophenone effluent concentration (CAF) is observed after 300 min, while the total 
concentration (CAF + CPEA) remains constant. A sudden change in parameters is excluded and 
a reduction of the catalyst activity is expected to give a gradual decrease and therefore not 
found plausible either. A competition effect of the increased hydrogen pressure from 15 to 30 
bar on the desorption kinetics should be visible in experiment 1-4 too, but here conversion is 
comparable to experiments 1-1 and 1-2. Extensive flushing of the catalyst with an EtOH/H2 
mixture prior to experiment 1-7 does not lead to the same high conversion as seen in 1-5a, 
showing that the initial high conversion in experiment 1-5 is not caused by a saturation of the 
catalyst by hydrogen. 
Alternatively, the higher conversion to PEA in 1-5a can be attributed to an adsorbed amount of 
AF on the catalyst, residual from experiment 1-4. Since the sum of the effluent concentrations 
remains quasi constant, this means that every adsorption site is immediately occupied by an 
acetophenone molecule. If this were to be the case, an additional 35.3 µmol of PEA is eluted 
from the CSRN Cartridge during the first 300 minutes. As the cartridge weight is 0.045 grams 
(ca. 0.7 mmol of supported Ni), the additional desorbed PEA is 5 mol% vs. the catalyst, hence 
not contradicting the hypothesis of desorption of residual PEA from a previous experiment. 
The long time to reach steady-state (tSS) might indicate an important temperature dependence 
of the adsorption/desorption equilibria. Although this is not experimentally verified, this 
observation is important because this means that during the probing of conversion 
dependence on temperature (as e.g. performed in experiment 1-8) every temperature should 
be held longer than 300 min. 
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Figure 42: Effluent concentrations during experiment 1-5 (red) and 1-6 (blue) of AF ( ), PEA ( )  
and the sum of both (●) with conditions as given in Table 26. 
In experiment 1-8 (Figure 43), the total effluent concentration significantly changes with 
varying temperature. Note that the raise in total concentration at 380 min is caused by 
switching of reagent solutions, while at 690 min, this is not the case. Although the increment of 
ܥ௧௢௧  after 690 min seems to be an analysis error, the effluent concentration exceeds the 
influent concentration over prolonged time. Once again, this significant change in effluent 
concentration occurs after 300 min The latter might indicate a higher desorption/adsorption 
ratio for higher temperatures, i.e. increasing temperature induces desorption of products 
adsorbed at lower temperatures. No side products are observed in the UV spectrum (200-400 
nm) of the samples.  
 
Figure 43: Effluent concentrations of AF ( ), PEA ( ) and the sum of both (●) in function of temperature during 
experiment 1-8 with conditions as given in Table 26 and TC2 as given in the graph (TC1 = TC2 + 15 °C). 
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1.3. Hydrogenation with commercial RaNi 
The activity of the copper supported catalyst (CSRN) is compared to the commercial Raney 
Nickel CatCart purchased from ThalesNano (batch n°: 02619) (TNRN). The information 
gathered could also be applied for reduction of other compounds. The influence of different 
parameters on the reduction of several acetophenone solutions was analysed. For best 
comparison, the system was evaluated with ethanol solutions (in experiments 2-1 and 2-2). 
Unfortunately, the pressure drop (݀݌ୱ୷ୱ) increased over time, obliging to use less adsorbing 
solvents such as hexanes during the temperature dependence experiment. The use of 
hexanes implies analysis of the samples by means of GC-FID; the calibration curves are given 
in the experimental section, Figure 52. Moreover, cartridge 1 (C1, Figure 39) is by-passed by 
connecting the bubble detector (B) to cartridge 2 (C2). 
From these analyses, it is immediately observed that the conversion is remarkably higher on 
the TNRN than on the CSRN cartridge, giving more than one compound (see Scheme 59). 
 
Scheme 59: Reduction and elimination of acetophenone (AF, 130) towards 1-phenylethanol (PEA, 131) and 
ethylbenzene (EB, 133) with H2 in a continuous flow setup with TNRN Raney Nickel catalyst. 
1.3.1) Reactant concentration and pump speed dependence 
The hydrogen concentration in the liquid phase, related to the partial pressure of H2 (pgas) is 
altered via the system pressure (psys) parameter. There is no influence of the partial pressure 
of hydrogen on the conversion for different pump speeds (the plot of the experiments is given 
in the experimental part, Figure 56). 
In a subsequent experiment, different influent concentrations of acetophenone beneath the 
desired concentration of 120mM are evaluated, (20 mM (blue) and 60 mM (red) in Figure 44). 
At these conditions, all starting material (AF, 130) is consumed. At 80 °C, a small amount of 1-
phenylethanol (PEA, 131) is collected, while most is converted to the alkane, ethylbenzene 
(EB, 133). At 100 °C, PEA is completely hydrogenated to form EB and starting from 100 °C, 
Continuous flow analysis of catalysts 
 120  
the EB concentration decreases by reduction of the aromatic ring, rendering the end product 
undetectable by UV (134). Remarkably, for the first experiments (80 and 100 °C at 0.5 mL 
min-1), the same conversion percentages are observed for both 20 and 60 mM solutions (e.g. 
75% EB formed at 100 °C and 0.5 mL min-1), indicating an incomplete occupancy of the 
catalyst surface. For higher temperatures or pump speeds, the ratios are no longer constant, 
as for a 60 mM AF solution reacted at 80 °C and 1.5 mL min-1, the EB/PEA ratio is smaller 
than for a 20 mM AF solution. This indicates a competition for adsorption sites between PEA, 
and freshly delivered AF. For the 20 mM solution the competition is smaller, allowing more 
PEA to be absorbed and hence more EB to be formed. The collected results for AF to PEA 
convertion, indicate that 120 mM concentrations can be applied at this pump speed and at 
about the same temperatures. 
 
Figure 44: Effluent concentration of PEA ( ) and EB ( ) during experiment 2-2 after reduction of acetophenone 
solutions of 20 mM (blue) and 60 mM (red) in EtOH at different parameters on a commercial RaNi (TNRN) 
cartridge. 
This plot also indicates that, although a 20 mM solution pumped at 1.5 mL min-1 and a 60 mM 
solution at 0.5 mL min-1 have the same reagent throughput per time unit, the effluent 
composition is completely different, i.e. conversions at high pump speeds are lower, due to 
smaller catalyst contact time (tres). 
1.3.2) Temperature dependence 
In Figure 45 the effluent concentrations of AF, PEA and EB are demonstrated for a reagent 
solution of 120 mM AF in hexanes. Between 20 and 70 °C, ܥ஺ி decreases equally with the 
ܥ௉ா஺ increase, they follow a quasi linear regime. Beyond 70 °C, ethylbenzene (EB) is formed 
at the expense of the formed PEA. The formation of ethylbenzene is found to be complete at 
110 °C. 
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The temperature dependence on the reaction rate and thus on the effluent concentration is 
related to the ab/adsorption equilibria and reaction constants, which are dependent on the 
temperature. This complex behaviour is accounted for in the basic Langmuir-Hinshelwood 
equation (equation 12), which is valid for bimolecular batch reactions on the surface of 
heterogeneous catalysts.[197] 
 ݀ܥ௉ா஺
݀ݐ ൌ
݇ܭுమܥுమܭ஺ிܥ஺ி
൫1 ൅ ܭுమܥுమ ൅ ܭ஺ிܥ஺ி൯
ଶ (Equation 12)
Here k, ܭுమ and ܭ஺ி are temperature dependent. In the continuous flow system however, the 
conversion-temperature relation is more complex, since during steady-state, the equilibrium 
concentrations are variable in function of the position in the catalyst cartridge and they are 
also dependent on the flow-rate, which supplies fresh reactants and drains formed products 
(see Figure 46). 
 
Figure 45: Concentration of AF ( ), PEA ( ) and EB ( ) in the effluent of the X-Cube™ flow reactor with the 
TNRN catalyst. Parameters are psys = 5 bar, v1 = 1.5 mL min-1 and Cin = 120 mM AF in hexanes. 
 
Figure 46: Schematic presentation of the plug flow reactor with mean concentrations (࡯ഥࢄ) and overall rates (࢘ࢄ), 
amount of total adsorption sites (ࡺࡿ) and fraction of sites occupied by compound x (ࣂࢄ∗ ). 
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While the temperature dependent conversion of AF to PEA is linear, an exponential function 
can be fitted to the conversion of PEA to EB. The conversion to EB only initiates when AF is 
no longer present, if AF is more readily absorbed than PEA, then here too, formed PEA is 
immediately desorbed by AF, competing for adsorption sites (analogous to experiment 1-5). 
Moreover, the exponential character of the conversion of PEA to EB indicates a negligible 
contribution of the adsorption/desorption to the kinetics beyond 70 °C. Presumably, the PEA 
which is still absorbed after the reduction of AF, is used directly in the subsequent reduction, 
without desorption (rr2 > r-3; Figure 46). Moreover, styrene (132) is never detected by GC-FID 
in any of the effluent analysis, therefore, if styrene is formed in the reaction, then a very fast 
alkene reduction is imperative. Although this is not improbable at temperatures > 70 °C, this 
would mean that all styrene ever present in the liquid phase is hydrogenated. Alternatively, if 
the formation of ethylbenzene proceeds via a cleavage of the C-O -bond, a stabilised 
ethylbenzyl radical is formed, which reacts on the catalyst surface with an adsorbed hydrogen 
atom to form ethylbenzene, circumventing the formation of styrene via an elimination reaction 
in a neutral environment. 
1.3.3) Catalyst activity 
In the acetophenone hydrogenation, the TNRN is far more active than the CSRN catalyst. At 
70 °C, the small CSRN converts approximately 10% of a 10 mM AF in ethanol solution at 0.5 
mL min-1, while the TNRN converts 100% of a 120 mM hexane solution at this temperature at 
1.5 mL min-1. Unfortunately, the exact weight of the packed catalyst in the latter cartridge is 
not known.  
1.4. Hydrogenation of ethyl pyruvate 
As mentioned in the chapter on chiral ionic liquid synthesis, continuous flow hydrogenation of 
ethyl pyruvate (Etpyr) is applied to obtain the racemic ethyl lactate. In order to achieve the 
highest possible conversion, the results obtained earlier on the acetophenone conversion are 
considered. Table 28 shows the necessary parameters for complete acetophenone and ethyl 
pyruvate conversion, the hereby obtained theoretical maximum production rate (g h-1) and an 
indication of solvent usage (mL h-1) (see Figure 45 and Figure 47). 
Table 28: Ideal parameters with total pumped solution (hexanes, 120 mM) and maximum theoretical production 
rate (g h-1) for complete conversion with the TNRN cartridge. 
 Mm (g/mol) Cin (mM) v (mL min-1) T ( °C) mL h-1 g h-1 
AF 120.15 120 1.5 70 90 1.29 
Etpyr 116.12 120 0.5 120 30 0.42 
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The temperature dependence of the hydrogenation of ethyl pyruvate (120 mM in hexanes) is 
evaluated in experiment 3-1, analogously to the acetophenone conversion. The resulting GC-
FID plot, given in Figure 47, for a pump speed of 0.5 mL min-1 indicates that for the ethyl 
pyruvate hydrogenation lower pump speeds and higher temperatures were required than for 
acetophenone hydrogenation. At temperatures higher than 110 °C, the total effluent 
concentration decreases, degradation products might here too be formed (cfr. ethylbenzene 
formation). 
 
Figure 47: Effluent concentrations of ethyl pyruvate ( ) and ethyl (rac)-lactate ( ) in function of time and 
temperature during experiment 3-1 with v1 = 0.5 mL min-1, Cin = 120 mM and TC2 (°C) as given in the graph. 
In a subsequent production experiment 3-2 (with Cin = 120 mM), a temperature of 120 °C was 
applied, see Scheme 60. The applied conditions are chosen as a compromise between high 
ethyl (rac)-lactate production and low residual ethyl pyruvate. The mean ethyl (rac)-lactate and 
ethyl pyruvate concentrations over experiment 3-2 are 104.9 and 10.5 mM, respectively, i.e. a 
conversion of 87%. 
 
Scheme 60: Hydrogenation of ethyl pyruvate to ethyl (rac)-lactate over the TNRN cartridge mounted on the X-
Cube™ continuous flow system. 
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1.5. Deprotection of bicyclic amines 
Bicyclic amino compound 135 was synthesised for research towards epibatidine analogues 
(potent analgesics) by a student researcher at the department of Sustainable Organic 
Chemistry and Technology of Ghent University. This compound 135 was subjected to 
hydrogenation, to achieve cleavage of the benzyl moiety towards the free amine 136 (Scheme 
61). Given the low conversion in the batch hydrogenation reactions, continuous flow was 
proposed in order to achieve higher hydrogen pressures and reaction temperatures. This also 
allowed to investigate the chemoselectivity of the catalyst. As the product solutions were very 
diluted (4.0 to 5.0 mM in ethanol), the smaller copper gauze supported RaNi (CSRN cartridge) 
was initially used for the first evaluations. 
 
Scheme 61: Envisioned deprotection of picoline-substituted bicyclic amine 135 towards the ketone 136. 
1.5.1) Copper gauze supported Raney Nickel 
In these first experiments using the CSRN cartridge, the influence of pump speed and 
temperature was investigated under a psys of 30 bar (Table 29 and Figure 48). Pump speeds 
were from 0.2 (mixed with 0.3 mL min-1 solvent to achieve the minimum pump speed of 0.5 
mL min-1) to 0.7 mL min-1. Temperatures were in the range of 80 to 170 °C 
Table 29: Conditions of different X-Cube™ experiments with the CSRN cartridge  
with psys = 30 bar and Cin = 4-5 mM in EtOH. 
Exp. v1 (mL min-1)[a] 
T1 
( °C) 
4-1 0.5 80 
4-2 0.2 80 
4-3 0.2 100 
4-4 0.5 120 
4-5 0.5 150 
[a] Where v1 < 0.5 mL min-1: v1 + v2 = 0.5 mL min-1.  
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Analysis of the LC-MS spectra of samples, taken at times beyond the calculated steady-state 
time (t > tss), showed the formation of different products, with different molecular masses, 
eluting at different retention times. Figure 48 shows the response of the mass spectrometer 
for the different reaction products (represented in the plot by their molecular ion, [M+H]+), for 
the different conditions given in Table 29.  
Experiment 4-1 indicated a low conversion at 80 °C, (demonstrated by the high peak of 
starting ketone, [M+H]+: 307) and formation of two products, the alcohol 138 ([M+H]+: 309) 
and an unknown product ([M+H]+: 311), which was later identified as compound 145 (see 
Scheme 63). In experiments 4-2 and 4-3, the increased residence time allowed a higher 
conversion and the formation of another product ([M+H]+: 219). The new product could be 
identified as the debenzylated alcohol 139 (Scheme 62). From 120 °C onwards, an additional 
product was formed ([M+H]+: 203). It was believed that elimination of the latter alcohol 
occurred, with formation of the alkane 140, (analogous to the PEA to EB convertion in 
Scheme 59 and Figure 45). The formation would have been fruitful, as the debenzylated 
alkane (137) is the actual end-product of the reaction sequence of which the envisioned 
deprotection step is only a part, as depicted in Scheme 61. Finally, at 150 °C, all starting 
material was consumed.  
 
Figure 48: Profile (via LC-MS) of effluent composition of X-Cube™ experiments 4-1 to 4-5 with the CSRN 
cartridge in a sample (t > 50 min). The conditions of the experiments are given Table 29. The composition of the 
products with different mass units is represented by the response of the mass spectrometer in arbitrary units 
(A.U.) calibrated by the influent concentration of the starting material. 
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Scheme 62: Reduction over Cu gauze supported RaNi (CSRN) of the ketone 135 with formation of the alcohol 
138 and debenzylated alcohol 139 and initially proposed dehydrogenation and reduction towards the desired 
alkane 140 during hydrogenation (with dashed arrow as this reaction was later excluded). 
Throughout all the experiments with the CSRN cartridge, mixtures were obtained. Upon 
increasing the temperature, the amounts of the products with [M+H]+ 203, 219 and 309 
increased gradually, while the concentration of the unknown compound ([M+H]+: 311) 
remained quasi constant (see Figure 48). 
In general it was found that the CSRN catalyst was not sufficiently selective for the 
debenzylation of the ketone 135 towards the product 136 (Scheme 61), but reduces the 
ketone prior to the debenzylation (Scheme 62). In the following trials, on the one hand, a Pd/C 
cartridge was evaluated in order to increase the selectivity towards the debenzylation 
(Scheme 61), and on the other hand the commercial Raney Nickel (TNRN) cartridge to 
achieve full conversion of all the intermediates towards the desired alkane end-product 137. 
However, concurrent batch experiments (performed by the collaborating researcher) revealed 
the actual structure of the compounds. These were found not to comprise the proposed 
alkane 140 but the bicycle octane 144, formed by ring opening and subsequent closure 
(Scheme 63, pathway A). Upon ring-opening, a ketone is formed, which can be reduced to the 
unreactive alcohol 145 via pathway B, which was earlier reffered to as the unknown 
compound with mass 311. 
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Scheme 63: Formation of 2-azabicyclo[2.2.2]-octane 144 via ring-opening of the 2-azabicyclo[2.2.1]-heptane 
during hydrogenation over the copper supported RaNi, with the formation of the side-product 145. 
1.5.2) Commercial cartridges 
Since many product intermediates were formed with the small Mapil copper gauze suported 
RaNi (CSRN), but no complete conversion was obtained, the more active commercial 
catalysts were evaluated at high temperatures. Upon application of the ThalesNano Raney 
Nickel (TNRN) cartridge, also a mixture of compounds was formed, of which the main part 
was the protected alcohol 138 ([M+H]+: 309).  
Table 30: Conditions of different X-Cube™ experiments, using commercial catalysts, Cin: 4-5 mM in EtOH. 
Exp. CatCart®, psys v (mL min-1) T ( °C) AcOH (eq.) 
4-6 TNRN,  
30 bar 
0.5 50 0 
4-7 0.5 50 5 
4-8 10% Pd/C,  
10 bar” 
1.0 20 5.71 
4-9 1.0 50 6.31 
 
The conditions applied during the different experiments with the commercial catalysts are 
given in Table 30. In comparison to the CSRN experiments, mild conditions (i.e. 50 °C, 0.5 mL 
min-1) already led to significant conversion. As represented in Figure 49, the TNRN cartridge 
did not allow complete conversion of product 135 ([M+H]+: 307) towards 138, nor was the 
starting material completely consumed. The end product 144 ([M+H]+: 203) was only observed 
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in minute amounts, while also the side product 145 ([M+H]+: 311) was formed. Upon addition 
of 5 equivalents of acetic acid (experiment 4-7), the reaction was accelerated, i.e. more 
starting material was consumed, more end product 144 was formed but the profile of the 
intermediates remained the same.  
 
Figure 49: Profile of effluent composition of X-Cube™ experiments 4-6 to 4-9 in a sample (t > 50 min). The 
conditions of the experiments are given Table 30. The composition of the products with different mass units is 
represented by the response of the mass spectrometer in arbitrary units (A.U.) calibrated by the influent 
concentration of the starting material. 
As still not all starting material was converted and the side product 145 was still formed, using 
the TNRN cartridge, the 10% Pd/C CatCart® (batch n°: 03729) was mounted in the X-Cube™ 
system for evaluation. The Pd/C catalyst was expected to selectively deprotect the amine. If 
this was to be the case, a system set-up would have been considered in which the Pd/C is 
mounted before the TNRN cartridge, in order to allow a debenzylation of amine 135, followed 
by a Raney Nickel catalysed reduction of the deprotected ketone 136. 
Hydrogenation over the Pd/C catalyst, at 1.0 mL min-1 and with addition of acetic acid led to 
the very efficient (at 1.0 mL min-1) formation of compounds 139 (minor) and 144 (major), via 
different pathways, while the third pathway towards the inert alcohol 145 is no longer present. 
At low temperatures (experiment 4-8), both pathways occur, while increasing the temperature 
converts the starting material completely and selectively to the rearranged 2-
azabicyclo[2.2.2]octane compound 144. 
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In experiment 4-9, only after 30 min a steady-state effluent concentration LC-MS profile was 
obtained. Assumed was first that the catalyst needed some time to reach the set temperature 
(50 °C) in its core, therefore the catalyst was preheated before pumping the product solution 
through the 10% Pd/C CatCart in exp. 4-10. Here too, a steady state time is needed (at 80 
min, still a small amount of starting material 135 could be seen, see Figure 50). Interesting to 
note is that the profile of the effluent at 4 min has a 10-fold lower MS-detection response for 
the starting material than the influent solution (not plotted). As here products are not yet 
eluted, this indicates that substantial amounts of the reagents and products are absorbed and 
retained for a significant amount of time on the catalyst surface. Hence, it is rather this 
adsorption phenomenon which contributes to the steady-state formation than the internal 
heating of the catalyst. 
 
Figure 50: MS absorbance vs. LC retention time for undiluted effluent samples of experiment 4-10 taken after 4 
to 180 min. TC2: 50 °C, psys: 10 bar, v1: 1.0 mL min-1 and Cin: 4.47 mM with 6.31 eq. AcOH (EtOH). The figure 
contains arrows with the compound numbers indicating the peaks. 
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1.6. Conclusions 
The reactor kinetics are complex as they are dependent on internal adsorption/desorption 
equilibria, and on the reaction rates and pump speeds. A significant contribution of the 
adsorption equilibria is observed when performing subsequent experiments at different 
temperatures. Therefore, additional long term production vs. temperature experiments are 
needed, especially for the TNRN. To better discriminate between adsorption and reaction 
rates, the activity (production rate) of the catalysts might be evaluated for an array of influent 
concentrations, thus adsorption site competition might become apparent. The conversion is 
not related to the gas pressure, hence the hydrogen gas is not the limiting reagent. At low 
ketone (acetophenone) vs. catalyst loading, alkanes are formed as side products, while the 
alkene is never observed. Increment of ketone concentration leads to less side product 
formation, by increased competition of absorption sites. In general, long-term experiments are 
needed to probe late steady-state formation. 
Apart from an autonomous continuous meso-scale reactor, the continuous flow system is a 
versatile tool for relatively fast analysis of reaction parameters, such as conversion vs. 
temperature profiles, conversion vs. time and production rate of a catalyst. For example, the 
large amount of reaction parameters evaluated during the debenzylation of the bicyclic amine 
led to a substantial amount of data and combined with the batch experiments, they gave an 
insight in the different pathways involved. However, conditions need to be fine-tuned in order 
to optimise production and hinder product degradation (e.g. elimination of PEA to EB). 
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2. List of compounds 
a) Peralkylated imidazolium Ionic Liquids 
 
more information in Table 4, p38 
 
 
 more information in Table 5, p42 
 
 
b) Alkoxy and alkenylimidazolium Ionic Liquids 
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more information in Table 11, p53 
c) Chiral Ionic Liquids 
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d) Alternative Ionic Liquid preparation 
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VI) EXPERIMENTAL SECTION 
1. Used reagents 
Allyl bromide (≥97%), allyl alcohol (≥98.5%), methyl methanesulfonate (≥99%), 
methanesulfonylchloride (≥98%), allylamine (≥98%), 2-aminoethanol (≥98%), 2-
methoxyethanamine (≥98%), -Trisphat tetrabutylammonium salt (≥98.5), ammonium chloride 
(≥99%), (R)-(−)-1-(9-Anthryl)-2,2,2-trifluoroethanol, (≥98%), ethyl L-lactate (≥98%), ethyl 
pyruvate (≥97%), dimethyl sulfate (≥99%), thionyl chloride (≥99%), D/L-alanine (≥99%), L-
alanine methyl ester hydrochloride (≥99%), L-glycine methyl ester hydrochloride (≥99%), L-
serine methyl ester hydrochloride (≥98%), sulfuric acid (95.0-98.0%), hydrochloric acid (37%), 
ethylamine (≥99.5%), n-hexylamine (≥99%), 2,3-butanedione (≥97%), propionaldehyde 
(≥97%), isobutyraldehyde (≥98%), ammonium acetate (≥98%), silver nitrate (≥99.0%), sodium 
dicyanamide (96%), lithium bis(trifluoromethylsulfonyl)imide (≥99.0%), KOH (90%), NaOH 
(≥97%), CD3OD (99.96 atom% D), D2O (99.99 atom% D), nBuLi (2.3 M in hexanes), 
iodomethane (≥99.0%), bromobenzene (99%), benzaldehyde (≥99%), diphenylmethanol 
(≥99%), bromoethane (≥98%), acetophenone (≥99%), Amberlite™  IR120, magnesium, 
tetrahydrofuran, methanol, ethanol, n-pentanol, acetonitrile, dichloromethane and ethyl 
acetate were purchased from Sigma-Aldrich, paraformaldehyde and acetaldehyde from 
ACROS Organics, acetone from Fisher Chemicals and acetic acid from Riedel-de Haën. 
Hydrogen gas (≥99.0%) was purchased from Air Liquide and hydrogen 
bis(trifluoromethylsulfonyl)imide (98%) from IoLiTec GmbH. Acetone and acetonitrile were 
dried over 3Å molecular sieves and CH2Cl2 was refluxed with CaH and distilled prior to use. 
Allyl bromide was distilled prior to use. Acetone was dried over 3Å molecular sieves, 
acetonitrile was dried over anhydrous alumina and stored over 3Å molecular sieves and 
CH2Cl2 was refluxed with CaH2 and distilled prior to use. THF was refluxed with sodium wire, 
containing benzophenone ketyl radical as indicator, and distilled before use. 
2. Equipment and methodology 
Batch pressurised reactions were performed in 15 mL and 150 mL glass pressure vials with 
PBT cap (Schott) and PTFE seal for reactions up to 20 mmol and 200 mmol respectively. 
Microwave reactions were performed in a CEM FocusedTM Microwave Synthesis System, 
Model Discover, with adaptable power from 0-300W, equipped with infrared thermosensor and 
monitored with the Synergy-software v. 1.32. Reagents were held in an 8 mL vial, sealed with 
snap-on PTFE septum. During the isothermal experiments the maximal power was set to 50W.  
The continuous flow reactor used during imidazole synthesis was a Cytos® CPC College 
System, mixing unit and residence time unit were retained at 120 °C. The internal volume of 
mixing unit and residence time unit was 48 mL, applied flow rate was 0.5 to 2.0 mL min-1. The 
continuous flow reactor used during the hydrogenation experiments was a ThalesNano X-
Cube™. Experiments were started (0 min) when gas was detected by the system. Cartridges 
were always insulated by the special cartridge insulation caps, and the connecting SS tubing 
by means of paper and aluminium foil.  
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1H NMR, 13C NMR, 19F NMR and HSQC experiments were performed with a JEOL ECP+ 300 
spectrometer in CDCl3 with as internal reference TMS, CH3CN or CFCl3 for 19F NMR 
experiments. IR spectra were recorded on a Perkin Elmer Spectrum FT-IR apparatus (ZnSe 
crystal; ATR mode). HPLC-MS spectra were recorded on an Agilent 1100 Series (ES, 4000 V) 
preceded by a reverse phase LC column (Eclipse plus C18 column). The LC column has 
dimensions of 504.6 mm and has a particle size of 3.5 µm. GC analysis were performed on 
a Agilent 6890 GC Plus Series, with an EC5 capillary column (30 m0.25 mm; coating 
thickness 0.25 µm) (injector temp.: 250 °C; carrier gas: He; flow rate: 1.0 mL min-1, temp. 
profile: 80-200 °C at 10 °C min-1, 200-280 at 30 °C min-1, 5 min hold at 280 °C; detector: FID). 
High resolution electron spray atmospheric-pressure chemical ionisation (ES/APCI) mass 
spectra were obtained with an Agilent Technologies 6210 Series Time-of-Flight. Elemental 
analysis was performed with a Perkin Elmer Elemental Analyser 2400 Series II, connected to 
an AD6 Autobalance and controller.  
The optical rotations were measured with a Jasco P-2000 Polarimeter, in an optical cell with 
3.5 mm ID and length 100 mm at the sodium D line (589 nm). The temperature control was on 
the cell liquid and samples were recorded between 24.92 and 25.08 °C. Every compound was 
dissolved in chloroform and concentrations are given (C = 0.3 to 1.0×10-2 g mL-1), although 
the specific optical rotation ( ሾߙሿ஽ଶହ ) is concentration independent. Three times a different 
sample of the solution was brought in the optical cell and measured three times, the results 
were analysed with the Jasco Spectra Manager v2. The mean and deviation of the specific 
rotation between the three different samples were reported (in ° dm−1cm3g−1), while the 
standard deviation within the three measurements of each sample were always smaller than 
0.5 °.  
The compounds suitable for single crystal X-ray diffraction were mounted on a nylon loop 
attached to a copper pin and placed into the cold stream of an Oxford Cryostream 700 at 
100(2)K on an Agilent SuperNova diffractometer using Mo Kα radiation (λ = 0.71073 Å). The 
absorption corrections were applied using CrysAlisPro.[198] All structures were solved using 
direct methods and refined by the full-matrix least-squares procedure in SHELXL.[199] All 
hydrogen atoms were placed in calculated positions and refined using a riding model. CCDC 
941088-941093 contains the supplementary crystallographic data. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. The program OLEX2 was also used in refinement and 
making pictures.[200]  
Cyclic voltammograms were recorded with a Solartron SI 1287 Electrochemical Interface 
(scanning rate: 50 mV/s; platinum work and counter electrodes; reference electrode was 
platinum wire submerged in 1-butyl-3-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide 
separated from the testing solution by a fritted disk and calibrated with Fc+/Fc). All CVs were 
recorded at 90 °C under an argon atmosphere, samples were dried prior to recording. Water 
contents were measured in Hydranal 34812 (Fluka) with a 719S Titrino coulometric Karl 
Fischer titrator (Metrohm). DSC measurements were done with a Mettler-Toledo 822 DSC 
apparatus (heating rate: 10 C min-1), and all samples were analysed under a dry helium flow. 
Viscosities were analysed with a Brookfield Viscometer DV-II Pro at 23 °C. The thermal 
stability of the ionic liquids were analysed by thermogravimetric analysis at a heating rate of 
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10 °C min-1 in alumina pans under an argon atmosphere (100 mL min-1 flow) using a SDT 
Q600 V8.3 Build 101 apparatus, the sample weight was between 5 and 15 mg. 
ICP analysis was performed on a Thermo Scientific iCAP 6000 Series ICP spectrometer. 
Calibration was performed with aqueous calibration matrix solutions of 2, 5 and 10 ppm based 
on the Chem-Lab n.v. Multi Element ICP Standard solution (10E). The elements recorded are 
Ca (3968, 744.7 nm), Cu (324.6 nm), Fe (259.9 nm), K (766.5 nm), Mg (279.6 nm), Na (589.6 
nm), Ni (221.7 nm), S (180.7 nm), Si (212.4 nm) and P (177.5 nm).  
3. Procedures and spectra 
3.1. Synthesis of tetra- and penta-alkylimidazoles 
Procedure for the synthesis of 1-ethyl-2-isopropyl-4,5-dimethylimidazole (41d): A glass 
150 mL pressure vial was filled with MeOH (50 mL) and a PTFE stirring bar. The solvent was 
allowed to cool to 0 °C and isobutyraldehyde (100 mmol, 7.21 g) and ethylamine (120 mmol, 
5.41 g) were added. The vial was closed and submerged in a preheated oil bath at 120 °C 
with temperature controller. After heating for 2h with vigorous stirring, the reaction mixture was 
carefully cooled to 0 °C, the vial was opened and consecutively 2,3-butanedione (100 mmol, 
8.61 g) and NH4OAc (100 mmol, 7.71 g) were added. The vessel was closed immediately and 
heated in a preheated oil bath at 120 °C for 2 h under vigorous stirring. After cooling, MeOH 
and the reaction water were removed in vacuo. The reaction mixture was dissolved in CH2Cl2 
and extracted twice with 100 mL of an aqueous 0.5 M HCl solution. The aqueous phase was 
alkalinised with 50 mL of 3.0 M NaOH and extracted three times with 40 mL of EtOAc. The 
resulting organic phase was washed with 100 mL of water and dried over MgSO4. The solvent 
was removed in vacuo and 6.97 g (41%) of a black oil was obtained. The resulting oil was 
purified by vacuum distillation, yielding a yellow oil, which was further used for the synthesis of 
ionic liquids. 
1-Ethyl-4,5-dimethylimidazole (41a): b.p. 52 °C (1.0 mbar); 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.37 (t, 3J(H,H) = 7.4 Hz, 3H; CH3CH2), 2.12 (s, 3H; CH3C4/5), 
2.15 (s, 3H; CH3C4/5), 3.83 (q, 3J(H,H) = 7.4 Hz, 2H; CH2), 7.33 ppm (s, 1H; 
C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.32 (CH3C4/5), 12.75 
(CH3C4/5), 16.21 (CH3CH2), 39.68 (CH2), 121.79 (CH3C4/5), 133.79 (CH3C4/5), 
134.04 ppm (C2CH); IR (ATR):  = 1351, 1383, 1415, 2920, 2971 cm-1; MS 
(ES): m/z (%): 125.3 (100) [M+H+]; yield: 40%, yellow oil. 
1-Ethyl-4,5-dimethylimidazole (41b): b.p. 58 °C (1.0 mbar); 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.24 (t, 3J(H,H) = 7.2 Hz, 3H; CH3CH2), 2.10 (s, 3H; CH3C4/5), 
2.15 (s, 3H; CH3C4/5), 2.34 (s, 3H; C2CH3), 3.77 ppm (q, 3J(H,H) = 7.2 Hz, 2H; 
CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.79 (CH3C4/5), 12.49 (CH3), 
13.18 (C2CH3), 15.71 (CH3CH2), 38.38 (CH2), 121.15 (CH3C4/5), 131.26 
(CH3C4/5), 141.72 ppm (C2CH); IR (ATR):  = 1311, 1375, 1350, 1413, 2919, 
2974 cm-1; MS (ES): m/z (%): 139.3 (100) [M+H+]; yield: 39%, yellow oil. 
1,2-Diethyl-4,5-dimethylimidazole (41c): b.p. 51 °C (1.0 mbar); 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.25 (t, 3J(H,H) = 7.2 Hz, 3H; CH3CH2), 1.32 (t, 3H, 3J(H,H) = 7.7 Hz; 
C2CH2CH3), 2.11 (s, 3H; CH3C4/5), 2.13 (s, 3H; CH3C4/5), 2.65 (q, 2H, 3J(H,H) = 7.7 Hz; 
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C2CH2), 3.78 ppm (q, 3J(H,H) = 7.4 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 8.70 (CH3C4/5), 12.46 (CH3C4/5), 12.70 (CH3CH2C), 16.02 
(NCH2CH3), 20.32 (C2CH2), 38.08 (NCH2), 121.06 (CH3C4/5), 131.29 (CH3C4/5), 
146.68 ppm (C2CH2); IR (ATR):  = 1068, 1311, 1353, 1376, 1429, 2972 cm-1; 
MS (ES): m/z (%): 153.3 (100) [M+H+]; yield: 37%, clear liquid. 
1-Ethyl-2-isopropyl-4,5-dimethylimidazole (41d): b.p. 60 °C (1.0 mbar); 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.26 (t, 3J(H,H) = 7.2 Hz, 3H; CH3CH2), 1.32 (d, 
3J(H,H) = 6.6 Hz, 6H; CH(CH3)2), 2.10 (s, 3H; CH3C4/5), 2.14 (s, 3H; CH3C4/5), 
2.94 (m, 3J(H,H) = 6.6 Hz, 1H; CH), 3.80 ppm (q, 3J(H,H) = 7.2 Hz, 2H; CH2); 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.76 (CH3C4/5), 12.66 (CH3C4/5), 
16.38 (CH3CH2), 22.25 (CH(CH3)2), 26.02 (CH), 37.80 (CH2), 120.68 (CH3C4/5), 
131.37 (CH3C4/5), 150.48 ppm (C2CH); IR (ATR):  = 1088, 1311, 1321, 1438, 2924, 2968 cm-
1; MS (ES): m/z (%): 167.3 (100) [M+H+]; yield: 42%, yellow oil. 
Optimised continuous flow procedure for the synthesis of 1-hexyl-2-isopropyl-4,5-
dimethylimidazole (41h): In an oven dried 500 mL flask containing dry CH2Cl2 (200 mL) were 
added isobutyraldehyde (0.5 mol, 36.05 g), hexylamine (0.5 mol, 50.60 g) and MgSO4 (1 mol, 
120.37 g). The mixture was allowed to stir overnight, protected with a drying tube (CaCl2). The 
reaction mixture was filtered and the solvent was removed in vacuo. The product was diluted 
with n-pentanol in a 1 L volumetric flask to 0.5 M. To a second 1 L volumetric flask containing 
n-pentanol were added diacetyl (0.5 mol, 43.05 g) and NH4OAc (0.5 mol, 38.53 g), the 
solution was diluted to 0.5 M with n-pentanol. Both volumetric flasks were connected to the 
pumps on the CYTOS® CPC. The flow rate was set to 1.2 mL min-1 on each pump (tres = 20 
min) after volumetric calibration. Upon obtaining steady state conditions (32 min), a red to 
black solution was collected, containing 0.087 M (35%) of the product, with a product output of 
2.55 g h-1. Vacuum fractional distillation was used to recuperate the solvent (85 °C, 60 mbar), 
the residual black oil was dissolved in CH2Cl2, and extracted twice with 500 mL of 0.5 M HCl, 
the aqueous phase was alkalinised with 250 mL of 3.0 M NaOH and extracted with 3100 mL 
of hexanes. The organic layer was dried with MgSO4 and the solvent was removed in vacuo, 
yielding 31.1 g of a black oil. This oil was fractionally distilled under a high vacuum to afford 
the product as a yellow oil (83-86 °C, 1.0 mbar). 
1-Hexyl-4,5-dimethylimidazole (41e): b.p. 83 °C (1.0 mbar); 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 0.88 (t, 3J(H,H) = 6.6 Hz, 3H; CH2CH3), 1.27-1.34 (m; 6H; 
(CH2)3CH3), 1.63-1.70 (m, 2H; NCH2CH2), 2.11 (s, 3H; CH3C4/5), 2.15 (s, 3H; 
CH3C4/5), 3.76 (t, 3J(H,H) = 7.4 Hz, 2H; NCH2), 7.31 ppm (s, 1H; C2H); 13C NMR 
(75 MHz, CDCl3, 25 °C, TMS):  = 8.44 (CH3C4/5), 12.78 (CH3C4/5), 13.99 
(CH3(CH2)5), 22.51 (CH2), 26.29 (CH2), 30.78 (NCH2CH2), 31.33 (CH2), 44.96 
(NCH2), 121.87 (CH3C4/5), 133.70 (CH3C4/5), 134.76 ppm (C2H); IR (ATR):  = 647, 1232, 
1450, 1500, 2954 cm-1; MS (ES): m/z (%): 181.3 (100) [M+H+]; yield: 38%, clear liquid. 
1-Hexyl-2,4,5-trimethylimidazole (41f): b.p. 84 °C (1.0 mbar); 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 0.89 (t, 3J(H,H) = 6.6 Hz, 3H; CH2CH3), 1.25-1.34 (m; 6H; 
(CH2)3CH3), 1.53-1.62 (m, 2H; NCH2CH2), 2.08 (s, 3H; CH3C4/5), 2.10 (s, 3H; 
CH3C4/5), 2.32 (3H, C2CH3, s), 3.68 ppm (t, 3J(H,H) = 7.5 Hz, 2H; NCH2); 13C 
NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.95 (CH3C4/5), 12.53 (CH3C4/5), 13.36 
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(C2CH3), 13.98 (CH3(CH2)5), 22.55 (CH2), 26.49 (CH2), 30.60 (NCH2CH2), 31.47 (CH2), 43.83 
(NCH2), 121.40 (CH3C4/5), 131.20 (CH3C4/5), 141.95 ppm (CH); IR (ATR):  = 726, 1128, 1413, 
1603, 2925 cm-1; MS (ES): m/z (%): 195.3 (100) [M+H+]; yield: 36%, yellow oil. 
2-Ethyl-1-hexyl-4,5-dimethylimidazole (41g): b.p. 86 °C (1.0 mbar); 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 0.89 (t, 3J(H,H) = 6.6 Hz, 3H; CH2CH3), 1.26-1.37 (m; 
6H; (CH2)3CH3), 1.53-1.62 (m, 2H; NCH2CH2), 2.09 (s, 3H; CH3C4/5), 2.13 (s, 
3H; CH3C4/5), 2.63 (q, 3J(H,H) = 7.5 Hz, 2H; C2CH2CH3), 3.68 ppm (t, 3J(H,H) = 
7.7 Hz, 2H, NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.92 
(CH3CH2C2), 12.63 (CH3C4, CH3C5), 13.97 (CH3CH2C2), 13.97 (CH3(CH2)5), 
22.56 (CH2), 26.55 (CH2), 30.89 (NCH2CH2), 31.48 (CH2), 43.54 (NCH2), 121.26 (CH3C4/5), 
131.35 (CH3C4/5), 146.91 ppm (C2CH2); IR (ATR):  = 1070, 1310, 1372, 1426, 2928, 2957 
cm-1; MS (ES): m/z (%): 209.3 (100) [M+H+]; yield: 32%, yellow oil. 
1-Hexyl-2-isopropyl-4,5-dimethylimidazole (41h): b.p. 86 °C (1.0 mbar); 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 0.90 (t, 3J(H,H) = 6.6 Hz, 3H; CH2CH3), 1.24-1.36 (m; 
6H; (CH2)3CH3), 1.31 (d, 3J(H,H) = 6.6 Hz, 6H; CH(CH3)2), 1.53-1.65 (m, 2H; 
NCH2CH2), 2.09 (s, 3H; CH3C4/5), 2.14 (s, 3H; CH3C4/5), 2.86-2.99 (1H, CH, m), 
3.70 ppm (t, 3J(H,H) = 8.0 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, 
TMS):  = 8.92 (CH3C4/5), 12.73 (CH3C4/5), 13.99 (CH3CH2), 22.28 (CH(CH3)2), 
22.57 (CH2), 26.05 (CH2), 26.57 (NCH2CH2), 31.27 (CH2), 31.48 (CH), 43.30 (NCH2), 120.19 
(CH3C4/5), 131.32 (CH3C4/5), 150.71 ppm (C2CH); IR (ATR):  = 1085, 1312, 1433, 2926, 2960 
cm-1; MS (ES): m/z (%): 223.3 (100) [M+H+]; yield: 40%, yellow oil. 
3.2. Synthesis of N-alkoxy- and N-alkenylimidazoles 
1-Allyl-2-isopropyl-4,5-dimethylimidazole (59a): b.p. 52 °C (1.0 mbar); 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.29 (d, 3J(H,H) = 6.9 Hz, 6H; CH(CH3)2), 2.05 (s, 
3H; CH3C4/5), 2.16 (s, 3H; CH3C4/5), 2.81-2.95 (m, 1H; CH(CH3)2), 4.38 (dt, 
3J(H,H) = 4.2 Hz, 4J(H,H) = 2.0 Hz, 2H; CH2), 4.79 (dtd, 3J(H,H) = 17.2 Hz, 
4J(H,H) = 2.0 Hz, 2J(H,H) = 1.1 Hz, 1H; CH=CHEHZ), 5.15 (dtd, 3J(H,H) = 
10.3 Hz, 4J(H,H) = 2.0 Hz, 2J(H,H) = 1.1 Hz, 1H; CH=CHEHZ), 5.87 ppm (ddt, 
3J(H,H) = 17.2 Hz, 3J(H,H) = 10.3 Hz, 3J(H,H) = 4.2 Hz, 1H; CH=CH2); 13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 8.58 (CH3C4/5), 12.70 (CH3C4/5), 22.11 (CH(CH3)2), 26.03 (CH(CH3)2), 
45.13 (NCH2), 116.07 (CH=CH2), 121.27 (C4/5), 131.26 (C4/5), 133.44 (CH=CH2), 150.99 ppm 
(C2); IR (ATR):  = 917, 1087, 1304, 1434, 2965 cm-1; HRMS (ESI/APCI) calcd for [C11H19N2+]: 
179.1543; found: 179.1540; yield: 63%, colourless liquid. 
2-Isopropyl-1-(2-methoxyethyl)-4,5-dimethylimidazole (59c): b.p. 82 °C (1.0 mbar); 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.30 (d, 3J(H,H) = 7.2 Hz, 6H; 
CH(CH3)2), 2.10 (s, 3H; CH3C4/5), 2.14 (s, 3H; CH3C4/5), 2.93-3.06 (m, 1H; 
CH), 3.31 ppm (t, 3J(H,H) = 6.1 Hz, 2H; CH2O), 3.50 (s, 3H, OCH3), 3.93 (t, 
3J(H,H) = 4.8 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 
8.92 (CH3C4), 12.63 (CH3C4/5), 22.18 (CH(CH3)2), 25.88 (CH), 43.07 
(NCH2), 59.09 (OCH3), 71.94 (CH2O), 121.06 (C4/5), 131.35 (C4/5), 151.44 ppm (C2); IR (ATR): 
 = 1086, 1119, 1438, 2925 cm-1; HRMS (ESI/APCI) calcd for [C11H21N2O+]: 197.1648; found: 
197.1649; yield: 53%, white waxy solid.  
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Procedure for the synthesis of 2-(2-isopropyl-4,5-dimethylimidazol-1-yl)ethanol (59b): A 
glass 150 mL pressure vial was filled with MeOH (50 mL) and a PTFE stirring bar. The solvent 
was allowed to cool to 0 °C and isobutyraldehyde (100 mmol, 7.21 g) and 2-aminoethanol 
(100 mmol, 6.11 g) were added. The vial was closed and submerged in a preheated oil bath at 
120 °C with a temperature controller. After heating for 2h with vigorous stirring, the reaction 
mixture was carefully cooled to 0 °C, the vial was opened and consecutively 2,3-butanedione 
(25 mmol, 2.15 g) and NH4OAc (25 mmol, 1.93 g) were added. The vessel was closed 
immediately and heated in a preheated oil bath at 120 °C for 30 min under vigorous stirring. 
The reaction mixture was again carefully cooled and 2,3-butanedione and NH4OAc were 
added and heated for 30 min three times more. After cooling, MeOH and the reaction water 
were removed in vacuo. The reaction mixture was dissolved in EtOAc and extracted twice with 
100 mL of an aqueous 0.5 M HCl solution. The aqueous phase was alkalinised with 50 mL of 
3.0 M NaOH and extracted three times with 40 mL of EtOAc. The combined organic phase 
was dried with MgSO4. The solvent was removed in vacuo and 7.31 g of a black oil was 
obtained. The resulting oil was dissolved in an equal volume of boiling CH3CN and stored at -
18 °C until all 1H-2-isopropyl-4,5-dimethylimidazole precipitated. If the oil was not sufficiently 
pure as monitored by GC, an additional precipitation can be applied. The solvent was 
removed from the resulting mother liquid by rotary evaporation and the resulting product was 
further used for the synthesis of compound 4d. 
2-(2-Isopropyl-4,5-dimethylimidazol-1-yl)ethanol (59b): Rf = 0.07 (hexanes/EtOAc 4:6); 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.28 (d, 3J(H,H) = 7.2 Hz, 6H; 
CH(CH3)2), 2.11 (s, 6H; CH3C4/5), 2.94-3.09 (m, 1H; CH), 3.79 (t, 3J(H,H) = 
6.1 Hz, 2H; CH2O), 3.94 ppm (t, 3J(H,H) = 6.1 Hz, 2H; NCH2); 13C NMR (75 
MHz, CDCl3, 25 °C, TMS):  = 8.84 (CH3C4/5), 12.09 (CH3C4/5), 22.02 
(CH(CH3)2), 25.77 (CH(CH3)2), 45.42 (NCH2), 60.71 (CH2O), 121.34 (C4/5), 
130.71 (C4/5), 151.41 ppm (C2); IR (ATR):  = 729, 1086, 1738, 2966, 3112 cm-1; HRMS 
(ESI/APCI) calcd for [C10H19N2O+]: 183.1492; found: 183.1495; yield (crude): 38%, black oil.  
Procedure for the synthesis of 1-(2-allyloxyethyl)-2-isopropyl-4,5-dimethylimidazole 
(59d): In a flame dried 250 mL flask containing crude 2-(2-isopropyl-4,5-dimethylimidazol-1-
yl)ethanol (70 mmol, 12.81 g), dry THF (80 mL) was added under a nitrogen atmosphere. The 
mixture was cooled to 0 °C and then slowly pure NaH (77 mmol, 1.85 g) was added. After 
stirring for 15 min, allyl bromide (73,5 mmol, 8.90 g) was added dropwise. The mixture was 
allowed to warm to room temperature overnight. After reaction, a fraction of the solvent was 
evaporated and the resulting slurry was diluted in EtOAc and washed twice with 80 mL of a 
saturated aqueous NaHCO3 solution and once with 40 mL of water. The organic layer was 
dried with MgSO4 after which the solvent was removed by rotary evaporation. The resulting oil 
was distilled via short-path vacuum distillation (108 °C, 1.0 mbar) to obtain a yellow oil. 
1-(2-Allyloxyethyl)-2-isopropyl-4,5-dimethylimidazole (59d): b.p. 108 °C (1.0 mbar); 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.30 (d, 3J(H,H) = 6.8 Hz, 6H; 
CH(CH3)2), 2.11 (s, 3H; CH3C4/5), 2.14 (s, 3H; CH3C4/5), 2.95-3.09 (m, 1H; 
CH(CH3)2), 3.56 (t, 3J(H,H) = 6.3 Hz, 2H; CH2O), 3.93 (dt, 3J(H,H) = 5.4 Hz, 
4J(H,H) = 1.4 Hz, 2H; CH2CH=CH2), 3.96 (t, 3J(H,H) = 6.3 Hz, 2H; NCH2), 
5.17 (ddt, 3J(H,H) = 10.1 Hz, 2J(H,H) = 3.3 Hz, 4J(H,H) = 1.6 Hz, 1H; 
CH=CHEHZ), 5.22 (ddt, 3J(H,H) = 17.3 Hz, 2J(H,H) = 3.3 Hz, 4J(H,H) = 1.6 Hz, 1H; 
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CH=CHEHZ), 5.83 ppm (ddt, 3J(H,H) = 17.3 Hz, 3J(H,H) = 10.1 Hz, 3J(H,H) = 5.4 Hz, 1H; 
CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.95 (CH3C4/5), 12.69 (CH3C4/5), 22.18 
(CH(CH3)2), 25.82 (CH), 43.13 (NCH2), 69.33 (CH2CH2O), 77.20 (CH2CH=CH2), 117.04 
(CH2CH=CH2), 121.02 (C4/5), 131.32 (C4/5), 134.22 (CH=CH2), 151.37 ppm (C2); IR (ATR):  = 
1052, 1134, 1175, 1378 cm-1; HRMS (ESI/APCI) calcd for [C13H23N2O+]: 223.1805; found: 
223.1807; yield: 86%, light yellow oil.  
1-Allyl-4,5-dimethylimidazole (41i): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 2.08 (s, 3H; 
CH3C4/5), 2.16 (s, 3H; CH3C4/5), 4.41 (d, 3J(H,H) = 5.3 Hz, 2H; CH2), 4.98 (d, 
3J(H,H) = 17.1 Hz, 2H; CH=CHEHZ), 5.21 (d, 3J(H,H) = 10.3 Hz, 2H; 
CH=CHEHZ), 5.90 (ddt, 3J(H,H) = 17.1 Hz, 3J(H,H) = 10.3 Hz, 3J(H,H) = 5.3 
Hz, 2H; CH=CH2), 7.32 ppm (s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, 
TMS):  = 8.15 (CH3C4/5), 12.69 (CH3C4/5), 47.13 (NCH2), 117.05 (CH=CH2), 
122.24 (C4/5), 133.38 (CH), 133.67 (C4/5), 134.92 ppm (C2); IR (ATR):  = 918, 1239, 1443, 
1497, 2981 cm-1; HRMS (ESI/APCI) calcd for [C8H13N2+]: 137.1073; found: 137.1074; yield: 
29%, colourless oil. 
1-(2-Methoxyethyl)-4,5-dimethylimidazole (41j): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  
= 2.13 (s, 3H; CH3C4/5), 2.16 (s, 3H; CH3C4/5), 3.33 (s, 3H; OCH3), 3.57 (t, 
3J(H,H) = 5.5 Hz, 2H; CH2O), 3.95 (t, 3J(H,H) = 5.5 Hz, 2H; NCH2), 7.39 
ppm (s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.44 
(CH3C4/5), 12.78 (CH3C4/5), 44.72 (NCH2), 58.98 (OCH3), 71.76 (CH2O), 
122.04 (C4/5), 133.46 (C4/5), 135.37 ppm (C2); IR (ATR):  = 1120, 1190, 
1448, 1498, 1920 cm-1; HRMS (ESI/APCI) calcd for [C8H16N2O+]: 155.1179; found: 155.1181; 
yield: 42%, pale yellow oil. 
1-(2-Methoxyethyl)-2,4,5-trimethylimidazole (122a): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 2.10 (s, 6H; CH3C4/5), 2.35 (s, 3H; C2CH3), 3.30 (s, 3H; OCH3), 
3.51 (t, 3J(H,H) = 5.8 Hz, 2H; CH2O), 3.89 ppm (t, 3J(H,H) = 5.8 Hz, 2H; 
NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.93 (CH3C4/5), 12.54 
(C2CH3), 43.73 (NCH2), 59.04 (OCH3), 71.67 (CH2O), 121.75 (C4/5), 
131.09 (C4/5), 142.71 ppm (C2); IR (ATR):  = 862, 1317, 1545, 1638, 
2608, 2680 cm-1; HRMS (ESI/APCI) calcd for [C9H17N2O+]: 169.1342; found: 168.126924; 
yield: 42%, yellow oil. 
3.3. Synthesis of imidazolium hydrochloride salts 
Procedure for the synthesis of 1,2-diethyl-4,5-dimethylimidazolium hydrochloride (43c): 
Freshly distilled 1,2-diethyl-4,5-dimethylimidazole (73.6 mmol, 11.2 g) is brought in a 250mL 
flask containing dry CH2Cl2 (80 mL). The flask is provided with a septum with exhaust needle. 
Freshly prepared dry hydrogen chloride gas is added via a submerged pipet under vigorous 
stirring during 2h. After complete acidification (escape of hydrogen chloride gas via the 
exhaust), the solvent is removed in vacuo until a solid is obtained. This solid is recrystallised 
from a minimum amount of boiling acetone. A first crop yields 64% of transparent crystals, and 
a second crop an additional 28% of slightly yellow coloured crystals. Mass spectra of the salts 
are not recorded, as in the buffered LC eluent solution, the same spectra as for the free 
imidazole bases would be obtained.  
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Procedure for the neutralisation of 1,2-diethyl-4,5-dimethylimidazolium hydrochloride 
(43c): To a separation funnel containing 100 mL of an aqueous 1.0 M NaOH solution and 100 
mL of ice water is added 1,2-diethyl-4,5-dimethylimidazolium hydrochloride (50 mmol, 9.44 g). 
The mixture is shaken vigorously, after which it is extracted three times with EtOAc (50 mL). 
The organic fractions are combined and dried over MgSO4. The solvent is evaporated, 
yielding the pure imidazole quantitatively as a clear liquid. 
1-Ethyl-4,5-dimethylimidazolium hydrochloride (43a): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 1.53 (t, 3J(H,H) = 7.4 Hz, 3H; CH2CH3), 2.23 (s, 3H; CH3C4/5), 2.37 
(s, 3H; CH3C4/5), 4.17 (q, 3J(H,H) = 7.4 Hz, 2H; CH2CH3), 8.94 ppm (C2H); 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.20 (CH3C4/5), 9.65 (CH3C4/5), 
15.83 (NCH2CH3), 42.37 (NCH2), 124.88 (C4/5), 126.68 (C4/5), 132.71 ppm 
(C2); IR (ATR):  = 862, 1317, 1545, 1638, 2608, 2680 cm-1; MW (g mol-1): 
174.67; yield: 95%, colourless crystals. 
1-Ethyl-2,4,5-trimethylimidazolium hydrochloride (43b): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 1.35 (t, 3J(H,H) = 7.3 Hz, 3H; CH2CH3), 2.18 (s, 3H; CH3C4/5), 
2.28 (s, 3H; CH3C4/5), 2.65 (s, 3H; C2CH3), 3.92 ppm (q, 3J(H,H) = 7.3 Hz, 
2H; CH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.23 (CH3C4/5), 
9.19 (CH3C4/5), 10.78 (C2CH3), 15.04 (NCH2CH3), 39.96 (NCH2), 124.07 
(C4/5), 124.62 (C4/5), 140.96 ppm (C2); IR (ATR):  = 952, 1162, 1298, 1653, 
2966 cm-1; MW (g mol-1): 160.64; yield: 93%, colourless crystals. 
1,2-Diethyl-4,5-dimethylimidazolium hydrochloride (43c): 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.40 (t, 3J(H,H) = 7.3 Hz, 3H; NCH2CH3), 1.48 (t, 3J(H,H) = 
7.7 Hz, 3H; CH2CH3), 2.21 (s, 3H; CH3C4/5), 2.35 (s, 3H; CH3C4/5), 3.03 (t, 
3J(H,H) = 7.7 Hz, 3H; CH2CH3), 3.98 ppm (t, 3J(H,H) = 7.3 Hz, 3H; 
NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.28 (CH3C4/5), 9.15 
(CH3C4/5), 12.49 (CH2CH3), 15.54 (NCH2CH3), 18.43 (C2CH2), 39.91 (NCH2), 
124.05 (C4/5), 124.97 (C4/5), 145.44 ppm (C2); IR (ATR):  = 924, 1513, 1650, 
1819, 2484 cm-1; MW (g mol-1): 188.70; yield: 92%, colourless crystals. 
1-Ethyl-2-isopropyl-4,5-dimethylimidazolium hydrochloride (43d): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.40 (t, 3J(H,H) = 7.2 Hz, 3H; CH2CH3), 1.57 (d, 
3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.20 (s, 3H; CH3C4/5), 2.38 (s, 3H; CH3C4/5), 
3.14-3.28 (m, 1H; CH(CH3)2), 4.01 ppm (t, 3J(H,H) = 7.2 Hz, 3H; CH2CH3); 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.21 (CH3C4/5), 9.18 (CH3C4/5), 
15.85 (CH2CH3), 21.31 (CH(CH3)2), 25.88 (CH), 39.77 (NCH2), 123.27 (C4/5), 
125.92 (C4/5), 149.09 ppm (C2); IR (ATR):  = 926, 1331, 1509, 1645, 1822, 
2491 cm-1; MW (g mol-1): 202.72; yield: 76%, colourless crystals. 
1-Hexyl-2-isopropyl-4,5-dimethylimidazolium hydrochloride (43e): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 0.89 (t, 3J(H,H) = 6.9 Hz, 3H; CH2CH3), 1.27-1.38 
(m, 6H; (CH2)3CH3), 1.76-1.86 (m, 2H; NCH2CH2), 2.22 (s, 3H; CH3C4/5), 
2.37 (s, 3H; CH3C4/5), 4.09 (t, 3J(H,H) = 7.4 Hz, 2H; NCH2), 8.76 ppm (s, 1H; 
C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.05 (CH3C4/5), 9.42 
(CH3C4/5), 13.96 (CH2CH3), 22.43 (CH2CH3), 25.97 (CH2CH2CH3), 30.05 
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(NCH2CH2), 31.16 (NCH2CH2CH2), 47.01 (NCH2), 124.67 (C4/5), 126.40 (C4/5), 123.74 ppm 
(C2); IR (ATR):  = 887, 1162, 1320, 1661, 2855 cm-1; MW (g mol-1): 216.75; yield: 85%, white 
powder. 
1-Hexyl-2-isopropyl-4,5-dimethylimidazolium hydrochloride (43f):1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 0.87-0.95 (m, 3H; CH2CH3), 1.29-1.41 (m, 6H; 
(CH2)3CH3), 1.53-1.72 (2H, NCH2CH2, m), 1.57 (d, 3J(H,H) = 6.6 Hz, 6H; 
CHCH3), 2.18 (s, 3H; CH3C4/5), 2.39 (s, 3H; CH3C4/5), 3.09-3.22 (m, 1H; CH), 
3.88 ppm (t, 3J(H,H) = 7.7 Hz, 2H; NCH2,); 13C NMR (75 MHz, CDCl3, 25 °C, 
TMS):  = 8.43 (CH3C4/5), 9.16 (CH3C4/5), 13.92 (CH2CH3), 21.36 (CH(CH3)2), 
22.47 (CH2CH3), 26.00 (CH2CH2CH3), 26.28 (NCH2CH2), 30.57 (NCH2CH2CH2), 31.27 (CH), 
44.95 (NCH2), 123.61 (C4/5), 125.81 (C4/5), 149.37 ppm (C2); IR (ATR):  = 920, 1298, 1332, 
1509, 2483, 2928 cm-1; MW (g mol-1): 258.83; yield: 96%, white powder. 
1-Allyl-4,5-dimethylimidazolium hydrochloride (43g): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 2.19 (s, 3H; CH3C4/5), 2.37 (s, 3H; CH3C4/5), 4.82 (d, 3J(H,H) = 
5.4 Hz, 2H; CH2), 5.17 (d, 3J(H,H) = 17.1 Hz, 1H; CH=CHEHZ), 5.39 (d, 
3J(H,H) = 10.5 Hz, 1H; CH=CHEHZ), 5.96 (ddt, 3J(H,H) = 17.1 Hz, 3J(H,H) 
= 10.5 Hz, 3J(H,H) = 5.4 Hz, 1H; CH=CH2), 9.05 ppm (s, 1H; C2H); 13C 
NMR (75 MHz, CDCl3, 25 °C, TMS):  = 7.97 (CH3C4/5), 9.41 (CH3C4/5), 
49.16 (NCH2), 120.01 (CH=CH2), 125.21 (C4/5), 126.54 (C4/5), 130.54 (CH=CH2), 133.12 ppm 
(C2); IR (ATR):  = 844, 923, 1326, 1640, 2609, 2692 cm-1; elemental analysis calcd (%) for 
C8H13ClN2: C 55.65, H 7.59, N 16.23; found: C 55.44, H 7.93, N 16.10; MW (g mol-1): 172.66; 
yield: 87%, white powder. 
3.4. Synthesis of N-alkylimidazolium ionic liquids 
3.4.1) N-alkylimidazolium methanesulfonate ionic liquids 
Procedure for the synthesis of 1-ethyl-3,4,5-trimethylimidazolium methanesulfonate 
[C2m3im][OMs] (44d): To a flame dried 6 mL vial, containing 4 mL of dry acetonitrile, 1-ethyl-
4,5-dimethylimidazole (8.2 mmol, 1.02 g) was added via a syringe under a nitrogen 
atmosphere. To the mixture, 1.1 eq. of methyl methanesulfonate (9.0 mmol, 1.00 g) was 
added. The headspace was filled with nitrogen and the vial was sealed with a PTFE cap. The 
mixture was irradiated for 30 minutes in a microwave reactor to a temperature of 80 °C. After 
reaction, the solvent was removed in vacuo and the mixture was diluted in distilled  water (25 
mL) and washed twice with EtOAc (20 mL). The aqueous layer was evaporated and dried for 
6h at 100 °C and 1.0 mbar. 
1-Ethyl-3,4,5-trimethylimidazolium methanesulfonate [C2m3im][OMs] (44d): 1H NMR (300 
MHz, CDCl3, 25 °C, TMS):  = 1.54 (t, 3J(H,H) = 7.3 Hz, 3H; CH2CH3), 
2.23 (s, 3H; CH3C4/5), 2.25 (s, 3H; CH3C4/5), 2.81 (s, 3H; CH3SO3), 3.88 
(s, 3H; NCH3), 4.19 (t, 3J(H,H) = 7.3 Hz, 2H; CH2CH3), 9.91 ppm (s, 1H; 
C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.53 (CH3C4/5), 8.78 
(CH3C4/5), 14.95 (CH2CH3), 32.34 (NCH3), 39.38 (CH3SO3), 40.72 (CH2), 
124.56 (C4/5), 126.04 (C4/5), 142.19 ppm (C2); IR (ATR):  = 768, 1038, 1178, 3444 cm-1; MW 
(g mol-1): 234.32; yield: 97%, white powder. 
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1-Ethyl-2,3,4,5-tetramethylimidazolium methanesulfonate [C2C1m3im][OMs] (45d): 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.39 (t, 3J(H,H) = 7.5 Hz, 3H; 
CH2CH3), 2.23 (s, 6H; CH3C4/5), 2.69 (s, 3H; C2CH3), 2.79 (s, 3H; 
CH3SO3), 3.75 (s, 3H; NCH3), 4.14 ppm (t, 3J(H,H) = 7.5 Hz, 2H; 
CH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.50 (CH3C4/5), 
8.75 (CH3C4/5), 10.37 (C2CH3), 14.93 (CH2CH3), 32.32 (NCH3), 39.35 
(CH3SO3), 40.70 (CH2), 124.50 (C4/5), 126.02 (C4/5), 142.38 ppm (C2); 
IR (ATR):  = 767, 1038, 1180, 1449, 1537, 3444 cm-1; MW (g mol-1): 248.34; yield: 98%, pale 
yellow oil. 
1,2-Diethyl-3,4,5-trimethylimidazolium methanesulfonate [C2C2m3im][OMs] (46d): 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.31 (t, 3J(H,H) = 7.6 Hz, 3H; 
C2CH2CH3), 1.43 (t, 3J(H,H) = 7.3 Hz, 3H; NCH2CH3), 2.27 (s, 6H; 
CH3C4/5), 2.69 (s, 3H; CH3SO3), 3.20 (q, 3J(H,H) = 7.6 Hz, 2H; 
C2CH2CH3), 3.78 (s, 3H; NCH3), 4.15 ppm (q, 3J(H,H) = 7.3 Hz, 2H; 
NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.57 (CH3C4/5), 
8.76 (CH3C4/5), 11.91 (CH2CH3), 15.62 (NCH2CH3) 17.36 (CH2) 32.15 
(NCH3) 39.36 (CH3SO3) 40.67 (NCH2) 124.76 (C4/5), 126.44 (C4/5), 146.15 ppm (C2); IR (ATR): 
 = 766, 1037, 1178, 3444 cm-1; MW (g mol-1): 262.37; yield: 96%, reddish oil. 
1-Ethyl-2-isopropyl-3,4,5-trimethylimidazolium methanesulfonate [C2Ci3m3im][OMs] 
(47d): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.40 (t, 3J(H,H) = 
7.4 Hz, 3H; CH2CH3), 1.54 (d, 3J(H,H) = 7.3 Hz, 6H; CH(CH3)2), 2.28 (s, 
6H; CH3C4/5), 2.70 (s, 3H; CH3SO3), 3.60-3.75 (m, 1H; CH(CH3)2), 3.83 
(s, 3H; NCH3), 4.23 ppm (t, 3J(H,H) = 7.4 Hz, 2H; CH2CH3); 13C NMR 
(75 MHz, CDCl3, 25 °C, TMS):  = 8.73 (CH3C4/5), 8.90 (CH3C4/5), 15.79 
(CH2CH3), 19.31 (CH(CH3)2), 25.07 (CH), 33.09 (NCH3), 39.42 
(CH3SO3), 40.95 (CH2), 125.11 (C4/5), 127.09 (C4/5), 147.70 ppm (C2); IR (ATR):  = 770, 1039, 
1180, 3434 cm-1; MW (g mol-1): 276.40; yield: 99%, pale yellow oil. 
3.4.2) N-alkylimidazolium iodide ionic liquids 
Procedure for the synthesis of 1-ethyl-2-isopropyl-3,4,5-trimethylimidazolium iodide 
[C2Ci3m3im][I] (47a): In an oven dried flask of 100 mL, 1-ethyl-2-isopropyl-4,5-
dimethylimidazole (20 mmol, 3.32 g) was dissolved in dry CH3CN (40 mL). The solution was 
cooled to 0 °C and MeI (52 mmol, 7.34 g) was added dropwise at 0 °C. The reaction mixture 
was allowed to stir at room temperature for 8h. When the reaction was completed, the solvent 
and residual MeI were removed in vacuo. The resulting yellow solid was recrystallised in dry 
acetone to furnish colourless to white crystals (1st crop: 75%, 2nd crop: 11%). Residual solvent 
was removed in a high vacuum. 
1-Ethyl-3,4,5-trimethylimidazolium iodide [C2m3im][I] (44a): 1H NMR 
(300 MHz, CDCl3, 25 °C, TMS):  = 1.59 (t, 3J(H,H) = 7.4 Hz, 3H; 
NCH2CH3), 2.26 (s, 3H; CH3C4/5), 2.27 (s, 3H; CH3C4/5), 3.94 (s, 3H; NCH3), 
4.21 (q, 3J(H,H) = 7.4 Hz, 2H; NCH2CH3), 10.13 ppm (s, 1H; CH); 13C NMR 
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(75 MHz, CDCl3, 25 °C, TMS):  = 8.76 (CH3C4/5), 8.79 (CH3C4/5), 15.34 (CH3CH2), 34.41 
(NCH3), 42.70 (CH2), 126.30 (CH3C4/5), 127.34 (CH3C4/5), 134.92 ppm (CH); IR (ATR):  = 
1199, 1241, 1572, 1634, 3032 cm-1; MS (ES): m/z (%): 139.3 (100) [M+H+]; yield: 87%, 
colourless crystals. 
1-Ethyl-2,3,4,5-tetramethylimidazolium iodide [C2C1m3im][I] (45a): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.42 (t, 3J(H,H) = 7.4 Hz, 3H; NCH2CH3), 2.27 (s, 
6H; CH3C4/5), 2.86 (s, 3H; C2CH3), 3.79 (s, 3H; NCH3), 4.17 ppm (q, 3J(H,H) 
= 7.4 Hz, 2H; NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 9.04 
(CH3C4/5), 9.39 (CH3C4/5), 12.44 (C2CH3) , 15.33 (CH3CH2), 33.71 (NCH3), 
41.52 (CH2), 124.80 (C4/5), 126.25 (C4/5), 142.10 ppm (C2); IR (ATR):  = 
1198, 1456, 1572, 1634, 2358, 3032 cm-1; MS (ES): m/z (%): 153.3 (100) 
[M+H+]; yield: 89%, colourless crystals. 
1,2-Diethyl-3,4,5-trimethylimidazolium iodide [C2C2m3im][I] (46a): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.34 (t, 3J(H,H) = 7.7 Hz, 3H; C2CH2CH3), 1.46 (t, 
3J(H,H) = 7.4 Hz, 3H; NCH2CH3), 2.28 (s, 6H; CH3C4/5), 3.22 (q, 3J(H,H) = 
7.7 Hz, 2H; C2CH2CH3), 3.81 (s, 3H; NCH3), 4.16 ppm (q, 3J(H,H) = 7.4 Hz, 
2H; NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 6.99 (CH3C4/5), 
7.33 (CH3C4/5), 10.32 (CH3CH2C), 13.80 (NCH2CH3), 16.47 (C2CH2), 31.33 
(NCH3), 39.30 (NCH2), 122.86 (CH3C4/5), 124.47 (CH3C4/5), 143.89 ppm 
(C2CH2); IR (ATR):  = 1090, 1259, 1448, 1529, 1648, 2975 cm-1; MS (ES): m/z (%): 167.3 
(100) [M+H+]; yield: 99%, reddish oil. 
1-Ethyl-2-isopropyl-3,4,5-trimethylimidazolium iodide [C2Ci3m3im][I] (47a): 1H NMR (300 
MHz, CDCl3, 25 °C, TMS):  = 1.43 (t, 3J(H,H) = 7.2 Hz, 3H; NCH2CH3), 
1.55 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.30 (s, 6H; CH3C4/5), 3.66-3.81 
(m, 1H; CH), 3.87 (s, 3H; NCH3), 4.26 ppm (q, 3J(H,H) = 7.2 Hz, 2H; 
NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 9.26 (CH3C4/5), 
9.63 (CH3C4/5), 15.94 (CH3CH2), 19.91 (CH(CH3)2), 25.35 (CH), 34.06 
(NCH3), 41.65 (CH2), 125.18 (CH3C4/5), 127.17 (CH3C4/5), 147.72 ppm (C2CH); IR (ATR):  = 
1088, 1331, 1448, 1521, 1651, 2971 cm-1; MS (ES): m/z (%): 181.3 (100) [M+H+]; yield: 86%, 
colourless crystals. 
Procedure for the synthesis of 1-hexyl-2-isopropyl-3,4,5-trimethylimidazolium iodide 
[C6Ci3m3im][I] (51a): In an oven dried flask of 100 mL, 1-hexyl-2-isopropyl-4,5-
dimethylimidazole (20 mmol, 4.44 g) was dissolved in dry CH3CN (40 mL). The solution was 
cooled to 0 °C and MeI (52 mmol, 7.34 g) was added dropwise at 0 °C. The reaction mixture 
was allowed to stir at room temperature for 20h. When the reaction was completed, the 
solvent and residual MeI were removed in vacuo. The resulting yellow oil was dissolved in 20 
mL CH3CN and washed 3 times with 20 mL hexanes. The solvent was removed in vacuo, 
yielding 6.99 g (96%) of a yellow oil. 
1-Hexyl-3,4,5-trimethylimidazolium iodide [C6m3im][I] (48a): 1H NMR 
(300 MHz, CDCl3, 25 °C, TMS):  = 0.89 (t, 3J(H,H) = 6.6 Hz, 3H; CH2CH3), 
1.32-1.34 (m; 6H; (CH2)3CH3), 1.82-1.92 (m, 2H; NCH2CH2; m), 2.27 (s, 3H; 
CH3C4/5), 2.29 (s, 3H; CH3C4/5), 3.95 (s, 3H; NCH3), 4.15 (2H, t, 3J(H,H) = 
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7.4 Hz, 2H; NCH2), 9.96 ppm (s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.90 
(CH3C4, CH3C5), 14.00 (CH3(CH2)5), 22.46 (CH2), 26.05 (CH2), 29.93 (NCH2CH2), 31.16 (CH2), 
34.54 (NCH3), 47.47 (NCH2), 126.36 (CH3C4/5), 127.38 (CH3C4/5), 135.21 ppm (CH); IR (ATR): 
 = 1202, 1452, 1570, 1633, 2928 cm-1; MS (ES): m/z (%): 195.3 (100) [M+H+]; yield: 99%, 
yellow oil. 
1-Hexyl-2,3,4,5-tetramethylimidazolium iodide [C6C1m3im][I] (49a): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 0.89 (t, 3J(H,H) = 6.6 Hz, 3H; CH2CH3), 1.27-1.44 
(m; 6H; (CH2)3CH3), 1.67-1.77 (m, 2H; NCH2CH2; m), 2.27 (s, 3H; CH3C4/5), 
2.28 (s, 3H; CH3C4/5), 2.82 (s, 3H; C2CH3), 3.81 (s, 3H; NCH3), 4.06 ppm 
(2H, t, 3J(H,H) = 7.4 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, 
TMS):  = 9.22 (CH3C4/5), 9.47 (CH3C4/5), 12.43 (C2CH3), 14.00 (CH3(CH2)5), 
22.41 (CH2), 26.26 (CH2), 29.79 (NCH2CH2), 31.18 (CH2), 33.77 (NCH3), 46.29 (NCH2), 
125.03 (CH3C4/5), 126.25 (CH3C4/5), 142.02 ppm (C2); IR (ATR):  = 727, 920 1373, 1444, 
1533, 1648, 2929 cm-1; MS (ES): m/z (%): 209.3 (100) [M+H+]; yield: 99%, yellow oil. 
2-Ethyl-1-hexyl-3,4,5-trimethylimidazolium iodide [C6C2m3im][I] (50a): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 0.90 (t, 3J(H,H) = 6.9 Hz, 3H; CH2CH3), 1.26-1.44 
(m; 6H; (CH2)3CH3), 1.34 (t, 3J(H,H) = 7.7 Hz, 3H; C2CH2CH3), 1.69-1.80 (m, 
2H; NCH2CH2; m), 2.27 (s, 3H; CH3C4/5), 2.29 (s, 3H; CH3C4/5), 3.19 (q, 
3J(H,H) = 7.7 Hz, 2H; C2CH2CH3), 3.83 (s, 3H; NCH3), 4.04 ppm (2H, t, 
3J(H,H) = 8.0 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 
9.36 (CH3C4/5), 9.56 (CH3C4/5), 12.35 (CH3CH2C2), 13.94 (CH3(CH2)5), 18.49 (CH3CH2C2), 
22.35 (CH2), 26.23 (CH2), 30.38 (NCH2CH2), 31.15 (CH2), 33.64 (NCH3), 46.19 (NCH2), 
125.14 (CH3C4/5), 126.57 (CH3C4/5), 145.90 ppm (C2CH2); IR (ATR):  = 726, 1081, 1452, 
1528, 2929 cm-1; MS (ES): m/z (%): 223.3 (100) [M+H+]; yield: 99%, yellow oil. 
1-Hexyl-2-isopropyl-3,4,5-trimethylimidazolium iodide [C6Ci3m3im][I] (51a): 1H NMR (300 
MHz, CDCl3, 25 °C, TMS):  = 0.87-0.89 (m, 3H; CH2CH3), 1.28-1.48 (m; 
6H; (CH2)3CH3), 1.52-1.77 (m, 2H; NCH2CH2), 1.55 (d, 3J(H,H) = 7.2 Hz, 
6H; CH(CH3)2), 2.28 (s, 3H; CH3C4/5), 2.31 (s, 3H; CH3C4/5), 3.60-3.72 (m, 
1H; CH(CH3)2), 3.87 (s, 3H; NCH3), 4.10 ppm (2H, t, 3J(H,H) = 7.4 Hz, 2H; 
NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 9.50 (CH3C4/5), 9.73 
(CH3C4/5), 13.96 (CH3(CH2)5), 19.88 (CH(CH3)2), 22.44 (CH2), 25.36 (CH2), 26.28 (NCH2CH2), 
30.61 (CH2), 31.24 (NCH3), 34.29 (CH), 46.18 (CH2), 125.34 (CH3C4/5), 127.24 (CH3C4/5), 
147.72 ppm (C2CH); IR (ATR):  = 746, 1239, 1334, 1454, 1520, 2928 cm-1; MS (ES): m/z 
(%): 237.3 (100) [M+H+]; yield: 99%, yellow oil. 
3.4.3) N-alkylimidazolium bis(trifluoromethylsulfonyl)imide ionic liquids 
Procedure for the synthesis of 1-ethyl-2-isopropyl-3,4,5-trimethylimidazolium 
bis(trifluoromethylsulfonyl)imide [C2Ci3m3im][NTf2] (47b): To a 50 mL flask charged with 
ionic liquid [C2Ci3m3im][I] (20 mmol, 6.18 g) was added demineralised water (20 mL). Then 
lithium bis(trifluoromethylsulfonyl)imide (20.6 mmol, 5.79 g) was added to the solution. The 
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flask was provided with a cooler with cotton plug and the mixture was heated to 50 °C for 8h. 
After reaction, the mixture was allowed to cool to 0 °C and 10 mL of CH2Cl2 was added. The 
aqueous layer was decanted, and the organic layer was washed 3 times with demineralised 
water (40 mL), the dichloromethane was removed in vacuo. The ionic liquid was dried for 8h 
at 120 °C under reduced pressure (0.5 mbar). A white solid was obtained in 93% yield. 
1-Ethyl-3,4,5-trimethylimidazolium bis(trifluoromethylsulfonyl)imide [C2m3im]NTf2] 
(44b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.46 (t, 3J(H,H) = 7.2 
Hz, 3H; NCH2CH3), 2.23 (s, 3H; CH3C4/5), 2.24 (s, 3H; CH3C4/5), 3.72 (s, 
3H; NCH3), 4.07 (q, 3J(H,H) = 7.2 Hz, 2H; NCH2CH3), 8.47 ppm (s, 1H; 
CH); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.05 (CH3C4/5), 8.14 
(CH3C4/5), 14.60 (CH3CH2), 33.47 (NCH3), 42.35 (CH2), 119.87 (q, 1J(C,F) 
= 320.8 Hz; CF3), 126.85 (CH3C4/5), 127.82 (CH3C4/5), 133.44 ppm (CH); 
19F NMR (282 MHz, CDCl3, 25 °C):  = -78.95 ppm; IR (ATR):  = 1052, 1134, 1176, 1348, 
1575 cm-1; MS (ES): m/z (%): 139.3 (100) [M+H+]; yield: 93%, white solid. 
1-Ethyl-2,3,4,5-tetramethylimidazolium bis(trifluoromethylsulfonyl)imide 
[C2C1m3im]NTf2] (45b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.35 
(t, 3J(H,H) = 7.4 Hz, 3H; NCH2CH3), 2.20 (s, 3H; CH3C4/5), 2.22 (s, 3H; 
CH3C4/5), 2.56 (s, 3H; C2CH3), 3.60 (s, 3H; NCH3), 4.03 ppm (q, 3J(H,H) = 
7.4 Hz, 2H; NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.18 
(CH3C4/5), 8.38 (CH3C4/5), 9.76 (C2CH3), 14.54 (CH3CH2), 31.80 (NCH3), 
40.63 (CH2), 119.92 (q, 1J(C,F) = 320.8 Hz; CF3), 124.82 (CH3C4/5), 126.27 (CH3C4/5), 141.69 
ppm (C2CH3); 19F NMR (282 MHz, CDCl3, 25 °C):  = -79.25 ppm; IR (ATR):  = 613, 1049, 
1136, 1184, 1347 cm-1; MS (ES): m/z (%): 153.3 (100) [M+H+]; yield: 95%, yellow oil. 
1,2-Diethyl-3,4,5-trimethylimidazolium bis(trifluoromethylsulfonyl)imide 
[C2C2m3im][NTf2] (46b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
1.29 (t, 3J(H,H) = 7.7 Hz, 3H; C2CH2CH3), 1.40 (t, 3J(H,H) = 7.4 Hz, 3H; 
NCH2CH3), 2.23 (s, 3H; CH3C4/5), 2.25 (s, 3H; CH3C4/5), 3.00 (q, 3J(H,H) = 
7.7 Hz, 2H; C2CH2CH3), 3.66 (s, 3H; NCH3), 4.06 ppm (q, 3J(H,H) = 7.4 
Hz, 2H; NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.30 
(CH3C4/5), 8.46 (CH3C4/5), 11.48 (CH3CH2C), 15.25 (NCH2CH3), 17.24 
(CH2C), 31.67 (NCH3), 40.55 (NCH2), 119.82 (q, 1J(C,F) = 321.1 Hz; CF3) 124.95 (CH3C4/5), 
126.54 (CH3C4/5), 145.54 ppm (C2CH2); 19F NMR (282 MHz, CDCl3, 25 °C):  = -78.92 ppm; 
IR (ATR):  = 314, 788, 1053, 1135, 1176, 1348 cm-1; MS (ES): m/z (%): 167.3 (100) [M+H+]; 
yield: 97%, white solid. 
1-Ethyl-2-isopropyl-3,4,5-trimethylimidazolium bis(trifluoromethylsulfonyl)imide 
[C2Ci3m3im][NTf2] (47b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
1.37 (t, 3J(H,H) = 7.4 Hz, 3H; NCH2CH3), 1.47 (d, 3J(H,H) = 7.2 Hz, 6H; 
CH(CH3)2), 2.21 (s, 3H; CH3C4/5), 2.23 (s, 3H; CH3C4/5), 3.44-3.59 (m, 1H; 
CH), 3.70 (s, 3H; NCH3), 4.09 ppm (q, 3J(H,H) = 7.4 Hz, 2H; NCH2CH3); 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.47 (CH3C4/5), 8.58 
(CH3C4/5), 15.44 (CH3CH2), 19.01 (CH(CH3)2), 25.19 (CH), 32.55 (NCH3), 
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40.74 (CH2), 119.88 (q, 1J(C,F) = 321.5 Hz; CF3), 125.18 (CH3C4/5), 127.11 (CH3C4/5), 147.40 
ppm (C2CH); 19F NMR (282 MHz, CDCl3, 25 °C):  = -78.73 ppm; IR (ATR):  = 612, 1053, 
1137, 1180, 1347 cm-1; MS (ES): m/z (%): 181.3 (100) [M+H+]; yield:94%, yellow solid. 
1-Hexyl-3,4,5-trimethylimidazolium bis(trifluoromethylsulfonyl)imide [C6m3im][NTf2] 
(48b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 0.89 (t, 3J(H,H) = 6.6 
Hz, 3H; CH2CH3), 1.27-1.37 (m; 6H; (CH2)3CH3), 1.73-1.84 (m, 2H; 
NCH2CH2), 2.24 (s, 6H; CH3C4/5), 3.75 (s, 3H; NCH3), 4.01 (2H, t, 3J(H,H) 
= 7.7 Hz, 2H; NCH2), 8.55 ppm (s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 8.15 (CH3C4/5), 8.34 (CH3C4/5), 13.85 (CH3(CH2)5), 22.32 
(CH2), 25.87 (CH2), 29.68 (NCH2CH2), 31.04 (CH2), 33.51 (NCH3), 47.29 (NCH2), 119.86 (q, 
1J(C,F) = 321.8 Hz; CF3) 126.86 (CH3C4/5), 127.78 (CH3C4/5), 134.01 ppm (CH); 19F NMR (282 
MHz, CDCl3, 25 °C):  = -74.89 ppm; IR (ATR):  = 614, 1053, 1177, 1348, 1574, 2934 cm-1; 
MS (ES): m/z (%): 195.3 (100) [M+H+]; yield: 95%, colourless oil.  
1-Hexyl-2,3,4,5-tetramethylimidazolium bis(trifluoromethylsulfonyl)imide 
[C6C1m3im][NTf2] (49b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
0.89 (t, 3J(H,H) = 6.6 Hz, 3H; CH2CH3), 1.26-1.40 (m; 6H; (CH2)3CH3), 
1.60-1.71 (m, 2H; NCH2CH2; m), 2.20 (s, 6H; CH3C4/5), 2.55 (s, 3H; 
C2CH3), 3.59 (s, 3H; NCH3), 3.92 ppm (2H, t, 3J(H,H) = 7.7 Hz, 2H; 
NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.47 (CH3C4/5), 10.08 
(C2CH3), 13.92 (CH3(CH2)5), 22.41 (CH2), 26.18 (CH2), 29.65 (NCH2CH2), 31.16 (CH2), 31.90 
(NCH3), 45.64 (NCH2), 119.89 (q, 1J(C,F) = 320.8 Hz; CF3); 125.05 (CH3C4/5), 126.25 
(CH3C4/5), 141.81 ppm (C2); 19F NMR (282 MHz, CDCl3, 25 °C):  = -78.95 ppm; IR (ATR):  = 
1053, 1135, 1176, 1331, 1348 cm-1; MS (ES): m/z (%): 209.3 (100) [M+H+]; yield: 98%, yellow 
oil. 
2-Ethyl-1-hexyl-4,5-dimethylimidazolium bis(trifluoromethylsulfonyl)imide 
[C6C2m3im][NTf2] (50b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
0.91 (t, 3J(H,H) = 6.3 Hz, 3H; CH2CH3), 1.25-1.42 (m; 6H; (CH2)3CH3), 
1.30 (t, 3J(H,H) = 7.7 Hz, 3H; C2CH2CH3), 1.65-1.73 (m, 2H; NCH2CH2; m), 
2.23 (s, 6H; CH3C4/5), 2.99 (q, 3J(H,H) = 7.7 Hz, 2H; C2CH2CH3), 3.66 (s, 
3H; NCH3), 3.94 ppm (2H, t, 3J(H,H) = 8.3 Hz, 2H; NCH2); 13C NMR (75 
MHz, CDCl3, 25 °C, TMS):  = 8.43 (CH3C4/5), 8.47 (CH3C4/5), 11.36 
(CH3CH2C2), 13.91 (CH3(CH2)5), 17.38 (CH3CH2C2), 22.46 (CH2), 26.23 (CH2), 30.24 
(NCH2CH2), 31.25 (CH2), 31.74 (NCH3), 45.59 (NCH2), 120.02 (q, 1J(C,F) = 321.8 Hz; CF3), 
125.29 (CH3C4/5), 126.69 (CH3C4/5), 145.72 ppm (C2CH2); 19F NMR (282 MHz, CDCl3, 25 °C): 
 = -79.21 ppm; IR (ATR):  = 615, 1053, 1134, 1176 cm-1; MS (ES): m/z (%): 223.3 (100) 
[M+H+]; yield: 98%, yellow oil. 
1-Hexyl-2-isopropyl-3,4,5-trimethylimidazolium bis(trifluoromethylsulfonyl)imide 
[C6Ci3m3im][NTf2] (51b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
0.90 (m, 3J(H,H) = 6.6 Hz, 3H; CH2CH3), 1.24-1.40 (m; 6H; (CH2)3CH3), 
1.47 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2),1.61-1.69 (m, 2H; NCH2CH2; m), 
2.21 (s, 6H; CH3C4/5), 3.41-3.65 (m, 1H; CH), 3.70 (s, 3H; NCH3), 3.97 
ppm (2H, t, 3J(H,H) = 8.2 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 8.53 (CH3C4/5), 8.67 (CH3C4/5), 13.88 (CH3CH2), 18.93 (CH(CH3)2), 22.40 
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(CH2), 25.25 (CH2), 26.12 (CH2) 30.40 (CH2) 31.16 (NCH3), 32.63 (CH), 45.68 (NCH2), 119.94 
(q, 1J(C,F) = 321.1 Hz; CF3), 125.37 (CH3C4/5), 127.18 (CH3C4/5), 147.49 ppm (C2CH); 19F 
NMR (282 MHz, CDCl3, 25 °C):  = -78.96 ppm; IR (ATR):  = 1054, 1135, 1177, 1349, 2360 
cm-1; MS (ES): m/z (%): 237.3 (100) [M+H+]; yield: 97%, yellow oil. 
3.4.4) N-alkylimidazolium dicyanamide ionic liquids 
Procedure for the sodium mediated metathesis towards 1-ethyl-2-isopropyl-3,4,5-
trimethylimidazolium dicyanamide [C2Ci3m3im][N(CN)2] (47c): To a 50 mL flask charged 
with the ionic liquid [C2Ci3m3im][OMs] (20 mmol, 5.53 g) was added demineralised water (20 
mL) and Na(CN)2 (24 mmol, 2.14 g). The mixture was heated to 50 °C and stirred overnight to 
ensure complete exchange of the ions. After reaction, the water was removed by rotary 
evaporation, and acetone was added. After storage at -18 °C, the precipitate was filtered off. 
The solvent and residual water were removed from the filtrate by rotary evaporation and the 
resulting ionic liquid was dissolved in 30 mL of chloroform and stored at -18 °C for at least 4h. 
Again, the precipitate was filtered off and the filtrate evaporated. This last step was repeated 
until no further precipitation was observed after storage at -18 °C. The solvent was removed in 
vacuo to lead to a yellow oil in quantitative yield. 
Procedure for the silver mediated metathesis towards 1-ethyl-2-isopropyl-3,4,5-
trimethylimidazolium dicyanamide [C2Ci3m3im][N(CN)2] (47c): To a 50 mL flask charged 
with the ionic liquid [C2Ci3m3im][I] (20 mmol, 6.18 g) was added demineralised water (20 mL) 
and CH3CN (10 mL). Then silver dicyanamide (24 mmol, 4.15g) was added to the solution. 
The flask was equipped with a cooler with cotton plug and the mixture was heated to 50 °C for 
8h. After reaction, the mixture was allowed to cool to 0 °C. The precipitate was filtered off and 
the water was removed in vacuo. The resulting yellow oil was dissolved in dry CH2Cl2 and 
cooled to -18 °C, after filtration of a white precipitate, this step was repeated until no further 
precipitation was visible, and dichloromethane was removed in vacuo. The ionic liquid was 
dried for 8 h at 80 °C under reduced pressure (0.5 mbar). An opaque white solid was obtained 
in quantitative yield. 
1-Ethyl-3,4,5-trimethylimidazolium dicyanamide [C2m3im][N(CN)2] (44c): 1H NMR (300 
MHz, CDCl3, 25 °C, TMS):  = 1.58 (t, 3J(H,H) = 7.3 Hz, 3H; NCH2CH3), 
2.30 (s, 3H; CH3C4/5), 2.31 (s, 3H; CH3C4/5), 3.87 (s, 3H; NCH3), 4.18 
(q, 3J(H,H) = 7.4 Hz, 2H; NCH2CH3), 9.05 ppm (s, 1H; CH); 13C NMR 
(75 MHz, CDCl3, 25 °C, TMS):  = 8.20 (CH3C4/5), 8.31 (CH3C4/5), 
14.67 (CH3CH2), 33.61 (NCH2), 42.29 (NCH3), 119.50 (N(CN)2), 
126.86 (CH3C4/5), 127.70 (CH3C4/5), 133.60 ppm (CH); IR (ATR):  = 1313, 1571, 2131, 2230, 
2362, 2980 cm-1; MS (ES): m/z (%): 139.3 (100) [M+H+]; yield: 86%, white powder.  
1-Ethyl-2,3,4,5-tetramethylimidazolium dicyanamide [C2C1m3im][N(CN)2] (45c): 1H NMR 
(300 MHz, CDCl3, 25 °C, TMS):  = 1.42 (t, 3J(H,H) = 7.4 Hz, 3H; 
NCH2CH3), 2.29 (s, 3H; CH3C4/5), 2.31 (s, 3H; CH3C4/5), 2.71 (s, 3H; 
C2CH3), 3.72 (s, 3H; NCH3), 4.14 ppm (q, 3J(H,H) = 7.4 Hz, 2H; 
NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.55 (CH3C4/5), 
8.76 (CH3C4/5), 10.18 (C2CH3), 14.86 (CH3CH2), 32.12 (CH2), 40.83 
(NCH3), 119.56 (N(CN)2), 125.03 (CH3C4/5), 126.34 (CH3C4/5), 141.67 ppm (C2); IR (ATR):  = 
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1302, 1447, 1537, 2125, 2223 cm-1; MS (ES): m/z (%): 153.3 (100) [M+H+]; yield: 83%, yellow 
oil. 
1,2-Diethyl-3,4,5-trimethylimidazolium dicyanamide [C2C2m3im][N(CN)2] (46c): 1H NMR 
(300 MHz, CDCl3, 25 °C, TMS):  = 1.36 (t, 3J(H,H) = 7.7 Hz, 3H; 
C2CH2CH3), 1.45 (t, 3J(H,H) = 7.4 Hz, 3H; NCH2CH3), 2.30 (s, 3H; 
CH3C4/5), 2.32 (s, 3H; CH3C4/5), 3.09 (q, 3J(H,H) = 7.7 Hz, 2H; 
C2CH2CH3), 3.75 (s, 3H; NCH3), 4.14 ppm (q, 3J(H,H) = 7.4 Hz, 2H; 
NCH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.52 (CH3C4/5), 
8.69 (CH3C4/5), 11.73 (CH3CH2C), 15.47 (NCH2CH3), 17,36 (CH2C), 
31.88 (NCH2), 40.67 (NCH3), 119.63 (N(CN)2), 125.09 (CH3C4/5), 126.59 (CH3C4/5), 145.55 
ppm (C2CH2); IR (ATR):  = 736, 919, 1307, 1530, 2128, 2227 cm-1; MS (ES): m/z (%): 167.3 
(100) [M+H+]; yield: 89%, yellow oil. 
1-Ethyl-2-isopropyl-3,4,5-trimethylimidazolium dicyanamide [C2Ci3m3im][N(CN)2] (47c): 
1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.43 (t, 3J(H,H) = 7.4 Hz, 
3H; NCH2CH3), 1.54 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.30 (s, 3H; 
CH3C4/5), 2.31 (s, 3H; CH3C4/5), 3.53-3.68 (m, 1H; CH), 3.76 (s, 3H; 
NCH3), 4.18 ppm (q, 3J(H,H) = 7.4 Hz, 2H; NCH2CH3); 13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 8.64 (CH3C4/5), 8.76 (CH3C4/5), 15.59 (CH3CH2), 
19.12 (CH3CH), 25.13 (CH), 32.70 (NCH3), 40.81 (CH2), 119.56 (N(CN)2), 125.21 (CH3C4/5), 
127.05 (CH3C4/5), 147.43 ppm (C2CH); IR (ATR):  = 1089, 1303, 1523, 2126, 2225 cm-1; MS 
(ES): m/z (%): 181.3 (100) [M+H+]; yield:82%, yellow oil. 
1-Hexyl-3,4,5-trimethylimidazolium dicyanamide [C6m3im][N(CN)2] (48c): 1H NMR (300 
MHz, CDCl3, 25 °C, TMS):  = 0.90 (t, 3J(H,H) = 6.9 Hz, 3H; CH2CH3), 
1.25-1.41 (m; 6H; (CH2)3CH3), 1.80-1.90 (m, 2H; NCH2CH2), 2.30 (s, 6H; 
CH3C4/5), 3.86 (s, 3H; NCH3), 4.08 (2H, t, 3J(H,H) = 7.7 Hz, 2H; NCH2), 
8.94 ppm (s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.44 
(CH3C4/5), 8.61 (CH3C4/5), 13.97 (CH3(CH2)5), 22.41 (CH2), 25.99 (CH2), 
29.70 (NCH2CH2), 31.12 (CH2), 33.91 (NCH3), 47.41 (NCH2), 119.79 (N(CN)2), 126.89 
(CH3C4/5), 127.79 (CH3C4/5), 134.57 ppm (CH); IR (ATR):  = 1303, 1452, 1572, 2126, 2224 
cm-1; MS (ES): m/z (%): 195.3 (100) [M+H+]; yield: 91%, yellow oil.  
1-Hexyl-2,3,4,5-tetramethylimidazolium dicyanamide [C6C1m3im][N(CN)2] (49c): 1H NMR 
(300 MHz, CDCl3, 25 °C, TMS):  = 0.90 (t, 3J(H,H) = 6.6 Hz, 3H; 
CH2CH3), 1.29-1.41 (m; 6H; (CH2)3CH3), 1.66-1.76 (m, 2H; NCH2CH2; 
m), 2.29 (s, 6H; CH3C4/5), 2.69 (s, 3H; C2CH3), 3.73 (s, 3H; NCH3), 4.03 
ppm (2H, t, 3J(H,H) = 7.7 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 8.75 (CH3C4/5), 8.81 (CH3C4/5), 10.44 (C2CH3), 13.94 
(CH3(CH2)5), 22.40 (CH2), 26.17 (CH2), 29.64 (NCH2CH2), 31.12 (CH2), 32.19 (NCH3), 45.77 
(NCH2), 119.60 (N(CN)2), 125.26 (CH3C4/5), 126.36 (CH3C4/5), 141.73 ppm (C2); IR (ATR):  = 
1310, 1538, 1650, 2132, 2238 cm-1; MS (ES): m/z (%): 209.3 (100) [M+H+]; yield: 99%, yellow 
oil. 
2-Ethyl-1-hexyl-3,4,5-trimethylimidazolium dicyanamide [C6C2m3im][N(CN)2] (50c): 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 0.91 (t, 3J(H,H) = 6.9 Hz, 3H; CH2CH3), 1.25-1.44 
NN Me
Me N(CN)2
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(m; 6H; (CH2)3CH3), 1.36 (t, 3J(H,H) = 7.7 Hz, 3H; C2CH2CH3), 1.69-1.85 
(m, 2H; NCH2CH2; m), 2.30 (s, 6H; CH3C4/5), 3.07 (q, 3J(H,H) = 7.7 Hz, 
2H; C2CH2CH3), 3.75 (s, 3H; NCH3), 4.02 ppm (2H, t, 3J(H,H) = 8.3 Hz, 
2H; NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.81 (CH3C4/5), 
11.71 (CH3CH2C2), 13.94 (CH3(CH2)5), 17.59 (CH3CH2C2), 22.41 (CH2), 
26.26 (CH2), 30.31 (NCH2CH2), 31.16 (CH2), 32.03 (NCH3), 45.71 (NCH2), 119.73 (N(CN)2), 
125.35 (CH3C4/5), 126.68 (CH3C4/5), 145.72 ppm (C2CH2); IR (ATR):  = 1301, 1453, 1531, 
2125, 2222 cm-1; MS (ES): m/z (%): 223.3 (100) [M+H+]; yield: 89%, yellow oil. 
1-Hexyl-2-isopropyl-3,4,5-trimethylimidazolium dicyanamide [C6Ci3m3im][N(CN)2] (51c): 
1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 0.91 (m, 3J(H,H) = 6.9 Hz, 
3H; CH2CH3), 1.30-1.44 (m; 6H; (CH2)3CH3), 1.53 (d, 3J(H,H) = 7.2 Hz, 
6H; CH(CH3)2),1.66-1.76 (m, 2H; NCH2CH2; m), 2.29 (s, 6H; CH3C4/5), 
3.49-3.63 (m, 1H; CH), 3.80 (s, 3H; NCH3), 4.06 ppm (2H, t, 3J(H,H) = 8.0 
Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.84 
(CH3C4/5), 8.92 (CH3C4/5), 13.91 (CH3(CH2)5), 19.16 (CH(CH3)2), 22.40 (CH2), 25.31 (CH2), 
26.15 (NCH2CH2), 30.44 (CH2), 31.16 (NCH3), 32.85 (CH), 45.80 (CH2), 119.41 (N(CN)2), 
125.46 (CH3C4/5), 127.18 (CH3C4/5), 147.53 ppm (C2CH); IR (ATR):  = 1300, 1456, 1522, 
2124, 2221 cm-1; MS (ES): m/z (%): 237.3 (100) [M+H+]; yield: 93%, yellow oil. 
3.5. Synthesis of N-alkoxy and N-alkenylimidazolium ionic liquids 
3.5.1) N-alkoxy- and N-alkenylimidazolium methanesulfonate ionic liquids 
Compounds 61-62a were synthesised using the procedure for compound 44d described at 
page 142. 
1-Allyl-2-isopropyl-3,4,5-trimethylimidazolium methanesulfonate [CAC1Ci3m2im][OMs] 
(61a): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.50 (d, 3J(H,H) = 7.2 
Hz, 6H; CH(CH3)2), 2.23 (s, 3H; CH3C4/5), 2.29 (s, 3H; CH3C4/5), 2.70 (s, 
3H; CH3SO3), 3.53-3.67 (m, 1H; CH(CH3)2), 3.84 (s, 3H; CH3SO3), 4.84-
4.89 (m, 2H; NCH2), 4.89 (d, 3J(H,H) = 17.1 Hz, 1H; CH=CHEHZ), 5.32 (d, 
3J(H,H) = 10.5 Hz, 1H; CH=CHEHZ), 5.90-6.04 ppm (ddt, 3J(H,H) = 17.1 
Hz, 3J(H,H) = 10.5 Hz, 3J(H,H) = 4.4 Hz, 1H; CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, 
TMS):  = 8.66 (CH3C4/5), 8.98 (CH3C4/5), 19.27 (CH(CH3)2), 25.31 (CH(CH3)2), 33.09 (NCH3), 
39.39 (CH3SO3), 47.65 (NCH2), 117.76 (CH=CH2), 125.90 (C4/5), 126.97 (C4/5), 131.02 
(CH=CH2), 148.39 ppm (C2); IR (ATR):  = 726, 1036, 1192, 1452, 1523, 1651 cm-1; MS (ES): 
m/z [%]: 193.3 (100) [M+H+]; yield: 98%, light yellow oil. 
2-Isopropyl-1-(2-methoxyethyl)-3,4,5-trimethylimidazolium methanesulfonate 
[C2O1C1Ci3m2im][OMs] (62a): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 1.48 (d, 3J(H,H) = 7.7 Hz, 6H; CH(CH3)2), 2.28 (s, 3H; 
CH3C4/5), 2.30 (s, 3H; CH3C4/5), 2.71 (s, 3H; CH3SO3), 3.31 (s, 3H; 
OCH3), 3.65 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 3.67-3.81 (m, 1H; CH), 
3.83 (s, 3H, NCH3), 4.47 ppm (t, 3J(H,H) = 5.0 Hz, 2H; NCH2); 13C 
NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.89 (CH3C4/5), 9.21 (CH3C4/5), 18.93 (CH(CH3)2), 
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25.18 (CH), 33.19 (NCH3), 39.42 (CH3SO3), 46.00 (NCH2), 59.09 (OCH3), 70.36 (CH2O), 
125.76 (C4/5), 126.76 (C4/5), 148.96 ppm (C2); IR (ATR):  = 1039, 1119, 1184, 1458, 1523 cm-
1; HRMS (ESI/APCI) calcd for [C12H23N2O+]: 211.1805; found: 211.1803; elemental analysis 
calcd (%) for C13H26N2O4S: C 50.96, H 8.55, N 9.14; found C 50.51, H 9.11, N 9.00; yield: 
96%, white crystals. 
Procedure for the synthesis of 1-(2-allyloxyethyl)-2-isopropyl-3,4,5-
trimethylimidazolium methanesulfonate [C2OAC1Ci3m2im][OMs] (63a): The synthesis 
procedure is analogous to the procedure applied for 61a, although longer irradiation times are 
to be applied for better conversion. The mixture was irradiated for 40 minutes in a microwave 
reactor to a temperature of 80 °C, longer reaction times lead to significant colouration. After 
reaction, the solvent was removed in vacuo and the mixture was diluted in distilled water (25 
mL) and washed twice with Et2O (20 mL), due to the better solubility of 63a in EtOAc 
compared to 61a. The aqueous layer was evaporated and dried for 6h at 100 °C and 1.0 mbar. 
1-(2-Allyloxyethyl)-2-isopropyl-3,4,5-trimethylimidazolium methanesulfonate 
[C2OAC1Ci3m2im][OMs] (63a): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 1.48 (d, 3J(H,H) = 7.7 Hz, 6H; CH(CH3)2), 2.28 (s, 3H; 
CH3C4/5), 2.31 (s, 3H; CH3C4/5), 2.71 (s, 3H; CH3SO3), 3.65-3.85 
(m, 1H; CH(CH3)2), 3.71 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 3.82 (m, 
3H; NCH3), 3.95 (d, 3J(H,H) = 5.5 Hz; OCH2CH), 4.49 (t, 3J(H,H) 
= 5.0 Hz, 2H; NCH2), 5.18 (d, 3J(H,H) = 10.8 Hz, 1H; CH=CHZHE), 5.19 (d, 3J(H,H) = 16.8 Hz, 
1H; CH=CHZHE), 5.79 ppm (ddt, 3J(H,H) = 16.8 Hz, 3J(H,H) = 10.8 Hz, 3J(H,H) = 5.5 Hz, 1H; 
CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.89 (CH3C4/5), 9.24 (CH3C4/5), 18.99 
(CH(CH3)2), 25.13 (CH(CH3)2), 32.21 (NCH3), 39.45 (CH3SO3), 46.06 (NCH2), 68.05 
(OCH2CH), 72.36 (CH2O), 118.05 (CH=CH2), 125.84 (C4/5), 126.80 (C4/5), 133.69 (CH=CH2), 
148.96 ppm (C2); IR (ATR):  = 763, 1036, 1107, 1190 cm-1; MS (ES): m/z [%]: 237.3 (100) 
[M+H+]; yield: 92%, yellow liquid. 
Procedure for the synthesis of allyl methanesulfonate: To a flame dried 250 mL flask, 
containing 80 mL of dry CH2Cl2 and equipped with a CaCl2 tube, ally alcohol (189 mmol, 11.05 
g,) and 1.1 eq. triethylamine (207 mmol, 29.2 mL) were added. The mixture was vigorously 
stirred and allowed to cool in an ice bath, after which dropwise 1.1 eq. methanesulfonate 
chloride (207 mmol, 12.89 mL) was added via a syringe. The reaction mixture was then 
allowed to warm to room temperature and stirred for 1 hour. After reaction, the mixture was 
washed once with a saturated NaHCO3 mixture and once with water. The organic layer was 
dried with MgSO4 and filtered. The filtrate was evaporated in vacuo and the product was 
distilled via short-path vacuum distillation (53 °C, 1.0 mbar). 
Procedure for the synthesis of 1-allyl-3-ethyl-2-isopropyl-4,5-dimethylimidazolium 
methanesulfonate [CAC2Ci3m2im][OMs] (64a): To a flame dried 8 mL vial, containing 4 mL 
of dry acetonitrile, 1-ethyl-2-isopropyl-4,5-dimethylimidazole (10 mmol, 1.66 g) was added via 
a syringe under a nitrogen atmosphere. To the mixture, freshly distilled allyl methanesulfonate 
(10.5 mmol, 1.43 g) was added. The headspace was filled with nitrogen and the vial was 
sealed with a PTFE cap. The mixture was irradiated for 45 minutes in a microwave reactor to 
a temperature of 100 °C. After reaction, the solvent was removed in vacuo and the mixture 
was diluted in distilled water (25 mL) containing 0.05 mol equivalents NaOH (dependent on 
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the fraction of 12 observed by 1H NMR in CDCl3). The aqueous layer was washed twice with 
20 mL of EtOAc. The water was removed by evaporation or lyophilisation and the product was 
diluted in an excess of boiling acetone and stored at -18 °C for several hours. The formed 
crystals were filtered off. The filtrate was evaporated and again diluted in boiling acetone, until 
no more crystals could be filtered off after storage at -18 °C. The resulting clear solution was 
evaporated and the obtained oil was dried for 6h at 100 °C and 1.0 mbar. 
1-Allyl-3-ethyl-2-isopropyl-4,5-dimethylimidazolium methanesulfonate 
[CAC2Ci3m2im][OMs] (64a): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
1.44 (d, 3J(H,H) = 7.3 Hz, 3H; CH2CH3), 1.51 (d, 3J(H,H) = 7.7 Hz, 6H; 
CH(CH3)2), 2.23 (s, 3H; CH3C4/5), 2.31 (s, 3H; CH3C4/5), 2.71 (s, 3H; 
CH3SO3), 3.59-3.68 (m, 1H; CH(CH3)2), 4.29 (t, 3J(H,H) = 7.3 Hz, 3H; 
CH2CH3), 4.89 (d, 3J(H,H) = 18.7 Hz, 1H; CH=CHEHZ), 4.89-4.97 (m, 2H; 
CH2CH=CH2), 5.33 (d, 3J(H,H) = 11.0 Hz, 1H; CH=CHEHZ), 5.94-6.03 ppm (m, 1H; CH=CH2); 
13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.49 (CH3C4/5), 8.64 (CH3C4/5), 15.60 (CH2CH3), 
19.91 (CH(CH3)2), 25.18 (CH(CH3)2), 39.35 (CH3SO3), 41.15 (CH2CH3), 47.71 (CH2CH=CH2), 
117.53 (CH=CH2), 125.86 (C4/5), 126.77 (C4/5), 131.17 (CH=CH2), 148.09 ppm (C2); IR (ATR): 
 = 1039, 1181, 1513, 1648, 3432 cm-1; MS (ES): m/z [%]: 207.3 (100) [M+H+]; yield: 78%, 
yellow oil. 
1,3-Diallyl-2-isopropyl-4,5-dimethylimidazolium methanesulfonate [CACACi3m2im][OMs] 
(65a): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.45 (d, 3J(H,H) = 
7.2 Hz, 6H; CH(CH3)2), 2.28 (s, 6H; CH3C4/5), 2.83 (s, 3H; CH3SO3), 
3.57-3.71 (m, 1H; CH(CH3)2), 4.86 (dt, 3J(H,H) = 17.5 Hz, 4J(H,H) = 
2.0 Hz, 2H; CH=CHEHZ), 5.02 (dt, 3J(H,H) = 4.2 Hz, 4J(H,H) = 2.0 Hz, 
4H; NCH2), 5.35 (dt, 3J(H,H) = 10.6 Hz, 4J(H,H) = 1.9 Hz, 2H; 
CH=CHEHZ), 5.95 ppm (ddt, 3J(H,H) = 17.5 Hz, 3J(H,H) = 10.6 Hz, 3J(H,H) = 4.2 Hz, 2H, 
CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.58 (CH3C4/5), 19.88 (CH(CH3)2), 
25.30 (CH(CH3)2), 39.45 (CH3SO3), 47.82 (CH2CH=CH2), 117.48 (CH=CH2), 126.58 (C4, C5), 
131.08 (CH), 148.86 ppm (C2); IR (ATR):  = 920, 1511, 1646; 2358, 3424 cm-1; MS (ES): m/z 
[%]: 219.3 (100) [M+H+]; yield: 76%, colourless oil. 
1-Allyl-2-isopropyl-3-(2-methoxyethyl)-4,5-dimethylimidazolium methanesulfonate 
[C2O1CACi3m2im][OMs] (66a): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 1.46 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.20 (s, 3H; 
CH3C4/5), 2.33 (s, 3H; CH3C4/5), 2.72 (s, 3H; CH3SO3), 3.32 (s, 3H; 
OCH3), 3.69 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 3.69-3.85 (m, 1H; 
CH(CH3)2), 4.58 (t, 3J(H,H) = 5.0 Hz, 2H; CH2CH2O), 4.82-4.83 (m, 
2H; CH2CH=CH2), 4.95 (d, 3J(H,H) = 17.1 Hz, 1H; CH=CHZHE), 5.38 (d, 3J(H,H) = 10.5 Hz, 
1H; CH=CHZHE), 5.90-6.02 ppm (m, 1H; CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  
= 8.52 (CH3C4/5), 9.25 (CH3C4/5), 19.86 (CH(CH3)2), 25.39 (CH(CH3)2), 39.45 (CH3SO3), 46.23 
(CH2CH2O), 47.94 (CH2CH=CH2), 59.12 (OCH3), 70.32 (CH2O), 118.07 (CH=CH2), 126.49 
(C4/5), 126.57 (C4/5), 130.82 (CH=CH2), 149.51 ppm (C2); IR (ATR):  = 1038, 1117, 1181, 
1513 cm-1; MS (ES): m/z [%]: 237.3 (100) [M+H+]; yield: 75%, white glass. 
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3.5.2) N-alkoxy- and N-alkenylimidazolium iodide ionic liquids 
Compounds 61-63b and 122b were synthesised using the procedure for compound 47a 
described at page 143. 
1-Allyl-2-isopropyl-3,4,5-trimethylimidazolium iodide [CAC1Ci3m2im][I] (61b): 1H NMR 
(300 MHz, CDCl3, 25 °C, TMS):  = 1.52 (d, 3J(H,H) = 7.2 Hz, 6H; 
CH(CH3)2), 2.25 (s, 3H; CH3C4/5), 2.33 (s, 3H; CH3C4/5), 3.56-3.68 (m, 1H; 
CH(CH3)2), 3.88 (s, 3H; NCH3), 4.87-4.91 (m, 2H; NCH2), 4.98 (d, 3J(H,H) 
= 17.1 Hz, 1H; CH=CHEHZ), 5.35 (d, 3J(H,H) = 10.5 Hz, 1H; CH=CHEHZ), 
5.93-6.02 ppm (m, 1H; CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS): 
 = 9.24 (CH3C4/5), 9.82 (CH3C4/5), 19.73 (CH(CH3)2), 25.24 (CH(CH3)2), 34.43 (NCH3), 48.32 
(NCH2), 118.07 (CH=CH2), 125.78 (C4/5), 127.02 (C4/5), 130.63 (CH=CH2), 148.25 ppm (C2); 
IR (ATR):  = 1222, 1362, 1444, 1521, 1707 cm-1; MS (ES): m/z [%]: 193.3 (100) [M+H+]; 
yield: 98%, light yellow oil. 
2-Isopropyl-1-(2-methoxyethyl)-3,4,5-trimethylimidazolium iodide [C2O1C1Ci3m2im][I] 
(62b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.50 (d, 3J(H,H) = 
7.2 Hz, 6H; CH(CH3)2), 2.30 (s, 6H; CH3C4/5), 3.32 (s, 3H; OCH3), 3.67 (t, 
3J(H,H) = 4.8 Hz, 2H; CH2O), 3.70-3.84 (m, 1H; CH), 3.84 (s, 3H, NCH3), 
4.46 ppm (t, 3J(H,H) = 4.8 Hz, 2H; NCH2);13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 9.65 (CH3C4/5), 9.88 (CH3C4/5), 19.36 (CH(CH3)2), 
25.25 (CH), 34.31 (NCH3), 46.71 (NCH2), 59.26 (OCH3), 70.39 (CH2O), 125.73 (C4/5), 126.89 
(C4/5), 148.86 ppm (C2); IR (ATR):  = 1108, 1446, 1523, 2971 cm-1; HRMS (ESI/APCI) calcd 
for [C12H23N2O+]: 211.1805; found: 211.1810; elemental analysis calcd (%) for C12H23IN2O: C 
42.61, H 6.85, N 8.28; found: C 42.09, H 6.77, N 8.09; yield: 99%, white crystals. 
1-(2-Allyloxyethyl)-2-isopropyl-3,4,5-trimethylimidazolium iodide [C2OAC1Ci3m2im][I] 
(63b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.51 (d, 
3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.29 (s, 3H; CH3C4/5), 2.32 (s, 
3H; CH3C4/5), 3.72-3.90 (m, 1H; CH(CH3)2) 3.73 (t, 3J(H,H) = 5.1 
Hz, 2H; CH2O), 3.83 (s, 3H; NCH3), 3.96 (dt, 3J(H,H) = 6.1 Hz, 
4J(H,H) = 1.5 Hz; OCH2CH), 4.49 (t, 3J(H,H) = 5.1 Hz, 2H; NCH2), 
5.19 (dt, 3J(H,H) = 10.6 Hz, 4J(H,H) = 1.5 Hz, 1H; CH=CHZHE), 
5.20 (dt, 3J(H,H) = 16.7 Hz, 4J(H,H) = 1.5 Hz, 1H; CH=CHZHE), 5.80 ppm (ddt, 3J(H,H) = 16.7 
Hz, 3J(H,H) = 10.6 Hz, 3J(H,H) = 6.1 Hz, 1H; CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, 
TMS):  = 9.63 (CH3C4/5), 9.86 (CH3C4/5), 19.39 (CH(CH3)2), 25.18 (CH(CH3)2), 34.28 (NCH2), 
46.75 (NCH3), 68.02 (OCH2CH), 72.36 (CH2O), 118.08 (CH=CH2), 125.76 (C4/5), 126.89 (C4/5), 
133.63 (CH=CH2), 148.82 ppm (C2); IR (ATR):  = 746, 920, 1110, 1447, 1522 cm-1; HRMS 
(ESI/APCI) calcd for [C14H25N2O+]: 237.1961; found: 237.1963; yield: 99%, yellow liquid. 
1-(2-Methoxyethyl)-2,3,4,5-tetramethylimidazolium iodide (122b): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 2.27 (s, 6H; CH3C4/5), 2.82 (s, 3H; C2CH3), 
3.33 (s, 3H; OCH3), 3.67 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 3.75 (s, 3H; 
NCH3), 4.34 ppm (t, 3J(H,H) = 5.0 Hz, 2H; NCH2); 13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 9.42 (CH3C4/5), 12.52 (C2CH3), 33.63 (NCH3), 
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46.71 (NCH2), 59.29 (OCH3), 70.40 (CH2O), 125.81 (C4/5), 125.87 (C4/5), 143.31 ppm (C2); IR 
(ATR):  = 1037, 1094, 1117, 1444, 2900 cm-1; elemental analysis calcd (%) for C10H20IN2O: 
C 38.60, H 6.48, N 9.00; found: C 38.73, H 6.26, N 8.94; yield: 97%, white powder. 
3.5.3) N-alkoxy- and N-alkenylimidazolium bromide ionic liquids 
Procedure for the synthesis of 1-allyl-3-ethyl-2-isopropyl-4,5-dimethylimidazolium 
bromide [CAC2Ci3m2im][Br] (64b): To a flame dried 8 mL vial, containing 4 mL of dry 
acetonitrile, 1-ethyl-2-isopropyl-4,5-dimethylimidazole (10 mmol, 1.66 g) was added via a 
syringe under a nitrogen atmosphere. To the mixture distilled allyl bromide (10.5 mmol, 1.27 
g) was added. The headspace was filled with nitrogen and the vial was sealed with a PTFE 
cap. The mixture was irradiated for 45 minutes in a microwave reactor to a temperature of 
100 °C. After reaction, the solvent was removed in vacuo and the mixture was diluted in 25 
mL distilled water containing 0.09 mol eq. NaOH (dependent on the fraction of protonated 
imidazole observed by 1H NMR in CDCl3). The aqueous layer was washed twice with 20 mL of 
EtOAc. The water was removed by evaporation or lyophilisation and the product was diluted in 
an excess of boiling dichloromethane and stored at -18 °C for several hours. The formed 
suspension was filtered off over filter paper. The filtrate was evaporated and again diluted in 
boiling dichloromethane, until no more suspension was visible after storage at -18 °C. The 
resulting clear solution was evaporated and the obtained oil was dried for 6h at 80 °C and 1.0 
mbar. 
1-Allyl-3-ethyl-2-isopropyl-4,5-dimethylimidazolium bromide [CAC2Ci3m2im][Br] (64b): 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.45 (d, 3J(H,H) = 7.3 Hz, 3H; 
CH2CH3), 1.52 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.26 (s, 3H; CH3C4/5), 
2.34 (s, 3H; CH3C4/5), 3.67-3.82 (m, 1H; CH(CH3)2), 4.36 (t, 3J(H,H) = 7.3 
Hz, 3H; CH2CH3), 4.91 (d, 3J(H,H) = 17.2 Hz, 1H; CH=CHEHZ), 4.98-5.04 
(m, 2H; CH2CH=CH2), 5.35 (d, 3J(H,H) = 10.5 Hz, 1H; CH=CHEHZ), 6.00 
ppm (ddt, 3J(H,H) = 17.2 Hz, 3J(H,H) = 10.5 Hz, 3J(H,H) = 4.8 Hz, 1H; CH=CH2); 13C NMR (75 
MHz, CDCl3, 25 °C, TMS):  = 8.99 (CH3C4/5), 9.13 (CH3C4/5), 15.80 (CH2CH3), 20.35 
(CH(CH3)2), 25.42 (CH(CH3)2), 41.77 (CH2CH3), 48.43 (CH2CH=CH2), 118.04 (CH=CH2), 
125.95 (C4/5), 126.94 (C4/5), 130.85 (CH=CH2), 148.30 ppm (C2); IR (ATR):  = 1091, 1331, 
1451, 1511, 1646, 2973, 3455 cm-1; MS (ES): m/z [%]: 207.3 (100) [M+H+]; elemental 
analysis calcd (%) for C13H23BrN2: C 54.36, H 8.07, N 9.75; found: C 54.11, H 8.67, N 9.61; 
yield: 81%, white flakes. 
1,3-Diallyl-2-isopropyl-4,5-dimethylimidazolium bromide [CACACi3m2im][Br] (65b): 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.46 (d, 3J(H,H) = 7.2 Hz, 
6H; CH(CH3)2), 2.30 (s, 6H; CH3C4/5), 3.60-3.75 (m, 1H; CH(CH3)2), 
4.87 (dt, 3J(H,H) = 17.1 Hz, 4J(H,H) = 1.8 Hz, 2H; CH=CHEHZ), 5.05-
5.08 (m, 4H; NCH2), 5.35 (dt, 3J(H,H) = 10.5 Hz, 4J(H,H) = 1.8 Hz, 
2H; CH=CHEHZ), 6.06 ppm (ddt, 3J(H,H) = 17.1 Hz, 3J(H,H) = 10.5 Hz, 
3J(H,H) = 4.3 Hz, 2H; CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.81 (CH3C4/5), 
20.05 (CH(CH3)2), 25.36 (CH(CH3)2), 48.09 (CH2CH=CH2), 117.55 (CH=CH2), 126.69 (C4, C5), 
131.00 (CH=CH2), 148.88 ppm (C2); IR (ATR):  = 724, 921, 1510, 2175, 2977, 3416 cm-1; 
HRMS (ESI/APCI) calcd for [C14H23N2+]: 219.1856; found: 219.1856; yield: 79%, reddish oil. 
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1-Allyl-2-isopropyl-3-(2-methoxyethyl)-4,5-dimethylimidazolium bromide 
[C2O1CACi3m2im][Br] (66b): 1H NMR (300 MHz, CDCl3, 25 °C, TMS): 
 = 1.46 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.23 (s, 3H; CH3C4/5), 
2.35 (s, 3H; CH3C4/5), 3.32 (s, 3H; OCH3), 3.70 (t, 3J(H,H) = 5.1 Hz, 
2H; CH2O), 3.78-3.91 (m, 1H; CH(CH3)2), 4.65 (t, 3J(H,H) = 5.1 Hz, 
2H; CH2CH2O), 4.86-4.91 (m, 2H; CH2CH=CH2), 4.97 (dt, 3J(H,H) = 
17.3 Hz, 4J(H,H) = 1.9 Hz, 1H; CH=CHZHE), 5.39 (dt, 3J(H,H) = 11.0 Hz, 4J(H,H) = 1.9 Hz, 1H; 
CH=CHZHE), 5.96 ppm (ddt, 3J(H,H) = 17.3 Hz, 3J(H,H) = 11.0 Hz, 3J(H,H) = 4.4 Hz, 1H; 
CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.87 (CH3C4/5), 9.65 (CH3C4/5), 19.97 
(CH(CH3)2), 25.30 (CH(CH3)2), 46.60 (CH2CH2O), 48.32 (CH2CH=CH2), 59.10 (OCH3), 70.31 
(CH2O), 117.75 (CH=CH2), 126.33 (C4/5), 126.69 (C4/5), 130.91 (CH=CH2), 149.32 ppm (C2); 
IR (ATR):  = 1116, 1451, 1509, 1648, 2978, 3430 cm-1; MS (ES): m/z [%]: 237.3 (100) 
[M+H+]; yield: 74%, yellow oil. 
3.5.4) N-alkoxy- and N-alkenylimidazolium bis(trifluoromethylsulfonyl)imide 
ionic liquids 
Compounds 61-66c and 122c were synthesised using the procedure for compound 47b 
described at page 145. 
1-Allyl-2-isopropyl-3,4,5-trimethylimidazolium bis(trifluoromethylsulfonyl)imide 
[CAC1Ci3m2im][NTf2] (61c): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  
= 1.45 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.19 (s, 3H; CH3C4/5), 2.25 
(s, 3H; CH3C4/5), 3.38-3.50 (m, 1H; CH(CH3)2), 3.74 (s, 3H; NCH3), 
4.69-4.72 (m, 2H; NCH2), 4.90 (d, 3J(H,H) = 17.1 Hz, 1H; CH=CHEHZ), 
5.34 (d, 3J(H,H) = 10.5 Hz, 1H; CH=CHEHZ), 5.86-5.98 ppm (ddt, 
3J(H,H) = 17.1 Hz, 3J(H,H) = 10.5 Hz, 3J(H,H) = 4.4 Hz, 1H; CH=CH2); 13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 8.34 (CH3C4/5), 8.57 (CH3C4/5), 18.89 (CH(CH3)2), 25.36 (CH(CH3)2), 
32.66 (NCH3), 47.39 (NCH2), 118.02 (CH=CH2), 119.94 (q, 1J(C,F) = 321.1 Hz; CF3), 125.92 
(C4/5), 127.17 (C4/5), 130.56 (CH=CH2), 148.21 ppm (C2); 19F NMR (282 MHz, CDCl3, 25 °C, 
CFCl3): -79.32 ppm; IR (ATR):  = 1053, 1134, 1176, 1348 cm-1; HRMS (ESI/APCI) calcd for 
[C12H21N2+]: 193.1699; found: 193.1697; yield: 95%, light yellow oil. 
2-Isopropyl-1-(2-methoxyethyl)-3,4,5-trimethylimidazolium bis(trifluoromethyl-
sulfonyl)imide [C2O1C1Ci3m2im][NTf2] (62c): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.45 (d, 3J(H,H) = 7.7 Hz, 6H; CH(CH3)2), 
2.23 (s, 3H; CH3C4/5), 2.24 (s, 3H; CH3C4/5), 3.31 (s, 3H; OCH3), 
3.53-3.66 (m, 1H; CH), 3.59 (t, 3J(H,H) = 5.1 Hz, 2H; CH2O), 3.73 (s, 
3H, NCH3), 4.25 ppm (t, 3J(H,H) = 5.1 Hz, 2H; NCH2); 13C NMR (75 
MHz, CDCl3, 25 °C, TMS):  = 8.50 (CH3C4/5), 8.86 (CH3C4/5), 18.60 (CH(CH3)2), 25.31 (CH), 
32.81 (NCH3), 45.70 (NCH2), 59.04 (OCH3), 70.13 (CH2O), 119.98 (q, 1J(C,F) = 321.5 Hz; 
CF3), 125.70 (C4/5), 127.02 (C4/5), 148.88 ppm (C2); 19F NMR (282 MHz, CDCl3, 25 °C, CFCl3): 
-79.37 ppm; IR (ATR):  = 1052, 1134, 1175, 1348 cm-1; HRMS (ESI/APCI) calcd for 
[C12H23N2O+]: 211.1805; found: 211.1806; yield: 99%, white crystals. 
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1-(2-Allyloxyethyl)-2-isopropyl-3,4,5-trimethylimidazolium bis(trifluoromethylsulfonyl)-
imide [C2OAC1Ci3m2im][NTf2] (63c): 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.43 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 
2.22 (CH3C4/5), 2.23 (CH3C4/5), 3.58-3.70 (m, 1H; CH(CH3)2), 
3.65 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 3.73 (m, 3H; NCH3), 3.93 
(d, 3J(H,H) = 5.4 Hz; OCH2CH), 4.25 (t, 3J(H,H) = 5.0 Hz, 2H; 
NCH2), 5.18 (d, 3J(H,H) = 10.6 Hz, 1H; CH=CHZHE), 5.19 (d, 3J(H,H) = 17.3 Hz, 1H; 
CH=CHZHE), 5.79 ppm (ddt, 3J(H,H) = 17.3 Hz, 3J(H,H) = 10.6 Hz, 3J(H,H) = 5.4 Hz, 1H; 
CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.47 (CH3C4/5), 8.87 (CH3C4/5), 18.64 
(CH(CH3)2), 25.24 (CH(CH3)2), 32.81 (NCH2), 45.73 (NCH3), 67.81 (OCH2CH), 72.40 (CH2O), 
118.02 (CH=CH2), 120.00 (q, 1J(C,F) = 321.5 Hz; CF3), 125.75 (C4/5), 127.02 (C4/5), 133.79 
(CH=CH2), 148.83 ppm (C2); 19F NMR (282 MHz, CDCl3, 25 °C, CFCl3): -79.35 ppm; IR 
(ATR):  = 1054, 1135, 1179, 1348 cm-1; MS (ES): m/z [%]: 237.3 (100) [M+H+]; yield: 99%, 
yellow liquid. 
1-Allyl-3-ethyl-2-isopropyl-4,5-dimethylimidazolium bis(trifluoromethylsulfonyl)imide 
[CAC2Ci3m2im][NTf2] (64c): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
1.42 (d, 3J(H,H) = 7.3 Hz, 3H; CH2CH3), 1.45 (d, 3J(H,H) = 7.2 Hz, 6H; 
CH(CH3)2), 2.19 (s, 3H; CH3C4/5), 2.27 (s, 3H; CH3C4/5), 3.41-3.55 (m, 
1H; CH(CH3)2), 4.16 (t, 3J(H,H) = 7.3 Hz, 3H; CH2CH3), 4.73-4.74 (m, 
2H; CH2CH=CH2), 4.89 (d, 3J(H,H) = 17.1 Hz, 1H; CH=CHEHZ), 5.35 (d, 
3J(H,H) = 10.5 Hz, 1H; CH=CHEHZ), 5.99 ppm (ddt, 3J(H,H) = 17.1 Hz, 3J(H,H) = 10.5 Hz, 
3J(H,H) = 4.4 Hz, 1H; CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.29 (CH3C4/5), 
8.43 (CH3C4/5), 15.33 (CH2CH3), 19.70 (CH(CH3)2), 25.38 (CH(CH3)2), 41.06 (CH2CH3), 47.62 
(CH2CH=CH2), 118.14 (CH=CH2), 119.96 (q, 1J(C,F) = 321.5 Hz; CF3), 126.04 (C4/5), 126.88 
(C4/5), 130.53 (CH=CH2), 147.95 ppm (C2); 19F NMR (282 MHz, CDCl3, 25 °C, CFCl3): -79.36 
ppm; IR (ATR):  = 1054, 1137, 1180, 1334, 1349 cm-1; HRMS (ESI/APCI) calcd for 
[C13H23N2+]: 207.1856; found: 207.1850; yield: 98%, white crystals. 
1,3-Diallyl-2-isopropyl-4,5-dimethylimidazolium bis(trifluoromethylsulfonyl)imide 
[CACACi3m2im][NTf2] (65c): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 1.40 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.20 (s, 6H; 
CH3C4/5), 3.36-3.51 (m, 1H; CH(CH3)2), 4.75-4.77 (m, 4H; NCH2), 
4.86 (dt, 3J(H,H) = 17.1 Hz, 4J(H,H) = 1.9 Hz, 2H; CH=CHEHZ), 5.35 
(dt, 3J(H,H) = 10.8 Hz, 4J(H,H) = 1.9 Hz, 2H; CH=CHEHZ), 5.95 ppm 
(ddt, 3J(H,H) = 17.1 Hz, 3J(H,H) = 10.8 Hz, 3J(H,H) = 4.1 Hz, 2H; 
CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.37 (CH3C4/5), 19.65 (CH(CH3)2), 
25.47 (CH(CH3)2), 47.64 (CH2CH=CH2), 118.07 (CH=CH2), 119.83 (q, 1J(C,F) = 321.9 Hz; 
CF3), 126.74 (C4, C5), 130.45 (CH), 148.60 ppm (C2); 19F NMR (282 MHz, CDCl3, 25 °C, 
CFCl3): -79.31 ppm; IR (ATR):  = 1053, 1138, 1177, 1347 cm-1; HRMS (ESI/APCI) calcd for 
[C14H23N2+]: 219.1856; found: 219.1848; elemental analysis calcd (%) for C16H23F6N3O4S2: C 
38.47, H 4.64, N 8.41; found: C 38.29, H 4.26, N 8.28; yield: 98%, white crystals. 
1-Allyl-2-isopropyl-3-(2-methoxyethyl)-4,5-dimethylimidazolium bis(trifluoromethyl-
sulfonyl)imide [C2O1CACi3m2im][NTf2] (66c): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
1.43 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.19 (s, 3H; CH3C4/5), 2.27 (s, 3H; CH3C4/5), 3.33 (s, 
3H; OCH3), 3.55-3.66 (m, 1H; CH(CH3)2), 3.63 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 4.32 (t, 
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3J(H,H) = 5.0 Hz, 2H; CH2CH2O), 4.74-4.78 (m, 2H; 
CH2CH=CH2), 4.95 (dd, 3J(H,H) = 18.2 Hz, 2J(H,H) = 1.1 Hz, 
1H; CH=CHEHZ), 5.39 (dd, 3J(H,H) = 10.5 Hz, 2J(H,H) = 1.1 Hz, 
1H; CH=CHEHZ), 5.87-5.98 ppm (m, 1H; CH=CH2); 13C NMR (75 
MHz, CDCl3, 25 °C, TMS):  = 8.28 (CH3C4/5), 8.93 (CH3C4/5), 
19.56 (CH(CH3)2), 25.48 (CH(CH3)2), 45.88 (CH2CH2O), 47.79 
(CH2CH=CH2), 59.07 (OCH3), 69.97 (CH2O), 118.31 (CH=CH2), 119.91 (q, 1J(C,F) = 321.5 
Hz; CF3), 126.41 (C4/5), 126.77 (C4/5), 130.39 (CH=CH2), 149.34 ppm (C2); 19F NMR (282 MHz, 
CDCl3, 25 °C, CFCl3): -79.36 ppm; IR (ATR):  = 1054, 1135, 1178, 1348 cm-1; HRMS 
(ESI/APCI) calcd for [C14H25N2O+]: 237.1961; found: 237.1960; yield: 99%, yellow oil. 
1-(2-Methoxyethyl)-2,3,4,5-tetramethylimidazolium bis(trifluoromethylsulfonyl)imide 
(122c): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 2.23 (s, 6H; 
CH3C4/5), 2.60 (s, 3H; C2CH3), 3.31 (s, 3H; OCH3), 3.61 (t, 3J(H,H) 
= 4.8 Hz, 2H; CH2O), 3.64 (s, 3H; NCH3), 4.20 ppm (t, 3J(H,H) = 
4.8 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 
8.57 (CH3C4/5), 10.41 (C2CH3), 31.94 (NCH3), 45.77 (NCH2), 59.03 
(OCH3), 70.17 (CH2O), 119.89 (q, 1J(C,F) = 321.13 Hz; CF3), 
125.31 (C4/5), 125.89 (C4/5), 143.14 ppm (C2); 19F NMR (282 MHz, CDCl3, 25 °C, CFCl3): -
79.41 ppm; IR (ATR):  = 1052, 1134, 1176, 1331, 1348 cm-1; MW (g mol-1): 449.40; yield: 
97%, white powder. 
3.5.5) N-alkoxy- and N-alkenylimidazolium dicyanamide ionic liquids 
Compounds 61-66d were synthesised using the silver mediated metathesis procedure for 
compound 47c described at page 148. 
1-Allyl-2-isopropyl-3,4,5-trimethylimidazolium dicyanamide [CAC1Ci3m2im][N(CN)2] 
(61d): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.52 (d, 3J(H,H) 
= 7.2 Hz, 6H; CH(CH3)2), 2.27 (s, 3H; CH3C4/5), 2.33 (s, 3H; CH3C4/5), 
3.45-3.58 (m, 1H; CH(CH3)2), 3.83 (s, 3H; NCH3), 4.79-4.83 (m, 2H; 
NCH2), 4.94 (d, 3J(H,H) = 17.1 Hz, 1H; CH=CHEHZ), 5.38 (d, 3J(H,H) 
= 10.5 Hz, 1H; CH=CHEHZ), 5.89-6.02 ppm (m, 1H; CH=CH2); 13C 
NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.69 (CH3C4/5), 8.96 (CH3C4/5), 19.18 (CH(CH3)2), 
25.42 (CH(CH3)2), 32.93 (NCH3), 47.58 (NCH2), 118.36 (CH=CH2), 119.69 (N(CN)2), 126.02 
(C4/5), 127.15 (C4/5), 130.42 (CH=CH2), 148.24 ppm (C2); IR (ATR):  = 749, 1301, 1522, 2124, 
2222 cm-1; MS (ES): m/z [%]: 193.3 (100) [M+H+]; yield: 97%, light yellow oil. 
2-Isopropyl-1-(2-methoxyethyl)-3,4,5-trimethylimidazolium dicyanamide 
[C2O1C1Ci3m2im][N(CN)2] (62d): 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.51 (d, 3J(H,H) = 7.7 Hz, 6H; CH(CH3)2), 2.30 
(s, 3H; CH3C4/5), 2.32 (s, 3H; CH3C4/5), 3.34 (s, 3H; OCH3), 3.57-
3.66 (m, 1H; CH), 3.64 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 3.81 (s, 
3H, NCH3), 4.35 ppm (t, 3J(H,H) = 5.0 Hz, 2H; NCH2); 13C NMR 
(75 MHz, CDCl3, 25 °C, TMS):  = 8.84 (CH3C4/5), 9.16 (CH3C4/5), 18.87 (CH(CH3)2), 25.36 
(CH), 32.99 (NCH3), 45.85 (NCH2), 59.19 (OCH3), 70.02 (CH2O), 119.78 (N(CN)2), 125.69 
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(C4/5), 126.98 (C4/5), 148.94 ppm (C2); IR (ATR):  = 1052, 1134, 1175, 1348 cm-1; HRMS 
(ESI/APCI) calcd for [C12H23N2O+]: 211.1805; found: 211.1806; yield: 99%, white crystals. 
1-(2-Allyloxyethyl)-2-isopropyl-3,4,5-trimethylimidazolium dicyanamide 
[C2OAC1Ci3m2im][N(CN)2] (63d): 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.50 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 
2.30 (CH3C4/5), 2.31 (CH3C4/5), 3.62-3.77 (m, 1H; CH(CH3)2), 
3.70 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 3.81 (m, 3H; NCH3), 
3.97 (d, 3J(H,H) = 5.5 Hz; OCH2CH), 4.35 (t, 3J(H,H) = 5.0 Hz, 
2H; NCH2), 5.20 (d, 3J(H,H) = 10.8 Hz, 1H; CH=CHZHE), 5.21 (d, 3J(H,H) = 16.9 Hz, 1H; 
CH=CHZHE), 5.81 ppm (ddt, 3J(H,H) = 16.9 Hz, 3J(H,H) = 10.8 Hz, 3J(H,H) = 5.5 Hz, 1H; 
CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.78 (CH3C4/5), 9.11 (CH3C4/5), 18.86 
(CH(CH3)2), 25.21 (CH(CH3)2), 32.98 (NCH3), 45.82 (NCH2), 67.67 (OCH2CH), 72.36 (CH2O), 
118.14 (CH=CH2), 119.69 (N(CN)2), 125.69 (C4/5), 126.95 (C4/5), 133.60 (CH=CH2), 148.82 
ppm (C2); IR (ATR):  = 1111, 1311, 1523, 2130, 2232 cm-1; HRMS (ESI/APCI) calcd for 
[C14H25N2O+]: 237.1961; found: 237.1965; yield: 96%, yellow liquid. 
1-Allyl-3-ethyl-2-isopropyl-4,5-dimethylimidazolium dicyanamide [CAC2Ci3m2im][N(CN)2] 
(64d): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.47 (d, 3J(H,H) = 
7.2 Hz, 3H; CH2CH3), 1.53 (d, 3J(H,H) = 7.7 Hz, 6H; CH(CH3)2), 2.27 (s, 
3H; CH3C4/5), 2.35 (s, 3H; CH3C4/5), 3.49-3.56 (m, 1H; CH(CH3)2), 4.25 
(t, 3J(H,H) = 7.2 Hz, 3H; CH2CH3), 4.81-4.85 (m, 2H; CH2CH=CH2), 
4.95 (d, 3J(H,H) = 17.1 Hz, 1H; CH=CHEHZ), 5.39 (d, 3J(H,H) = 10.5 Hz, 
1H; CH=CHEHZ), 5.96 ppm (ddt, 3J(H,H) = 17.1 Hz, 3J(H,H) = 10.5 Hz, 
3J(H,H) = 4.6 Hz, 1H; CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.66 (CH3C4/5), 
8.79 (CH3C4/5), 15.57 (CH2CH3), 20.00 (CH(CH3)2), 25.53 (CH(CH3)2), 41.25 (CH2CH3), 47.82 
(CH2CH=CH2), 118.53 (CH=CH2), 119.78 (N(CN)2), 126.11 (C4/5), 126.97 (C4/5), 130.37 
(CH=CH2), 147.95 ppm (C2); IR (ATR):  = 1054, 1137, 1180, 1334, 1349 cm-1; MS (ES): m/z 
[%]: 207.3 (100) [M+H+]; yield: 97%, yellow oil. 
1,3-Diallyl-2-isopropyl-4,5-dimethylimidazolium dicyanamide [CACACi3m2im][N(CN)2] 
(65d): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.48 (d, 3J(H,H) 
= 7.2 Hz, 6H; CH(CH3)2), 2.28 (s, 6H; CH3C4/5), 3.47-3.52 (m, 1H; 
CH(CH3)2), 4.85-4.87 (m, 4H; NCH2), 4.92 (dt, 3J(H,H) = 17.4 Hz, 
4J(H,H) = 1.9 Hz, 2H; CH=CHEHZ), 5.40 (dt, 3J(H,H) = 10.6 Hz, 
4J(H,H) = 1.9 Hz, 2H; CH=CHEHZ), 5.99 ppm (ddt, 3J(H,H) = 17.4 Hz, 
3J(H,H) = 10.6 Hz, 3J(H,H) = 4.4 Hz, 2H, CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  
= 8.72 (CH3C4/5), 19.91 (CH(CH3)2), 25.65 (CH(CH3)2), 47.90 (CH2CH=CH2), 118.30 
(CH=CH2), 119.73 (N(CN)2), 126.91 (C4, C5), 130.47 (CH), 148.60 ppm (C2); IR (ATR):  = 
1302, 1514, 1648, 2131, 2224, 3463 cm-1; MS (ES): m/z [%]: 219.3 (100) [M+H+]; yield: 98%, 
white crystals. 
1-Allyl-2-isopropyl-3-(2-methoxyethyl)-4,5-dimethylimidazolium dicyanamide 
[C2O1CACi3m2im][N(CN)2] (66d): 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.47 (d, 3J(H,H) = 7.2 Hz, 6H; CH(CH3)2), 2.25 
(s, 3H; CH3C4/5) , 2.34 (s, 3H; CH3C4/5), 3.35 (s, 3H; OCH3), 3.59-
3.73 (m, 1H; CH(CH3)2), 3.67 (t, 3J(H,H) = 5.0 Hz, 2H; CH2O), 
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4.40 (t, 3J(H,H) = 5.0 Hz, 2H; CH2CH2O), 4.81-4.86 (m, 2H;CH2CH=CH2), 4.97 (d, 3J(H,H) = 
17.1 Hz, 1H; CH=CHEHZ), 5.41 (d, 3J(H,H) = 10.5 Hz, 1H; CH=CHEHZ), 5.90-6.00 ppm (m, 1H; 
CH=CH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.47 (CH3C4/5), 8.86 (CH3C4/5), 19.70 
(CH(CH3)2), 25.48 (CH(CH3)2), 45.94 (CH2CH2O), 47.85 (CH2CH=CH2), 59.15 (OCH3), 69.93 
(CH2O), 118.42 (CH=CH2), 119.73 (N(CN)2), 126.34 (C4/5), 126.79 (C4/5), 130.36 (CH=CH2), 
149.35 ppm (C2); IR (ATR):  = 1304, 1513, 2126, 2224 cm-1; MS (ES): m/z [%]: 237.3 (100) 
[M+H+]; yield: 86%, yellow oil. 
3.6. Synthesis of chiral imidazoles and imidazolium ionic liquids 
3.6.1) Synthesis of amino acid based imidazoles and ionic liquids 
Procedure for the synthesis of (rac)-methyl-2-(2-isopropyl-4,5-dimethylimidazol-1-yl)-
propionate ((rac)-88b): A 150 mL glass pressure vial was filled with 50 mL of MeOH and a 
PTFE stirring bar. The solvent was allowed to cool to 0 °C and isobutyraldehyde (4.56 mL, 50 
mmol), L-alanine methyl ester hydrochloride (6.98g, 50 mmol) and NaOH (2.00 g, 50 mmol) 
were added. The vial was closed and submerged in a preheated oil bath at 120 °C with 
temperature controller. After heating for 2h with vigorous stirring, the reaction mixture was 
carefully cooled to 0 °C, the vial was opened and consecutively 2,3-butandione (1.08 g, 12,5 
mmol) and NH4OAc (0.96 g, 12.5 mmol) were added. The vessel was closed immediately and 
heated in a preheated oil bath at 120 °C for 30 min under vigorous stirring. The cooling to 0 °C 
and consecutive addition of diacetyl and NH4OAc were repeated three more times, until 50 
mmol of each reagent was added. After final cooling, MeOH and the reaction water were 
evaporated. The resulting mixture was dissolved in EtOAc and extracted twice with 50 mL of 
an aqueous 0.5 M HCl solution. The combined aqueous phases were alkalinised with a 3.0 M 
NaOH (40 mL) solution and extracted three times with EtOAc (40 mL). The organic phases 
were combined and dried with MgSO4. The solvent was removed in vacuo and boiling 
acetonitrile was added until all solid particles dissolved. After storage at -18 °C, the precipitate 
was removed and the solvent of the filtrate was evaporated. The resulting oil was brought on a 
column with neutral alumina packing and eluted with a 1:9 EtOAc:hexanes mixture. The eluted 
fractions were combined as long as no presence of 1H-2-isopropyl-4,5-dimethylimidazole 
could be detected by GC-FID. 
(rac)-O-methyl-2-(2-isopropyl-4,5-dimethylimidazol-1-yl)propionate ((rac)-88b): b.p. 
90 °C (1.0 mbar); ሾࢻሿࡰ૛૞ = -0.3 ± 0.1 (C = 1.1 in CHCl3); 1H NMR (300 
MHz, CDCl3, 25 °C, TMS):  = 1.30 (d, 3J(H,H) = 6.6 Hz, 3H; CH(CH3)2,), 
1.31 (d, 3J(H,H) = 6.6 Hz, 3H; CH(CH3)2), 1.64 (d, 3J(H,H) = 7.3 Hz 3H; 
NCHCH3,), 2.05 (s, 3H; CH3C4/5), 2.13 (s, 3H; CH3C4/5), 2.78-2.91 (m, 
1H; CH(CH3)2), 3.75 (s, 3H; OCH3), 4.87 ppm (q, 3J(H,H) = 7.3 Hz, 1H; 
NCH); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 9.48 (CH3C4/5), 12.63 (CH3C4/5), 17.73 
(NCHCH3), 21.88 (CH(CH3)A(CH3)B), 22.29 (CH(CH3)A(CH3)B) 26.51 (CH(CH3)2), 51.94 (NCH), 
52.81 (OCH3), 120.72 (C4/5), 132.28 (C4/5), 150.99 (C2), 171.06 ppm (C=O); IR (ATR):  = 
1092, 1316, 1434, 1742, 2965 cm-1; HRMS (ESI/APCI) calcd for [C12H21N2O2+]: 225.1603; 
found: 225.1595; yield: 26%, brown oil. 
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Procedure for the synthesis of (rac)-2-(2-isopropyl-4,5-dimethylimidazol-1-yl)-propanol 
((rac)-89b): To a 100 mL flask containing 50 mL of THF was added (rac)-methyl-2-(2-
isopropyl-4,5-dimethylimidazol-1-yl)-propanoate (11.2 g, 50 mmol) and methanol (12.15 mL, 
9.6 g, 300 mmol). The mixture was cooled to 0 °C and slowly 3 equivalents of NaBH4 were 
added (5.67 g, 150 mmol). After refluxing for 1 hour, the mixture was allowed to cool and 200 
mL of an aqueous 1.5 M NaOH solution was added. After stirring for 20 min, the mixture was 
extracted 4 times with EtOAc (40 mL). The combined organic phases were washed with a 
saturated NaCl solution. The organic fraction was dried with MgSO4 and the solvent was 
removed in vacuo. If the thus obtained product was not sufficiently pure, an extraction was 
applied from EtOAc with an aqueous 0.5 M HCl solution (150 mL), followed by neutralisation 
with an aqueous 3 M NaOH (40 mL) solution and extraction with EtOAc (3 × 40 mL). 
(rac)-2-(2-Isopropyl-4,5-dimethylimidazol-1-yl)-propanol ((rac)-89b): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.28 (d, 3J(H,H) = 7.2 Hz, 3H; CH(CH3)2), 1.33 (d, 
J3(H,H) = 6.6 Hz, 3H; CH(CH3)2), 1.46 (d, J3(H,H) = 7.2 Hz, 3H; NCHCH3), 
2.12 (s, 3H; CH3C4/5), 2.18 (s, 3H; CH3C4/5), 2.96-3.09 (m, 1H; CH(CH3)2), 
3.80 (dd, 2J(H,H) = 11.4 Hz, 3J(H,H) = 6.1 Hz, 1H; CHaHbOH), 3.92 (dd, 
2J(H,H) = 11.4 Hz, 3J(H,H) = 8.5 Hz, 1H; CHaHbOH), 4.36-4.47 ppm (m, 
1H; NCH); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 10.64 (CH3C4/5)12.28 (CH3C4/5)17.22 
(NCHCH3) 21.93 (CH(CH3)2)22.38 (CH(CH3)2)26.49 (CH(CH3)2)53.24 (NCHCH3) 64.54 (CH2) 
120.95 (C4/5) 132.02 (C4/5) 151.72 ppm (C2); IR (ATR):  = 720, 1030, 1069, 1382, 1432, 2970 
cm-1; MW (g mol-1) 196.29; yield: 73%, pale yellow oil. 
Procedure for the synthesis of (rac)-1-(1-methoxyprop-2-yl)-2-isopropyl-4,5-
dimethylimidazole ((rac)-90): In a flame dried flask of 100 mL containing 40 mL of dry THF 
under nitrogen atmosphere, (rac)-2-(2-isopropyl-4,5-dimethylimidazol-1-yl)-propanol (3.93 g, 
20 mmol) was added. The mixture was cooled to -78 °C and then slowly pure NaH (0.50 g, 21 
mmol) was added. The reaction was stirred for 15 min and dimethylsulfate (1.99 mL, 21 mmol) 
was added dropwise via a syringe. The reaction was allowed to warm to room temperature 
overnight. After reaction, distilled water (20 mL) and a saturated aqueous NaHCO3 solution 
(20 mL) were added and the mixture was extracted 3 times with 20 mL of EtOAc. The 
combined organic fractions were extracted with an aqueous 0.5 M HCl solution (2 × 25 mL). 
The combined aqueous phases were neutralised with an aqueous 3 M NaOH (15 mL) solution 
and the product was extracted with EtOAc (3 × 25 mL). The combined organic layers were 
dried with MgSO4 and the solvent was removed under reduced pressure. A light yellow oil was 
obtained. 
(rac)-2-Isopropyl-1-(3-methoxyxyprop-2-yl)-4,5-dimethylimidazole ((rac)-90): b.p. 87 °C 
(1.0 mbar); ሾࢻሿࡰ૛૞ = -0.3 ± 0.1 (C = 1.0 in CHCl3); 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.29 (d, 3J(H,H) = 6.6 Hz, 3H; CH(CH3)A(CH3)B), 
1.33 (d, 3J(H,H) = 6.6 Hz, 3H; CH(CH3)A(CH3),1.46 (d, 3J(H,H) = 7.2 Hz, 
3H; NCHCH3), 2.12 (s, 3H; CH3C4/5), 2.16 (s, 3H; CH3C4/5), 2.94-3.06 (m, 
1H; CH(CH3)2), 3.32 (s, 3H; CH2OCH3), 3.61 (d, 3J(H,H) = 6.6 Hz, 2H; 
CH2OCH3), 4.37-4.48 ppm (m, 1H; NCHCH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 
10.66 (CH3C4/5), 12.63 (CH3C4/5), 17.65 (NCHCH3), 22.12(CH(CH3)2), 22.44(CH(CH3)2), 
26.57(CH(CH3)2), 50.78 (NCHCH3), 59.09 (OCH3), 75.29 (CH2), 120.80 (C4/5), 132.31 (C4/5), 
NN
HO
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151.47 ppm (C2); IR (ATR):  = 1106, 1307, 1432, 2926 cm-1; HRMS (ESI/APCI) calcd for 
[C12H23N2O +]: 211.1805; found: 211.1807; yield: 58%, pale yellow liquid. 
(rac)-2-Isopropyl-1-(3-methoxyprop-2-yl)-4,5-dimethylimidazolium bis(trifluoromethyl-
sulfonyl)imide ((rac)-92b): 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  =1.50 (d, 3J(H,H) = 7.7 Hz, 3H; NCH(CH3)A(CH3)B), 1.51 
(d, 3J(H,H) = 7.2 Hz, 3H; NCH(CH3)A(CH3)B), 1.64 (d, 3J(H,H) = 7.2 
Hz, 3H; NCHCH3),2.30 (s, 3H; CH3C4/5), 2.33 (s, 3H; CH3C4/5), 
3.34 (m, 3H; OCH3), 3.68-3.84 (m, 1H; NCHCH2), 3.76-3.88 (m, 
1H; CH(CH3)2), 3.86 (s, 3H; NCH3), 4.84-4-95 ppm (m, 1H; NCHCH2); 13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 9.13 (CH3C4/5), 10.98 (CH3C4/5), 16.99 (CHCH3), 19.41 (CH(CH3)2), 
25.34 (CH(CH3)2), 34.14 (NCH3), 54.49 (NCH), 59.21 (OCH3), 73.07 (CH2O), 119.84 (q, 
1J(C,F) = 321.5 Hz; CF3), 125.06 (C4/5), 127.92 (C4/5), 148.99 ppm (C2); 19F NMR (282 MHz, 
CDCl3, 25 °C):  = -79.46 ppm; IR (ATR):  = 716, 1058, 1106, 1188, 1351, 1519 cm-1; MW (g 
mol-1) 506.50; yield: 97%, brown oil. 
3.6.2) Synthesis of lactate based imidazoles and imidazolium ionic liquids 
Procedure for the synthesis of (S)-2-methoxypropanol ((S)-95): To a flame dried 250 mL 
flask, containing a solution of ethyl L-lactate (20 mL, 174 mmol) in dry THF (100 mL) at 0 °C, 
methyl iodide (17.32 mL, 279 mmol) was added under a nitrogen flow. After cooling, pure NaH 
(5.00 g, 208 mmol) was added in 5 portions (every 15 min) and the reaction was stirred 
overnight. After reaction, THF was removed via cold rotary evaporation until a precipitate 
became visible. A minimal amount of H2O was added until the mixture became clear, then the 
mixture was extracted Et2O (3 × 40 mL), the organic fractions were washed with a saturated 
NaCl solution and after drying over MgSO4, most of the solvent was removed by cold 
evaporation. The resulting solution was diluted with dry THF (80 mL) and cooled to -78 °C 
under a nitrogen flow. Crushed LiAlH4 (6.58 g, 174 mmol) was added very slowly (attention, 
violent reaction), and stirred for 60 min at -78 °C. The reaction was further stirred 30 min at 
room temperature. The reaction was quenched at 0 °C with 4 equivalents of H2O (12.5 mL, 
0.7 mol) in a 1:1 mixture with THF and stirred for 1 h. The resulting slurry was filtered over 
celite with THF and the solvent was removed by cold evaporation to obtain a clear to pale 
yellow liquid in 32% overall yield. 
Procedure for the synthesis of (S)-2-methoxy-1-propyl methanesulfonate ((S)-96): To a 
solution of (S)-2-methoxypropanol (4.50 g, 50 mmol) in dry CH2Cl2 at 0 °C provided with a 
CaCl2-tube was added Et3N (7.66 mL, 55 mmol). After slowly adding MsCl (4.26 mL, 55 mmol), 
the reaction was stirred for 6 h, while warming to room temperature. The reaction mixture was 
washed with a saturated NaHCO3 (2 × 50 mL) solution and once with H2O. The organic 
fraction was dried with MgSO4 and the solvent was removed via rotary evaporation. The 
resulting yellow oil was purified by distillation (151 °C, 1.0 mbar), yielding a clear liquid. 
(S)-2-Methoxypropyl methanesulfonate ((S)-96): b.p. 68 °C (1.0 mbar); ሾࢻሿࡰ૛૞ = 23.2 ± 0.1 
(C = 0.3 in CHCl3); 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.21 (d, 
3J(H,H) = 6.6 Hz, 3H; CHCH3), 3.06 (s, 3H; CH3SO3), 3.40 (s, 3H; OCH3), 
3.58-3.68 (m, 1H; CH), 4.14 (dd, 2J(H,H) = 10.9 Hz, 3J(H,H) = 6.1 Hz, 1H; 
Procedures and spectra 
 162  
CH2), 4.23 ppm (dd, 2J(H,H) = 10.9 Hz, 3J(H,H) = 3.6 Hz, 1H; CH2); 13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 15.60 (CHCH3), 37.28 (CH3SO3), 56.58 (OCH3), 72.52 (CH2), 74.55 ppm 
(CH); IR (ATR):  = 958, 1171, 1347 cm-1; HRMS (ESI/APCI) calcd for [C5H13O4S+]: 169.0529; 
found: 169.0532; yield: 89%, colourless liquid. 
Procedure for the synthesis of (S)-1-ethyl-3-(2-methoxyprop-1-yl)-2,4,5-
trimethylimidazolium methanesulfonate (98a): To a flame dried 8 mL vial equipped with 
PTFE stirring bar, containing dry CH3CN (1 mL), were added (S)-2-methoxy-1-propyl 
methanesulfonate (0.84 g, 5 mmol) and 1-ethyl-2,4,5-trimethylimidazole (0.70 g, 5.05 mmol) 
under a nitrogen atmosphere. The vial was sealed and locked in the MW apparatus. The 
sample was isothermally irradiated for 90 min at 100 °C. After reaction, the solvent was 
removed by rotary evaporation, furnishing a dark oil which was dried for 4h at 80 °C at 0.5 
mbar. 
(S)-1-Ethyl-3-(2-methoxypropyl)-4,5-dimethylimidazolium methanesulfonate (97a): ሾࢻሿࡰ૛૞ 
= 20.3 ± 0.5 (C = 0.4 in CHCl3); 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  1.26 (d, 3J(H,H) = 6.1 Hz, 3H; CHCH3), 1.55 (t, 3J(H,H) = 7.3 
Hz, 3H; CH2CH3), 2.24 (s, 3H; CH3C4/5), 2.25 (s, 3H; CH3C4/5), 2.79 (s, 
3H; CH3SO3), 3.26 (s, 3H; OCH3), 3.77-3.87 (m, 1H; CH2CH), 4.02 (dd, 
2J(H,H) = 14.2 Hz, 3J(H,H) = 8.3 Hz, 2H; CHAHBCH), 4.21 (qd, 3J(H,H) 
= 7.3 Hz, 2J(H,H) = 2.8 Hz, 2H; CH2CH3), 4.44 (dd, 2J(H,H) = 14.2 Hz, 3J(H,H) = 2.8 Hz, 2H; 
CHAHBCH), 9.91 ppm (s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  8.41 (CH3C4/5), 
8.75 (CH3C4/5), 15.21 (CH2CH3), 16.14 (CHCH3), 39.48 (CH3SO3), 42.40 (CH2CH3), 51.55 
(CH2CH), 56.37 (OCH3), 75.73 (NCH2CH), 125.56 (C4/5), 127.75 (C4/5), 135.83 ppm (C2); IR 
(ATR):  770, 1039, 1176, 1623, 2360, 3447 cm-1; HRMS (ESI/APCI) calcd for [C11H22N2O+]: 
197.1648; found: 197.1648; yield: 83%, pale yellow oil. 
(S)-1-Ethyl-3-(2-methoxypropyl)-4,5-dimethylimidazolium bis(trifluoromethylsulfonyl)-
imide (97b): ሾࢻሿࡰ૛૞ = 14.9 ± 0.7 (C = 0.4 in CHCl3); 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.20 (d, 3J(H,H) = 6.1 Hz, 3H; CHCH3), 1.50 (t, 
3J(H,H) = 7.4 Hz, 3H; CH2CH3), 2.25 (s, 3H; CH3C4/5), 2.27 (s, 3H; 
CH3C4/5), 3.26 (s, 3H; OCH3), 3.61-3.70 (m, 1H; CH2CH), 3.93 (dd, 
2J(H,H) = 13.2 Hz, 3J(H,H) = 8.3 Hz, 2H; CHAHBCH), 4.12 (q, 3J(H,H) = 
7.4 Hz, 2H; CH2CH3), 4.17 (dd, 2J(H,H) = 13.2 Hz, 3J(H,H) = 2.8 Hz, 2H; CHAHBCH), 8.54 ppm 
(s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.21 (CH3C4/5), 8.52 (CH3C4/5), 
14.75 (CH2CH3), 15.94 (CHCH3), 42.52 (CH2CH3), 51.73 (CH2CH), 56.31 (OCH3), 75.07 
(NCH2CH), 119.97 (q, 1J(C,F) = 321.1 Hz; CF3), 126.48 (C4/5), 128.18 (C4/5), 133.70 ppm (C2); 
IR (ATR):  = 1052, 1134, 1178, 1348 cm-1; MS (ES): m/z (%): 197.3 (100) [M+H+]; yield: 98%, 
pale yellow oil. 
(S)-1-Ethyl-3-(2-methoxypropyl)-2,4,5-trimethylimidazolium methanesulfonate (98a): 
ሾࢻሿࡰ૛૞ = 16.1 ± 0.5 (C = 0.4 in CHCl3); 1H NMR (300 MHz, CDCl3, 25 °C, 
TMS):  = 1.28 (d, 3J(H,H) = 6.1 Hz, 3H; CHCH3), 1.40 (t, 3J(H,H) = 6.8 
Hz, 3H; CH2CH3), 2.25 (s, 3H; CH3C4/5), 2.26 (s, 3H; CH3C4/5), 2.68 
(CH3SO3), 2.76 (C2CH3), 3.22 (s, 3H; OCH3), 3.53-3.64 (m, 1H; 
CH2CH), 4.05 (dd, 2J(H,H) = 15.3 Hz, 3J(H,H) = 9.3 Hz, 2H; CHAHBCH), 
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4.15 (q, 3J(H,H) = 6.8 Hz, 2H; CH2CH3), 4.25 ppm (dd, 2J(H,H) = 15.3 Hz, 3J(H,H) = 2.8 Hz, 
2H; CHAHBCH); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.66 (CH3C4/5), 9.04 (CH3C4/5), 
10.99 (C2CH3), 14.87 (CH2CH3), 16.52 (CHCH3), 39.45 (CH3SO3), 40.87 (CH2CH3), 51.00 
(CH2CH), 56.51 (OCH3), 75.46 (NCH2CH), 124.47 (C4/5), 126.22 (C4/5), 143.34 ppm (C2); IR 
(ATR):  1053, 1135, 1177 1348, 1452, 1530 cm-1; MS (ES): m/z (%): 211.3 (100) [M+H+]; 
yield: 78%, brown oil. 
(S)-1-Ethyl-3-(2-methoxypropyl)-2,4,5-trimethylimidazolium bis(trifluoromethyl-
sulfonyl)imide (98b): ሾࢻሿࡰ૛૞ = 12.3 ± 0.2 (C = 0.4 in CHCl3); 1H NMR 
(300 MHz, CDCl3, 25 °C, TMS):  = 1.27 (d, 3J(H,H) = 6.6 Hz, 3H; 
CHCH3), 1.38 (t, 3J(H,H) = 7.4 Hz, 3H; CH2CH3), 2.23 (s, 3H; CH3C4/5), 
2.26 (s, 3H; CH3C4/5), 2.62 (C2CH3), 3.22 (s, 3H; OCH3), 3.49-3.59 (m, 
1H; CH2CH), 3.95 (dd, 2J(H,H) = 14.9 Hz, 3J(H,H) = 9.4 Hz, 2H; 
CHAHBCH), 4.04 (dd, 2J(H,H) = 14.9 Hz, 3J(H,H) = 3.3 Hz, 2H; CHAHBCH), 4.07 ppm (q, 
3J(H,H) = 7.4 Hz, 2H; CH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.34 (CH3C4/5), 
8.66 (CH3C4/5), 10.34 (C2CH3), 14.54 (CH2CH3), 16.35 (CHCH3), 40.72 (CH2CH3), 50.86 
(CH2CH), 56.46 (OCH3), 75.26 (NCH2CH), 119.91 (q, 1J(C,F) = 321.5 Hz; CF3), 124.89 (C4/5), 
126.18 (C4/5), 142.67 ppm (C2); IR (ATR):  = 1053, 1135, 1177, 1452, 1530 cm-1; MS (ES): 
m/z (%): 211.3 (100) [M+H+]; yield: 97%, brown oil. 
Procedure for the synthesis of 1H-2-isopropyl-4,5-dimethylimidazole (60): A glass 150 
mL pressure vial was filled with MeOH (50 mL) and a PTFE stirring bar. The solvent was 
allowed to cool to 0 °C and isobutyraldehyde (100 mmol, 7.21 g), diacetyl (100 mmol, 8.61 g) 
and NH4OAc (200 mmol, 15.62 g) were added. The vessel was closed immediately and 
submerged in a preheated oil bath at 120 °C for 2 h under vigorous stirring. After cooling, 
MeOH and the reaction water were removed in vacuo. The reaction mixture was dissolved in 
EtOAc (80 mL) and extracted twice with an aqueous 0.5 M HCl solution (100 mL). The 
aqueous phase was alkalinised with 50 mL of a 3.0 M NaOH and extracted three times with 
EtOAc (40 mL). The resulting organic phase was dried over MgSO4. The solvent was removed 
in vacuo and 12.26 g (89%) of a white powder was obtained. 
1H-2-Isopropyl-4,5-dimethylimidazole (60): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 
2.19 (s, 3H; CH3C4/5), 2.37 (s, 3H; CH3C4/5), 4.82 (d, 3J(H,H) = 5.4, 2H; CH2), 5.17 
(d, 3J(H,H) = 17.1 Hz, 1H; CH = CHEHZ), 5.39 (d, 3J(H,H) = 10.5 Hz, 1H; CH = 
CHEHZ), 5.96 (ddt, 3J(H,H) = 17.1 Hz, 3J(H,H) = 10.5 Hz, 3J(H,H) = 5.4 Hz, 1H; CH 
= CH2), 9.05 ppm (s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 10.76 
(CH3C4/5), 21.83 (CH(CH3)2), 28.23 (CH(CH3)2), 118.69 (C4/5), 150.94 ppm (C2); IR 
(ATR):  = 1020, 1440, 1462, 1621, 2965 cm-1; MS (ES): m/z (%): 139.3 (100) 
[M+H+]; elemental analysis calcd (%) for C8H14N2: C 69.52, H 10.21, N 20.27; found: C 69.36, 
H 10.89, N 20.28; Tm (°C): 202; yield: 89%, white flakes. 
Procedure for the synthesis of (S)-1-(2-methoxyprop-1-yl)-2-isopropyl-4,5-
dimethylimidazole ((S)-100): To a flame dried 100 mL two-necked reaction flask, provided 
with a water cooler and under nitrogen atmosphere, dry THF (40 mL) and a PTFE stirring bar 
were added. To the solvent was added 1H-2-isopropyl-4,5-dimethylimidazole (20 mmol, 2.76 
g). The mixture was stirred (and heated if needed), until all product was dissolved, after which 
the mixture was cooled to 0 °C. After careful addition of NaH (22 mmol, 0.53 g), the mixture 
Procedures and spectra 
 164  
was allowed to reflux for 15 min The sodium imidazolate solution was again cooled to 0 °C 
and (S)-2-methoxypropyl methanesulfonate (20 mmol, 3.36 g) was added dropwise. The 
mixture was again refluxed for 4h. After reaction, the mixture was cooled to room temperature 
and a 1 M NaOH solution (40 mL) was added, and allowed to stir for 15 min while cooling to 
0 °C. The mixture was extracted 3 times with a 2:1 EtOAc:Et2O mixture (40 mL). The 
combined organic phase was dried over MgSO4. The solvent was removed in vacuo and the 
mixture was dissolved in a minimum amount of boiling acetonitrile. The solution was stored at 
-18 °C for at least 4h. The precipitate was filtered off and the purity of the filtrate monitored by 
GC-FID. The side product was consecutively crystallised until the amount of starting 1H-2-
isopropyl-4,5-dimethylimidazole was sufficiently low. The solvent was removed in vacuo and 
the resulting oil was purified by short-path vacuum distillation. Hereby, the still was kept at 
75 °C sufficiently long to remove all (S)-2-methoxypropyl methanesulfonate. At 83 °C (1.0 
mbar), 2.1 g of the product was collected as a colourless oil, which was further used for the 
synthesis of ionic liquids. 
(S)-2-Isopropyl-1-(2-methoxypropyl)-4,5-dimethylimidazole ((S)-100): b.p. 83 °C (1.0 
mbar); ሾࢻሿࡰ૛૞ = 40.3 ± 0.5 (C = 0.3 in CHCl3); 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.13 (d, 3J(H,H) = 6.1 Hz, 3H; CH(OCH3)CH3), 1.26 (d, 
3J(H,H) = 7.2 Hz, 3H; CH(CH3)A(CH3)B), 1.28 (d, 3J(H,H) = 7.2 Hz, 3H; 
CH(CH3)A(CH3)B), 2.07 (s, 3H; CH3C4/5), 2.12 (s, 3H; CH3C4/5), 2-93-3.06 (m, 
1H; CH) 3.18 (s, 3H; OCH3), 3.37-3.47 (m, 1H; CH2CH), 3.63 (dd, 2J(H,H) = 
14.7 Hz, 3J(H,H) = 4.4 Hz, 1H; NCHAHB), 3.79 ppm (dd, 2J(H,H) = 14.7, 3J(H,H) = 8.0 Hz, 1H; 
NCHAHB); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 9.16 (CH3C4/5), 12.70 CH3C4/5), 17.23 
(CHCH3), 22.08 (CH(CH3)A(CH3)B), 22.24 (CH(CH3)A(CH3)B), 25.89 (CH(CH3)2), 48.81 
(CH2CH), 57.24 (OCH3), 76.78 (NCH2CH), 121.14 (C4/5), 131.38 (C4/5), 151.75 ppm (C2); IR 
(ATR):  = 1087, 1140, 1308, 1438, 2928, 2970 cm-1; MS (ES): m/z (%): 211.3 (100) [M+H+]; 
yield: 61%, colourless oil.  
(S)-2-Isopropyl-1-(2-methoxypropyl)-3,4,5-trimethylimidazolium iodide ((S)-99b): ሾࢻሿࡰ૛૞ = 
18.8 ± 0.3 (C = 0.4 in CHCl3); 1H NMR (300 MHz, CDCl3, 25 °C, TMS): 
 = 1.33 (d, 3J(H,H) = 6.1 Hz, 3H; CH(OCH3)CH3), 1.50 (d, 3J(H,H) = 7.7 
Hz, 3H; CH(CH3)A(CH3)B), 1.51 (d, 3J(H,H) = 7.2 Hz, 3H; 
CH(CH3)A(CH3)B), 2.30 (s, 6H; CH3C4/5), 3.25 (s, 3H; OCH3), 3.51-3.61 
(m, 1H; CH), 3.66-3.80 (m, 1H; CHOCH3), 3.84 (s, 3H; NCH3), 4.05 (dd, 
2J(H,H) = 15.4 Hz, 3J(H,H) = 9.9 Hz, 1H; NCHAHB), 4.33 ppm (dd, 2J(H,H) = 15.4, 3J(H,H) = 
2.2 Hz, 1H; NCHAHB); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 9.70 (CH3C4/5), 10.05 
(CH3C4/5), 16.72 (CHCH3), 19.30 (CH(CH3)A(CH3)B), 19.47 (CH(CH3)A(CH3)B), 25.35 
(CH(CH3)2), 34.37 (NCH3), 51.55 (CH2CH), 56.75 (OCH3), 75.24 (NCH2CH), 125.81 (C4/5), 
126.82 (C4/5), 148.97 ppm (C2); IR (ATR):  = 1083, 1148, 1450 1521, 1651, 2361, 2976, 3435 
cm-1; MS (ES): m/z (%): 225.3 (100) [M+H+]; yield: 98%, yellow oil.  
(S)-2-Isopropyl-1-(2-methoxypropyl)-3,4,5-trimethylimidazolium bis(trifluoromethyl-
sulfonyl)imide ((S)-99c): ሾࢻሿࡰ૛૞ = 16.0 ± 0.5 (C = 0.4 in CHCl3); 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.27 (d, 3J(H,H) = 6.1 Hz, 
3H; CH(OCH3)CH3), 1.43 (d, 3J(H,H) = 7.2 Hz, 3H; CH(CH3)A(CH3)B), 
1.46 (d, 3J(H,H) = 7.7 Hz, 3H; CH(CH3)A(CH3)B), 2.23 (s, 6H; 
CH3C4/5), 3.23 (s, 3H; OCH3), 3.45-3.55 (m, 1H; CHOCH3), 3.53-3.66 
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(m, 1H; CH), 3.74 (s, 3H; NCH3), 3.96 (dd, 2J(H,H) = 15.3 Hz, 3J(H,H) = 9.4 Hz, 1H; NCHAHB), 
4.05 ppm (dd, 2J(H,H) = 15.3, 3J(H,H) = 2.5 Hz, 1H; NCHAHB); 13C NMR (75 MHz, CDCl3, 
25 °C, TMS):  = 8.49 (CH3C4/5), 8.95 (CH3C4/5), 16.17 (CHCH3), 18.57 (CH(CH3)2), 25.39 
(CH(CH3)2), 32.80 (NCH3), 50.75 (CH2CH), 56.54 (OCH3), 75.13 (NCH2CH), 119.91 (q, 
1J(C,F) = 321.5 Hz; CF3), 125.66 (C4/5), 126.86 (C4/5), 148.96 ppm (C2); IR (ATR):  = 1053, 
1134, 1177, 1348 cm-1; MS (ES): m/z (%): 225.3 (100) [M+H+]; yield: 97%, yellow oil.  
3.7. Synthesis of N-alkylimidazolium salts with dimethyl carbonate 
3.7.1) Synthesis of N-alkylimidazolium carbonate ionic liquids 
Procedure for the synthesis of 1-ethyl-2-isopropyl-3,4,5-trimethylimidazolium hydrogen 
carbonate [C2Ci3m3im][HCO3] (47e): A flame-dried glass 15 mL pressure vial was filled with 
MeOH (5 mmol ,160 mg), dimethyl carbonate (30 mmol, 2.7 g), 1-ethyl-2-isopropyl-4,5-
dimethylimidazole (10 mmol, 1.67 g), Montmorillonite K10 (0.83 g) and a PTFE stirring bar. 
The pressure vial was flushed with nitrogen, closed and submerged in a preheated oil bath at 
170 °C. After 24h, the vial was allowed to cool and opened, the mixture was diluted in 
methanol and filtrated over a filter paper (Euro Scientific, 90 mm) on a sintered glass filter. 
The solvents were removed by rotary evaporation at room temperature. The resulting oil was 
brought into 10 mL of demineralised water and stirred at 0 °C. After 3h, the mixture was 
allowed to cool and the water and methanol were removed via lyophilisation or rotary 
evaporation. The different spectral data sets of the 1-ethyl-3,4,5-trimethylimidazolium 
carbonate salts were obtained by dissolving these crystals in different solvents. 
1-Ethyl-3,4,5-trimethylimidazolium hydrogen carbonate [C2m3im][HCO3] (44h+114): 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = (maj.):  
= 1.49 (t, 3J(H,H) = 7.2 Hz, 3H; CH2CH3), 2.23 (s, 
3H; CH3C4/5), 2.24 (s, 3H; CH3C4/5), 3.87 (s, 3H; 
NCH3), 4.19 (t, 3J(H,H) = 7.2 Hz, 2H; CH2CH3), 
10.07 ppm (s; C2H), (min.):  = 1.42 (t, 3J(H,H) = 
7.1 Hz, 3H; CH2CH3), 2.24 (s, 3H; CH3C4/5), 2.26 (s, 3H; CH3C4/5), 3.97 (s, 3H; NCH3), 4.51 
ppm (t, 3J(H,H) = 7.1 Hz, 2H; CH2CH3); 13C NMR (75 MHz, CDCl3, 25 °C, TMS): (maj.):  = 
8.29 (CH3C4/5), 8.38 (CH3C4/5), 15.31 (CH2CH3), 33.53 (NCH3), 42.22 (NCH2), 125.90 (C4/5), 
127.03 (C4/5), 136.30-136.59 (m, C2), 160.86 ppm ([HCO3]-), (min.):  = 8.52 (CH3C4/5), 8.73 
(CH3C4/5), 15.76 (CH2CH3), 33.24 (NCH3), 41.65 (CH2), 124.44 (C4/5), 125.79 (C4/5), 141.58 
(C2), 156.04 ppm (CO2); IR (ATR):  = 625, 985, 1203, 1342, 1377, 1570, 1617, 2341, 2360, 
3386 (broad) cm-1; MW (g mol-1): 200.24; yield: 52%, colourless crystals. 
1-Ethyl-2-deutero-3,4,5-trimethylimidazolium deutero carbonate [C2m3im][HCO3]-d2 
(44i): 1H NMR (300 MHz, D2O, 25 °C, CH3CN):  = 1.43 (t, 3J(H,H) = 
7.3 Hz, 3H; CH2CH3) , 2.21 (s, 3H; CH3C4/5), 2.23 (s, 3H; CH3C4/5), 
3.71 (s, 3H; NCH3), 4.08 ppm (q, 3J(H,H) = 7.3 Hz, 2H; NCH2); 13C 
NMR (75 MHz, CDCl3, 25 °C, TMS):  = 7.78 (CH3C4/5), 7.92 
(CH3C4/5), 14.65 (CH2CH3), 33.46 (NCH3), 42.41 (CH2CH3), 127.16 
(C4/5), 128.06 (C4/5), 132.92 (C2), 161.61 ppm (HCO3); 
NN Me
OD
O
O
H
NN Me
O O
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1-Ethyl-3,4,5-trimethylimidazolium methyl carbonate [C2m3im][CH3OCO2] (44e): 1H NMR 
(300 MHz, CDCl3, 25 °C, TMS):  = 1.52 (t, 3J(H,H) = 7.4 Hz, 3H; 
CH2CH3), 2.24 (s, 3H; CH3C4/5), 2.26 (s, 3H; CH3C4/5), 3.55 (s, 3H; 
CH3OCO2), 3.88 (s, 3H; NCH3), 4.20 (t, 3J(H,H) = 7.4 Hz, 2H; 
CH2CH3), 10.43 ppm (s; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, 
TMS):  = 8.23 (CH3C4/5), 15.19 (CH2CH3), 33.44 (NCH3), 42.19 
(NCH2), 52.28 (CH3O), 126.05 (C4/5), 127.11 (C4/5), 136.28 (C2), 
158.76 ppm (C=O); 
1-Ethyl-2,3,4,5-tetramethylimidazolium deutero carbonate [C2C1m3im][HCO3]-d (45f): 1H 
NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.31 (t, 3J(H,H) = 7.3 Hz, 
3H; CH2CH3) , 2.23 (s, 3H; CH3C4/5), 2.24 (s, 3H; CH3C4/5), 2.70 (s, 
3H, C2CH3), 3.71 (s, 3H; NCH3), 4.15 ppm (q, 3J(H,H) = 7.3 Hz, 2H; 
NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 8.50 (CH3C4/5), 
8.75 (CH3C4/5), 10.23 (C2CH3), 14.93 (CH2CH3), 32.15 (NCH3), 
40.55 (NCH2), 124.69 (C4/5), 126.08 (C4/5), 142.07 (C2), 160.27 ppm (HCO3); IR (ATR):  = 
740, 1372, 1626, 2928, 3390 cm-1; MW (g mol-1): 214.26; yield: 47%, transparent crystals. 
1-Ethyl-2-isopropyl-3,4,5-trimethylimidazolium deutero carbonate [C2Ci3m3im][HCO3]-d 
(47f): 1H NMR (300 MHz, CDCl3, 25 °C, TMS):  = 1.36 (t, 3J(H,H) = 
7.4 Hz, 3H; CH2CH3), 1.51 (t, 3J(H,H) = 7.1 Hz, 6H; CH(CH3)2), 2.27 
(s, 6H; CH3C4/5), 3.58-3.72 (m, 1H; CH(CH3)2), 3.83 (s, 3H; NCH3), 
4.24 ppm (q, 3J(H,H) = 7.4 Hz, 2H; CH2CH3); 13C NMR (75 MHz, 
CDCl3, 25 °C, TMS):  = 8.69 (CH3C4/5), 8.86 (CH3C4/5), 15.73 
(CH2CH3), 19.30 (CH(CH3)2), 25.16 (CH(CH3)2), 32.98 (NCH3), 40.87 (NCH2), 125.15 (C4/5), 
127.15 (C4/5), 147.43 (C2), 160.41 ppm (HCO3); IR (ATR):  = 1334, 1385, 1522, 1649, 3388 
cm-1; MW (g mol-1): 242.32; yield: 89%, brown oil. 
3.7.2) Carbonate mediated metathesis of N-alkylimidazolium ionic liquids 
Procedure for the synthesis of ammonium dicyanamide (121): A glass column was 
packed with 2.74 g of Amberlite IR120 in distilled water (column height: 3.5 cm). The resin 
was slowly percolated with a 1 M NH4Cl solution (200 mL) until the effluent stream pH, 
monitored by pH indicator paper, had raised to that of the influent. Subsequently, the column 
was rinsed with aq. dest. (75 mL) until the effluent samples did no longer show precipitation 
upon addition of AgNO3. Sodium dicyanamide (2 mmol, 178 mg) was dissolved in aq. dest. 
(40 mL) and MeOH (20 mL), and this solution was percolated very slowly over the column. 
The percolated solution and the rinsing water (aq. dest., 20 mL) were subjected to 
lyophilisation to yield the ammonium dicyanamide. Elemental analysis calcd (%) for C2H4N4: C 
28.57, H 4.80, N 66.64; found: C 27.83, H 4.49, N 64.82; yield: 95%; white powder. 
Procedure for the ammonium dicyanamide mediated metathesis towards 1-ethyl-3,4,5-
trimethylimidazolium dicyanamide [C2m3im][N(CN)2] (44c): To a 50 mL flask charged with 
the crystalline [C2m3im][HCO3]-d2 (10 mmol, 2.02 g) were added demineralised water (25 mL) 
and a PTFE stirring bar. Then ammonium dicyanamide (10.5 mmol, 0.88g) was added to the 
solution. The flask was equipped with a cooler with cotton plug and the mixture was heated to 
50 °C for 16h. After reaction, the water was removed by rotary evaporation. The resulting oil 
Experimental Section 
167 
was dissolved in dry CH2Cl2 and cooled to -18 °C, after which a precipitate was filtrated off. 
Dichloromethane was removed in vacuo. The ionic liquid was dried for 8 h at 80 °C under 
reduced pressure (0.5 mbar). A white solid was obtained in quantitative yield. 
Procedure for the synthesis of 1-ethyl-3,4,5-trimethylimidazolium chloride [C2m3im][Cl] 
(44k): To a flame-dried glass 15 mL pressure vial, charged with the 1-ethyl-4,5-
dimethylimidazolium hydrochloride (10 mmol, 1.75 g) crystals, were added MeOH (5 
mmol ,160 mg), dimethyl carbonate (30 mmol, 2.7 g) and a PTFE stirring bar. The pressure 
vial was flushed with nitrogen, closed and submerged in a preheated oil bath at 170 °C. After 
3h, the vial was allowed to cool to room temperature. The volatiles were removed by rotary 
evaporation and an opaque powder was obtained 
1-Ethyl-3,4,5-trimethylimidazolium chloride [C2m3im][Cl] (44k): 1H NMR (300 MHz, CDCl3, 
25 °C, TMS):  = 1.55 (t, J3(H,H) = 7.3 Hz, 3H; CH2CH3) , 2.26 (s, 3H; 
CH3C4/5), 2.27 (s, 3H; CH3C4/5), 3.95 (s, 3H; NCH3), 4.24 (q, J3(H,H) = 7.3 
Hz, 2H; NCH2) 10.74 ppm (s, 1H; C2H); 13C NMR (75 MHz, CDCl3, 25 °C, 
TMS):  = 8.47 (CH3C4/5), 8.55 (CH3C4/5), 15.42 (CH2CH3), 33.85 (NCH3), 
42.45 (NCH2), 125.98 (C4/5), 127.08 (C4/5), 136.27 ppm (C2); IR (ATR):  = 
1200, 1252, 1457, 1572, 1637, 2342, 2362, 2953, 3390 cm-1; MW (g mol-1): 174.67; 
elemental analysis calcd (%) for C8H15ClN2: C 55.01, H 8.66, N 16.04; found: C 54.32, H 
8.75, N 15.79; yield: 81%, opaque powder. 
1-Ethyl-2,3,4,5-tetramethylimidazolium chloride [C2C1m3im][Cl] (45i): 1H NMR (300 MHz, 
CDCl3, 25 °C, TMS):  = 1.40 (t, 3J(H,H) = 7.4 Hz, 3H; CH2CH3), 2.26 (s, 
6H; CH3C4/5), 2.94 (s, 3H; C2CH3), 3.87 (s, 3H; NCH3), 4.23 ppm (q, 
J3(H,H) = 7.4 Hz, 2H; NCH2); 13C NMR (75 MHz, CDCl3, 25 °C, TMS):  = 
8.70 (CH3C4/5), 8.99 (CH3C4/5), 11.18 (C2CH3), 15.12 (CH2CH3), 32.89 
(NCH2), 41.07 (NCH3), 124.69 (C4/5), 126.16 (C4/5), 142.45 ppm (C2); IR 
(ATR):  = 1091, 1346, 1446, 1649, 2978, 3393 cm-1; MW (g mol-1): 188.70; yield: 99%, white 
powder. 
3.8. Base stability testing 
Procedure for the synthesis of diphenylmethanol (55) in the IL [C6Ci3m3im][NTf2]: A 
flame-dried 10 mL flask, equipped with septum and nitrogen flow, was charged with 
intensively dried ionic liquid [C6Ci3m3im][NTf2] (4.8 mmol, 2.50 g). The ionic liquid was cooled 
to -10 °C in a NaCl/ice bath and bromobenzene (2 mmol, 314 mg) was added with a syringe. 
After cooling and controlled stirring for 5 min, a homogenous mixture was obtained, to which a 
2.3 M nBuli solution (2.1 mmol, 0.91 mL) was added dropwise over 15 min, while maintaining a 
constant temperature of -10 °C. After controlled stirring for 10 min, benzaldehyde (2 mmol, 
212 mg) was added dropwise over 5 min with a syringe. The mixture was stirred for 60 min 
and allowed to obtain room temperature. After reaction, 1 mL of demineralised water was 
added and the organic fraction was extracted 2 times with 5 mL of dichloromethane. The 
organic solution was extracted 2 times with 10 mL of diethyl ether, the extracts were combined 
and GC samples were prepared from the ethereal solution. The presence of diphenylmethanol 
was demonstrated by comparison of the latter with GC analysis of pure commercial 
diphenylmethanol. 
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Procedure for the synthesis of 2-phenylpropan-2-ol (69) in the IL [C201Ci3m3im][NTf2]: A 
flame-dried 10 mL flask, equipped with a water cooler and nitrogen flow, was charged with 
intensively dried ionic liquid [C201Ci3m3im][NTf2] (4.9 mmol, 2.40 g) and 2 mL of dry THF. To 
the mixture was added Mg (2 mmol, 50 mg) and ethyl bromide (2 mmol, 224 mg). The mixture 
was heated in an oil bath at 100 °C, after 30 minutes when all magnesium was reacted, the 
mixture was allowed to cool to room temperature. The solvent was evaporated by rotary 
evaporation, after evaporation, the rotavapor was filled with nitrogen, to remove the flask and 
provide it with a septum. The flask was cooled to 0 °C, and very slowly acetophenone (2 mmol, 
247 mg) was added via a syringe under controlled stirring. The reaction was stirred 2h further 
at room temperature. After reaction CH2Cl2 (20 mL) and distilled water (20 mL) were added. 
The aqueous phase was extracted twice more with CH2Cl2 (10 mL). The combined organic 
phases were evaporated and extracted twice with cold Et2O (10 mL). The combined ethereal 
fractions were, analysed by GC-FID and evaporated. The ionic liquid phase was intensively 
dried at 100 °C for 4h under reduced pressure, yielding 91% of the pure IL. 
4. Mineral composition of dicyanamide ionic liquids 
Table 31: Complete mineral composition (in ppm) as analysed by ICP of 4 different 1-ethyl-(2-alkyl)-3,4,5-
trimethylimidazolium dicyanamide salts. The alkylgroup/proton on C2 is given under R2. 
Sample R2 sample mass (g)
total mass  
(g) Ca Cu Fe K 
KAS1 Et 0.5188 20.3346 1.37 0.12 0.13 0.26 
KAS2 Me 0.449 20.0089 0.041 0.12 0.154 0.0061 
KAS3 H 1.0027 20.0124 2.6 0.30 0.115 0.17 
KAS4 iPr 0.9992 21.7718 1.47 0.12 0.12 0.1 
 
Sample Mg Na Ni P S Si 
KAS1 0.2 41.61 0.079 0.996 3.14 0.974 
KAS2 0.064 0.28 0.072 0.282 0.8 0.81 
KAS3 0.24 8.16 0.077 1.08 19.3 0.24 
KAS4 0.2 0.773 0.074 0.86 1.77 0.118 
 
In Table 31 the content of different minerals is presented in the dicyanamide salts 44-47c, 
prepared via the intermediate methanesulfonate salts 44-47d as well as the used sample 
mass and the total mass of the aqueous solution (= sample + water). 
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5. Continuous flow experiments 
5.1. Calibration experiments 
5.1.1)  Ethanol solutions: LC-UV 
 
Figure 51: Calibration curve of acetophenone solutions in ethanol on LC-UV at different wavelengths. Calibration 
of AF is performed by recording three LC-UV measurements of different dilution samples of one stock solution. 
The mean of these three values is plotted. 
In experiment 2-1 the same calibration curves are used and extrapolated to up to 80 mM. This 
is also applied for the PEA concentration in experiment 2-2. The amount of EtPh (EB) was 
calculated by assuming only EB and PEA are present when appearing together in the effluent 
mixture. The experiment at 20 mM is analyzed at 256nm while 60 mM is analyzed at 214nm. 
5.1.2)  Hexane solutions: GC-FID 
 
Figure 52: Calibration curve of acetophenone (AF) 
solutions in hexanes on GC-FID. Calibration of AF 
is performed by recording three GC-FID 
measurements of two different samples of one 
stock solution. The mean of these six values is 
plotted. 
 
Figure 53: Calibration curve of ethyl lactate ( ) and 
ethyl pyruvate ( ) solutions in hexanes on GC-FID. 
Calibration is performed by recording one GC-FID 
measurement of two different samples of one stock 
solution. The mean of these two values is plotted. 
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In experiment 1-3, the products (AF, PEA and EB) were calibrated by assuming the highest 
possible concentration; the side-products formed over 80 °C were not taken into account. 
5.2. Long term hydrogenation experiments with the CSRN CatCart 
 
Figure 54: Plot of effluent concentration of PEA ( ) and AF ( ) during experiments 1-1 (red) and 1-7 (blue) 
demonstrating the lower conversion at higher pgas and quasi steady conversion over time. 
 
Figure 55: Plot of effluent concentration of PEA ( ) and AF ( ) during experiments 1-2 (blue) and 1-3 (red), 
indicating steady-state formation and anomaly at t=30 and t =300 min respectively. 
5.3. Hydrogenation with the TNRN CatCart 
 
Figure 56: Effluent concentrations of PEA ( ) and AF ( ) during experiment 2-1 for different psys and pump 
speeds, performed at 50 °C, Cin: 120 mM.
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VII) SUMMARY 
Peralkylated imidazoles were easily obtained via the optimised Debus-Radziszewski reaction 
procedure. This reaction allows the condensation of a myriad of aldehydes and primary 
amines with an ,-diketone and an ammonia source, although the yields were only 
moderate. The a priori synthesis of the imine (iii) allowed an increased selectivity towards the 
N-substituted imidazole (v) vs. the 1H-imidazole (vi). The type of aldehyde only influenced the 
selectivity and yield to some extent. More sterically hindered amines decreased the selectivity 
while N-ethylimidazoles are produced with a 100% selectivity. 
 
Thus, the lower selectivity was attributed to a higher transimination upon the addition of the 
ammonia source. For more sterically hindered amines, the selectivity could be further 
increased by slowly adding the ammonia and diketone source. Alternatively, the diketone and 
ammonia could be mixed prior to the addition. In this way, the preformed imine could be 
reacted with this mixture. The success of the reaction with the two mixtures in the formation of 
imidazoles was shown in a continuous flow setup.  
 
The use of the Cytos CPC continuous flow system did not allow pressurised reactions, 
therefore n-pentanol was used as the solvent. This solvent was found to be recyclable by 
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distillation without further processing. While the low boiling point of ethyl amine did not allow 
its application in the micro reactor system, hexyl amine could be used to produce N-
hexylimidazoles at a production rate of 3.5 to 4 grams h-1 with a yield comparable to the 
maximum yields obtained in batch. Hereby it was important to keep the concentration at 0.5 M, 
since higher concentrations induced the formation of the 1H-imidazole. 
The choice of amine allowed different substitution patterns to be easily introduced on the 
imidazole. Thus, N-alkyl, -alkenyl and -alkoxyl functionalisation of the imidazole was efficiently 
obtained. The different alkyl- and alkenylimidazoles could be obtained as their hydrochloride 
salts, which allowed to purify the imidazoles extensively via recrystallisation or filtration. 
 
Quaternisation with methyl iodide or methyl methanesulfonate, allowed the imidazoles to be 
quantitatively transformed into the corresponding N-methylimidazolium ionic liquids (vii, viii) 
without the formation of side products. The excess of quaternisation agent could be 
evaporated or extracted. Although higher temperatures were applied when using methyl 
methanesulfonate, the colouration was more intense during quaternisation with methyl iodide, 
indicating that an oxidation reaction is responsible for the formation of intensively coloured 
contaminants. The iodide ionic liquids were often solid, which allowed for recrystallisation prior 
to metathesis, while most of the methanesulfonate ionic liquids were liquid. Metathesis could 
be obtained via standard literature procedures, although the methanesulfonate ionic liquids 
allowed the use of sodium dicyanamide. The purity of the thus resulting ionic liquids was very 
satisfying, indicating no residual sodium. This method reduced both the cost and 
environmental impact of the dicyanamide ionic liquid synthesis. 
An alternative way to reduce the environmental impact comprises the use of dimethyl 
carbonate (DMC) as the quaternisation agent. This environmentally benign quaternisation 
agent allowed the formation of different methyl carbonates (xi) in good yields. However, high 
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temperatures were needed, leading to an intensive colouration. The metathesis towards the 
[NTf2]- ionic liquids (ix) was successfully performed. For other Brønsted acids, the strong 
interaction of acid with the ionic liquids and the unknown stoichiometry of the extracted 
carbonate ionic liquids, containing a mixture of anions, led to incomplete removal of the 
excess Brønsted acids. 
 
The 1-ethyl-2H-imidazole was found to have a crystalline hydrogen carbonate salt, which 
could be purified by recrystallisation. In deuterated solvents (for 1H NMR analysis), the high 
basicity of the anion induced a complete deuteration of the anion and the C2 proton (xii). This 
hydrogen carbonate salt showed formation of the carboxylate (xiii) upon dissolution in some 
solvents. In the C2 substituted salts, only the 2-methyl moiety was deuterated (xiv, xv), albeit 
slower than the C2 proton. This confirmed the high chemical stability of 2-isopropyl substituted 
imidazoles and invites for the application of 2-isopropylimidazolium carbonate salts as very 
alkaline ionic liquids. 
 
Alternative to the previous quaternisation agents (MeI, MeOMs and DMC), functionalised 
quaternisation agents could introduce functionalities in the ionic liquids. Thus, an allyl 
functionalisation could also be established via quaternisation with allyl bromide or allyl 
methanesulfonate. 
Together with the introduction of functionalities in the imidazole, the functionalisation during 
quaternisation allowed for the variation in viscosities and melting points of 2-
isopropylimidazolium ionic liquids. Methoxyethyl substitution decreased the viscosity but the 
resulting ionic liquids readily formed crystals. Introduction of an N-allyl group hindered 
solidification but increased the viscosity of the ionic liquids. When the symmetry increased, the 
N-allyl functionalised imidazolium salts did solidify. Combination of the N,N’-diallylimidazolium 
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analogue with the [Ntf2]- anion resulted in a melting point of 63 °C (xvi), while the 
methoxyethyl cation formed a room temperature ionic liquid (Tm: 22 °C) (xvii). 
 
The incorporation of the amine substitution into the imidazoles also allowed for the 
incorporation of naturally occurring amines, such as amino acids. Modification of the alanine 
derived imidazole ((rac)-xviii) towards the alkoxyl derivative ((rac)-xix) allowed for (i) the 
combination of the previously described alkoxyl moieties with an asymmetric centre and (ii) 
the preparation of ionic liquids with high chemical stability. Unfortunately, the chiral centre was 
completely racemised and it was found that branching in the -position significantly decreased 
the selectivity during the imidazole synthesis. 
  
Alternatively, the methanesulfonate ester of a chiral primary alcohol could be applied for 
quaternisation. This allows to exploit many naturally occurring or semi-synthetic alcohols as 
quaternisation agents. These compounds introduce a renewable moiety, and when chiral pool 
molecules are employed, chiral centres are introduced without the need for asymmetric 
synthesis. In contrast to the linear synthesis applied in the amino acid derived imidazoles, the 
convergent synthesis using a lactate derived quaternisation agent ((S)-xxiii), utilised the 
imidazole core more efficiently, while the chiral centre was not racemised. 
The increased bulk of the C2 substitution on the imidazole decreased the efficiency of 
quaternisation with the lactate derived agent, hence only 2H- and 2-methyl substituted 
imidazoles could be quaternised, with the formation of (S)-xxiv and (S)-xxv, respectively. The 
formation of the 2-isopropyl substituted imidazolium salt (S)-xxviii could be established by the 
synthesis of the chiral imidazole xxvii.  
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To obtain racemic mixtures of the lactate derived quaternisation agent and the derived ionic 
liquids, the naturally occurring ethyl pyruvate could be hydrogenated by a continuous flow 
process over a commercial Raney Nickel catalyst (TNRN). In this green method, metal 
hydrides were substituted for hydrogen gas and the production rate was about ± 0.4 g h-1 of 
ethyl D/L-lactate. 
 
Apart from the rheological properties, the thermal, chemical and electrochemical stabilities of 
the newly synthesised ionic liquids were assessed. The thermal stability was found to be 
dependent on the presence of a C2 proton. Alkyl substitution increased the stability, while the 
nature of the substituent did not further influence the degradation temperatures. On the 
contrary, the electrochemical stability was found to increase further upon increment of the 2-
alkyl substituent. The chemical stability was evaluated by adding different strong bases or 
alkaline solutions to the ionic liquids. Thus, it was found that in a 0.1 M KOH solution in 
D2O/CD3OD, the C2 proton of [C6m3im][NTf2] was immediately deuterated, while after 12h, still 
no deuteration of the [C6Ci3m3im][NTf2] salt was observed. The isopropyl substituted ionic 
liquid was also stable enough to withstand 24 h in a refluxing 1.0 M KOH solution. 
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The base stability could be successfully exploited by performing lithiation reactions in the 
[C6Ci3m3im][NTf2] ionic liquid. The 1-alkoxyl-2-isopropyl substituted ionic liquids 
([C201C1Ci3m2im][NTf2] and [C20AC1Ci3m2im][NTf2]) were successfully applied in the addition of 
ethylmagnesiumbromide (xxxii) to acetophenone. Unfortunately, the Grignard reagent itself 
could not be synthesised in the ionic liquid. 
 
Different analogues were evaluated on their biodegradability. They were all found to be 
neither readily nor inherently biodegradable. It is to say, the compounds are biodegraded very 
slowly, but only in the presence of other carbon sources. The 1-hexyl-2H-4,5-
dimethylimidazolium iodide showed the highest biodegradation and a relatively high 
adsorption on activated sludge. Overall, the increased lipophilicity was proposed to be the 
main factor determining the biodegradation of ionic liquids. 
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VIII) SAMENVATTING 
Volledig gesubstitueerde imidazolen werden efficiënt gesynthetiseerd via de geoptimaliseerde 
Debus-Radziszewski reactie. Tijdens deze condensatiereactie kan een waaier aan aldehyden 
en primaire aminen gereageerd worden met een ,-diketon en ammoniak, hoewel de 
opbrengsten slechts matig waren. Door in een eerste stap het imine (iii) te synthetiseren, kon 
de selectiviteit van het N-gesubstitueerde imidazool (v) t.o.v. het 1H-imidazool (vi) verhoogd 
worden. De keuze van het aldehyde had slechts een geringe invloed op de selectiviteit en het 
rendement. De selectiviteit daalde echter bij het aanwenden van sterisch gehinderde aminen, 
terwijl N-ethylimidazolen met een selectiviteit van 100% konden worden gesynthetiseerd. 
 
Dit leidde tot de veronderstelling dat de lage selectiviteit te wijten is aan een transiminering die 
aan belang wint naarmate het amine meer sterisch gehinderd is. De selectiviteit kon voor 
deze aminen verhoogd worden door ammoniak en het diketon traag toe te voegen. Deze twee 
reagentia konden ook worden gemengd alvorens toe te voegen. Dit werd succesvol toegepast 
in de continue imidazoolsynthese in de Cytos CPC flow reactor. 
 
Aangezien het gebruik van de Cytos CPC niet toelaat reacties onder verhoogde druk uit te 
voeren, werd n-pentanol als solvent gebruikt. Deze keuze liet bovendien toe om het solvent 
na reactie te recycleren door middel van destillatie. Verdere behandeling van het solvent was 
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niet nodig voor hergebruik. Wegens het lage kookpunt van ethylamine was de synthese van 
N-ethylimidazolen niet mogelijk, terwijl hexylamine toeliet N-hexylimidazolen te synthetiseren 
met een productiesnelheid van 3.5 tot 4 gram h-1. Hierbij was de opbrengst slechts weinig 
lager dan in de batchreacties. Het was wel belangrijk de concentratie aan reagentia te 
beperken tot 0.5 M, aangezien hogere concentraties aanleiding gaven tot de vorming van het 
1H-imidazool. 
De keuze van het amine liet toe verschillende substituenten te introduceren op de imidazolen. 
Op die manier konden N-alkyl, N-alkenyl en N-alkoxylsubstituenten zeer efficiënt worden 
ingevoerd. De verschillende alkyl-, en alkenylimidazolen konden worden omgezet in hun 
hydrochloridezouten. Deze vaste zouten konden worden omgekristalliseerd of gefiltreerd, wat 
toeliet een extra opzuivering uit te voeren.  
 
Door te alkyleren met methyljodide of methylmethaansulfonaat, kon een volledige omzetting in 
de N-methylimidazolium ionische vloeistoffen (vii, viii) bekomen worden, zonder de vorming 
van nevenproducten. De overmaat aan alkyleringsreagentia kon worden afgedampt of 
geëxtraheerd. Hoewel tijdens de reactie met methylmethaansulfonaat hogere temperaturen 
werden aangewend, was de verkleuring van het eindproduct groter na reactie met 
methyljodide. Dit toonde aan dat een oxidatiereactie aan de basis ligt van de vorming van de 
intens gekleurde contaminanten. De jodidezouten waren vaak vast of kristallijn, wat een extra 
omkristallisatie toeliet alvorens de anionuitwisseling uit te voeren. De meeste 
methaansulfonaatzouten waren vloeibaar. De anionuitwisseling kon worden uitgevoerd via 
standaard procedures, beschreven in de literatuur. Daarnaast was het mogelijk een 
anionuitwisseling van de methaansulfonaatzouten uit te voeren met behulp van 
natriumdicyanamide. De zeer lage natriumconcentratie in het eindproduct toonde aan dat dit 
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een zeer efficiënte methode is, die toelaat zowel de economische als de ecologische impact 
van de standaard zilver gemedieerde procedure te omzeilen. 
Een alternatieve manier om de ecologische impact van de synthese van ionische vloeistoffen 
te verlagen is het gebruik van dimethylcarbonaat als alkyleringsreagens. Na toepassen van dit 
milieuvriendelijke reagens werden imidazoliummethylcarbonaat zouten (xi) in goede 
rendementen bekomen. De reactie vereist echter hoge temperaturen, waardoor de verkleuring 
van de ionische vloeistoffen intens was. Het carbonaat anion kon succesvol worden omgezet 
in het [NTf2]- anion, waardoor efficiënt en snel de hydrofobe [NTf2]- ionische vloeistoffen (ix) 
werden bekomen. Andere Brønstedzuren leidden tot een residuele hoeveelheid zuur in het 
eindproduct wegens de grote interactie tussen ionische vloeistof en zuur en de moeilijke 
bepaling van de hoeveelheid geëxtraheerd carbonaatzout. 
 
Het 1-ethyl-2H-imidazolium waterstofcarbonaatzout werd verkregen als een kristallijn product. 
Dit liet toe het product op te zuiveren via omkristallisatie. Het erg basische anion leidde in 
gedeutereerde solventen (voor 1H NMR analyse) tot een complete waterstof/deuterium 
uitwisseling op het anion en op de C2 positie, maar dit werd niet waargenomen op de andere 
posities (xii). In bepaalde solventen werd dit waterstofcarbonaatzout omgezet in het 
carboxylaat (xiii). Onder de 2-alkylimidazolium kationen werd waterstof/deuterium uitwisseling 
alleen waargenomen op de 2-methylgroep van het corresponderende analoog (xiv, xv). Deze 
uitwisseling verliep trager dan de uitwisseling van het C2 proton. Deze observaties 
bevestigden de chemische stabiliteit van de 2-isopropyl gesubstitueerde imidazolen en 
nodigen uit tot het toepassen van deze erg basische ionische vloeistoffen. 
 
Naast het gebruik van de eerder vermelde alkyleringsreagentia (methyljodide, methyl 
methaansulfonaat en dimethylcarbonaat), kunnen gefunctionaliseerde alkyleringsreagentia 
functionele groepen introduceren in de ionische vloeistoffen tijdens de alkyleringsreactie. Op 
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deze manier kon een allylgroep worden geïntroduceerd door gebruik te maken van 
allylbromide of allylmethaansulfonaat. 
Gecombineerd met het makkelijk te modificeren substitutiepatroon van de neutrale 
imidazolen, laat het invoeren van functionele groepen tijdens de alkyleringsstap toe om te 
variëren in de viscositeiten en smeltpunten van de 2-isopropylimidazolium ionische 
vloeistoffen. Het invoeren van een methoxyethylgroep leidde tot een verlaging van de 
viscositeit, maar de verkregen zouten waren vaak kristallijn. Het invoeren van een N-allyl 
functionaliteit verhinderde de kristallisatie, maar verhoogde hierbij de viscositeit. De N-allyl 
gesubstitueerde zouten vormden toch kristallen wanneer het kation meer symmetrisch is. Zo 
resulteerde bijvoorbeeld het N,N’-diallylderivaat, gecombineerd met het [NTf2]- anion in de 
vorming van een zout met een smeltpunt van 63 °C (xvi). Het methoxyethyl analoog vormde 
op die manier een ionische vloeistof bij omgevingstemperatuur (Tm: 22 °C) (xvii). 
 
Het rechtstreekse invoeren van de aminesubstituenten op de imidazooleenheid liet toe 
natuurlijk voorkomende aminen, zoals bijvoorbeeld aminozuren, te gebruiken. De modificatie 
van het imidazool gebaseerd op alanine ((rac)-xviii) tot het alkoxylderivaat ((rac)-xix) maakte 
het mogelijk om (i) de hiervoor beschreven alkoxylderivaten te combineren met een 
asymmetrisch centrum en (ii) ionische vloeistoffen met hoge chemische stabiliteit te 
synthetiseren. Het chirale centrum werd tijdens de reactie volledig geracemiseerd en de 
sterische hindering, veroorzaakt door de substitutie in de -positie, was nadelig voor de 
selectiviteit van de imidazool synthese.  
 
Een andere mogelijkheid bestaat erin het methaansulfonaatester van een natuurlijk 
voorkomend alcohol te gebruiken. Op die manier kan een waaier aan natuurlijk voorkomende 
of semi-synthetische alcoholen aangewend worden. Hierdoor wordt ook een hernieuwbare 
fractie in de molecule ingebouwd, maar indien verbindingen uit de ‘chiral pool’ worden 
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aangewend, kan ook een asymmetrisch centrum worden ingevoerd, zonder daarbij gebruik te 
maken van asymmetrische synthese. In tegenstelling tot de lineaire synthese die toegepast 
werd om de aminozuur gebaseerde analoga te synthetiseren, werd hierbij een convergente 
syntheseweg gevolgd, waarbij het imidazool als bouwsteen efficiënter werd benut en 
bovendien geen racemisatie optrad van het asymmetrisch centrum. 
 
De efficiëntie waarmee dit semi-synthetisch alkyleringsreagens reageerde met imidazolen 
was sterk afhankelijk van de omvang van de 2-alkylsubstituent. Zo konden alleen de 2H- en 
de 2-methyl derivaten worden gealkyleerd met de respectievelijke vorming van ionische 
vloeistoffen (S)-xxiv en (S)-xxv. De synthese van de 2-isopropyl gesubstitueerde imidazolium 
ionische vloeistof (S)-xxviii kon bewerkstelligd worden via de synthese van het chirale 
imidazool xxvii.  
 
Om een racemisch mengsel te bekomen van het lactaatgebaseerde alkyleringreagens en de 
daarvan afgeleide ionische vloeistoffen, volstond het om het natuurlijk voorkomend 
ethylpyruvaat (xxix) te reduceren in een continue reactor over een commercieel beschikbare 
Raney Nickel (TSRN) katalysator. Deze groene alternatieve methode maakte het mogelijk 
metaal hydrides te vervangen door waterstofgas en D/L-ethyllactaat (xxx) te synthetiseren aan 
een snelheid van ± 0.4 g h-1. 
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Behalve de invloed op de viscositeit en het smeltpunt werden ook de thermische, chemische 
en elektrochemische stabiliteit van deze innovatieve ionische vloeistoffen onderzocht. De 
thermische stabiliteit bleek in sterke mate afhankelijk te zijn van de aanwezigheid van een C2 
proton. Na substitutie van dit proton werden hogere decompositietemperaturen bekomen. De 
aard van de substituent op de C2 positie had weinig of geen invloed op de thermische 
stabiliteit. Daarentegen leek de elektrochemische stabiliteit wel onderhevig te zijn aan de 
variatie in de C2 substituent. Zo werd een grotere elektrochemische stabiliteit verkregen 
naarmate de C2 substituent in grote toenam. 
De chemische stabiliteit werd geëvalueerd door verschillende ionische vloeistoffen toe te 
voegen aan basische oplossingen of toe te passen in reacties met sterke basen. In een 0.1 M 
KOH oplossing in D2O/CD3OD werd het C2 proton van [C6m3im][NTf2] onmiddellijk 
uitgewisseld met deuterium, terwijl na 12 uur nog steeds geen deuteriumuitwisseling kon 
worden waargenomen bij de [C6Ci3m3im][NTf2] ionische vloeistof. Bij deze 2-isopropyl 
gesubstitueerde ionische vloeistof kon geen verandering worden waargenomen na 24 uur 
koken in een 1.0 M KOH oplossing. Deze base stabiliteit kon succesvol toegepast worden 
door lithieringsreacties te laten plaatsvinden in de [C6Ci3m3im][NTf2] ionische vloeistof. De 1-
alkoxyl-2-isopropyl gesubstitueerde analogen ([C201C1Ci3m2im][NTf2] en 
[C20AC1Ci3m2im][NTf2]) werden succesvol gebruikt in de additiereactie van 
ethylmagnesiumbromide (xxxii) met acetofenon. Grignardreagentia konden echter niet 
worden gesynthetiseerd in de ionische vloeistoffen. 
 
De biodegradeerbaarheid van dit type volledig gesubstitueerde imidazolium ionische 
vloeistoffen werd geanalyseerd aan de hand van enkele derivaten. De derivaten bleken 
nauwelijks biodegradeerbaar te zijn, en dan nog enkel in aanwezigheid van een andere 
koolstofbron. Het 1-hexyl-2H-4,5-dimethylimidazolium iodidezout vertoonde de grootste 
biodegradeerbaarheid en absorptie in actief slib. In het algemeen kon gesteld worden dat de 
biodegradeerbaarheid beter is voor meer hydrofobe verbindingen. 
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